Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,-0.6057325216990405,-1.8756219976147652,0.0,0.43415121863270556,0.3,12/20,25.73%,ANAPC2;CDC16;ANAPC11;CDC26;PLK1;ANAPC5;ANAPC10;UBE2E1;UBE2C;ANAPC4;CDK1;ANAPC7
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.57423375491734,-1.7835895989969222,0.0,0.6216256084968284,0.63,11/21,25.73%,ANAPC2;CDC16;ANAPC11;CDC26;BUB3;ANAPC5;ANAPC10;UBE2E1;UBE2C;ANAPC4;ANAPC7
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.5576682928424839,-1.7800125576815227,0.0,0.45388536493419224,0.66,10/20,25.73%,ANAPC2;CDC16;ANAPC11;CDC26;ANAPC5;ANAPC10;UBE2E1;UBE2C;ANAPC4;ANAPC7
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,-0.6001436437520595,-1.7691038203942244,0.0,0.39221615774204655,0.67,11/21,19.14%,MAML2;FOXO1;GATD3;EP300;MAML3;MAMLD1;KAT2B;AKT2;AKT3;KAT2A;AKT1
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,-0.5489448729621541,-1.764366507513246,0.023529411764705882,0.3236399993443805,0.7,11/23,22.46%,LPIN1;PCTP;ABHD3;STARD7;ACHE;SLC44A4;CSNK2A2;CHKB;CHPT1;MFSD2A;SH2D3C
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,-0.6896671911053477,-1.7240273636334738,0.0,0.4571743893177733,0.84,8/15,12.58%,MTHFD1;SLC46A1;MTHFD1L;FPGS;SLC25A32;MTHFR;SLC19A1;DHFR
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,-0.6283819061305331,-1.7043881080867327,0.0,0.48489616626509974,0.89,7/16,16.54%,PIKFYVE;MTM1;PIK3R4;MTMR12;MTMR4;MTMR2;VAC14
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.5753863724017609,-1.6956009775136132,0.012345679012345678,0.46991935880415003,0.93,6/19,7.75%,PLXNA4;SMAD2;ABCA6;FOXO1;SIRT3;SIN3A
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.5238921909993327,-1.6898791009690668,0.010638297872340425,0.44401829178344887,0.95,10/26,18.72%,NEK2;ANAPC2;CDC16;ANAPC11;CDC26;BUB3;ANAPC5;ANAPC10;UBE2E1;UBE2C
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.5691836795898562,-1.6618838423477034,0.025,0.5328219501401387,0.98,9/18,22.29%,MAML2;ACTA2;GATD3;EP300;MAML3;MAMLD1;KAT2B;KAT2A;HEY1
prerank,KEGG_2021_Human__Lysine degradation,-0.4514330922381065,-1.6536959481609115,0.0,0.5256458969395981,0.98,16/58,17.54%,KMT5B;ALDH2;DOT1L;ACAT1;PLOD3;KMT2B;PLOD1;EZH2;AASS;DLST;ALDH1B1;KMT2D;PRDM7;CAMKMT;SETDB2;HADH
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,-0.524899679361561,-1.6404809282416397,0.0,0.563245425688264,0.99,15/27,28.68%,CREB1;MAML2;JAG1;GATD3;EP300;MAML3;MAMLD1;CNTN1;PSEN1;PSENEN;NCSTN;ADAM10;GZMB;NEURL1;RPS27A
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,-0.5203654218408853,-1.6393582799735567,0.0,0.5259908994973164,0.99,9/34,7.47%,B4GALT2;B3GLCT;PLOD3;RFNG;GALNT14;C1GALT1;LFNG;POGLUT1;POFUT2
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,-0.4863914891504987,-1.6123807437146798,0.011111111111111112,0.6477028732523643,1.0,18/40,22.29%,MAML2;JAG1;PBX1;GATD3;EP300;MAML3;MAMLD1;KAT2B;PSEN1;TACC3;STAT1;PSENEN;IKZF1;NCSTN;KAT2A;ADAM10;YBX1;HEY1
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,-0.49185471458242086,-1.6090653352759137,0.022988505747126436,0.6255724377571258,1.0,12/25,26.97%,KIF4A;RPS6KA4;AP2M1;SHTN1;DNM1;MSN;RPS6KA1;L1CAM;CLTC;RPS6KA5;RPS6KA3;MAPK1
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,0.37763847967003766,1.6074490358107933,0.1111111111111111,1.0,0.73,6/21,10.16%,TMOD2;MYL4;TMOD1;MYBPC3;TNNT2;TMOD4
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.5206991411847033,-1.5933941206848936,0.011363636363636364,0.6968620412712462,1.0,10/20,25.73%,ANAPC2;CDC16;ANAPC11;CDC26;ANAPC5;ANAPC10;UBE2E1;UBE2C;ANAPC4;ANAPC7
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,-0.40704800108073447,-1.5860612809238483,0.0,0.711009682921209,1.0,56/133,29.92%,KLHL9;ANAPC2;CDC16;ANAPC11;NEDD4;SMURF1;BIRC3;ELOC;UBE2W;SIAH1;CUL5;UBA3;PIAS2;MAP3K1;UBE2E2;PPIL2;SAE1;CBLB;SKP1;FANCL;CDC26;PIAS4;RHOBTB1;PML;ANAPC5;ANAPC10;UBE2E3;NEDD4L;FBXO4;RNF7;UBE2E1;DDB2;UBE2H;UBE2Z;DDB1;UBE2M;UBA7;SMURF2;UBE2C;UBE2N;SOCS3;TRAF6;FBXW11;WWP1;ANAPC4;COP1;VHL;UBE4B;ANAPC7;UBA6;CUL7;UBE4A;RPS27A;UBE2R2;UBE2G1;DET1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.4973839740364199,-1.5816068911783416,0.0,0.7022067058945655,1.0,12/24,28.68%,ANAPC2;CDC16;ANAPC11;CDC26;ANAPC5;ANAPC10;UBE2E1;UBE2C;ANAPC4;CDK1;ANAPC7;RPS27A
prerank,KEGG_2021_Human__Fat digestion and absorption,-0.5221030746037942,-1.5810640164746996,0.025,0.6699223349715193,1.0,5/19,12.21%,ACAT1;DGAT2;PLA2G2C;ABCA1;SLC27A1
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.42024970496560343,-1.5697962471926474,0.010309278350515464,0.7079624985658323,1.0,45/77,35.64%,ANAPC2;CDC16;ANAPC11;CDC25C;CDC26;PLK1;MAPK10;SPDYE18;IGF1R;ANAPC5;ANAPC10;MAD1L1;PIK3R3;CPEB2;CDC25B;AKT2;PIK3CB;AKT3;PIK3R1;RPS6KA1;KIF22;GNAI1;AKT1;ADCY3;MAPK8;ANAPC4;RPS6KA3;CDK1;ANAPC7;CPEB4;MAPK14;MAPK1;PDE3B;HSP90AB1;MAP2K1;BUB1;AURKA;MAPK11;ADCY7;RPS6KA2;MAPK13;GNAI3;CDC25A;CDK2;SPDYE16
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.508157289228952,-1.565235664923942,0.023809523809523808,0.707610103096163,1.0,6/20,15.78%,CDK5R1;BCL2L11;GOLGA2;CDC25C;CDC25B;CAPN2
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.546811426414182,-1.5620996314888744,0.036585365853658534,0.6942831471523018,1.0,11/21,22.29%,MAML2;PBX1;GATD3;EP300;MAML3;MAMLD1;KAT2B;STAT1;IKZF1;KAT2A;HEY1
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.46563072237135106,-1.560801528223935,0.010752688172043012,0.6748220028747489,1.0,18/46,19.76%,DDX20;RPS4X;SNRPE;RPS20;RPS15A;SNRPB;RPS8;RPS16;GEMIN8;GEMIN5;GEMIN6;RPS11;RPS10;RPS14;SNRPF;RPS23;RPS29;RPSA
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.5372974427796754,-1.5598932253928641,0.036585365853658534,0.6524602120929013,1.0,12/18,34.39%,REXO2;CDC25C;EP300;BAX;PCNA;CDK1;TP53;GADD45A;ZNF385A;CARM1;AURKA;TFDP2
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,-0.4783994528564121,-1.5550512072227032,0.0,0.6603045352477422,1.0,20/40,28.41%,CREB1;SLC46A1;HDAC3;XPO1;NCOA1;CRTC1;RORA;LIN9;EP300;NR1D1;PPARA;BMAL1;CLEC1B;HBA1;LY96;MEF2C;NCOR1;TBL1XR1;NRIP1;CARM1
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.3369188907865641,1.5523313598006658,0.0,1.0,0.88,5/19,8.31%,SCD5;HMGCR;HDAC2;NAB1;EGR2
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.4909853161383712,-1.5515045596792278,0.02247191011235955,0.6538833476434893,1.0,9/26,18.29%,XPO1;SMURF1;TGFBR2;SMAD2;SRFBP1;MTMR4;NEDD4L;SMURF2;SMAD7
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.46465399402478175,-1.5450770614172045,0.010752688172043012,0.6705955270968137,1.0,17/35,30.51%,EDEM2;PDIA3;UBXN1;DERL1;NGLY1;VCP;GANAB;RNF139;RNF185;TRIM13;UGGT1;PRKCSH;RPS27A;ENGASE;RNF103;CALR;UGGT2
prerank,KEGG_2021_Human__Mismatch repair,-0.5106892789396963,-1.5393165408311866,0.06097560975609756,0.6861139794463295,1.0,13/23,31.59%,LIG1;RPA3;RFC1;RPA1;MLH1;EXO1;MLH3;RPA2;PCNA;RFC3;MSH6;POLD4;RPA4
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.41812483277479273,-1.5358625300249407,0.021052631578947368,0.6883134132397832,1.0,35/82,29.05%,HIPK2;CDK5R1;PRKAG2;DNA2;RPA3;TAF5;MDM4;PDZD2;TAF1;TAF4;STK11;HUS1;EXO1;RAD50;RBBP8;RAD9B;RMI2;CSNK2A2;TP53RK;HIPK1;SSRP1;PRKAG1;POLR1B;TAF12;TAF15;CHEK1;RFC3;TOP3A;TP53;MAPK14;TAF9B;TAF2;PRKAB1;RPS27A;TOPBP1
prerank,KEGG_2021_Human__Lysosome,-0.40512294930897813,-1.5288042430143067,0.0,0.7087847546617276,1.0,44/120,24.36%,CTNS;CTSF;CTSL;AP1M1;GGA3;AP3S1;AP3B2;PPT1;CLTCL1;AP3S2;M6PR;GALC;ATP6V0B;LAMP3;CTSG;GNPTAB;AP4S1;IDUA;IGF2R;GALNS;MANBA;AP3M1;GNS;CLTB;HYAL3;HEXA;TCIRG1;AP3D1;ATP6V0D1;IDS;SGSH;CTSS;AP1S1;AP4B1;NAGLU;PLA2G15;CLN3;CD164;HGSNAT;CLN5;CLTC;SUMF1;FUCA2;ACP2
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,-0.44571472432687015,-1.528631007143747,0.010309278350515464,0.6868756083646471,1.0,15/39,25.73%,ANAPC2;CDC16;ANAPC11;AGO1;IL6;CDC26;ANAPC5;ANAPC10;TCF7L2;UBE2E1;UBE2C;TNRC6A;ANAPC4;TP53;ANAPC7
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.43137171706131766,-1.5102910681013983,0.022988505747126436,0.7816572011604465,1.0,25/47,30.90%,REXO2;CNOT10;CDC25C;CCNE1;ARID3A;BTG2;EP300;CNOT6L;E2F1;CNOT9;CNOT2;BAX;PCNA;NPM1;RGCC;CDK1;TP53;GADD45A;CNOT8;ZNF385A;CARM1;CNOT11;CDKN1B;PCBP4;AURKA
prerank,KEGG_2021_Human__Pentose phosphate pathway,0.35766757239033103,1.5060878445639585,0.07692307692307693,1.0,0.91,5/24,6.16%,PGD;FBP1;G6PD;H6PD;TKT
prerank,KEGG_2021_Human__One carbon pool by folate,-0.5406088588499649,-1.4998061690717608,0.03614457831325301,0.833618180129465,1.0,5/17,12.58%,MTHFD1;MTHFD1L;MTHFR;AMT;DHFR
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,-0.5164402543169572,-1.4900047292962226,0.08045977011494253,0.8900680398038154,1.0,8/18,23.10%,ACVR2B;SMURF1;SMAD5;ACVR2A;SMURF2;SMAD7;BMPR1A;BMPR2
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.4752612666308971,-1.4807547615652004,0.011235955056179775,0.9370900329448788,1.0,10/33,13.33%,HIPK2;PCGF5;PHC3;SCMH1;SMARCD2;CBX4;RNF2;EP300;CSNK2A2;ARID1A
prerank,KEGG_2021_Human__Glycerolipid metabolism,-0.43199150320769686,-1.4653702451644395,0.07777777777777778,1.0,1.0,16/46,19.79%,ALDH2;DGKQ;LPIN1;DGAT2;AKR1A1;GPAT3;DGKH;MBOAT1;LCLAT1;ALDH1B1;DGKA;DGKG;GLYCTK;GPAT2;LIPG;PLPP5
prerank,KEGG_2021_Human__beta-Alanine metabolism,-0.5023701047078102,-1.4608846391136543,0.047058823529411764,1.0,1.0,7/24,13.21%,ALDH2;CARNS1;DPYD;SMOX;UPB1;ALDH1B1;ALDH3B1
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.4755069959064058,-1.4587064845771383,0.11842105263157894,1.0,1.0,11/19,35.15%,DNA2;RPA3;POT1;LRIG1;PCNA;POLR1B;TERF1;TINF2;POLD4;POLD2;TERF2IP
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,-0.502871350723783,-1.45582548967075,0.07058823529411765,1.0,1.0,7/18,19.43%,ALDH2;DPYD;UPB1;PANK1;ALDH1B1;PPCDC;ENPP3
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,-0.3857963423206002,-1.454619418239077,0.0,1.0,1.0,32/107,18.72%,ANAPC2;CDC16;ANAPC11;PPP2CB;XPO1;NUP37;CLASP1;CENPO;NUP133;SKA1;CENPU;DYNC1LI2;SPDL1;CENPF;CDC26;INCENP;PLK1;CENPA;BUB3;PPP2R5E;ITGB3BP;ANAPC5;ANAPC10;MAD1L1;ZWINT;SPC25;UBE2E1;CDCA8;CLASP2;DYNLL2;PPP2R1A;UBE2C
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",-0.4472565182354028,-1.4537955222322907,0.031914893617021274,1.0,1.0,10/34,18.17%,BPGM;GCSH;SDSL;GNMT;AMT;GCAT;DMGDH;PGAM2;GLYCTK;SARDH
prerank,KEGG_2021_Human__Tryptophan metabolism,-0.47801843204462036,-1.4517560196103958,0.034482758620689655,1.0,1.0,12/31,17.58%,TPH1;ALDH2;ACAT1;KMO;INMT;KYAT3;DLST;ALDH1B1;IL4I1;KYAT1;HADH;TPH2
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.4847549525725416,-1.4498915619502888,0.11842105263157894,1.0,1.0,10/17,35.15%,DNA2;RPA3;POT1;PCNA;POLR1B;TERF1;TINF2;POLD4;POLD2;TERF2IP
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,-0.5238401271998817,-1.4440790202940366,0.0945945945945946,1.0,1.0,6/15,17.64%,NAMPT;NUDT12;PARP16;NAXD;PARP4;PARP14
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.3495385249694077,1.4438242510903259,0.0,1.0,0.98,7/22,13.10%,VAMP1;MAP2K6;ANTXR2;CALM1;HBEGF;TXNRD1;PDCD6IP
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.43976646312268686,-1.4403305110086364,0.056179775280898875,1.0,1.0,16/35,29.18%,IFT172;DYNC2I1;TTC21B;IFT22;IFT20;IFT43;KIF3C;DYNLL2;DYNC2H1;IFT122;CLUAP1;DYNC2LI1;DYNLT2;DYNLT2B;TRIP11;KIF3B
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.23000198148004167,1.4343574180278926,0.0,1.0,0.98,33/75,24.27%,PSMB5;ATF4;SQSTM1;PSMD9;PSMC3;PSMC6;PSMB7;TKT;PSME2;CREBBP;MAFG;SRXN1;UBC;PSMD11;TXNRD1;UBL4A;PSMD6;UBB;SLC7A11;PSMF1;GSR;PSMD3;BTRC;PHGDH;CUL1;MAFK;PSMB3;PSMB2;PSMA7;BRIP1;PSMA6;PSMB4;NOTCH1
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,-0.40871790533682695,-1.4338823288773281,0.0851063829787234,1.0,1.0,16/46,25.67%,KMT5B;DOT1L;NFKB2;KMT2B;AEBP2;EZH2;H3C7;RBBP7;KMT2D;H3C13;SETD3;SETDB2;SETD6;NSD1;EED;RBBP4
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,-0.43259620152271866,-1.4338414906264387,0.045454545454545456,1.0,1.0,8/43,7.75%,HIPK2;PVALB;CREB1;PTPN4;HDAC3;CAMK2A;AGO1;SIN3A
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,-0.5087640699182566,-1.4305816425769036,0.023809523809523808,1.0,1.0,6/16,17.84%,KCNG1;KCND3;KCNA3;KCNQ1;KCNC4;KCNC2
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.4295647921034632,-1.429218898523966,0.047058823529411764,1.0,1.0,8/33,12.42%,CLSPN;MCM5;RPA3;ORC3;CDC25C;HUS1;ORC6;RAD9B
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.4604551408860858,-1.4291365507153544,0.047619047619047616,1.0,1.0,4/23,4.05%,CDK5R1;BCL2L11;GOLGA2;CDC25C
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.4352933809573629,-1.4254141931119348,0.0449438202247191,1.0,1.0,10/40,10.27%,HIPK2;PHC3;NCOA1;SCMH1;PIAS2;SIN3A;CBX4;RNF2;PIAS4;EP300
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.46356234149847697,-1.4235009096287676,0.0375,1.0,1.0,17/27,33.96%,CREB1;PPP2CB;MAPK10;RPS6KA1;PPP2R1A;MEF2C;MAPK8;FOS;RPS6KA5;RPS6KA3;MAPK7;DUSP6;MAPK14;MAPK1;JUN;MAPK11;RPS6KA2
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,-0.5371370326486411,-1.4161517538204558,0.11494252873563218,1.0,1.0,7/15,16.91%,RHD;FUT1;FUT4;FUT2;RHCE;B4GALNT2;ABO
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,-0.3925782186771312,-1.406309589297511,0.042105263157894736,1.0,1.0,25/65,23.75%,DTX4;MAML2;HDAC3;JAG1;GATD3;CDK8;SKP1;TLE2;EP300;MAML3;MAMLD1;KAT2B;CNTN1;PSEN1;PSENEN;HDAC11;ARRB1;HDAC6;TLE1;NCSTN;KAT2A;ADAM10;HEY1;DTX2;NCOR1
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,0.28689535548795025,1.4049516879361503,0.09090909090909091,1.0,0.99,3/22,2.64%,HMBS;UGT2B4;HMOX2
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,-0.4499165806136327,-1.4047677097456575,0.08641975308641975,1.0,1.0,7/29,12.38%,HIPK2;CREB1;HDAC3;CAMK2A;AGO1;SIN3A;MECP2
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.4212645368651233,-1.4040741532683632,0.05555555555555555,1.0,1.0,8/46,6.33%,LIG1;ERCC5;XPC;RPA3;RFC1;ERCC4;RPA1;MNAT1
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,-0.48085902708100775,-1.4013576339185903,0.09090909090909091,1.0,1.0,12/21,29.41%,DUSP12;TYK2;PEA15;IL6;DUSP10;DUSP2;DUSP6;CDK1;JAK2;IL6ST;MAPK1;MAP2K1
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,0.41788615388447947,1.4002491234437273,0.1111111111111111,1.0,0.99,5/15,14.67%,LPCAT2;PLB1;PLAAT3;PLA2G4C;MBOAT2
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.4044562960897783,-1.3957928722449804,0.05319148936170213,1.0,1.0,12/41,18.29%,XPO1;SMURF1;TGFBR2;SMAD2;SRFBP1;ITGB5;LTBP1;MTMR4;NEDD4L;UBE2M;SMURF2;SMAD7
prerank,KEGG_2021_Human__Notch signaling pathway,-0.4090605252893091,-1.3956356117976199,0.031578947368421054,1.0,1.0,17/48,22.81%,DTX4;MAML2;RFNG;JAG1;LFNG;TLE2;EP300;MAML3;KAT2B;PSEN1;PSENEN;DTX3L;TLE1;NCSTN;KAT2A;HEY1;DTX2
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.4666897192695536,-1.3951487644440015,0.06329113924050633,1.0,1.0,5/20,11.58%,AKAP5;CAMK2A;CACNG8;AP2M1;LGALS12
prerank,KEGG_2021_Human__GnRH secretion,-0.40176460971062045,-1.3949188170364841,0.041237113402061855,1.0,1.0,16/44,21.00%,CACNA1I;GNA11;GNRH1;PLCB2;PIK3R3;HCN2;ARRB1;AKT2;PIK3CB;PLCB4;AKT3;PIK3R1;CACNA1H;AKT1;KISS1R;KCNN4
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.42845096498257085,-1.391999006690871,0.05747126436781609,1.0,1.0,13/34,24.74%,DNA2;RPA3;ERCC4;HUS1;EXO1;RAD50;RBBP8;RAD9B;RMI2;POLR1B;ABL1;RFC3;TOP3A
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,-0.39589891355435475,-1.3875266422778092,0.061855670103092786,1.0,1.0,29/61,34.49%,MMP9;CTSL;MMP11;COL9A1;CAPN5;KLKB1;CTSG;LAMC1;HTRA1;PSEN1;HSPG2;CTSS;CAPN2;BMP1;NCSTN;ADAM10;MMP28;DCN;PLG;ADAM9;COL13A1;MMP17;CASP3;MMP8;CAPN3;CD44;PHYKPL;CAPN7;CTSB
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,-0.5136852674585393,-1.3873854133934964,0.11688311688311688,1.0,1.0,9/16,21.64%,IDUA;GALNS;GNS;HYAL3;HEXA;IDS;SGSH;NAGLU;HGSNAT
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.38914160786997404,-1.3845002004576759,0.06382978723404255,1.0,1.0,22/51,28.68%,MAML2;HDAC3;JAG1;GATD3;CDK8;SKP1;EP300;MAML3;MAMLD1;KAT2B;PSEN1;PSENEN;HDAC11;HDAC6;NCSTN;KAT2A;ADAM10;HEY1;NCOR1;TBL1XR1;NEURL1;RPS27A
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,-0.3526737793220877,-1.384397546579657,0.050505050505050504,1.0,1.0,26/115,15.59%,TRPV2;CLCN6;ATP6V1E1;ATP10D;TRPC4AP;CAMK2A;TSC22D3;FXYD2;TRPM7;ANO9;FKBP1B;ATP8A1;SCNN1D;ATP6V0B;ATP6V1E2;MCOLN2;ATP2C2;ANO5;TCIRG1;ATP13A2;ATP11A;ANO8;ATP6V0D1;SGK3;NEDD4L;SLC9B1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,-0.38243401802346844,-1.3837082817602895,0.06060606060606061,1.0,1.0,25/71,23.85%,KIF4A;ITGA10;RPS6KA4;NCAM1;ITGA5;AP2M1;LYPLA2;LAMC1;SHTN1;RANBP9;CNTN1;CSNK2A2;ANK2;DNM1;ALCAM;FGFR1;MSN;RPS6KA1;SPTBN1;RNASE1;CNTNAP1;L1CAM;CLTC;RPS6KA5;RPS6KA3
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,-0.3860883055367101,-1.3832362544688768,0.07291666666666667,1.0,1.0,19/57,21.79%,TRPV2;CLCN6;TRPC4AP;TSC22D3;TRPM7;ANO9;FKBP1B;SCNN1D;MCOLN2;ANO5;ANO8;SGK3;NEDD4L;SLC9B1;NALCN;CLCN5;TRPC6;TRPM6;WWP1
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,-0.41768490792671886,-1.3827501952546395,0.08139534883720931,1.0,1.0,10/29,23.98%,SIRT2;NAMPT;NMNAT3;NUDT12;SIRT3;NT5E;NT5C1A;ENPP3;NADK;NADK2
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.46572967350219086,-1.3806343561280496,0.05813953488372093,1.0,1.0,5/24,7.77%,FARSA;DARS1;NARS1;PPA1;QARS1
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,-0.4498007008131232,-1.3788681168654562,0.09090909090909091,1.0,1.0,10/29,16.59%,MGST1;AKR1A1;MGST2;HPGDS;GGT1;GSTA4;GSTO1;GGT7;MGST3;GSTM1
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.45906222635072247,-1.3750052686553649,0.09195402298850575,1.0,1.0,7/26,13.32%,GCSH;BCKDHA;DLAT;GNMT;AMT;DLST;ALDH4A1
prerank,KEGG_2021_Human__DNA replication,-0.425978019984639,-1.372511958081646,0.08139534883720931,1.0,1.0,6/36,5.98%,LIG1;DNA2;MCM5;RPA3;RFC1;RPA1
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.3685931230296768,-1.3694685104413118,0.04040404040404041,1.0,1.0,50/102,35.25%,CREB1;NKIRAS2;NFKB2;PPP2CB;ECSIT;TMED7-TICAM2;MAP3K1;SKP1;PIK3R4;MAPK10;ALPK1;TNIP2;LRRC14;IKBKB;RPS6KA1;NLRC5;EEA1;N4BP1;PPP2R1A;LY96;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;PIK3C3;TLR7;MAP2K1;JUN;NDUFA2;MAPK11;CHUK;RPS6KA2;MAPKAPK3;IRAK4;S100B
prerank,KEGG_2021_Human__Pyruvate metabolism,-0.4344676518184569,-1.3693814978494836,0.09302325581395349,1.0,1.0,14/34,28.78%,ALDH2;PC;ACAT1;AKR1A1;DLAT;ACYP2;ALDH1B1;ACSS2;LDHB;HAGH;ME3;ACSS1;ALDH9A1;LDHA
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,-0.37428925139633573,-1.3688392387320036,0.031578947368421054,1.0,1.0,15/71,11.93%,HIPK2;ABCC9;KCND3;CAMK2A;FXYD2;CORIN;FKBP1B;KCNJ2;AKAP9;CACNG8;RANGRF;KCNE1;KAT2B;STIM1;KCNQ1
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,-0.43239645676266897,-1.3670225877437487,0.09090909090909091,1.0,1.0,13/26,33.89%,VPS4B;VPS37B;MVB12B;MVB12A;CHMP4B;NEDD4L;UBAP1;RNF103-CHMP3;CHMP5;RPS27A;SGIP1;VPS4A;VPS37C
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.35583226624665854,-1.3635897739015626,0.0,1.0,1.0,59/159,26.56%,DOT1L;MMP9;BMP2K;CDKN2C;TGFBR2;BIRC3;AFF1;CEBPE;CXCL8;PBX1;FOXO1;JUP;LMO2;JMJD1C;SIN3A;PLAT;TRAF1;MLF1;IL6;FUS;CD14;RUNX1T1;H3C7;ZBTB16;PML;IGF1R;H3C13;MLLT3;GADD45G;H3C6;DDB2;CCNT2;MLLT1;H3-3A;HPGD;RUNX2;BAX;CCND2;MEIS1;MEF2C;CDK14;DEFA3;ATF1;TAF15;ID2;IGFBP3;FUT8;H3C15;H3-3B;GZMB;NCOR1;CDK9;DUSP6;HMGA2;NTRK1;TP53;SLC45A3;GADD45A;NFKBIZ
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,-0.45593751751456363,-1.360961099770636,0.1111111111111111,1.0,1.0,7/20,24.87%,CTNS;NIPAL2;BPNT1;ANKH;ADD1;MRS2;LRRC8D
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,-0.43662375352250116,-1.360870847629234,0.13580246913580246,1.0,1.0,10/25,23.98%,NAMPT;NMNAT3;NUDT12;PARP16;NAXD;PARP4;PARP14;NT5E;NADK;NADK2
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,-0.4634658931076019,-1.3602054068951939,0.08235294117647059,1.0,1.0,4/23,4.65%,MMP9;CTSL;MMP11;COL9A1
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,-0.4380347930831383,-1.3571362066011536,0.09090909090909091,1.0,1.0,12/26,30.51%,EDEM2;PDIA3;GANAB;RNF139;RNF185;TRIM13;UGGT1;PRKCSH;RPS27A;RNF103;CALR;UGGT2
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.40010107297623493,-1.356887989663468,0.09278350515463918,1.0,1.0,9/44,9.12%,PHC3;NUP88;NUP37;SCMH1;NUP133;HNRNPC;POM121;CBX4;RNF2
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,-0.46566719965625075,-1.35527614357756,0.13953488372093023,1.0,1.0,10/18,32.75%,SLC30A7;SLC39A3;SLC39A8;SLC39A1;SLC41A1;SLC30A1;SLC30A6;SLC39A14;SLC11A1;SLC31A1
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,-0.3737251676346837,-1.3510679715922684,0.12903225806451613,1.0,1.0,16/53,19.14%,PLXNA4;REXO2;BCL2L11;SMAD2;ABCA6;FOXO1;SIRT3;SIN3A;STK11;EP300;KAT2B;BBC3;AKT2;AKT3;CCNG2;AKT1
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,0.3834924550779444,1.350085703808688,0.15384615384615385,1.0,0.99,7/15,10.48%,PDP2;RXRA;LDHD;PDPK1;GSTZ1;PDHA1;PDPR
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,-0.3757164026696518,-1.3491318516918174,0.08333333333333333,1.0,1.0,22/64,24.44%,GFER;TIMM8B;CMC4;GRPEL1;SAMM50;TOMM7;BCS1L;CHCHD3;TOMM20;TOMM6;SLC25A12;PMPCA;TIMM9;TIMM17A;TIMM13;TIMM23;TIMM50;CMC2;TIMM10B;CHCHD7;IDH3G;CS
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.41918183043678015,-1.3488779290401365,0.12643678160919541,1.0,1.0,8/32,12.52%,DNA2;RPA3;HUS1;EXO1;RAD50;RBBP8;RAD9B;RMI2
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.36664471307245683,-1.345210829391462,0.07216494845360824,1.0,1.0,39/92,30.09%,CREB1;NKIRAS2;NFKB2;PPP2CB;ECSIT;MAP3K1;TLR5;SKP1;MAPK10;ALPK1;TNIP2;LRRC14;TLR10;IKBKB;RPS6KA1;NLRC5;N4BP1;PPP2R1A;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;MAP2K1;JUN
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.4874130362045091,-1.3441646638662197,0.12345679012345678,1.0,1.0,8/22,18.48%,BBS5;BBS2;SMOX;BBS12;BBS1;BBS9;BBS10;BBIP1
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.36123505741626316,-1.3437861453655142,0.08080808080808081,1.0,1.0,47/97,35.25%,CREB1;NKIRAS2;NFKB2;PPP2CB;ECSIT;TMED7-TICAM2;MAP3K1;SKP1;MAPK10;ALPK1;TNIP2;LRRC14;IKBKB;RPS6KA1;NLRC5;N4BP1;PPP2R1A;LY96;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;TLR7;MAP2K1;JUN;NDUFA2;MAPK11;CHUK;RPS6KA2;MAPKAPK3;IRAK4;S100B
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.41951759056273275,-1.3336250188697631,0.07526881720430108,1.0,1.0,9/42,7.77%,FARSA;DARS1;PPA2;NARS1;MARS2;PPA1;AARS2;EARS2;QARS1
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.35914919010365665,-1.3323146797099923,0.09090909090909091,1.0,1.0,47/98,35.25%,CREB1;NKIRAS2;NFKB2;PPP2CB;ECSIT;TMED7-TICAM2;MAP3K1;SKP1;MAPK10;ALPK1;TNIP2;LRRC14;IKBKB;RPS6KA1;NLRC5;N4BP1;PPP2R1A;LY96;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;TLR7;MAP2K1;JUN;NDUFA2;MAPK11;CHUK;RPS6KA2;MAPKAPK3;IRAK4;S100B
prerank,KEGG_2021_Human__Collecting duct acid secretion,-0.4482756928611041,-1.3320701242952615,0.1518987341772152,1.0,1.0,6/19,20.32%,ATP6V1E1;ATP6V1E2;SLC4A1;TCIRG1;ATP6V0D1;CA2
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,-0.369413357123977,-1.3308052175043732,0.07142857142857142,1.0,1.0,38/83,32.77%,PRKAG2;CREB1;ATP5F1E;GLUD1;HDAC3;POLRMT;NCOA1;CRTC1;SAMM50;SIRT3;CHCHD3;LIN9;DNAJC11;DMAC2L;NR1D1;ATP5ME;ATP5MG;PPARA;ACSS2;MICOS13;IMMT;PRKAG1;MEF2C;ATP5F1C;NCOR1;TFB2M;PPARGC1B;MAPK14;TBL1XR1;PRKAB1;CARM1;MTX1;ATP5PO;IDH2;GABPA;MAPK11;SIRT5;CHD9
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.4241599809413713,-1.3305649525352474,0.09782608695652174,1.0,1.0,6/28,11.20%,VPS4B;VPS37B;MVB12B;SNF8;MVB12A;CHMP4B
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.3571651973045699,-1.328759698425783,0.10101010101010101,1.0,1.0,47/99,35.25%,CREB1;NKIRAS2;NFKB2;PPP2CB;ECSIT;TMED7-TICAM2;MAP3K1;SKP1;MAPK10;ALPK1;TNIP2;LRRC14;IKBKB;RPS6KA1;NLRC5;N4BP1;PPP2R1A;LY96;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;TLR7;MAP2K1;JUN;NDUFA2;MAPK11;CHUK;RPS6KA2;MAPKAPK3;IRAK4;S100B
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,-0.395328848761419,-1.3274259667646675,0.14285714285714285,1.0,1.0,12/51,12.18%,DDX20;NUP88;SNRPE;NUP37;SNRPB;NUP133;NCBP2;POM121;LIN9;GEMIN8;GEMIN5;GEMIN6
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.4605029094333411,-1.3234873582686395,0.16455696202531644,1.0,1.0,11/20,29.06%,CNOT10;CDC25C;BTG2;CNOT6L;CNOT9;CNOT2;NPM1;RGCC;TP53;CNOT8;CNOT11
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.4056996371962346,-1.3234064831781138,0.15555555555555556,1.0,1.0,13/39,22.44%,MMP9;CLTCL1;EPHB3;EPHA1;AP2M1;PSEN1;CLTB;PSENEN;DNM1;RNASE1;NCSTN;ADAM10;CLTC
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.45619753633337673,-1.322739530336063,0.12359550561797752,1.0,1.0,6/20,16.27%,DTX4;NKIRAS2;NFKB2;ZBP1;DHX9;IKBKB
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,-0.3484812279700531,-1.3190898797432407,0.04040404040404041,1.0,1.0,60/157,27.07%,ANAPC2;PHC3;CDC16;ANAPC11;MAP3K5;CDKN2C;SCMH1;CXCL8;AGO1;MDM4;H2BC14;CCNE1;POT1;EP400;CBX4;EZH2;IL6;RNF2;CDC26;ETS1;H3C7;MAPK10;RAD50;H2BC13;H1-2;ANAPC5;RBBP7;ANAPC10;H1-3;H2AC14;H3C13;H2AZ1;UBE2E1;E2F1;RPS6KA1;UBE2C;CBX6;TNRC6A;CABIN1;MAPK8;FOS;CDKN2B;ANAPC4;H3-3B;MAP2K4;RPS6KA3;H2AX;MINK1;MAPK7;TERF1;HMGA2;TINF2;EED;TP53;RBBP4;ANAPC7;DAND5;MAPK14;MAPK1;H2AC19
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,-0.3914502191121723,-1.3189174646511157,0.07368421052631578,1.0,1.0,18/51,26.01%,MMP9;CTSL;P3H1;PLOD3;SERPINH1;COL9A1;PLOD1;P3H2;PLEC;CTSS;BMP1;DST;PCOLCE2;PPIB;MMP28;COL8A2;COL13A1;LOXL1
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,-0.42526855417256926,-1.318119968548852,0.11827956989247312,1.0,1.0,10/32,17.18%,AP1M1;CLVS1;DNAJC6;M6PR;AP4S1;GNS;CLTB;ARRB1;AP1S1;AP4B1
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.348315268735329,-1.3169335250491763,0.09473684210526316,1.0,1.0,43/82,37.37%,PRKCD;TGFBR2;SMAD2;CXCL8;FOXO1;PLCB2;IL6;MAPK10;PIK3R3;STAT1;DIAPH1;PIM1;AKT2;PIK3CB;PLCB4;AKT3;PIK3R1;STAT5A;AKT1;BAX;PLCD3;MAPK8;EGR1;JAK2;TGFB1;MAPK14;CASP3;MAPK1;RAC1;THBD;HRAS;CDKN1B;JUN;CCL2;MAPK11;PRKCB;MAPK13;COL4A4;PRKCZ;STAT5B;TGFB3;NFATC1;IL1B
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,-0.43441721711465586,-1.316396344940393,0.16883116883116883,1.0,1.0,5/20,14.41%,ATP6V1E1;ATP6V0B;ATP6V1E2;TCIRG1;ATP6V0D1
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.35681279870762855,-1.3140209435152925,0.06060606060606061,1.0,1.0,34/88,29.41%,PCGF5;ACVR2B;SMARCAD1;SMAD2;JARID2;SMAD5;FZD2;OTX1;WNT10A;FZD6;HESX1;IGF1R;PIK3R3;AKT2;ACVR2A;FGFR1;PIK3CB;AKT3;PIK3R1;FZD3;AKT1;BMPR1A;MEIS1;KAT6A;ID2;BMPR2;WNT5B;JAK2;MAPK14;IL6ST;MAPK1;NANOG;HRAS;MAP2K1
prerank,KEGG_2021_Human__Histidine metabolism,-0.486647582394091,-1.3128192333121191,0.13580246913580246,1.0,1.0,5/16,13.21%,ALDH2;CARNS1;HNMT;ALDH1B1;ALDH3B1
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.3593670494681163,-1.3127980852280043,0.09574468085106383,1.0,1.0,27/67,33.31%,CTNS;SLC8B1;SLC25A22;SLC25A26;SLC43A2;SLC5A5;SLC9A3;SLC4A5;SLC20A1;SLC36A2;SLC24A4;SLC4A10;SLC4A1;SLC7A8;SLC15A4;SLC9A9;SLC8A1;SLC25A29;AHCYL2;SLC4A2;SLC9A4;SLC9A7;SLC1A4;SLC36A1;SLC24A3;SLC16A10;SLC6A15
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",-0.3882934632345339,-1.3113904507104996,0.13043478260869565,1.0,1.0,16/43,30.38%,ALDH2;ACAT1;BCKDHA;MMUT;OXCT1;ALDH1B1;IL4I1;HMGCL;HADH;HSD17B10;IVD;MCEE;ALDH9A1;ACADSB;BCAT1;HADHA
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.38329225554004875,-1.3113403399464811,0.10752688172043011,1.0,1.0,21/50,26.97%,TPH1;CDK5R1;CREB1;PPP2CB;TRIB1;EP300;FOSL1;RPS6KA1;PPP2R1A;MEF2C;FOS;ID2;RPS6KA5;CHD4;RPS6KA3;MAPK7;DUSP6;FOSB;EGR1;MAPK14;MAPK1
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,-0.3632009232490267,-1.3105099644130362,0.041666666666666664,1.0,1.0,31/71,32.34%,REXO2;DNA2;RPA3;CDC25C;H2BC14;PIAS4;HUS1;EXO1;RAD50;H2BC13;RBBP8;RAD9B;RMI2;MDC1;POLR1B;UBE2N;CHEK1;H2AX;RFC3;TOP3A;CDK1;TP53;WEE1;YWHAZ;TOPBP1;ABRAXAS1;YWHAQ;RNF168;H2BC17;RAD9A;H2BC12
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.4221242224370673,-1.3097998140084697,0.14285714285714285,1.0,1.0,11/24,28.68%,ELOC;CUL5;TYK2;SYK;STAT1;RNF7;STAT5A;SOCS3;JAK2;LYN;RPS27A
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.4771931495038362,-1.3097671804857531,0.15476190476190477,1.0,1.0,4/17,8.20%,MMP9;MMP11;KLKB1;CTSG
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,-0.33692994433656487,-1.3090438868149958,0.05,1.0,1.0,55/145,29.23%,HIPK2;CDK5R1;PRKAG2;DNA2;PPP2CB;RPA3;TAF5;MDM4;PDZD2;TAF1;TAF4;STK11;HUS1;EP300;EXO1;PML;ING5;RAD50;RBBP8;RBBP7;RAD9B;RMI2;CSNK2A2;MTA2;TP53RK;PRDM1;AKT2;AKT3;HIPK1;PPP2R1A;AKT1;BANP;SSRP1;PRKAG1;POLR1B;TAF12;KAT6A;TAF15;CHEK1;CHD4;RFC3;TOP3A;CDK1;TP53;RBBP4;MAPK14;TAF9B;DPEP3;TAF2;PRKAB1;ZNF385A;RPS27A;CHD3;TOPBP1;RICTOR
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,0.19459209829509944,1.306386915975634,0.0,1.0,1.0,25/83,18.41%,SPTAN1;LIMS2;WASL;CLDN9;FLNA;SKAP2;NECTIN2;CLDN5;CD47;FBLIM1;PIK3R2;AFDN;FYN;SIRPG;CD151;SIRPB1;NCK1;PRKCI;CLDN12;CASK;ILK;ARHGEF6;CDH13;ITGA6;CADM1
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,-0.44798281359207703,-1.3058485364631818,0.16666666666666666,1.0,1.0,13/22,36.94%,GALNT14;C1GALT1;GCNT4;GALNT10;ST6GALNAC4;ST6GALNAC3;POC1B-GALNT4;GCNT1;GALNT3;GALNT2;GALNT4;GALNT6;ST3GAL1
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.44032709703765927,-1.3041063208196775,0.23076923076923078,1.0,1.0,7/21,18.78%,CNTRL;FGFR1OP2;ERLIN2;STAT1;FGFR1;PIK3R1;STAT5A
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,-0.3476857798020276,-1.3008298021834568,0.03,1.0,1.0,35/99,28.68%,USP9X;ACVR2B;XPO1;SMURF1;TGFBR2;SMAD2;SRFBP1;SMAD5;PARP1;ITGB5;LTBP1;CDK8;ARHGEF18;MTMR4;EP300;STAT1;NEDD4L;ACVR2A;UBE2M;CCNT2;SMURF2;SMAD7;FSTL3;BMPR1A;YBX1;PPM1A;CDKN2B;BMPR2;NCOR1;CDK9;TGFB1;DAND5;MAPK1;ITGB8;RPS27A
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,-0.4125771050248458,-1.2980618859636321,0.13095238095238096,1.0,1.0,16/31,34.51%,DNA2;MCM5;RPA3;GINS4;SLC19A1;LRIG1;GINS3;PCNA;POLR1B;GINS1;RFC3;GINS2;PRIM1;POLD4;MCM8;POLD2
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.4464261459751216,-1.2964802576326406,0.18181818181818182,1.0,1.0,6/22,14.45%,PRKCD;DGKQ;ABHD12;DGKH;DGKA;DGKG
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,-0.3958792371921349,-1.2955932004312505,0.17777777777777778,1.0,1.0,18/34,34.52%,ALDH2;ACTA2;ITGB5;SORBS3;CACNA1H;PKN2;MYL12A;SORBS1;MYL9;MYLK;GUCY1B1;TPM2;CALD1;MYL11;MYL5;TLN1;MYL6B;ANXA2
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.3553622986329149,-1.2955565871626098,0.10101010101010101,1.0,1.0,15/73,12.82%,PHC3;XPC;NUP88;NUP37;SCMH1;NUP133;PARP1;PIAS2;POM121;NSMCE2;CBX4;RNF2;PIAS4;PML;MDC1
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.3033449117121167,1.2951469862143499,0.15789473684210525,1.0,1.0,9/23,14.49%,UBIAD1;PLB1;SDC3;AKR1C1;SDC2;SDC4;RETSAT;RDH11;LRP12
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.4448299392005203,-1.2936840741610824,0.18421052631578946,1.0,1.0,17/25,40.86%,PPP2CB;XPO1;CDC25C;MNAT1;PLK1;CDC25B;PPP2R1A;CDK1;WEE1;PPP2R3B;CDC25A;CDK2;CDK7;FOXM1;PPME1;PPP2CA;PPP2R1B
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.4145990988363495,-1.2927976473159084,0.17857142857142858,1.0,1.0,12/25,31.29%,DTX4;JAG1;CNTN1;PSEN1;PSENEN;ARRB1;NCSTN;ADAM10;DTX2;NEURL1;RPS27A;DTX1
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.4778377224251939,-1.289349454172866,0.18292682926829268,1.0,1.0,2/16,2.27%,NFKB2;MEFV
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,-0.40281624925577697,-1.2868775099348997,0.11827956989247312,1.0,1.0,16/30,32.67%,MGST1;MGST2;HPGDS;GSTA4;GSTO1;ALDH3B1;AKR7A2;MGST3;GSTM1;AKR7L;GSTM5;CYP1B1;CBR3;GSTM2;CYP3A5;GSTO2
prerank,KEGG_2021_Human__Butanoate metabolism,-0.4442789697082906,-1.2832051661789654,0.13095238095238096,1.0,1.0,6/19,17.54%,ACAT1;ALDH5A1;OXCT1;ACSM3;HMGCL;HADH
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,-0.33185004046424615,-1.2828901926133138,0.03,1.0,1.0,81/256,23.75%,PRKAG2;IFT172;CNTRL;NEK2;CDK5RAP2;CREB1;AHI1;ATP5F1E;GLUD1;PRKAR2B;HDAC3;DYNC2I1;DCTN3;POLRMT;NCOA1;TTC21B;CRTC1;BBS5;CLASP1;CSNK1D;ARF4;BBS2;IFT22;AKAP9;SAMM50;PKD1;IFT20;HAUS2;SMOX;SIRT3;EXOC5;CHCHD3;HAUS8;PLK1;LIN9;DNAJC11;BBS12;IFT43;BBS1;CEP76;KIF24;HAUS1;DMAC2L;NR1D1;KIF3C;ATP5ME;BBS9;ATP5MG;PPARA;HDAC6;TTBK2;ACSS2;BBS10;MICOS13;IMMT;EXOC7;EXOC3;CEP290;DYNLL2;BBIP1;PPP2R1A;NPHP4;DYNC2H1;IFT122;CEP192;CLUAP1;PRKAG1;UNC119B;TMEM67;MEF2C;ACTR1A;ATP5F1C;CEP164;CEP78;HAUS7;DYNC2LI1;INPP5E;DYNLT2;TUBB4A;NINL;NCOR1
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.39683514577987916,-1.2818938206393358,0.20454545454545456,1.0,1.0,19/35,32.57%,XPO1;BCL9;CBY1;TLE2;SOX13;KMT2D;TCF7L2;AKT2;TLE1;AKT1;CHD8;TCF7L1;PROC;SOX6;YWHAZ;BCL9L;RPS27A;ASH2L;TLE4
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,-0.3975199592022717,-1.2799745723776403,0.24719101123595505,1.0,1.0,11/29,25.29%,TPH1;CDK5R1;CREB1;TRIB1;EP300;FOSL1;FOS;ID2;CHD4;FOSB;EGR1
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,-0.4542074893572995,-1.2792136975894866,0.2,1.0,1.0,4/15,13.84%,SMAD2;PBX1;EPHA1;TSC22D1
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.35749571238948363,-1.277086452177957,0.13131313131313133,1.0,1.0,26/79,23.41%,CNTRL;NEK2;CDK5RAP2;MZT2A;PRKAR2B;DCTN3;TUBGCP6;CLASP1;CSNK1D;AKAP9;HAUS2;HAUS8;PLK1;CEP76;HAUS1;CEP290;PPP2R1A;CEP192;ACTR1A;CEP164;TUBGCP4;CEP78;HAUS7;TUBGCP2;TUBB4A;NINL
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,0.2959616654204377,1.277047057308225,0.15384615384615385,1.0,1.0,6/16,16.95%,STOML2;AFG3L2;MICU2;MCU;PMPCB;MICU3
prerank,Reactome_2022__CaM Pathway R-HSA-111997,-0.4101296040259776,-1.2751459110538843,0.12658227848101267,1.0,1.0,4/23,2.69%,PRKCD;CREB1;PRKAR2B;CAMK2A
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.3550710212231119,-1.274364913541546,0.11,1.0,1.0,25/70,27.37%,SEC22B;KIF4A;COPZ2;KIF6;ARF4;KIF5C;STX18;KIF19;KIF13B;KIF3C;COPB1;RINT1;NAPG;COPE;UBE2Z;ARF5;KIF22;COPZ1;NBAS;ARFGAP3;KIF1C;KIF9;ARCN1;KIF21B;COPB2
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.3447362458852106,-1.2708804666243307,0.13541666666666666,1.0,1.0,24/75,25.06%,DGKQ;LPIN1;PLA2G2C;PNPLA7;CDS2;LPGAT1;LYPLA2;GPAT3;DGKH;MBOAT1;ACHE;LCLAT1;DGKA;DGKG;CHKB;PLD4;GPAT2;CHPT1;PLA2G15;PLPP5;LYPLA1;PNPLA6;LPCAT3;DGKE
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,-0.3352428432791342,-1.2688665766834122,0.06060606060606061,1.0,1.0,56/173,23.41%,IFT172;CNTRL;NEK2;CDK5RAP2;AHI1;PRKAR2B;DYNC2I1;DCTN3;TTC21B;BBS5;CLASP1;CSNK1D;ARF4;BBS2;IFT22;AKAP9;PKD1;IFT20;HAUS2;SMOX;EXOC5;HAUS8;PLK1;BBS12;IFT43;BBS1;CEP76;KIF24;HAUS1;KIF3C;BBS9;HDAC6;TTBK2;BBS10;EXOC7;EXOC3;CEP290;DYNLL2;BBIP1;PPP2R1A;NPHP4;DYNC2H1;IFT122;CEP192;CLUAP1;UNC119B;TMEM67;ACTR1A;CEP164;CEP78;HAUS7;DYNC2LI1;INPP5E;DYNLT2;TUBB4A;NINL
prerank,KEGG_2021_Human__Propanoate metabolism,-0.4003125617019858,-1.2676772023820138,0.21348314606741572,1.0,1.0,12/31,30.38%,ACAT1;BCKDHA;MMUT;SUCLG1;ACSS2;ACOX1;SUCLG2;LDHB;MCEE;ACSS1;LDHA;HADHA
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,-0.34374325849727433,-1.2643791140284117,0.12,1.0,1.0,32/88,29.19%,DNAJC3;RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;RPL38;RPS16;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;RPS28;XK;RPL15;RPL36AL;RPL11;RPL34;RPS27A;RPL36A;RPS27
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,0.25387855284860367,1.2643041587633388,0.25,1.0,1.0,3/20,4.55%,HMBS;HMOX2;ABCC1
prerank,KEGG_2021_Human__Circadian rhythm,-0.4064440809346586,-1.263051159131312,0.23595505617977527,1.0,1.0,9/26,21.66%,PRKAG2;CREB1;CSNK1D;RORA;SKP1;NR1D1;BHLHE41;PRKAG1;FBXW11
prerank,KEGG_2021_Human__RNA transport,-0.3288435433363936,-1.2628002019153695,0.04,1.0,1.0,39/164,17.72%,EIF4A1;ELAC2;RNU5A-1;DDX20;SAP18;NXF1;XPO1;NUP88;EIF2S1;NUP37;NUP133;EIF1;NCBP2;THOC7;CYFIP2;POM121;THOC6;EIF3B;FUS;FXR2;GEMIN8;RPP25;GEMIN5;SNORD3A;GEMIN6;GLE1;TGS1;TACC3;RAE1;EIF1AX;EIF4G3;SUMO4;EIF2B4;RPP38;XPO5;EIF4G2;RPP14;EIF4A2;ALYREF
prerank,KEGG_2021_Human__Asthma,0.2872831029353846,1.25953955570566,0.2222222222222222,1.0,1.0,16/22,37.78%,IL10;MS4A2;FCER1A;IL4;RNASE3;HLA-DPA1;HLA-DPB1;HLA-DQA1;HLA-DOB;TNF;HLA-DRA;HLA-DMA;HLA-DRB1;HLA-DMB;CD40;HLA-DRB5
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,-0.3615206477727485,-1.257877677176526,0.20652173913043478,1.0,1.0,11/47,17.57%,VAMP3;CPNE8;VRK2;ARHGAP17;STBD1;TOR1AIP1;STEAP3;PLXNB1;DIAPH1;ARHGAP1;PIK3R1
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,-0.4336135183588537,-1.2575393662311556,0.1951219512195122,1.0,1.0,13/17,47.92%,TYK2;IL6;STAT1;SOCS3;CRLF1;JAK2;IL6ST;JAK1;CBL;IL31RA;STAT3;CLCF1;PTPN11
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.34373169957435834,-1.2559967879648344,0.13131313131313133,1.0,1.0,33/88,29.19%,RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;SECISBP2;RPL38;RPS16;RPS11;RPL7A;RPL29;SARS1;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;PSTK;RPS28;RPL15;RPL36AL;RPL11;RPL34;RPS27A;RPL36A;RPS27
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,0.3249691499552847,1.2557720574218147,0.16666666666666666,1.0,1.0,6/17,13.21%,LTA4H;CYP4F2;ABCC1;GGT5;CYP4F3;LTC4S
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.3855405868590916,-1.2555736868585154,0.18292682926829268,1.0,1.0,10/33,15.18%,GPC2;CHSY1;IDUA;CHST7;VCAN;HYAL3;HEXA;B3GAT3;IDS;HSPG2
prerank,KEGG_2021_Human__Selenocompound metabolism,-0.44159888189773633,-1.2552888561060966,0.21951219512195122,1.0,1.0,7/16,26.82%,MARS2;INMT;KYAT3;KYAT1;PSTK;TXNRD2;MARS1
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,-0.37873416210710076,-1.2546044022320586,0.1875,1.0,1.0,15/40,29.39%,YKT6;GOLIM4;RGPD1;BET1L;STX16;MAN2A1;CYTH4;NAPG;GOSR1;COG3;STX5;COG2;COG7;TRIP11;RIC1
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.33768716805958743,-1.254589103233598,0.09183673469387756,1.0,1.0,27/103,19.43%,AMN;MTHFD1;SLC46A1;NAMPT;NMNAT3;CYB5R3;MMUT;NUDT12;MTHFD1L;FPGS;SLC25A32;LDLRAP1;MTHFR;CYB5A;PARP16;PANK1;SLC19A2;SLC19A1;GSTO1;DHFR;NAXD;PPCDC;PARP4;PARP14;NT5E;MMADHC;ENPP3
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,-0.35674922546130844,-1.2533610093541123,0.20430107526881722,1.0,1.0,15/50,19.87%,VAMP3;CPNE8;FMNL3;OPHN1;JUP;CDC42BPB;STEAP3;TRIO;NIPSNAP2;ARHGAP1;WAS;PIK3R1;PREX1;PKN2;FNBP1L
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,-0.392257171142038,-1.2489198167893933,0.15294117647058825,1.0,1.0,4/25,2.69%,PRKCD;CREB1;PRKAR2B;CAMK2A
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,-0.405819809601188,-1.2488236089290614,0.1978021978021978,1.0,1.0,10/29,21.52%,ATP5F1E;SAMM50;CHCHD3;DNAJC11;DMAC2L;ATP5ME;ATP5MG;MICOS13;IMMT;ATP5F1C
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,-0.35558560966221775,-1.2478549970869033,0.14893617021276595,1.0,1.0,31/59,34.51%,CREB1;PPP2CB;SKP1;MAPK10;TNIP2;IKBKB;RPS6KA1;PPP2R1A;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;MAP3K7;NOD2;MAPK14;MAPK1;RPS27A;MAP2K1;JUN;MAPK11;CHUK;RPS6KA2;MAPKAPK3
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,-0.34804775361644674,-1.2465928868897052,0.1414141414141414,1.0,1.0,26/80,23.41%,CNTRL;NEK2;CDK5RAP2;MZT2A;PRKAR2B;DCTN3;TUBGCP6;CLASP1;CSNK1D;AKAP9;HAUS2;HAUS8;PLK1;CEP76;HAUS1;CEP290;PPP2R1A;CEP192;ACTR1A;CEP164;TUBGCP4;CEP78;HAUS7;TUBGCP2;TUBB4A;NINL
prerank,KEGG_2021_Human__TNF signaling pathway,-0.34518723181637767,-1.2462081249354409,0.14893617021276595,1.0,1.0,46/100,34.79%,MMP9;CREB1;JUNB;MAP3K5;BIRC3;JAG1;RPS6KA4;TNFRSF1B;TRAF1;IL6;MAPK10;PIK3R3;TRAF2;AKT2;IKBKB;PIK3CB;AKT3;PIK3R1;AKT1;FADD;MAPK8;TAB3;SOCS3;FOS;RPS6KA5;MAP2K4;MLKL;MAP3K7;IRF1;NOD2;MAPK14;CASP3;MAPK1;TRAF5;CCL5;MAP2K1;CXCL3;JUN;CCL2;DNM1L;MAPK11;CSF1;CHUK;MAPK13;RIPK3;TRADD
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.4585098046312843,-1.2456743903994532,0.21518987341772153,1.0,1.0,7/16,29.42%,TPST2;BPNT1;BPNT2;SLC35B3;SULT1A2;ABHD14B;SULT1A1
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.33480102445737103,-1.2452007465365165,0.11,1.0,1.0,40/110,29.19%,DARS1;RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;GNMT;RPL26L1;SECISBP2;QARS1;INMT;RPL38;HNMT;RPS16;RPS11;RPL7A;RPL29;SARS1;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;PSTK;RPS28;RPL15;RPL36AL;RPL11;RPL34;MARS1;KARS1;RPS27A;RPL36A;RPS27
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,-0.3462352669367046,-1.2443846020322897,0.17525773195876287,1.0,1.0,22/64,27.60%,MACO1;FLOT2;VAMP3;FMNL3;OPHN1;JUP;SLK;RTKN;RHOC;IQGAP1;DIAPH1;ARHGAP1;PIK3R1;PREX1;PKN2;FMNL2;ANLN;LBR;TFRC;STX5;ACBD5;ARHGEF10L
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,-0.45716039832294136,-1.241620163532402,0.21794871794871795,1.0,1.0,9/15,34.51%,RPA3;MLH1;EXO1;LRIG1;PCNA;POLR1B;MSH6;POLD4;POLD2
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,-0.3481426536934802,-1.2391649254748318,0.13402061855670103,1.0,1.0,23/75,23.23%,PIKFYVE;MTM1;INPP5K;PNPLA7;PLEKHA4;GDPD1;PI4KA;PIK3C2B;PIK3R4;PIK3R5;MTMR12;MTMR4;MTMR2;TNFAIP8L2;GDPD5;PIK3R3;VAC14;PIK3CB;PIK3R1;MTMR3;TNFAIP8L3;INPP5E;PNPLA6
prerank,KEGG_2021_Human__Fatty acid degradation,-0.38431388590494586,-1.2372236096466382,0.18085106382978725,1.0,1.0,11/36,20.48%,ALDH2;ACAT1;CPT1A;CPT1B;ACSL4;ECI2;ALDH1B1;ACSL6;ACSL3;HADH;ACOX1
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,-0.3713417130010421,-1.235789751151383,0.13186813186813187,1.0,1.0,19/44,29.76%,ABCC9;KCNG1;KCND3;KCNJ15;KCNJ2;GNG5;KCNA3;KCNQ1;HCN2;KCNC4;KCNC2;KCNN4;GNG3;GNG10;KCNQ5;KCNK7;GNG7;KCNC3;GNG4
prerank,KEGG_2021_Human__Salivary secretion,0.21876012370797135,1.2346747882326186,0.0,1.0,1.0,20/53,22.07%,PRKACB;LYZ;KCNMA1;GUCY1A1;AMY2B;CALM1;PLCB1;ADCY9;CD38;ADRA1A;PLCB3;CST3;BST1;PRKG1;ITPR2;GNAQ;SLC9A1;RYR3;CALM2;ATP1A1
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.3891131244559423,-1.2327688669858168,0.18681318681318682,1.0,1.0,13/37,25.00%,XRCC1;MPG;RPA3;PARP1;OGG1;SLC19A1;PARG;LRIG1;APEX1;PCNA;POLR1B;RFC3;UNG
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,-0.43123530182223935,-1.2326954921033901,0.21052631578947367,1.0,1.0,2/15,3.43%,PLXNA4;SEMA6A
prerank,KEGG_2021_Human__Galactose metabolism,-0.40103783707776114,-1.2309480235153951,0.21839080459770116,1.0,1.0,4/24,8.01%,B4GALT2;GALK1;GANC;PFKL
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.33759759747876655,-1.2308161370043682,0.16326530612244897,1.0,1.0,33/78,30.90%,ANAPC2;CDC16;ANAPC11;CDKN2C;CXCL8;H2BC14;IL6;CDC26;H3C7;H2BC13;ANAPC5;ANAPC10;H2AC14;H3C13;H2AZ1;UBE2E1;RPS6KA1;UBE2C;FOS;CDKN2B;ANAPC4;H3-3B;RPS6KA3;H2AX;MAPK7;ANAPC7;MAPK1;H2AC19;H2AB1;RPS27A;CDKN1B;JUN;H2BC17
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.3505832899499475,-1.23081231951402,0.18,1.0,1.0,22/68,23.41%,CNTRL;NEK2;CDK5RAP2;PRKAR2B;DCTN3;CLASP1;CSNK1D;AKAP9;HAUS2;HAUS8;PLK1;CEP76;HAUS1;CEP290;PPP2R1A;CEP192;ACTR1A;CEP164;CEP78;HAUS7;TUBB4A;NINL
prerank,KEGG_2021_Human__Folate biosynthesis,-0.4337684042210054,-1.229612482895554,0.22093023255813954,1.0,1.0,7/18,26.64%,TPH1;FPGS;DHFR;SPR;TPH2;PCBD2;AKR1B1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.32972011138112806,-1.227804428667361,0.09090909090909091,1.0,1.0,29/85,28.68%,USP9X;XPO1;SMURF1;TGFBR2;SMAD2;SRFBP1;PARP1;ITGB5;LTBP1;CDK8;ARHGEF18;MTMR4;EP300;STAT1;NEDD4L;UBE2M;CCNT2;SMURF2;SMAD7;YBX1;PPM1A;CDKN2B;NCOR1;CDK9;TGFB1;DAND5;MAPK1;ITGB8;RPS27A
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.3358420704049462,-1.2257767467631107,0.1702127659574468,1.0,1.0,24/90,18.54%,PPP2CB;XPO1;NUP37;CLASP1;CENPO;NUP133;SKA1;CENPU;DYNC1LI2;SPDL1;CENPF;INCENP;PLK1;CENPA;BUB3;PPP2R5E;ITGB3BP;MAD1L1;ZWINT;SPC25;CDCA8;CLASP2;DYNLL2;PPP2R1A
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,-0.3064449680847644,-1.2256057696287554,0.02,1.0,1.0,49/259,12.82%,CLSPN;REXO2;ANAPC2;DNA2;MCM5;CDC16;ANAPC11;PPP2CB;XPO1;RPA3;ORC3;NUP37;CLASP1;CDC25C;CENPO;MDM4;NUP133;SKA1;H2BC14;CCNE1;PSMC5;CENPU;DYNC1LI2;SPDL1;CENPF;PSMD5;PSMD8;CDC26;PIAS4;INCENP;PLK1;CENPA;HUS1;BUB3;PSMD13;EXO1;ORC6;PSMB10;PPP2R5E;RAD50;H2BC13;ITGB3BP;RBBP8;ANAPC5;ANAPC10;RAD9B;MAD1L1;RMI2;MDC1
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,-0.43443933937011486,-1.2246273381503021,0.23809523809523808,1.0,1.0,3/18,4.78%,GLUD1;FXYD2;SLC9A3
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.3287511677773805,-1.224176392571716,0.20618556701030927,1.0,1.0,14/74,12.82%,PPP4R2;CLSPN;DNA2;RPA3;H2BC14;PIAS4;HUS1;EXO1;RAD50;H2BC13;RBBP8;RAD9B;RMI2;MDC1
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,-0.38109457657416584,-1.2235166401873432,0.21839080459770116,1.0,1.0,15/29,31.86%,REXO2;BCL2L11;BBC3;AKT2;E2F1;AKT3;DYNLL2;AKT1;BID;MAPK8;TP53;YWHAZ;YWHAQ;PPP3CC;BMF
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,-0.40721309821016516,-1.223350063082582,0.23170731707317074,1.0,1.0,4/23,8.41%,TAS2R50;KCNJ2;SCNN1D;PLCB2
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.36828518819065237,-1.2230803042836063,0.18478260869565216,1.0,1.0,15/44,22.96%,BBS5;ARF4;BBS2;PKD1;SMOX;EXOC5;BBS12;BBS1;BBS9;BBS10;EXOC7;EXOC3;BBIP1;UNC119B;INPP5E
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,-0.39561678951378115,-1.2228013713821793,0.19148936170212766,1.0,1.0,8/32,12.44%,YKT6;SEC22B;VAMP3;USE1;BET1L;STX18;STX16;VAMP5
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.3210645924063907,-1.2221107860886575,0.09,1.0,1.0,59/167,29.39%,YKT6;SEC22B;VAMP3;KIF4A;ACTR10;COPZ2;DCTN3;GOLIM4;KIF6;ARF4;M6PR;RAB6A;KIF5C;RAB3GAP1;RGPD1;DYNC1LI2;BET1L;RAB9A;STX18;IGF2R;KIF19;STX16;MAN2A1;KIF13B;KIF3C;COPB1;RINT1;RHOBTB3;CYTH4;NAPG;COPE;UBE2Z;ARF5;KIF22;ARFIP2;DYNLL2;SCOC;DCTN4;COPZ1;NBAS;SYS1;BICD2;ACTR1A;VPS51;ARFGAP3;GOSR1;KIF1C;KIF9;COG3;STX5;ARCN1;COG2;KIF21B;COPB2;COG7;TRIP11;GALNT2;KIF3B;RIC1
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,-0.3928578694336061,-1.221257195948438,0.21505376344086022,1.0,1.0,11/29,26.21%,COL9A1;NCAM1;ITGB5;LAMC1;DAG1;VCAN;HSPG2;ITGAX;LMNB2;DCN;TGFB1
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.29995315130321576,1.2207784904026735,0.125,1.0,1.0,9/34,8.53%,SERPINB2;VPS72;RALA;PDCD4;S100A9;IL10;CNN2;PSME2;HNRNPF
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,0.25326699108753903,1.2204720428473292,0.21428571428571427,1.0,1.0,29/29,74.71%,RALA;KIDINS220;CRKL;MAPK12;MAPK3;GRB2;RAPGEF1;SOS1;NRAS;FRS2;BRAF;MAPKAPK2;YWHAB;SHC1;SRC;RALGDS;BCL11B;RALB;MAP2K2;MAPKAPK3;MAPK13;MAPK11;MAP2K1;HRAS;CRK;MAPK1;MAPK14;RAP1A;NTRK1
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,-0.3556984800230016,-1.2203953501786315,0.2087912087912088,1.0,1.0,20/37,37.84%,OR2B11;OR4K17;OR10H5;EBF1;OR6C74;OR2T33;OR6N1;OR52K2;OR2A7;OR11G2;OR1A1;OR7A17;OR1I1;OR56A4;OR2AT4;OR52N4;OR5AS1;OR52K1;OR4F17;OR1F1
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,-0.3451323233761669,-1.2199902661077744,0.25,1.0,1.0,16/56,19.76%,EIF4A1;RPS4X;EIF2S1;RPS20;RPS15A;RPS8;EIF3B;RPS16;EIF1AX;RPS11;RPS10;RPS14;EIF4A2;RPS23;RPS29;RPSA
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,-0.33574400593360715,-1.2179422238005446,0.09183673469387756,1.0,1.0,45/123,28.94%,PRKCD;CREB1;DGKQ;ABHD12;RGS19;GPR132;GNA11;LPAR6;UTS2B;GPR68;RGS18;F2R;GNRH1;PLCB2;UTS2R;GNG5;NMUR1;GHRL;DGKH;DGKA;PIK3R3;UTS2;P2RY6;TRIO;DGKG;PLCB4;PIK3R1;RPS6KA1;DHX34;P2RY1;KISS1R;TRPC6;TBXA2R;GNG3;RPS6KA3;MAPK7;GNG10;DGKE;MAPK1;NTSR1;GNG7;AGXT;PTAFR;LTB4R2;HRAS
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,-0.3209077759905993,-1.217876953309347,0.09090909090909091,1.0,1.0,53/182,23.41%,CNTRL;NEK2;CDK5RAP2;MZT2A;PRKAR2B;PPP2CB;XPO1;DCTN3;TUBGCP6;NUP37;CLASP1;CSNK1D;CENPO;NUP133;SKA1;AKAP9;CENPU;HAUS2;DYNC1LI2;SPDL1;CENPF;HAUS8;WAPL;INCENP;PLK1;CENPA;BUB3;PPP2R5E;CEP76;ITGB3BP;HAUS1;MAD1L1;CSNK2A2;ZWINT;SPC25;NEK9;CDCA8;CLASP2;CEP290;DYNLL2;PPP2R1A;CEP192;PDS5B;CENPT;KNL1;ACTR1A;CEP164;TUBGCP4;CEP78;HAUS7;TUBGCP2;TUBB4A;NINL
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.3983426821172009,-1.2157257073787113,0.19767441860465115,1.0,1.0,9/25,24.05%,RPA3;PARP1;SLC19A1;PARG;LRIG1;APEX1;PCNA;POLR1B;RFC3
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,0.18192045809535262,1.2150977512892065,0.0,1.0,1.0,35/95,22.28%,PSMB5;MUL1;ATF4;SQSTM1;SKP2;PSMD9;PSMC3;PSMC6;PSMB7;TKT;MAP1LC3B;PSME2;CREBBP;MAFG;SRXN1;UBC;PSMD11;TXNRD1;UBXN7;UBL4A;PSMD6;UBB;SLC7A11;PSMF1;GSR;PSMD3;BTRC;PHGDH;CUL1;MAFK;PSMB3;PSMB2;SESN1;PSMA7;BRIP1
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.33255797099623624,-1.2142820026285908,0.1717171717171717,1.0,1.0,36/95,29.33%,EIF2AK4;RPS4X;EIF2S1;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;RPL38;RPS16;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;GCN1;RPL27;RPL14;RPSA;RPS28;RPL15;ATF3;RPL36AL;RPL11;ASNS;RPL34;RPS27A;RPL36A;RPS27;EIF2S3
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.36357498865200916,-1.212638626936999,0.20212765957446807,1.0,1.0,12/36,22.99%,ANAPC2;CDC16;ANAPC11;CCNE1;CDC26;ANAPC5;ANAPC10;UBE2E1;E2F1;UBE2C;CCND2;ANAPC4
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,-0.4648020995108849,-1.2123525723712076,0.23809523809523808,1.0,1.0,3/16,3.30%,ACOT8;ABCB11;NCOA1
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.3504786700355807,-1.2113244818525237,0.22916666666666666,1.0,1.0,8/44,10.53%,TOP2B;NUP88;NUP37;NUP133;POM121;PIAS4;INCENP;TOP1
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.33955223579447225,-1.2103771895763449,0.2268041237113402,1.0,1.0,16/57,19.76%,EIF4A1;RPS4X;EIF2S1;RPS20;RPS15A;RPS8;EIF3B;RPS16;EIF1AX;RPS11;RPS10;RPS14;EIF4A2;RPS23;RPS29;RPSA
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,-0.35176512065209986,-1.2102736033368169,0.15053763440860216,1.0,1.0,19/56,21.29%,PRKAG2;TNFRSF1B;CPT1A;CPT1B;ACSL4;STK11;MAPK10;ACSL6;TRAF2;PPARA;AKT2;IKBKB;ACSL3;G6PC3;AKT3;AKT1;PRKAG1;MAPK8;SOCS3
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,0.28405692489845247,1.2095905688316426,0.1875,1.0,1.0,6/24,7.59%,RARA;NR3C2;AREG;RXRA;THRA;NR4A2
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.33290124115376707,-1.2093671514221174,0.15053763440860216,1.0,1.0,25/94,18.54%,PPP2CB;XPO1;NUP37;CLASP1;CENPO;NUP133;SKA1;CENPU;DYNC1LI2;SPDL1;CENPF;INCENP;PLK1;CENPA;BUB3;PPP2R5E;ITGB3BP;MAD1L1;ZWINT;SPC25;NEK9;CDCA8;CLASP2;DYNLL2;PPP2R1A
prerank,KEGG_2021_Human__Oocyte meiosis,-0.3129180685406918,-1.207651979876204,0.17346938775510204,1.0,1.0,44/99,34.89%,ANAPC2;CDC16;ANAPC11;PPP2CB;CAMK2A;CDC25C;CCNE1;SLK;SKP1;CDC26;PLK1;PPP2R5E;SPDYE18;IGF1R;ANAPC5;ANAPC10;MAD1L1;FBXO5;CPEB2;RPS6KA1;PPP2R1A;ADCY3;FBXW11;PTTG2;ANAPC4;RPS6KA3;CDK1;ANAPC7;CPEB4;YWHAZ;MAPK14;MAPK1;MAP2K1;YWHAQ;BUB1;AURKA;PPP3CC;MAPK11;RBX1;ADCY7;RPS6KA2;MAPK13;CDK2;ESPL1
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,-0.3517872035137699,-1.207397981339992,0.21052631578947367,1.0,1.0,7/43,6.58%,GABARAPL2;GGA3;TBC1D10C;RAB6A;TBC1D10B;TBC1D15;TBC1D24
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.3812743549828259,-1.2072891153596546,0.21978021978021978,1.0,1.0,6/34,7.31%,NXF1;NUP88;NUP37;NUP133;NCBP2;POM121
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.44081645558280524,-1.2065962187603976,0.2235294117647059,1.0,1.0,3/18,5.34%,RFNG;RAB6A;LFNG
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",-0.3965883739426745,-1.2060022270204565,0.2261904761904762,1.0,1.0,10/25,27.91%,GLUD1;GFPT1;ALDH5A1;GOT1;ALDH4A1;IL4I1;PPAT;ASNS;AGXT;NIT2
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,-0.3131823103598675,-1.205676408707439,0.17,1.0,1.0,42/128,27.61%,YKT6;MACO1;ARHGEF4;FLOT2;VAMP3;FAM13A;ARHGAP11B;ARHGDIB;FMNL3;OPHN1;ARHGAP10;ARHGAP42;JUP;ARHGAP23;SLK;RHPN1;BCAP31;RTKN;ARHGEF18;STBD1;IQGAP1;DIAPH1;TRIO;OBSCN;ARHGAP1;ARHGEF15;PIK3R1;ARAP2;PREX1;PKN2;DEF6;ANLN;LBR;STARD8;DDRGK1;TFRC;PRKCSH;STX5;ACBD5;RHPN2;ARHGEF10L;TMEM87A
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,-0.341351950554274,-1.2034448086311016,0.1702127659574468,1.0,1.0,31/62,34.51%,CREB1;PPP2CB;SKP1;MAPK10;TNIP2;IKBKB;RPS6KA1;PPP2R1A;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;MAP3K7;NOD2;MAPK14;MAPK1;RPS27A;MAP2K1;JUN;MAPK11;CHUK;RPS6KA2;MAPKAPK3
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,-0.3736812424523501,-1.202450772911421,0.19148936170212766,1.0,1.0,19/40,28.31%,JARID2;H2BC14;AEBP2;EZH2;H3C7;H2BC13;DNMT1;RBBP7;H2AC14;MTF2;H3C13;H2AZ1;DNMT3B;H3-3B;H2AX;EED;RBBP4;H2AC19;H2AB1
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,-0.36506026970084415,-1.201880070681315,0.2111111111111111,1.0,1.0,18/44,29.48%,BPGM;ALDH2;AKR1A1;DLAT;PFKL;ALDH1B1;PGAM2;ALDH3B1;MINPP1;ACSS2;G6PC3;GPI;LDHB;ACSS1;ENO1;ALDH9A1;LDHA;PFKP
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.3303681351251651,-1.2015460079746232,0.20833333333333334,1.0,1.0,14/74,12.29%,NEK2;ANAPC2;CDC16;ANAPC11;PSMC5;PSMD5;PSMD8;CDC26;PLK1;BUB3;PSMD13;PSMB10;ANAPC5;ANAPC10
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,0.29445252127186383,1.2014586349184326,0.16666666666666666,1.0,1.0,4/15,10.27%,UGT2B4;DHRS11;AKR1C1;HSD17B12
prerank,Reactome_2022__Circadian Clock R-HSA-400253,-0.32207279394731736,-1.2012623642306215,0.15463917525773196,1.0,1.0,15/64,15.20%,CREB1;HDAC3;NAMPT;NCOA1;CRTC1;CSNK1D;RORA;SKP1;CPT1A;LIN9;EP300;NR1D1;PPARA;BHLHE41;BMAL1
prerank,KEGG_2021_Human__Drug metabolism,-0.3432143284255929,-1.199662791727272,0.17894736842105263,1.0,1.0,20/59,25.28%,UCKL1;MGST1;MGST2;IMPDH1;DPYD;HPGDS;UPB1;GSTA4;GSTO1;TK2;ALDH3B1;MGST3;UCK2;GSTM1;TK1;DUT;ITPA;RRM2B;GSTM5;NME1-NME2
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.3088171343387248,-1.1991006537004318,0.12,1.0,1.0,44/174,19.95%,PIKFYVE;LPIN1;DGAT2;MTM1;PCTP;INPP5K;PNPLA7;PLEKHA4;CDS2;GDPD1;ABHD3;PI4KA;PLAAT2;PIK3C2B;LPGAT1;PIK3R4;GPAT3;PIK3R5;MTMR12;MTMR4;MBOAT1;STARD7;ACHE;MTMR2;TNFAIP8L2;SLC44A4;LCLAT1;CSNK2A2;GDPD5;PIK3R3;CPNE3;PTPMT1;CHKB;VAC14;PIK3CB;PLD4;PITPNM2;GPAT2;PIK3R1;CHPT1;OSBPL8;MFSD2A;PLA2G15;MTMR3
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,-0.34675351411034167,-1.1969699834149257,0.25263157894736843,1.0,1.0,18/47,29.81%,CTSL;PARP16;PIK3R4;CHMP4B;VCP;GANAB;PARP4;UVRAG;PARP14;ST6GALNAC4;RNF103-CHMP3;VHL;ST6GALNAC3;PRKCSH;ST3GAL4;RPS27A;PIK3C3;ZCRB1
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,-0.3683607396553301,-1.1965980630655089,0.25301204819277107,1.0,1.0,4/29,2.69%,PRKCD;CREB1;PRKAR2B;CAMK2A
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.15660968839752298,1.1964806617146202,0.0,1.0,1.0,30/164,12.77%,GDF11;LEPR;IL24;IL23R;TNFSF14;IL13RA1;BMP7;CXCR1;IL18RAP;IL20RB;TNFSF8;IL1RL1;CCR9;TNFRSF10C;CXCR2;LTB;IFNLR1;IL10;CCL3;CD4;CCL28;IL15;IL1R1;IL4R;RELT;IL7;TNFRSF17;IL10RB;CCR8;LTBR
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.34088720261641176,-1.1947437493787825,0.25,1.0,1.0,16/56,19.76%,EIF4A1;RPS4X;EIF2S1;RPS20;RPS15A;RPS8;EIF3B;RPS16;EIF1AX;RPS11;RPS10;RPS14;EIF4A2;RPS23;RPS29;RPSA
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,-0.32434888463314115,-1.194440963104702,0.18556701030927836,1.0,1.0,46/103,35.25%,CREB1;NKIRAS2;NFKB2;PPP2CB;BIRC3;TMED7-TICAM2;SKP1;MAPK10;ALPK1;TNIP2;LRRC14;IKBKB;RPS6KA1;NLRC5;N4BP1;PPP2R1A;FADD;LY96;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;MAP2K1;JUN;NDUFA2;MAPK11;CHUK;RPS6KA2;MAPKAPK3;RIPK3;S100B
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.36284133000517893,-1.1943672084965509,0.27586206896551724,1.0,1.0,12/37,24.74%,DNA2;RPA3;HUS1;EXO1;RAD50;RBBP8;RAD9B;RMI2;POLR1B;CHEK1;RFC3;TOP3A
prerank,KEGG_2021_Human__Endocytosis,-0.29724429571681976,-1.1928248009390052,0.08,1.0,1.0,60/234,22.79%,VPS4B;PSD3;NEDD4;SNX5;VPS37B;DNAJC6;SMURF1;TGFBR2;SMAD2;RAB11B;CCR5;CLTCL1;IQSEC1;ARF4;IL2RA;VPS26A;MVB12B;VPS35;HSPA6;SNF8;KIF5C;SNX2;LDLRAP1;USP8;AP2M1;SNX12;CBLB;WASHC2A;RAB31;IST1;IGF2R;MVB12A;RNF41;PML;CHMP4B;IGF1R;CXCR4;ACAP1;CLTB;ASAP2;SPG21;NEDD4L;DNM1;ARRB1;CYTH4;SMAP2;ARF5;EEA1;ARAP2;SMURF2;ARPC3;BIN1;GRK3;TRAF6;CAV2;WWP1;AGAP6;ACTR3B;CLTC;ARFGAP3
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.40863772603172704,-1.191591698247611,0.3048780487804878,1.0,1.0,9/20,28.68%,JAG1;PSEN1;TACC3;PSENEN;NCSTN;ADAM10;YBX1;NEURL1;RPS27A
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.3155101902854125,-1.1912100821131897,0.21,1.0,1.0,16/87,12.29%,ANAPC2;MCM5;CDC16;ANAPC11;ORC3;CCNE1;PSMC5;SKP1;PSMD5;PSMD8;CDC26;PSMD13;ORC6;PSMB10;ANAPC5;ANAPC10
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,-0.4215046147842033,-1.1892600013100512,0.25609756097560976,1.0,1.0,5/16,17.35%,VPS37B;MVB12B;NMT2;MVB12A;UBAP1
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.4087994966647572,-1.1877760579063124,0.23255813953488372,1.0,1.0,4/24,5.69%,ACOT8;ABCB11;NCOA1;OSBPL3
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.3270215558667169,-1.1873707325420852,0.20202020202020202,1.0,1.0,34/77,33.48%,TCEA1;ELOC;TAF5;MNAT1;NCBP2;CDC73;TAF1;TAF4;POLR2I;ELOA;NELFA;MLLT3;CTR9;SUPT6H;CCNT2;MLLT1;SSRP1;GTF2A1;TAF12;LEO1;TAF15;SUPT4H1;CDK9;GTF2H3;TAF9B;TAF2;POLR2D;POLR2B;ELL;SUPT5H;RTF1;GTF2H1;NELFCD;TAF11
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,-0.3460409989578432,-1.187230262117621,0.26262626262626265,1.0,1.0,16/52,21.63%,ITGA10;JUP;ITGB5;CACNG8;ITGA5;CACNB3;CTNNA1;DAG1;TCF7L2;DES;ITGA4;CACNA2D2;CACNB2;CACNB4;TCF7L1;SLC8A1
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.3493370924234618,-1.1868467771918214,0.25806451612903225,1.0,1.0,6/42,6.33%,ERCC5;XPC;RPA3;ERCC4;PARP1;MNAT1
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,-0.4016979587056204,-1.1856367899865707,0.25609756097560976,1.0,1.0,7/20,17.37%,B4GALT2;LARGE2;POMGNT1;FUT4;B4GALT3;LARGE1;FKRP
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.4181060805417268,-1.1854314500983558,0.24705882352941178,1.0,1.0,8/17,28.68%,JAG1;CNTN1;PSEN1;PSENEN;NCSTN;ADAM10;NEURL1;RPS27A
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.39385169283418664,-1.1852741984109387,0.23863636363636365,1.0,1.0,13/27,34.63%,PC;DLAT;SDHC;SUCLG1;DLST;SDHA;SUCLG2;IDH3G;CS;IDH2;SDHD;OGDH;ACO1
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.28958583761337564,1.1849525334442026,0.125,1.0,1.0,16/16,71.07%,HBEGF;EREG;PLCG1;GRB2;SOS1;EGF;NRG4;NRAS;NRG1;CDC37;ERBB2;HSP90AA1;SHC1;ERBIN;ERBB3;HRAS
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,-0.32017447817422695,-1.1845410505708651,0.18556701030927836,1.0,1.0,32/114,21.30%,PPP2CB;XPO1;FMNL3;NUP37;CLASP1;CENPO;NUP133;SKA1;CENPU;DYNC1LI2;SPDL1;CENPF;INCENP;PLK1;CENPA;BUB3;PPP2R5E;ITGB3BP;RHOC;MAD1L1;ZWINT;SPC25;DIAPH1;CDCA8;CLASP2;DYNLL2;PFN2;PPP2R1A;RNASE1;FMNL2;CENPT;KNL1
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.3173896876030783,-1.1842206608701198,0.19,1.0,1.0,44/112,28.92%,SAP30;SAP18;JARID2;H2BC14;AEBP2;MNAT1;SIN3A;EZH2;DEK;EP300;SAP30BP;H3C7;H2BC13;UBTF;KAT2B;TAF1C;DNMT1;RBBP7;SAP130;MTA2;H2AC14;MTF2;H3C13;TAF1B;H2AZ1;POLR1G;POLR1E;DNMT3B;KAT2A;POLR1B;SMARCA5;TTF1;H3-3B;CHD4;H2AX;GTF2H3;EED;RBBP4;BAZ2A;DPEP3;H2AC19;H2AB1;TET2;CHD3
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.37669669427437347,-1.1837793567684498,0.21978021978021978,1.0,1.0,6/35,7.31%,NXF1;NUP88;NUP37;NUP133;NCBP2;POM121
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,-0.40234909513697475,-1.1834709135472115,0.26506024096385544,1.0,1.0,10/20,34.51%,DNA2;RPA3;SLC19A1;LRIG1;PCNA;POLR1B;RFC3;PRIM1;POLD4;POLD2
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,-0.41383987050808957,-1.1833710910412154,0.25,1.0,1.0,12/20,33.96%,PPP2CB;RPS6KA1;PPP2R1A;MEF2C;RPS6KA5;RPS6KA3;MAPK7;DUSP6;MAPK14;MAPK1;MAPK11;RPS6KA2
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,-0.33461630779777674,-1.182999806453049,0.21212121212121213,1.0,1.0,22/71,23.41%,CNTRL;NEK2;CDK5RAP2;PRKAR2B;DCTN3;CLASP1;CSNK1D;AKAP9;HAUS2;HAUS8;PLK1;CEP76;HAUS1;CEP290;PPP2R1A;CEP192;ACTR1A;CEP164;CEP78;HAUS7;TUBB4A;NINL
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.37463380369090593,-1.182113981015476,0.27058823529411763,1.0,1.0,8/29,17.39%,LSM10;SNRPE;SNRPB;NCBP2;CPSF2;PAPOLA;CSTF2;SNRPF
prerank,KEGG_2021_Human__Ether lipid metabolism,0.23742367919926413,1.181048102640765,0.4,1.0,1.0,8/35,8.12%,LPCAT2;PLB1;UGT8;PLAAT3;PAFAH1B1;PAFAH1B2;PEDS1-UBE2V1;AGPS
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,-0.310804742701102,-1.1792719071830324,0.18,1.0,1.0,55/142,33.89%,VPS4B;TCEA1;VPS37B;XPO1;NUP88;ELOC;CCR5;NUP37;TAF5;NUP133;MVB12B;MNAT1;NCBP2;TAF1;POM121;NMT2;TAF4;POLR2I;XRCC5;MVB12A;CHMP4B;CXCR4;ELOA;NELFA;NEDD4L;LRIG1;RNGTT;UBAP1;CCNT2;SSRP1;GTF2A1;XRCC4;TAF12;TAF15;SUPT4H1;RNF103-CHMP3;CDK9;GTF2H3;CHMP5;TAF9B;TAF2;POLR2D;KPNA1;NUP43;RPS27A;POLR2B;SGIP1;NUP85;ELL;SUPT5H;VPS4A;GTF2H1;NELFCD;TAF11;VPS37C
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,-0.42679515731183726,-1.1784476451700792,0.23255813953488372,1.0,1.0,9/19,33.72%,UCKL1;APRT;TK2;UCK2;TK1;SCO2;AMPD2;AMPD3;GMPR
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.35403216804821974,-1.1769550678471947,0.31521739130434784,1.0,1.0,7/38,10.74%,NUP88;NUP37;NUP133;PIAS2;POM121;PIAS4;PML
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.4366261857067437,-1.1764284048000924,0.325,1.0,1.0,3/15,7.48%,AMN;MMUT;LDLRAP1
prerank,KEGG_2021_Human__Pyrimidine metabolism,-0.3366856411341889,-1.1757540789258754,0.23333333333333334,1.0,1.0,15/50,19.93%,UCKL1;CTPS2;DPYD;UPB1;CANT1;TK2;UCK2;CMPK2;TK1;NT5E;NT5C1A;DTYMK;NT5C3B;ENPP3;DUT
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,-0.30740227067659465,-1.175245938800513,0.2,1.0,1.0,52/145,29.74%,ATP6V1E1;EIF2AK4;RPS4X;EIF2S1;RPS20;RPS15A;RPL39;RPL4;RPS8;LAMTOR2;RPL26L1;ATP6V0B;RPL38;ATP6V1E2;WDR59;RPS16;RRAGB;RPS11;TCIRG1;RPL7A;ATP6V0D1;FNIP1;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;GCN1;RPL27;RPL14;RPSA;SZT2;RPS28;NPRL3;RPL15;ATF3;RPL36AL;RPL11;RPTOR;ASNS;RPL34;MIOS;RPS27A;ATP6V0C;RPL36A;RPS27;EIF2S3;NPRL2;ITFG2
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.3181098744423413,-1.1748181398006434,0.19,1.0,1.0,34/102,27.37%,SEC22B;KIF4A;ACTR10;COPZ2;DCTN3;KIF6;ARF4;RAB6A;KIF5C;RAB3GAP1;DYNC1LI2;STX18;KIF19;KIF13B;KIF3C;COPB1;RINT1;NAPG;COPE;UBE2Z;ARF5;KIF22;DYNLL2;DCTN4;COPZ1;NBAS;BICD2;ACTR1A;ARFGAP3;KIF1C;KIF9;ARCN1;KIF21B;COPB2
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.3230308237154341,-1.1743714654052828,0.21875,1.0,1.0,13/71,12.29%,NEK2;ANAPC2;CDC16;ANAPC11;PSMC5;PSMD5;PSMD8;CDC26;BUB3;PSMD13;PSMB10;ANAPC5;ANAPC10
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,-0.40151421637155993,-1.1743628223021407,0.2857142857142857,1.0,1.0,2/18,1.45%,PTPN4;PTPN23
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.3135782144198067,-1.1728743810568079,0.2268041237113402,1.0,1.0,28/103,21.30%,PPP2CB;XPO1;NUP37;CLASP1;CENPO;NUP133;SKA1;CENPU;DYNC1LI2;SPDL1;CENPF;WAPL;INCENP;PLK1;CENPA;BUB3;PPP2R5E;ITGB3BP;MAD1L1;ZWINT;SPC25;CDCA8;CLASP2;DYNLL2;PPP2R1A;PDS5B;CENPT;KNL1
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.3631858523641706,-1.1722213190211574,0.24731182795698925,1.0,1.0,5/34,7.31%,XPO1;NUP88;NUP37;NUP133;POM121
prerank,KEGG_2021_Human__Measles,-0.29926865006972353,-1.1700984677303221,0.22448979591836735,1.0,1.0,34/117,21.80%,CD3D;EIF2AK4;EIF2S1;IL2RA;CCNE1;HSPA6;TYK2;CBLB;RAB9A;IL6;EIF2AK2;MAPK10;CSNK2A2;PIK3R3;STAT1;BBC3;AKT2;IKBKB;MSN;PIK3CB;CD3E;AKT3;CD3G;PIK3R1;STAT5A;AKT1;BAX;BID;FADD;CCND2;MAPK8;TRAF6;FOS;IFNAR1
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.3074722688386151,-1.1697081121053328,0.17,1.0,1.0,53/153,30.61%,DNAJC3;XPO1;NUP88;RPS4X;RPS20;RPS15A;NUP37;RPL39;RPL4;NUP133;RPS8;PARP1;RPL26L1;POM121;RPL38;POLR2I;IPO5;RPS16;EIF2AK2;KPNA4;KPNA2;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;RPS28;CLTC;XK;RPL15;RPL36AL;RPL11;TGFB1;RPL34;POLR2D;KPNA3;KPNA1;NUP43;RPS27A;RPL36A;RPS27;POLR2B;CALR;NUP85;RPL26
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,-0.3205046443433509,-1.1691636007823392,0.23232323232323232,1.0,1.0,28/66,33.48%,TCEA1;ELOC;TAF5;MNAT1;NCBP2;TAF1;TAF4;POLR2I;ELOA;NELFA;RNGTT;CCNT2;SSRP1;GTF2A1;TAF12;TAF15;SUPT4H1;CDK9;GTF2H3;TAF9B;TAF2;POLR2D;POLR2B;ELL;SUPT5H;GTF2H1;NELFCD;TAF11
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.3158909700948099,-1.1670572260885035,0.2222222222222222,1.0,1.0,17/78,13.65%,MAML2;JAG1;ACTA2;PSMC5;GATD3;SKP1;PSMD5;PSMD8;EP300;PSMD13;MAML3;PSMB10;MAMLD1;KAT2B;PSEN1;TACC3;PSENEN
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.33595424047717504,-1.1670135928548169,0.2857142857142857,1.0,1.0,9/54,9.12%,PHC3;NUP88;NUP37;SCMH1;NUP133;PIAS2;POM121;CBX4;RNF2
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.3405501030735224,-1.1647490714343203,0.30526315789473685,1.0,1.0,19/49,29.33%,RPS4X;EIF2S1;RPS20;RPS15A;RPS8;EIF3B;RPS16;EIF1AX;RPS11;RPS10;RPS14;RPS23;RPS29;RPSA;RPS28;EIF3L;RPS27A;RPS27;EIF2S3
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,0.29253519125901406,1.1645450931646841,0.3,1.0,1.0,8/20,14.49%,PLB1;SDC3;AKR1C1;SDC2;SDC4;RETSAT;RDH11;LRP12
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.3515982438489544,-1.1636947655582506,0.27956989247311825,1.0,1.0,12/38,22.99%,ANAPC2;CDC16;ANAPC11;CCNE1;CDC26;ANAPC5;ANAPC10;UBE2E1;E2F1;UBE2C;CCND2;ANAPC4
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,-0.39532941947985994,-1.1635142995645766,0.27380952380952384,1.0,1.0,12/28,27.74%,GCSH;ACAT1;MMUT;AMT;ACSS2;GLYCTK;CAT;MCEE;CS;PGP;ACSS1;AGXT
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.3341146834876147,-1.162940941906479,0.2,1.0,1.0,25/57,33.13%,TCEA1;ELOC;MNAT1;NCBP2;CDC73;POLR2I;ELOA;NELFA;MLLT3;CTR9;SUPT6H;CCNT2;MLLT1;SSRP1;LEO1;SUPT4H1;CDK9;GTF2H3;POLR2D;POLR2B;ELL;SUPT5H;RTF1;GTF2H1;NELFCD
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.36958086815684316,-1.1619834522300974,0.23255813953488372,1.0,1.0,19/29,45.21%,ELOC;CUL5;TYK2;SYK;STAT1;RNF7;STAT5A;SOCS3;JAK2;LYN;RPS27A;STAT5B;UBE2D2;CSF3R;JAK1;GAB2;UBA52;SHC1;STAT3
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.2462400436878017,1.1616123116431527,0.26666666666666666,1.0,1.0,7/20,18.33%,AHCY;PRNP;OPLAH;TBXAS1;FDXR;CYP2R1;FMO3
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,-0.31987602649442115,-1.1612055793897795,0.23232323232323232,1.0,1.0,40/104,28.91%,INSL3;LPAR6;P2RY14;MC1R;UTS2B;F2R;P2RX4;GNRH1;S1PR2;CTSG;UTS2R;NMUR1;GHRL;S1PR1;HRH2;ADM;CHRNE;UTS2;P2RY6;C5AR1;RLN2;GABRR2;S1PR5;CHRNA5;ADORA2A;SCT;P2RY1;KISS1R;CNR2;TBXA2R;P2RX1;GZMA;SSTR2;PLG;ADORA2B;ADORA3;CHRNB1;NTSR1;PTAFR;LTB4R2
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.3365234475097101,-1.1610738208180655,0.24175824175824176,1.0,1.0,21/48,32.77%,CREB1;GLUD1;HDAC3;POLRMT;NCOA1;CRTC1;SIRT3;LIN9;NR1D1;PPARA;ACSS2;MEF2C;NCOR1;TFB2M;PPARGC1B;TBL1XR1;CARM1;IDH2;GABPA;SIRT5;CHD9
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,-0.3617043208936735,-1.1608201972905148,0.3333333333333333,1.0,1.0,6/25,14.41%,ATP6V1E1;ATP6V0B;ATP6V1E2;STEAP3;TCIRG1;ATP6V0D1
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.3109244818489954,-1.159565175031306,0.25263157894736843,1.0,1.0,38/102,29.64%,GLIPR1;MED18;HDAC3;NCOA1;GRHL1;RORA;CDK8;SIN3A;CPT1A;MED25;MED27;LIN9;EP300;MED30;ABCA1;SLC27A1;NCOA3;NR1D1;PPARA;BMAL1;MED24;PLIN2;PEX11A;MIA3;ACOX1;MED17;MED15;MED21;NCOR1;MED26;PPARGC1B;DAND5;TBL1XR1;AGXT;CARM1;MED4;MED12;FDFT1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.3158875788338186,-1.159401163279266,0.27835051546391754,1.0,1.0,13/73,12.29%,NEK2;ANAPC2;CDC16;ANAPC11;PSMC5;PSMD5;PSMD8;CDC26;BUB3;PSMD13;PSMB10;ANAPC5;ANAPC10
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.32638613540483385,-1.1589962808988374,0.25773195876288657,1.0,1.0,18/49,28.68%,USP9X;SMAD2;PARP1;CDK8;EP300;STAT1;NEDD4L;CCNT2;SMURF2;SMAD7;YBX1;PPM1A;CDKN2B;NCOR1;CDK9;DAND5;MAPK1;RPS27A
prerank,KEGG_2021_Human__Mitophagy,-0.31993765706916555,-1.1585875616462549,0.2708333333333333,1.0,1.0,22/65,22.31%,GABARAPL2;BNIP3;TFEB;TBC1D15;USP8;FIS1;TOMM7;MRAS;FUNDC1;MAPK10;RRAS;CSNK2A2;E2F1;RRAS2;ATG5;MFN1;TAX1BP1;MAPK8;USP30;RHOT2;BCL2L13;ATG9A
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,-0.33808669670185965,-1.1583430759018565,0.20408163265306123,1.0,1.0,15/69,17.18%,AP1M1;CLVS1;SNX5;DNAJC6;AP3S1;M6PR;SNX2;AP4S1;IGF2R;GNS;BLOC1S3;CLTB;ARRB1;AP1S1;AP4B1
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.3539587075615507,-1.1581983660877315,0.24719101123595505,1.0,1.0,14/45,18.87%,MAML2;HDAC3;GATD3;CDK8;SKP1;TLE2;EP300;MAML3;MAMLD1;KAT2B;HDAC11;HDAC6;TLE1;KAT2A
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,-0.36689859149428705,-1.1580077977028962,0.2857142857142857,1.0,1.0,7/30,16.64%,B3GLCT;C1GALT1;LFNG;POMGNT1;DAG1;SEMA5B;LARGE1
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.3519814929167333,-1.1573079012526541,0.28735632183908044,1.0,1.0,13/40,24.74%,DNA2;RPA3;HUS1;EXO1;RAD50;RBBP8;RAD9B;RMI2;POLR1B;CHEK1;RAD51AP1;RFC3;TOP3A
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,-0.33219943260098983,-1.156961996241558,0.25773195876288657,1.0,1.0,27/73,27.79%,YKT6;ACTR10;COPZ2;DCTN3;GOLGA2;ARF4;TMEM115;DYNC1LI2;BET1L;COPB1;ANK2;NAPG;COPE;ARF5;SPTBN1;DYNLL2;DCTN4;COPZ1;ACTR1A;ARFGAP3;GOSR1;COG3;STX5;ARCN1;COG2;COPB2;COG7
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,-0.35558556965380594,-1.156883934482906,0.25842696629213485,1.0,1.0,14/32,33.13%,TCEA1;ELOC;POLR2I;ELOA;NELFA;CCNT2;SSRP1;SUPT4H1;CDK9;POLR2D;POLR2B;ELL;SUPT5H;NELFCD
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,-0.42323886674644884,-1.1568023604175113,0.27906976744186046,1.0,1.0,5/16,10.27%,CDC25C;CENPF;PLK1;LIN9;EP300
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,-0.40973502124397265,-1.1567434818365778,0.2716049382716049,1.0,1.0,6/18,15.07%,NCOA1;RORA;CPT1A;LIN9;EP300;PPARA
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.3388722923842894,-1.1564145335391425,0.21428571428571427,1.0,1.0,23/49,35.15%,DNA2;RPA3;POT1;CTC1;SLC19A1;WRAP53;LRIG1;ANKRD28;PCNA;POLR1B;RTEL1;RFC3;TERF1;TINF2;PIF1;DKC1;PPP6C;PRIM1;POLD4;POLD2;CDK2;RUVBL1;TERF2IP
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.3196889420692024,-1.15626257414394,0.15306122448979592,1.0,1.0,50/113,34.02%,MMP9;MGST1;CTSL;ACVR2B;MAP3K5;MGST2;PLAT;PIAS4;GSTA4;MAPK10;MAP2K5;GSTO1;PIK3R3;SUMO4;AKT2;MGST3;IKBKB;ACVR2A;GSTM1;PIK3CB;AKT3;PIK3R1;AKT1;BMPR1A;MEF2C;MAPK8;FOS;CAV2;BMPR2;MAP2K4;DUSP1;GSTM5;MAPK7;TP53;KLF2;MAP3K7;MAPK14;RAC1;THBD;RAC3;HSP90AB1;ARHGEF2;GSTM2;JUN;CCL2;MAPK11;GSTO2;CHUK;RAC2;MAPK13
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,-0.3102224503712694,-1.1544256792027963,0.2765957446808511,1.0,1.0,37/100,29.64%,GLIPR1;MED18;HDAC3;NCOA1;GRHL1;RORA;CDK8;CPT1A;MED25;MED27;LIN9;EP300;MED30;ABCA1;SLC27A1;NCOA3;NR1D1;PPARA;BMAL1;MED24;PLIN2;PEX11A;MIA3;ACOX1;MED17;MED15;MED21;NCOR1;MED26;PPARGC1B;DAND5;TBL1XR1;AGXT;CARM1;MED4;MED12;FDFT1
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,-0.3032741833328824,-1.1540788872394092,0.23,1.0,1.0,49/129,33.89%,VPS4B;TCEA1;VPS37B;XPO1;NUP88;ELOC;NUP37;TAF5;NUP133;MVB12B;MNAT1;NCBP2;TAF1;POM121;NMT2;TAF4;POLR2I;MVB12A;CHMP4B;ELOA;NELFA;NEDD4L;RNGTT;UBAP1;CCNT2;SSRP1;GTF2A1;TAF12;TAF15;SUPT4H1;RNF103-CHMP3;CDK9;GTF2H3;CHMP5;TAF9B;TAF2;POLR2D;NUP43;RPS27A;POLR2B;SGIP1;NUP85;ELL;SUPT5H;VPS4A;GTF2H1;NELFCD;TAF11;VPS37C
prerank,KEGG_2021_Human__TGF-beta signaling pathway,-0.33203502645774574,-1.1540452693417216,0.3118279569892473,1.0,1.0,19/64,23.10%,ACVR2B;PPP2CB;SMURF1;TGFBR2;SMAD2;SMAD5;LTBP1;SKP1;EP300;BMP6;ACVR2A;SMURF2;SMAD7;PPP2R1A;BMPR1A;CDKN2B;ID2;DCN;BMPR2
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,-0.4273144103898568,-1.1535041742315186,0.3037974683544304,1.0,1.0,7/15,29.50%,CCR5;XRCC5;CXCR4;LRIG1;XRCC4;KPNA1;SGIP1
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,-0.2987447775818211,-1.1532936056434733,0.24242424242424243,1.0,1.0,43/121,30.59%,HIPK2;ABCC9;ALDH2;KCND3;CAMK2A;FXYD2;CORIN;ACTA2;FKBP1B;KCNJ2;AKAP9;ITGB5;CACNG8;RANGRF;KCNE1;KAT2B;STIM1;TNNI2;KCNQ1;SORBS3;DES;FGF11;CACNA1H;CACNA2D2;HIPK1;PKN2;MYL12A;CACNB2;SORBS1;SLC8A1;MYL9;MYLK;GUCY1B1;ORAI1;TPM2;KCNK7;ATP1B2;CALD1;NPRL2;MYL11;MYL5;TLN1;ATP2A1
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,-0.35090854619968637,-1.152437708492684,0.26595744680851063,1.0,1.0,27/47,41.42%,PLA2G7;SLC30A7;KIF5C;CTSG;EXOC5;GHRL;ACHE;TCF7L2;EXOC7;EXOC3;KCTD11;AOPEP;AGXT;SPCS1;SPCS3;SLC30A6;DPP4;POMC;SEC11C;EXOC1;SEC11A;KIF5A;ERO1A;GNB3;KLF4;UCN;STX1A
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.4122333986060492,-1.1515778614944938,0.273972602739726,1.0,1.0,5/17,18.78%,CNTRL;FGFR1OP2;STAT1;PIK3R1;STAT5A
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.30864578609538695,-1.1508378343327228,0.3163265306122449,1.0,1.0,17/85,15.31%,NEK2;ANAPC2;CDC16;ANAPC11;PSMC5;SKP1;PSMD5;PSMD8;CDC26;PLK1;BUB3;PSMD13;PSMB10;ANAPC5;ANAPC10;FBXO5;UBE2E1
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.40553272715046274,-1.1480628728470452,0.30666666666666664,1.0,1.0,8/18,26.54%,MAPK10;MAPK8;UBE2N;TAB3;TRAF6;MAP2K4;MAP3K7;NOD2
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.3639082948986922,-1.1478125661201986,0.2808988764044944,1.0,1.0,5/31,7.31%,NUP88;NUP37;NUP133;MAP4K5;POM121
prerank,KEGG_2021_Human__Hedgehog signaling pathway,-0.3563902785655494,-1.1472179652109633,0.3333333333333333,1.0,1.0,12/36,23.22%,EFCAB7;SMURF1;CSNK1D;SPOPL;HHAT;ARRB1;SMURF2;SCUBE2;CCND2;GRK3;FBXW11;CSNK1G2
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,-0.3002482140433113,-1.1468927753639728,0.22,1.0,1.0,39/139,25.44%,XRCC1;PPP4R2;CLSPN;DNA2;RPA3;ERCC4;H2BC14;PARP1;TDP1;UBXN1;XRCC5;PIAS4;APBB1;HUS1;EXO1;RAD50;H2BC13;RBBP8;KPNA2;SLC19A1;RAD9B;RMI2;MDC1;TDP2;PCNA;POLR1B;MAPK8;UBE2N;XRCC4;SMARCA5;ABL1;RTEL1;CHEK1;EYA3;RAD51AP1;H2AX;RFC3;TOP3A;TP53
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.31207334606419374,-1.1465964279386458,0.27,1.0,1.0,30/84,29.19%,RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;RPL38;RPS16;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;RPS28;RPL15;RPL36AL;RPL11;RPL34;RPS27A;RPL36A;RPS27
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.3524488071452006,-1.1459244124171417,0.2261904761904762,1.0,1.0,15/33,35.15%,DNA2;RPA3;POT1;CTC1;SLC19A1;LRIG1;PCNA;POLR1B;RFC3;TERF1;TINF2;PRIM1;POLD4;POLD2;TERF2IP
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.35915137905028804,-1.1459102041703386,0.27956989247311825,1.0,1.0,8/44,7.77%,FARSA;DARS1;HARS2;NARS1;MARS2;AARS2;EARS2;QARS1
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,-0.35346495315785587,-1.1444732703154912,0.23863636363636365,1.0,1.0,7/26,20.71%,RPA3;SERPINH1;HSPA6;VCP;HDAC6;HSBP1;POLR1B
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,-0.3710578023289013,-1.1442359968801519,0.3614457831325301,1.0,1.0,7/27,18.78%,CNTRL;FGFR1OP2;ERLIN2;STAT1;FGFR1;PIK3R1;STAT5A
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,-0.30899246220908905,-1.143853149742678,0.27,1.0,1.0,31/88,29.19%,RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;RPL38;RPS16;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;EEF1D;RPS28;RPL15;RPL36AL;RPL11;RPL34;RPS27A;RPL36A;RPS27
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.3559745716181688,-1.1437084875576073,0.28888888888888886,1.0,1.0,13/30,33.13%,TCEA1;ELOC;POLR2I;ELOA;NELFA;SSRP1;SUPT4H1;CDK9;POLR2D;POLR2B;ELL;SUPT5H;NELFCD
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.3068631389930047,-1.1433762931112497,0.2755102040816326,1.0,1.0,16/78,15.31%,ANAPC2;CDC16;ANAPC11;PSMC5;SKP1;PSMD5;PSMD8;CDC26;PLK1;BUB3;PSMD13;PSMB10;ANAPC5;ANAPC10;FBXO5;UBE2E1
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.3283068999873996,-1.1431626165939384,0.28421052631578947,1.0,1.0,25/59,33.13%,TCEA1;ELOC;MNAT1;POLR2I;MLH1;ELOA;MDC1;NELFA;DDB2;CDK12;CCNT2;SSRP1;FOS;CHEK1;SUPT4H1;CDK9;GTF2H3;TP53;POLR2D;POLR2B;JUN;ELL;SUPT5H;GTF2H1;NELFCD
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,-0.36635191470654377,-1.142687624062128,0.3764705882352941,1.0,1.0,8/28,18.87%,MAML2;HDAC3;MAML3;MAMLD1;KAT2B;HDAC11;HDAC6;KAT2A
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.3165914400639337,-1.14260101678038,0.2828282828282828,1.0,1.0,25/85,23.41%,CNTRL;NEK2;CDK5RAP2;PRKAR2B;DCTN3;CLASP1;CSNK1D;AKAP9;HAUS2;SKP1;HAUS8;PLK1;CEP76;HAUS1;CEP290;PPP2R1A;BORA;CEP192;ACTR1A;CEP164;FBXW11;CEP78;HAUS7;TUBB4A;NINL
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,-0.2944782352227074,-1.1421602762044982,0.26262626262626265,1.0,1.0,38/165,18.72%,ANAPC2;CDC16;ANAPC11;PPP2CB;XPO1;NUP37;CLASP1;CENPO;NUP133;SKA1;PSMC5;CENPU;DYNC1LI2;SPDL1;CENPF;PSMD5;PSMD8;WAPL;CDC26;INCENP;PLK1;CENPA;BUB3;PSMD13;PSMB10;PPP2R5E;ITGB3BP;ANAPC5;ANAPC10;MAD1L1;ZWINT;SPC25;UBE2E1;CDCA8;CLASP2;DYNLL2;PPP2R1A;UBE2C
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,-0.2869658834005829,-1.141898991222525,0.12,1.0,1.0,129/336,33.48%,HIPK2;CDK5R1;PRKAG2;REXO2;CNOT10;TCEA1;DNA2;PPP2CB;COX5A;RPA3;ELOC;TAF5;CDC25C;AGO1;MDM4;PDZD2;CCNE1;BCL2L14;MNAT1;LAMTOR2;TAF1;TAF4;POLR2I;STK11;ARID3A;BTG2;HUS1;EP300;MLH1;EXO1;PML;ING5;RAD50;CNOT6L;RBBP8;ELOA;RBBP7;STEAP3;RRAGB;RAD9B;RMI2;CSNK2A2;MDC1;MTA2;TP53RK;NELFA;PRDM1;BBC3;AKT2;E2F1;CNOT9;DDB2;TNFRSF10D;CDK12;AKT3;PRELID3A;CNOT2;CCNT2;HIPK1;PPP2R1A;AKT1;TNRC6A;BAX;PCNA;BID;BANP;SSRP1;PRKAG1;NPM1;POLR1B;TAF12;COX20;KAT6A;FOS;TAF15;CHEK1;IGFBP3;RRM2B;SUPT4H1;RGCC;TSC1;CHD4;RFC3;CDK9;COX8A;TOP3A;SCO2;GTF2H3;RPTOR;CDK1;TP53;RBBP4;COX18;GADD45A;YWHAZ;MAPK14;TAF9B;COX7B;DPEP3;COX5B;TAF2;POLR2D;PRKAB1;CNOT8;ZNF385A;CARM1;RPS27A;CHD3;TOPBP1;CNOT11;RICTOR;POLR2B;YWHAQ;CDKN1B;JUN;PCBP4;ELL;AURKA;TRIAP1;TNFRSF10B;RAD9A;MAPK11;SUPT5H;RRAGD;GTF2H1;NELFCD;LRPPRC;ING3;TAF11
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.3083455842836001,-1.1416113680305422,0.2727272727272727,1.0,1.0,37/106,29.33%,EIF4A1;RPS4X;EIF2S1;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;RPL38;EIF3B;RPS16;EIF1AX;RPS11;RPL7A;RPL29;RPS10;RPS14;EIF4A2;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;RPS28;RPL15;RPL36AL;RPL11;RPL34;EIF3L;RPS27A;RPL36A;RPS27;EIF2S3
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,-0.31767854458438594,-1.1405705336192264,0.2857142857142857,1.0,1.0,27/68,30.90%,CDK5R1;BCL2L11;GOLGA2;CDC25C;H2BC14;EZH2;H3C7;H2BC13;DNMT1;RBBP7;H2AC14;H3C13;CDC25B;H2AZ1;CAPN2;DNMT3B;FADD;H3-3B;H2AX;EED;TP53;RBBP4;H2AC19;H2AB1;PRIM1;JUN;H2BC17
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.3638661429000331,-1.140498672439917,0.30337078651685395,1.0,1.0,6/37,7.36%,P3H1;PLOD3;SERPINH1;COL9A1;PLOD1;P3H2
prerank,KEGG_2021_Human__Insulin resistance,-0.30908599388492786,-1.138720617576492,0.25252525252525254,1.0,1.0,25/91,21.29%,PRKAG2;PRKCD;CREB1;GFPT1;FOXO1;CPT1A;IL6;CPT1B;MAPK10;PYGB;SLC27A1;PIK3R3;PPP1R3E;PPARA;AKT2;IKBKB;PIK3CB;G6PC3;AKT3;PIK3R1;RPS6KA1;AKT1;PRKAG1;MAPK8;SOCS3
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.4012405081248571,-1.137719371246484,0.32142857142857145,1.0,1.0,10/17,36.17%,TBCA;TBCC;ARL2;TUBA8;TUBB2A;TUBB4A;TBCE;TUBB6;TUBB3;TUBB4B
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,-0.2995905915505772,-1.1374904524817688,0.2828282828282828,1.0,1.0,37/129,24.64%,YKT6;ARHGEF4;VAMP3;CPNE8;ARHGAP17;ARHGAP11B;ARHGDIB;FMNL3;OPHN1;CDC42EP2;ARHGAP10;ARHGAP42;DNMBP;JUP;KCTD3;CDC42BPB;FAM13B;ARHGAP27;STEAP3;IQGAP1;TRIO;ARHGAP1;ARHGEF15;WAS;PIK3R1;ARAP2;PREX1;PKN2;FMNL2;FNBP1L;DEF6;GNA13;ARFGAP3;LBR;STARD8;TFRC;PLEKHG1
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,-0.3142757906446503,-1.1367567003984664,0.3229166666666667,1.0,1.0,33/74,32.34%,USP9X;RNF20;UBE2W;H2BC14;CDC73;DERL1;PEX2;VCP;H2BC13;SHPRH;PEX14;UBE2E3;BCL10;UBE2E1;CTR9;UBE2H;UBE2Z;PEX12;UBE2C;PCNA;UBE2N;LEO1;TMEM129;PEX10;UBA6;RPS27A;UBE2R2;RNF40;UBE2G1;UBE2T;H2BC17;RTF1;H2BC12
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.3862258845943869,-1.1363899897407914,0.32941176470588235,1.0,1.0,13/21,40.86%,PPP2CB;ORC3;ORC6;E2F1;PPP2R1A;CDK1;PRIM1;PPP2R3B;MCM8;TFDP2;PPP2CA;ORC4;PPP2R1B
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.2063778877117444,1.1363241745814407,0.2,1.0,1.0,19/76,12.54%,PRKACB;GCM1;RXRA;ATF4;GNA12;AKAP13;CDKN1A;ARHGEF11;CASR;PLCB1;NR4A2;CREB3L2;HBEGF;RAF1;ADCY9;LRP6;ATF2;PLCB3;CREB3L4
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.35350528235786616,-1.135542527048964,0.2857142857142857,1.0,1.0,5/35,7.31%,XPO1;NUP88;NUP37;NUP133;POM121
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.37304304885474143,-1.1354150662527116,0.32558139534883723,1.0,1.0,8/24,23.53%,MATK;CUL5;USP8;RNF41;AKT2;AKT3;AKT1;PTPN12
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.4018306861220756,-1.1347979862626614,0.3372093023255814,1.0,1.0,12/20,39.14%,PEX2;FIS1;PEX14;PEX12;PEX11B;SLC25A17;ACBD5;PEX3;PEX19;ABCD1;ATAD1;PXMP4
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.423554214025671,-1.1336923435043114,0.3411764705882353,1.0,1.0,2/15,3.85%,GALK1;GFPT1
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.34413023086678823,-1.1315759931629152,0.3068181818181818,1.0,1.0,12/38,24.74%,DNA2;RPA3;HUS1;EXO1;RAD50;RBBP8;RAD9B;RMI2;POLR1B;RAD51AP1;RFC3;TOP3A
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.37071927517096415,-1.1315081703992458,0.31868131868131866,1.0,1.0,7/27,14.89%,POU2F1;CRCP;ZNF143;POLR3B;SNAPC1;POLR3D;POLR3C
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.3001262675569643,-1.1292054920765788,0.27,1.0,1.0,40/106,31.85%,RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;SRP14;RPL38;RPS16;SSR2;RPS11;RPL7A;RPL29;SRP19;RPS10;SEC61G;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;SRPRB;RPL27;RPL14;RPSA;RPS28;SRPRA;RPL15;RPL36AL;RPL11;RPL34;RPS27A;RPL36A;RPS27;SPCS1;RPL26;SPCS3;RPS12
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,-0.4218686313977247,-1.128930741333467,0.2987012987012987,1.0,1.0,8/15,34.51%,DNA2;RPA3;LRIG1;PCNA;POLR1B;PRIM1;POLD4;POLD2
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,-0.40729419535465794,-1.1279479862812132,0.36470588235294116,1.0,1.0,4/18,8.73%,ABCC9;KCNJ15;KCNJ2;GNG5
prerank,KEGG_2021_Human__Oxidative phosphorylation,-0.3006216315499332,-1.127763007739511,0.25,1.0,1.0,19/106,14.41%,NDUFB2;ATP5F1E;ATP6V1E1;COX5A;PPA2;PPA1;UQCR10;LHPP;NDUFC1;SDHC;NDUFB7;ATP6V0B;ATP6V1E2;NDUFS7;NDUFS2;ATP5ME;ATP5MG;TCIRG1;ATP6V0D1
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.1788462187090885,1.1277030865661501,0.0,1.0,1.0,18/78,12.67%,AREG;IL1RL1;PIP5K1C;PPP2R5B;KIT;FGFR2;RNMT;CLSTN1;PPP2R5C;PIK3R2;HBEGF;PDGFRB;FYN;MYD88;ESR1;LCK;IRS2;EREG
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.30366919130303927,-1.1269578703119145,0.3,1.0,1.0,37/107,29.33%,EIF4A1;RPS4X;EIF2S1;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;RPL38;EIF3B;RPS16;EIF1AX;RPS11;RPL7A;RPL29;RPS10;RPS14;EIF4A2;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;RPS28;RPL15;RPL36AL;RPL11;RPL34;EIF3L;RPS27A;RPL36A;RPS27;EIF2S3
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.360104522752593,-1.1263885635832662,0.2967032967032967,1.0,1.0,13/28,37.50%,TTLL4;VASH2;TTLL7;TTL;TUBB2A;TUBB4A;SVBP;AGTPBP1;TUBB6;TPGS2;TUBB3;TUBB4B;TTLL3
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.2992812323972841,-1.1260672486874854,0.31,1.0,1.0,29/114,19.81%,EIF4A1;RPS4X;EIF2S1;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;RPL38;EIF3B;RPS16;EIF1AX;RPS11;RPL7A;EIF2B4;RPL29;RPS10;RPS14;EIF4A2;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;EIF2B3
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.3568088626023957,-1.1257046562933926,0.2948717948717949,1.0,1.0,2/19,1.61%,SIRT2;VRK2
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.33017052025086707,-1.1252913916102196,0.3118279569892473,1.0,1.0,18/44,33.13%,TCEA1;ELOC;MNAT1;NCBP2;POLR2I;ELOA;NELFA;CCNT2;SSRP1;SUPT4H1;CDK9;GTF2H3;POLR2D;POLR2B;ELL;SUPT5H;GTF2H1;NELFCD
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,-0.36545829151416276,-1.1252649235042897,0.2702702702702703,1.0,1.0,12/22,35.15%,POT1;WRAP53;ANKRD28;RTEL1;TERF1;TINF2;PIF1;DKC1;PPP6C;CDK2;RUVBL1;TERF2IP
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.2902443586521149,-1.1251813519306473,0.26,1.0,1.0,33/155,17.33%,HIPK2;PHC3;NFKB2;XPC;TOP2B;NUP88;NR2C1;NCOA1;NUP37;SCMH1;NUP133;RORA;PARP1;PIAS2;HNRNPC;POM121;NSMCE2;SIN3A;CBX4;RNF2;PIAS4;INCENP;EP300;TOP1;PML;DNMT1;MDC1;PPARA;L3MBTL2;DNMT3B;NSMCE1;ZNF350;CDCA8
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.37360380855905906,-1.1251791115619532,0.25,1.0,1.0,15/29,28.92%,PDZD2;EP300;PML;ING5;RBBP7;MTA2;AKT2;AKT3;AKT1;KAT6A;CHD4;TP53;RBBP4;DPEP3;CHD3
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,-0.33765272105754573,-1.125064561474141,0.27586206896551724,1.0,1.0,20/39,37.84%,OR2B11;OR4K17;OR10H5;EBF1;OR6C74;OR2T33;OR6N1;OR52K2;OR2A7;OR11G2;OR1A1;OR7A17;OR1I1;OR56A4;OR2AT4;OR52N4;OR5AS1;OR52K1;OR4F17;OR1F1
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,-0.37734208369823075,-1.1242290699508861,0.345679012345679,1.0,1.0,6/24,18.10%,EIF4A1;CNOT10;CNOT6L;CNOT9;EIF4A2;CNOT2
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.3772541304404312,-1.124164981659741,0.35064935064935066,1.0,1.0,6/21,15.18%,GPC2;CHSY1;VCAN;HEXA;B3GAT3;HSPG2
prerank,KEGG_2021_Human__Legionellosis,-0.31377637151918747,-1.124116963277855,0.3191489361702128,1.0,1.0,9/56,11.32%,SEC22B;NFKB2;BNIP3;CXCL8;HSPA6;TLR5;IL6;CD14;VCP
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,-0.33228611251936335,-1.1237902929792853,0.3146067415730337,1.0,1.0,7/36,11.87%,PRKCD;CREB1;PRKAR2B;CAMK2A;GNA11;PLCB2;KPNA2
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,-0.3734739326469427,-1.123623557983877,0.32954545454545453,1.0,1.0,8/24,25.43%,PRKCD;SYK;PIK3CB;PLD4;PIK3R1;PLPP5;TARP;PRKCSH
prerank,Reactome_2022__Neuronal System R-HSA-112316,-0.29108764861347713,-1.1234435632624828,0.25,1.0,1.0,49/203,21.04%,ABCC9;ALDH2;FLOT2;PRKAG2;KCNG1;CREB1;KCND3;PRKAR2B;AKAP5;CAMK2A;DNAJC5;KCNJ15;KCNJ2;CACNG8;LIN7C;ALDH5A1;RTN3;AP2M1;PLCB2;GNG5;SYN3;NRXN2;KCNA3;DBNL;CACNB3;ACHE;LGALS12;KPNA2;KCNQ1;HOMER1;CHRNE;LRFN1;PPFIBP1;GABRR2;HCN2;KCNC4;CHRNA5;RPS6KA1;CACNA2D2;KCNC2;NCALD;RNASE1;GNAI1;HOMER3;PRKAG1;PDLIM5;CACNB2;KCNN4;CACNB4
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,-0.2942137288613941,-1.1229646116085952,0.29292929292929293,1.0,1.0,20/116,12.29%,ANAPC2;DNA2;MCM5;CDC16;ANAPC11;RPA3;ORC3;GINS4;CCNE1;PSMC5;SKP1;PSMD5;PSMD8;CDC26;PSMD13;ORC6;PSMB10;ANAPC5;SLC19A1;ANAPC10
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,0.27397409977596854,1.1229431959255232,0.35,1.0,1.0,17/17,72.63%,CLDN9;CLDN5;PRKCI;CLDN12;PALS1;PARD3;F11R;CLDN4;CLDN15;PARD6A;CLDN7;CLDN16;CLDN10;PATJ;PARD6G;PARD6B;CRB3
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.3769453541928945,-1.1228935586170683,0.3488372093023256,1.0,1.0,4/28,5.69%,ACOT8;ABCB11;NCOA1;OSBPL3
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.31147413593955664,-1.1218047465704817,0.29292929292929293,1.0,1.0,28/72,28.31%,SAP30;SAP18;H2BC14;MNAT1;SIN3A;SAP30BP;H3C7;H2BC13;UBTF;TAF1C;DNMT1;SAP130;H2AC14;H3C13;TAF1B;H2AZ1;POLR1G;POLR1E;DNMT3B;POLR1B;SMARCA5;TTF1;H3-3B;H2AX;GTF2H3;BAZ2A;H2AC19;H2AB1
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.40291675430264556,-1.1206566533793472,0.3333333333333333,1.0,1.0,8/15,31.31%,REXO2;AKT2;AKT3;AKT1;BID;YWHAZ;YWHAQ;PPP3CC
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,-0.28752838536654945,-1.1200091784029205,0.25510204081632654,1.0,1.0,50/159,30.51%,EDEM2;PDIA3;DNAJC3;SEC23B;MAP3K5;EIF2AK4;SEC62;EIF2S1;DNAJC5;SEC31A;HSPA6;UBXN1;DERL1;NGLY1;BCAP31;SKP1;UBXN2A;EIF2AK2;MAPK10;VCP;SSR2;GANAB;TRAF2;CAPN2;SEC61G;RNF185;UBQLN4;STT3B;SEC63;BAX;MAPK8;DNAJB11;DNAJB12;HSPA4L;SEC24D;UBXN6;UGGT1;PRKCSH;YOD1;UBE4B;BAG2;ERP29;HSP90AB1;PLAA;HYOU1;UBE2G1;CALR;NSFL1C;MBTPS2;UGGT2
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,-0.3652376296384974,-1.1197904471285407,0.31868131868131866,1.0,1.0,12/29,30.09%,MAP3K1;SYK;MAPK10;RNASE1;PKN2;MAPK8;FOS;MAP2K4;MAPK1;LYN;HRAS;JUN
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.38297311123081557,-1.1193783700907638,0.3258426966292135,1.0,1.0,8/24,19.27%,JUP;CTNNA1;THEM4;AKT2;AKT3;RNASE1;AKT1;PKN2
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.3910865661272695,-1.1174197547438176,0.3373493975903614,1.0,1.0,8/18,26.97%,HDAC3;GATD3;HDAC6;RUNX2;CBFB;ABL1;HEY1;MAPK1
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.40866541970815706,-1.1166041827407736,0.36363636363636365,1.0,1.0,5/16,15.42%,BCL2L11;FOXO1;STK11;EP300;BBC3
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.30187761854309114,-1.1165095983019513,0.2653061224489796,1.0,1.0,37/99,30.09%,CREB1;NKIRAS2;NFKB2;PPP2CB;BIRC3;SKP1;MAPK10;ALPK1;TNIP2;LRRC14;IKBKB;RPS6KA1;NLRC5;N4BP1;PPP2R1A;FADD;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;MAP2K1;JUN
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.2974365708601758,-1.1164617935330796,0.2828282828282828,1.0,1.0,46/104,35.25%,CREB1;NKIRAS2;NFKB2;PPP2CB;ECSIT;MAP3K1;SKP1;MAPK10;ALPK1;TNIP2;LRRC14;IKBKB;RPS6KA1;NLRC5;N4BP1;PPP2R1A;LY96;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;MAP2K1;JUN;S100A8;NDUFA2;MAPK11;CHUK;RPS6KA2;MAPKAPK3;IRAK4;S100B
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,-0.3687623128636647,-1.1156573541012487,0.36904761904761907,1.0,1.0,8/22,22.29%,HDAC3;GATD3;RBM14-RBM4;HDAC6;RUNX2;CBFB;ABL1;HEY1
prerank,KEGG_2021_Human__Chagas disease,-0.3055657217372494,-1.1154572013892379,0.26804123711340205,1.0,1.0,40/91,34.61%,CD3D;PPP2CB;TGFBR2;SMAD2;GNA11;CXCL8;PLCB2;IL6;MAPK10;PIK3R3;AKT2;IKBKB;PIK3CB;PLCB4;CD3E;AKT3;CD3G;PIK3R1;PPP2R1A;GNAI1;AKT1;FADD;MAPK8;TRAF6;FOS;MAP2K4;IFNGR2;TGFB1;MAPK14;MAPK1;CCL5;CALR;JUN;CCL2;MAPK11;CHUK;MAPK13;GNAI3;IRAK4;IL12A
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,0.23024286521210152,1.1141466206754662,0.1,1.0,1.0,9/30,15.83%,WASL;VPS72;LIMK1;ROCK2;SDC2;FYN;KALRN;ARPC2;TIAM1
prerank,Reactome_2022__SUMOylation R-HSA-2990846,-0.288917841806265,-1.1141159111108085,0.26,1.0,1.0,34/161,17.33%,HIPK2;PHC3;NFKB2;XPC;TOP2B;NUP88;NR2C1;NCOA1;NUP37;SCMH1;NUP133;RORA;PARP1;PIAS2;HNRNPC;POM121;NSMCE2;SIN3A;SAE1;CBX4;RNF2;PIAS4;INCENP;EP300;TOP1;PML;DNMT1;MDC1;PPARA;L3MBTL2;DNMT3B;NSMCE1;ZNF350;CDCA8
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.32915942957747013,-1.1114366710594452,0.3191489361702128,1.0,1.0,17/42,33.13%,TCEA1;ELOC;MNAT1;NCBP2;POLR2I;ELOA;NELFA;SSRP1;SUPT4H1;CDK9;GTF2H3;POLR2D;POLR2B;ELL;SUPT5H;GTF2H1;NELFCD
prerank,KEGG_2021_Human__Synaptic vesicle cycle,-0.32123464350137376,-1.1105214814242321,0.3333333333333333,1.0,1.0,9/50,14.60%,ATP6V1E1;CLTCL1;ATP6V0B;AP2M1;ATP6V1E2;CLTB;TCIRG1;ATP6V0D1;DNM1
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.3526163247939744,-1.109072821775926,0.34831460674157305,1.0,1.0,13/31,25.69%,GPC2;IDUA;GLCE;VCAN;SLC35D2;B3GAT3;IDS;HSPG2;SGSH;NAGLU;HS2ST1;DCN;GLB1L
prerank,KEGG_2021_Human__Olfactory transduction,-0.31149311989078704,-1.107250216882264,0.3368421052631579,1.0,1.0,21/60,23.97%,CAMK2A;OR2B11;OR4K17;OR10H5;OR6C74;OR2T33;SLC24A4;OR6N1;RGS2;OR52K2;ARRB1;PDE2A;NCALD;ADCY3;OR2A7;OR11G2;GRK3;SLC8A1;OR1A1;OR7A17;OR1I1
prerank,KEGG_2021_Human__Autophagy,-0.2781618315474186,-1.1070542059473116,0.32,1.0,1.0,44/129,29.41%,PRKCD;CTSL;PPP2CB;GABARAPL2;EIF2AK4;EIF2S1;BNIP3;WDR41;ATG16L1;DEPTOR;MRAS;PIK3R4;STK11;MTMR4;MAPK10;DAPK2;RRAS;IGF1R;RRAGB;PIK3R3;IGBP1;AKT2;RRAS2;PIK3CB;UVRAG;AKT3;ATG5;PIK3R1;AKT1;MTMR3;MAPK8;WIPI1;TRAF6;ATG9A;TSC1;ATG7;RPTOR;MAP3K7;MAPK1;RUBCN;ATG2A;PIK3C3;HRAS;MAP2K1
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.29389626632213917,-1.1062178723368867,0.31,1.0,1.0,44/134,30.61%,DNAJC3;NUP88;RPS4X;RPS20;RPS15A;NUP37;RPL39;RPL4;NUP133;RPS8;PARP1;RPL26L1;POM121;RPL38;POLR2I;IPO5;RPS16;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;RPS28;XK;RPL15;RPL36AL;RPL11;RPL34;POLR2D;NUP43;RPS27A;RPL36A;RPS27;POLR2B;NUP85;RPL26
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,-0.29612943108662854,-1.104704905498625,0.3125,1.0,1.0,29/93,26.97%,PRKCD;CLEC7A;NFKB2;CLEC6A;CBLB;MRAS;IL6;CLEC4E;SYK;MAPK10;RRAS;PIK3R3;STAT1;BCL10;AKT2;RRAS2;IKBKB;CLEC1B;PIK3CB;AKT3;PIK3R1;AKT1;MAPK8;KSR1;PAK1;FCER1G;IRF1;MAPK14;MAPK1
prerank,KEGG_2021_Human__Inositol phosphate metabolism,-0.3095212170340079,-1.1043874268983336,0.34375,1.0,1.0,16/66,20.11%,PIKFYVE;MTM1;INPP5K;PI4KA;PIK3C2B;PLCB2;MTMR4;MTMR2;MIOX;ISYNA1;MINPP1;PIK3CB;PLCB4;ITPKB;MTMR3;PLCD3
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.34432705933495966,-1.103318942537859,0.3829787234042553,1.0,1.0,14/31,34.74%,MMP9;CTSL;COL9A1;PLEC;CTSS;BMP1;DST;MMP28;COL8A2;LOXL1;COL6A3;LOXL2;CTSB;COL4A4
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,-0.28869573719716285,-1.1023999316621862,0.28,1.0,1.0,64/190,28.84%,DTX4;CREB1;MAML2;RFNG;HDAC3;JAG1;AGO1;RAB6A;ACTA2;LFNG;H2BC14;PBX1;POGLUT1;PSMC5;GATD3;CDK8;SKP1;PSMD5;PSMD8;TLE2;EP300;PSMD13;H3C7;MAML3;PSMB10;MAMLD1;H2BC13;KAT2B;CNTN1;PSEN1;TACC3;STAT1;H2AC14;PSENEN;H3C13;HDAC11;ARRB1;IKZF1;H2AZ1;HDAC6;E2F1;TLE1;NCSTN;KAT2A;AKT1;TNRC6A;ADAM10;YBX1;HEY1;DTX2;H3-3B;GZMB;NCOR1;H2AX;TP53;YWHAZ;H2AC19;TBL1XR1;PSME1;ST3GAL4;H2AB1;NEURL1;RPS27A;PSMA4
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.3544017190345458,-1.0995987886927727,0.34444444444444444,1.0,1.0,5/34,7.31%,XPO1;NUP88;NUP37;NUP133;POM121
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,-0.4032646318623013,-1.0977777431772782,0.35064935064935066,1.0,1.0,9/17,32.05%,RPA3;SLC19A1;PCNA;POLR1B;REV1;RFC3;POLI;RPS27A;REV3L
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.3354849558020807,-1.0974202885924116,0.3488372093023256,1.0,1.0,12/32,29.28%,HDAC3;NCOA1;APOE;AGO1;EP300;ABCA1;TNRC6A;NCOR1;EEPD1;CETP;TBL1XR1;KDM3A
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,0.15745030380101704,1.0973146877899207,0.0,1.0,1.0,18/78,13.03%,AREG;CDKN1A;BAD;KIT;PDPK1;FGFR2;RNMT;CLSTN1;PIK3R2;HBEGF;PDGFRB;PRR5;FYN;ESR1;LCK;IRS2;EREG;MLST8
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,-0.31134199476711577,-1.096052786383958,0.3711340206185567,1.0,1.0,35/89,28.68%,PHC3;MAP3K5;CDKN2C;SCMH1;AGO1;MDM4;H2BC14;CBX4;EZH2;RNF2;H3C7;MAPK10;H2BC13;RBBP7;H2AC14;H3C13;H2AZ1;E2F1;CBX6;TNRC6A;MAPK8;FOS;CDKN2B;H3-3B;MAP2K4;H2AX;MINK1;EED;TP53;RBBP4;MAPK14;MAPK1;H2AC19;H2AB1;RPS27A
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,-0.2965563699547856,-1.0951877287758651,0.35051546391752575,1.0,1.0,44/95,36.55%,TPH1;CDK5R1;CREB1;PPP2CB;TRIB1;AP2M1;EP300;MAP2K5;FOSL1;DNM1;PIK3CB;PIK3R1;ADORA2A;RPS6KA1;PPP2R1A;MEF2C;FOS;ID2;CLTC;RPS6KA5;CHD4;RPS6KA3;MAPK7;DUSP6;FOSB;EGR1;NTRK1;RAP1A;MAPK14;MAPK1;CRK;DNAL4;HRAS;MAP2K1;JUND;MAPK11;RPS6KA2;REST;MAPK13;MAPKAPK3;MAP2K2;RALB;RHOA;BCL11B
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.30325834134732077,-1.0949674428044927,0.2857142857142857,1.0,1.0,31/90,29.19%,RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;NCBP2;RPL26L1;RPL38;RPS16;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;RPS28;RPL15;RPL36AL;RPL11;RPL34;RPS27A;RPL36A;RPS27
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,0.31189819454780404,1.0948557076326364,0.3333333333333333,1.0,1.0,7/16,17.92%,SDC3;ITGAV;SDC2;SDC4;TRAPPC4;CASK;ITGA6
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.317196971611684,-1.094199299490737,0.3409090909090909,1.0,1.0,8/51,10.08%,NDUFB2;TMEM126B;ECSIT;NDUFC1;NDUFB7;NDUFAF6;NDUFS7;NDUFS2
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.4041323043754257,-1.0939326687947806,0.3488372093023256,1.0,1.0,3/15,9.67%,SMURF1;TGFBR2;ARHGEF18
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.32694785401593074,-1.0922671177920162,0.34782608695652173,1.0,1.0,10/34,24.28%,PCTP;MMUT;ACSM3;THEM5;ACOT9;THEM4;HADH;ACOT13;MCEE;ACOT2
prerank,KEGG_2021_Human__Cell cycle,-0.28780259391895807,-1.0920256117250124,0.28865979381443296,1.0,1.0,35/120,26.71%,ANAPC2;MCM5;CDC16;ANAPC11;CDKN2C;SMAD2;ORC3;CDC25C;CCNE1;SKP1;CDC26;PLK1;EP300;BUB3;ORC6;ANAPC5;ANAPC10;MAD1L1;GADD45G;CDC25B;E2F1;PCNA;CCND2;CDKN2B;ABL1;PTTG2;CHEK1;ANAPC4;CDK1;TP53;ANAPC7;WEE1;TGFB1;GADD45A;YWHAZ
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,-0.35332610547121884,-1.0918946278109696,0.325,1.0,1.0,4/30,8.10%,AMN;APOE;LDLRAP1;AP2M1
prerank,KEGG_2021_Human__Prolactin signaling pathway,-0.31674212618200936,-1.0915564342852018,0.3804347826086957,1.0,1.0,25/54,35.84%,MAPK10;PIK3R3;SOCS6;STAT1;AKT2;PIK3CB;AKT3;PIK3R1;STAT5A;AKT1;CCND2;MAPK8;SOCS3;FOS;JAK2;IRF1;MAPK14;MAPK1;HRAS;MAP2K1;GALT;MAPK11;MAPK13;STAT5B;MAP2K2
prerank,KEGG_2021_Human__Amphetamine addiction,0.21507734168913162,1.0908775662053942,0.25,1.0,1.0,9/38,12.54%,PRKACB;ATF4;HDAC2;CALM1;CAMK2G;CREB3L2;PPP3CA;ATF2;CREB3L4
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.3864437956937108,-1.0902165724401514,0.3855421686746988,1.0,1.0,2/19,4.07%,AMN;MMUT
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.3229417795160498,-1.0897637022813769,0.33707865168539325,1.0,1.0,19/46,31.19%,VAMP3;M6PR;RAB6A;RGPD1;RAB9A;IGF2R;STX16;RHOBTB3;NAPG;ARFIP2;SCOC;SYS1;VPS51;COG3;COG2;COG7;RIC1;USP6NL;GOLGA1
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.27188712122269276,-1.0896412116890373,0.28,1.0,1.0,66/278,21.98%,KLHL9;BTBD1;ANAPC2;KLHL25;TRAIP;DZIP3;CDC16;ANAPC11;NEDD4;FBXO7;SMURF1;KCTD6;ELOC;UBE2W;SIAH1;RNF123;CUL5;UBA3;HECW2;PSMC5;FBXL18;GLMN;UBE3D;UBE2E2;CBLB;SKP1;PSMD5;PSMD8;CDC26;RNF41;PSMD13;UFL1;ZBTB16;PSMB10;FBXO44;ANAPC5;ANAPC10;UBE2E3;NEDD4L;FBXO4;AREL1;RNF7;UBE2E1;DTX3L;SIAH2;RNF213;UBE2H;UBE2Z;UBE2M;FBXO9;UBA7;SMURF2;RNF138;LNPEP;FBXO10;UBE2C;FBXO21;FBXL20;UBE2N;SPSB1;SOCS3;FBXW9;FBXW11;UBAC1;WWP1;UBR1
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.29934037079170245,-1.0891348303038446,0.375,1.0,1.0,32/69,34.79%,MMP9;CXCL8;IL6;MAPK10;ANAPC5;FOSL1;TRAF2;IKBKB;FADD;MAPK8;TAB3;TRAF6;FOS;MAPK7;FOSB;MAP3K7;MAPK14;CASP3;MAPK1;TRAF5;HSP90AB1;CXCL3;JUN;CCL2;TRAF4;S100A8;JUND;TRAF3IP2;MAPK11;CHUK;MAPK13;TRADD
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,0.25599169919274517,1.0888623781426132,0.3333333333333333,1.0,1.0,8/18,18.11%,EEF1A1;ARL13B;PLIN3;UBC;PARK7;UBB;PCNT;IFT88
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,-0.29221289149286284,-1.0888608289190422,0.31313131313131315,1.0,1.0,51/114,35.52%,DNA2;RPA3;CENPO;H2BC14;CENPU;POT1;POLR2I;CTC1;CENPA;H2BC13;ITGB3BP;SLC19A1;RBBP7;WRAP53;H2AC14;LRIG1;H2AZ1;ANKRD28;PCNA;NPM1;POLR1B;SMARCA5;CENPT;KNL1;RTEL1;H3-3B;H2AX;RFC3;TERF1;MIS18A;TINF2;RBBP4;PIF1;DKC1;PPP6C;H2AC19;POLR2D;H2AB1;PRIM1;POLR2B;H2BC17;POLD4;CENPN;CENPM;H2BC12;MIS18BP1;POLD2;CDK2;RUVBL1;TERF2IP;H2AC7
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.30092847024475305,1.0885862344128676,0.3333333333333333,1.0,1.0,4/15,5.71%,DCP2;EDC3;DDX6;LSM7
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,-0.3300965518612963,-1.0881920631880548,0.3617021276595745,1.0,1.0,10/38,19.59%,CACNA1I;CREB1;GNA11;PBX1;NR4A1;PLCB2;PLCB4;CACNA1H;ADCY3;NCEH1
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.3919594267323829,-1.0873598016251718,0.38636363636363635,1.0,1.0,5/21,7.77%,PPA2;MARS2;AARS2;EARS2;QARS1
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.19841792468028863,1.0865271158628906,0.4,1.0,1.0,4/35,2.24%,DYNC1LI1;NR3C2;CAPZA2;AREG
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.38127956878930624,-1.0863855336783121,0.4268292682926829,1.0,1.0,4/24,8.20%,NFKB2;MEFV;P2RX4;CTSG
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.2944085796133141,-1.085754980028435,0.3469387755102041,1.0,1.0,37/103,30.09%,PRKCD;MAP3K5;CAMK2A;ARHGDIB;MAGED1;MATK;MAP3K1;MAPK10;MAP2K5;PSEN1;PIK3R3;AKT2;IKBKB;PIK3CB;AKT3;PIK3R1;RPS6KA1;AKT1;BAX;MAPK8;TRAF6;ABL1;RPS6KA5;SH2B2;RPS6KA3;MAPK7;NTRK1;TP53;RAP1A;MAPK14;MAPK1;CRK;RAC1;NFKBIE;HRAS;MAP2K1;JUN
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.29788841939051713,-1.0835839534749612,0.37755102040816324,1.0,1.0,33/96,29.19%,RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;RPL38;EIF3B;RPS16;EIF1AX;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;RPS28;RPL15;RPL36AL;RPL11;RPL34;EIF3L;RPS27A;RPL36A;RPS27
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,-0.29148345842457385,-1.0835090321314125,0.36363636363636365,1.0,1.0,48/110,36.09%,PPP2CB;NSMAF;MAP3K5;SPTLC1;SPTLC2;SGPP2;S1PR2;PLCB2;S1PR1;MAPK10;PPP2R5E;PPP2R3A;PIK3R3;TRAF2;AKT2;S1PR5;PIK3CB;PLCB4;AKT3;PIK3R1;PPP2R1A;GNAI1;AKT1;BAX;BID;MAPK8;GNA13;ACER2;FCER1G;TP53;ADORA3;MAPK14;MAPK1;RAC1;RAC3;HRAS;MAP2K1;PPP2R3B;MAPK11;PRKCB;RAC2;MAPK13;GNAI3;TRADD;PRKCZ;MAP2K2;PTEN;RHOA
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.27772785576252423,-1.0827560607369213,0.36,1.0,1.0,54/174,28.74%,EIF4A1;PRKCD;TRIM3;NEDD4;NUP88;CAMK2A;GBP5;TRIM45;NUP37;TRIM14;IFITM1;PDZD2;NUP133;NCAM1;TYK2;POM121;PDE12;EIF4E3;EIF2AK2;PML;TRIM68;KPNA4;KPNA2;TRIM35;IRF5;STAT1;EIF4G3;UBE2E1;EIF4G2;EIF4A2;UBA7;SMAD7;RSAD2;UBE2N;SOCS3;TRIM8;IFNAR1;IFIT5;CIITA;TRIM17;IFI27;IFNGR2;EGR1;TRIM46;JAK2;IP6K2;MX1;IRF1;B2M;KPNA3;KPNA1;NUP43;RPS27A;PTAFR
prerank,KEGG_2021_Human__FoxO signaling pathway,-0.28843422440535016,-1.0824246068195225,0.35,1.0,1.0,53/112,36.41%,PRKAG2;BCL2L11;GABARAPL2;TGFBR2;BNIP3;FOXO1;IL6;S1PR1;STK11;PLK1;EP300;MAPK10;IGF1R;HOMER1;PIK3R3;SGK3;GADD45G;AKT2;IKBKB;PIK3CB;G6PC3;AKT3;PIK3R1;CCNG2;NLK;AKT1;HOMER3;CCND2;PRKAG1;MAPK8;CAT;CDKN2B;KLF2;TGFB1;GADD45A;MAPK14;MAPK1;PRKAB1;SETD7;HRAS;MAP2K1;CDKN1B;MAPK11;INSR;CHUK;GADD45B;MAPK13;CDK2;GABARAP;SLC2A4;MAP2K2;PTEN;TGFB3
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.4083010776748618,-1.0821469354264137,0.38095238095238093,1.0,1.0,5/17,16.27%,NKIRAS2;NFKB2;ZBP1;DHX9;IKBKB
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,-0.2974567617927986,-1.0816113607532443,0.3870967741935484,1.0,1.0,25/60,34.02%,ATP6V1E1;CXCL8;ATP6V0B;ATP6V1E2;MAPK10;TCIRG1;ATP6V0D1;JAM3;IKBKB;ADAM10;MAPK8;PAK1;MAP2K4;MAPK14;CASP3;RAC1;CCL5;LYN;ATP6V0C;CXCL3;JUN;MAPK11;ATP6AP1;CHUK;MAPK13
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,0.23029620521944094,1.0813071119200297,0.42857142857142855,1.0,1.0,7/35,9.96%,RNF216;CYLD;RIGI;MAVS;HERC5;IKBKE;UBC
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,-0.340667478855177,-1.0802501261807833,0.3522727272727273,1.0,1.0,15/30,38.31%,GALNT14;C1GALT1;GCNT4;GALNT10;ST6GALNAC4;ST6GALNAC3;POC1B-GALNT4;GCNT1;ST3GAL4;GALNT3;GALNT2;B3GNT7;GALNT6;ST3GAL1;MUC1
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,-0.38512792208419233,-1.0795593191918766,0.4125,1.0,1.0,8/16,32.05%,RPA3;SLC19A1;PCNA;POLR1B;REV1;RFC3;RPS27A;REV3L
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.28351749088494305,-1.0793687035530992,0.35714285714285715,1.0,1.0,62/151,34.69%,CTSL;CREB1;NKIRAS2;PTPN4;NFKB2;PPP2CB;ECSIT;BIRC3;TMED7-TICAM2;MAP3K1;TLR5;SKP1;PIK3R4;MAPK10;ALPK1;TNIP2;DNM1;LRRC14;CTSS;TLR10;IKBKB;RPS6KA1;NLRC5;EEA1;N4BP1;PPP2R1A;ITGB2;FADD;LY96;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;CNPY3;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;PIK3C3;TLR7;MAP2K1;JUN;S100A8;NDUFA2;MAPK11;CHUK;RPS6KA2;CTSB;MAPKAPK3;IRAK4;RIPK3
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,-0.2958102742220146,-1.0780579234714887,0.4020618556701031,1.0,1.0,25/83,26.14%,PIKFYVE;DGKQ;MTM1;CDS2;PI4KA;PIK3C2B;PLCB2;MTMR4;DGKH;MTMR2;DGKA;PIK3R3;DGKG;BPNT2;PIK3CB;PLCB4;PIK3R1;ITPKB;MTMR3;PLCD3;INPP5E;PPIP5K1;DGKE;IMPA1;IP6K2
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.28533331195399836,-1.0779901660996483,0.375,1.0,1.0,24/100,19.59%,LPIN1;DGAT2;PCTP;CDS2;ABHD3;PLAAT2;LPGAT1;GPAT3;MBOAT1;STARD7;ACHE;SLC44A4;LCLAT1;CSNK2A2;CPNE3;PTPMT1;CHKB;PLD4;PITPNM2;GPAT2;CHPT1;OSBPL8;MFSD2A;PLA2G15
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.3108854163436488,-1.0774398316506977,0.36666666666666664,1.0,1.0,15/41,26.13%,FTSJ1;DUS2;METTL1;CTU1;CTU2;TP53RK;TRMT6;OSGEP;QTRT1;ADAT3;NSUN6;LAGE3;LCMT2;TRIT1;TRMT44
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.2974763701895006,-1.0773969335744065,0.38,1.0,1.0,30/87,29.19%,RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;RPL26L1;RPL38;RPS16;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;RPS28;RPL15;RPL36AL;RPL11;RPL34;RPS27A;RPL36A;RPS27
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.29135806584136303,-1.0769604035993874,0.3877551020408163,1.0,1.0,12/70,12.29%,ANAPC2;CDC16;ANAPC11;CCNE1;PSMC5;PSMD5;PSMD8;CDC26;PSMD13;PSMB10;ANAPC5;ANAPC10
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,-0.2940778929397537,-1.0764709312703546,0.3939393939393939,1.0,1.0,10/83,5.30%,YKT6;VAMP3;VRK2;ARHGAP17;ARHGDIB;OPHN1;JAG1;ABI1;WASF2;ARHGAP42
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,-0.37238428642023447,-1.0757629115835956,0.36363636363636365,1.0,1.0,6/22,17.57%,HDAC3;SIN3A;EP300;PRDM1;PIK3CB;PIK3R1
prerank,KEGG_2021_Human__ABC transporters,-0.3325006766668483,-1.0755821062423414,0.42045454545454547,1.0,1.0,6/34,11.66%,ABCC9;ABCB1;ABCB11;ABCA6;ABCG2;ABCA1
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,-0.34446336219199675,-1.0745943823395936,0.38095238095238093,1.0,1.0,6/28,14.41%,ATP6V1E1;HVCN1;ATP6V0B;ATP6V1E2;TCIRG1;ATP6V0D1
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.21147726861955599,1.074509203102307,0.0,1.0,1.0,13/52,12.67%,AREG;KIT;FGFR2;RNMT;CLSTN1;PIK3R2;HBEGF;PDGFRB;FYN;ESR1;LCK;IRS2;EREG
prerank,KEGG_2021_Human__Peroxisome,-0.3112600488628526,-1.0744379707399494,0.29591836734693877,1.0,1.0,32/75,34.36%,ACOT8;NUDT12;PAOX;PEX2;ACSL4;ECH1;ECI2;PEX14;ACSL6;HMGCL;ACSL3;PMVK;PEX12;PEX11A;MPV17L;PEX11B;SLC25A17;ACOX1;CAT;SOD1;HACL1;PEX10;AGXT;PEX3;IDH2;CROT;ABCD4;PEX19;ABCD1;PIPOX;AMACR;MVK
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.361006590575086,-1.0742910946518076,0.37209302325581395,1.0,1.0,5/23,12.52%,DNA2;EXO1;RAD50;RBBP8;RMI2
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,0.18863156426939745,1.0737551974446107,0.5,1.0,1.0,19/56,21.90%,PRKACB;SUFU;PSMB5;PSMD9;PSMC3;PSMC6;PSMB7;PSME2;UBC;PSMD11;PSMD6;UBB;PSMF1;PSMD3;BTRC;CUL1;PSMB3;PSMB2;PSMA7
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,-0.3684929782967358,-1.0733178300550161,0.36470588235294116,1.0,1.0,7/21,19.46%,PPP2CB;PPP2R5E;AKT2;AKT3;PPP2R1A;AKT1;CTLA4
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,-0.27560576809785,-1.0732839283413567,0.29,1.0,1.0,49/219,17.85%,BPGM;B4GALT2;PHKG1;GALK1;PPP2CB;AKR1A1;NUP88;NUP37;GPC2;NUP133;MAP4K5;CHSY1;LOC112694756;RHD;SLC37A1;FUT1;POM121;FUT4;PFKL;FUT2;RHCE;IDUA;CHST7;SLC25A11;SLC25A12;GLCE;MANBA;PYGB;VCAN;GNS;SLC35D2;PHKB;PGAM2;HYAL3;B4GALNT2;HEXA;PHKG2;MAN2C1;SLC25A1;B3GAT3;IDS;B4GALT3;HSPG2;SGSH;GLYCTK;ABO;G6PC3;SLC35B3;NAGLU
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.34961344548163126,-1.0730126449386612,0.35294117647058826,1.0,1.0,8/27,18.59%,VPS37B;MVB12B;MVB12A;CHMP4B;HDAC6;PLIN2;UBAP1;RNASE1
prerank,Reactome_2022__Glycolysis R-HSA-70171,-0.3060853770137656,-1.0725588505007213,0.34375,1.0,1.0,9/62,8.01%,BPGM;PPP2CB;NUP88;NUP37;NUP133;MAP4K5;LOC112694756;POM121;PFKL
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.29891852431526844,-1.0719052250381937,0.3402061855670103,1.0,1.0,27/75,27.07%,SAP30;SAP18;H2BC14;MNAT1;SIN3A;SAP30BP;H3C7;H2BC13;UBTF;TAF1C;DNMT1;SAP130;H2AC14;H3C13;TAF1B;H2AZ1;POLR1G;POLR1E;DNMT3B;POLR1B;SMARCA5;TTF1;H3-3B;H2AX;GTF2H3;BAZ2A;H2AC19
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.3342079277245662,-1.0713396758587141,0.4044943820224719,1.0,1.0,11/30,28.68%,USP9X;SMAD2;PARP1;STAT1;NEDD4L;SMURF2;SMAD7;PPM1A;NCOR1;MAPK1;RPS27A
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,-0.2813267876017382,-1.070268041025022,0.42,1.0,1.0,18/112,12.82%,XRCC1;PPP4R2;CLSPN;DNA2;RPA3;ERCC4;H2BC14;PARP1;PIAS4;HUS1;EXO1;RAD50;H2BC13;RBBP8;SLC19A1;RAD9B;RMI2;MDC1
prerank,KEGG_2021_Human__p53 signaling pathway,-0.28488649081475953,-1.0702597675504597,0.37894736842105264,1.0,1.0,30/68,35.88%,SIAH1;MDM4;CCNE1;ADGRB1;STEAP3;GADD45G;BBC3;DDB2;CCNG2;BAX;BID;CCND2;CHEK1;IGFBP3;RRM2B;PPM1D;COP1;CDK1;TP53;SIVA1;GADD45A;CASP3;GORAB;TNFRSF10B;RCHY1;GADD45B;CDK2;PERP;CCND3;PTEN
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,-0.3172878791467212,-1.070046378409291,0.4111111111111111,1.0,1.0,13/49,20.79%,ARHGEF4;BCL2L11;MAGED1;ARHGEF39;ARHGEF18;TRIO;OBSCN;ARHGEF35;ARHGEF15;RNASE1;PREX1;MAPK8;GNA13
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.2767577485447759,-1.0687439302438861,0.29,1.0,1.0,71/304,20.38%,GCSH;TPH1;RIDA;SDSL;GLUD1;BCKDHA;DARS1;RPS4X;OAZ1;RPS20;RPS15A;SLC5A5;DLAT;RPL39;KMO;CARNS1;RPL4;PSMC5;RPS8;GNMT;PAOX;RPL26L1;SECISBP2;SMOX;QARS1;INMT;RPL38;HNMT;AMT;GCAT;PSMD5;PSMD8;KYAT3;AASS;SLC25A12;PSMD13;RPS16;PSMB10;DLST;SLC25A44;DMGDH;PPM1K;ALDH4A1;ETHE1;RPS11;RPL7A;DUOX2;IL4I1;RPL29;OAZ3;SARS1;RPS10;RPS14;KYAT1;TPH2;HSD17B10;RPS23;RPS29;RPL30;MTAP;SARDH;RPLP2;LIPT1;IYD;RPL35;RPL27;RPL14;RPSA;ADI1;PSTK;IVD
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,-0.3175148558477866,-1.0686148710995302,0.40217391304347827,1.0,1.0,10/48,12.52%,DNA2;RPA3;OGG1;HUS1;MLH1;EXO1;RAD50;RBBP8;RAD9B;RMI2
prerank,KEGG_2021_Human__Base excision repair,-0.3567815874285077,-1.0682241095263802,0.3626373626373626,1.0,1.0,5/33,7.57%,LIG1;XRCC1;MPG;PARP1;OGG1
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,-0.28409483211452696,-1.0674571662751686,0.37,1.0,1.0,47/122,32.19%,YKT6;SEC22B;ACTR10;COPZ2;DCTN3;GOLGA2;SEC31A;CSNK1D;ARF4;TMEM115;DYNC1LI2;BET1L;COPB1;ANK2;TRAPPC1;ANKRD28;NAPG;COPE;ARF5;SPTBN1;DYNLL2;MIA3;DCTN4;COPZ1;ACTR1A;CNIH2;ARFGAP3;GOSR1;MCFD2;SEC24D;SERPINA1;COG3;STX5;ARCN1;PPP6C;COG2;COPB2;COG7;SEC16A;CNIH3;SPTA1;TFG;TRAPPC6A;CTSC;CD59;KDELR1;FOLR2
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.36495160734899235,-1.0674558967658059,0.38271604938271603,1.0,1.0,11/23,37.80%,MAGED1;TMED7-TICAM2;DAPK2;FADD;LY96;CASP3;TNFRSF10B;NDUFA2;TRADD;APPL1;CFLAR
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,-0.33123203565834863,-1.0667470815635813,0.3695652173913043,1.0,1.0,15/34,31.73%,B4GALT2;FUT1;FUT4;FUT2;A4GALT;SLC33A1;HEXA;B4GALT3;ABO;ST6GALNAC4;ST6GALNAC3;B3GALT4;ST3GAL4;NAGA;ST3GAL5
prerank,KEGG_2021_Human__Phagosome,-0.2724877362007429,-1.066116537398184,0.32989690721649484,1.0,1.0,26/127,20.47%,PIKFYVE;SEC22B;CTSL;VAMP3;CLEC7A;ATP6V1E1;M6PR;ITGB5;ITGA5;ATP6V0B;DYNC1LI2;STX18;ATP6V1E2;CD14;THBS4;TCIRG1;ATP6V0D1;CTSS;SEC61G;CORO1A;EEA1;TUBA8;DYNC2H1;ITGB2;MARCO;TUBB2A
prerank,Reactome_2022__Axon Guidance R-HSA-422475,-0.27109362977671747,-1.0655729923629702,0.27,1.0,1.0,111/403,24.77%,PLXNA4;CDK5R1;MMP9;CREB1;KIF4A;ITGA10;AKAP5;MYH9;RPS4X;ELOC;RPS20;SEMA6A;RPS15A;CLASP1;RPL39;CLTCL1;SIAH1;RPS6KA4;COL9A1;RPL4;EPHB3;DPYSL4;NCAM1;USP33;PSMC5;RPS8;NCBP2;RPL26L1;ITGA5;EPHA1;DOK4;RPL38;AP2M1;LYPLA2;LAMC1;PSMD5;PSMD8;SHTN1;PSMD13;RPS16;CACNB3;PSMB10;RANBP9;RRAS;DAG1;RHOC;CNTN1;CXCR4;CSNK2A2;PSEN1;PLXNB1;CLTB;PIK3R3;PSENEN;ANK2;RPS11;RPL7A;TRIO;DNM1;ALCAM;RPL29;SIAH2;RPS10;FGFR1;MSN;PIK3CB;RPS14;DOK2;PIK3R1;RPS6KA1;RPS23;CACNA1H;RPS29;CLASP2;RPL30;SPTBN1;RPLP2;ARPC3;PFN2;RELN;RNASE1;RPL35;NCSTN;RPL27;PKN2;MYL12A;RPL14;RPSA;LIMK2;ADAM10;CACNB2;MAPK8;CAP1;CACNB4;CNTNAP1;L1CAM;TRPC6;ABL1;RPS28;CLTC;RPS6KA5;MYL9;TYROBP;PDLIM7;PLXNB3;RPS6KA3;GRB10;RPL15;MAPK7;RPL36AL;RPL11
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.2460594899259126,1.0654901374490156,0.45454545454545453,1.0,1.0,8/27,12.05%,CITED2;CDKN1A;VEGFA;KIT;CREBBP;KDM5B;CITED4;ESR1
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.2907629432018348,-1.064288164640085,0.36082474226804123,1.0,1.0,12/70,12.29%,ANAPC2;CDC16;ANAPC11;PSMC5;PSMD5;PSMD8;CDC26;BUB3;PSMD13;PSMB10;ANAPC5;ANAPC10
prerank,KEGG_2021_Human__PPAR signaling pathway,0.2196011160069612,1.0623498292394469,0.25,1.0,1.0,8/50,6.78%,CPT2;SCD5;RXRA;PLIN5;FABP5;ACADL;PCK2;PDPK1
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,-0.26982736334921964,-1.0622330736956398,0.41,1.0,1.0,55/175,29.45%,LARP1;REXO2;DDX20;NUP88;RPS4X;SNRPE;RPS20;RPS15A;NUP37;SNRPB;SIKE1;NUP133;RPS8;TYK2;POM121;PIK3R4;RPS16;GEMIN8;VPS18;GEMIN5;KPNA2;GEMIN6;STAT1;RPS11;AKT2;RPS10;IKBKB;RPS14;UVRAG;AKT3;SNRPF;RPS23;RPS29;AKT1;RPSA;UBE2N;TAB3;TRAF6;IFNAR1;RPS28;SEC24D;MAP3K7;NOD2;YWHAZ;B2M;GEMIN2;CRB3;NUP43;RPS27A;PIK3C3;HSP90AB1;SMN1;RPS27;TLR7;YWHAQ
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,0.2620587703845105,1.0619207567376499,0.47619047619047616,1.0,1.0,6/17,16.16%,SPTAN1;WASL;PIK3R2;FYN;NCK1;CASK
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,-0.303240931320966,-1.061105395026149,0.3894736842105263,1.0,1.0,22/68,25.08%,XRCC1;MPG;RPA3;H2BC14;PARP1;OGG1;POT1;H2BC13;SLC19A1;PARG;H2AC14;LRIG1;H2AZ1;APEX1;PCNA;POLR1B;NEIL3;H2AX;RFC3;UNG;TERF1;TINF2
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.30530886399352,-1.060896210229078,0.3684210526315789,1.0,1.0,23/66,30.42%,SEPTIN6;CLTCL1;ARHGAP10;ELMO3;WASF2;HCLS1;ITGA5;CTNNA1;CLTB;PIK3R3;DNM1;PIK3CB;PIK3R1;ARPC3;CAV2;ACTR3B;CLTC;PXN;ARPC5;CRK;RAC1;RHOG;ACTR3
prerank,Reactome_2022__S Phase R-HSA-69242,-0.2769938655796807,-1.0603356347698598,0.37373737373737376,1.0,1.0,38/158,20.72%,ANAPC2;DNA2;MCM5;CDC16;ANAPC11;RPA3;ORC3;GINS4;CCNE1;PSMC5;MNAT1;SKP1;PSMD5;PSMD8;WAPL;CDC26;LIN9;PSMD13;ORC6;PSMB10;ESCO2;ANAPC5;SLC19A1;ANAPC10;CDC25B;LRIG1;UBE2E1;AKT2;E2F1;AKT3;GINS3;UBE2C;AKT1;ESCO1;PCNA;PDS5B;POLR1B;GINS1
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,-0.31166704967113446,-1.0602297671388752,0.41304347826086957,1.0,1.0,13/55,19.27%,VAMP3;CPNE8;ARHGAP17;OPHN1;CDC42EP2;JUP;CDC42BPB;STEAP3;IQGAP1;OBSCN;ARHGAP1;PREX1;PKN2
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,-0.2906549438945621,-1.0599140341200608,0.45161290322580644,1.0,1.0,22/79,26.72%,PRKCD;TRIM3;CAMK2A;GBP5;TRIM45;TRIM14;NCAM1;PML;TRIM68;TRIM35;IRF5;STAT1;SMAD7;SOCS3;TRIM8;CIITA;TRIM17;IFNGR2;TRIM46;JAK2;IRF1;B2M
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.2976915810883662,-1.058811247690279,0.3917525773195876,1.0,1.0,17/73,18.24%,EIF4A1;NEDD4;NUP88;NUP37;PDZD2;NUP133;POM121;EIF4E3;EIF2AK2;KPNA4;KPNA2;STAT1;EIF4G3;UBE2E1;EIF4G2;EIF4A2;UBA7
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.27836669603707487,-1.0586433245201825,0.41414141414141414,1.0,1.0,33/141,19.77%,AMN;MTHFD1;SLC46A1;NAMPT;NMNAT3;CYB5R3;MMUT;APOE;NUDT12;GPC2;MTHFD1L;FPGS;SLC25A32;LDLRAP1;MTHFR;CYB5A;PARP16;PANK1;SLC19A2;SLC19A1;GSTO1;DHFR;NAXD;HSPG2;PPCDC;PARP4;PARP14;NT5E;MMADHC;AKT1;ENPP3;VKORC1;COQ5
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.2627764974537384,-1.0585704290248805,0.3,1.0,1.0,148/500,28.85%,TRPV2;CTNS;ZDHHC8;AMN;ABCC9;CLCN6;ABCB1;SLC8B1;SLC25A22;SLC46A1;NIPAL2;ATP6V1E1;SLC30A7;PRKAR2B;ATP10D;ARL2BP;SLC39A3;TRPC4AP;CAMK2A;SLC25A26;SLC16A7;SLC39A8;SLC43A2;EIF2S1;TSC22D3;SLC5A5;APOE;FXYD2;TRPM7;SLC9A3;ANO9;FKBP1B;ABCA6;ATP8A1;SLC4A5;BPNT1;PSMC5;PHB2;SCNN1D;SLC39A1;ATP6V0B;DERL1;AQP9;LDLRAP1;AP2M1;SKP1;GNG5;ATP6V1E2;PSMD5;PSMD8;SLC33A1;MCOLN2;ABCG2;SLC20A1;ERLIN2;PSMD13;SLC36A2;SLC24A4;PSMB10;ATP2C2;SLC44A4;VCP;ABCA1;AQP10;SLC27A1;STEAP3;SLC35D2;SLC4A10;ANO5;SLC4A1;PMPCA;TCIRG1;ATP13A2;ATP11A;ANO8;ATP6V0D1;SGK3;NEDD4L;LCN15;ANKH;SLC9B1;ABCC2;LMF1;SLC35A3;ARL2;BMP1;RNF185;SLC35B3;SLC7A8;SLC15A4;IREB2;SLC2A14;LIPG;SLC41A1;NCEH1;ADD1;HBA1;CA2;NALCN;ABCF1;SLC35B4;CLCN5;SLC9A9;SLC16A3;TRPC6;TRPM6;SLC8A1;WWP1;MRS2;CLTC;SLC22A16;SLCO4A1;GNG3;EMB;RAB11FIP2;SLC25A29;TFRC;ATP10B;GNG10;AHCYL2;LRRC8D;ABCC6;ATP9B;MAIP1;MFSD4B;ABCB8;RSC1A1;SLC45A3;ABCC4;CYB5R1;ATP8B3;ASIC3;FTH1;CETP;LCAT;ATP8B2;ATP1B2;GNG7;VDAC2;PSME1;ANO10;SLC30A1;SLC4A2;SLC9A4;RPS27A;ATP6V0C;PSMA4;PEX3
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.2957135633068539,-1.0582832398667175,0.40625,1.0,1.0,9/63,16.37%,PDIA3;CTSL;CREB1;KLRD1;HSPA6;RFXAP;KLRC3;CTSS;HSPA4
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,-0.2958935454769313,-1.057616623687024,0.3877551020408163,1.0,1.0,30/63,38.48%,MGST1;AKR1A1;TPST2;MGST2;BPNT1;HPGDS;GGT1;GSTA4;GSTO1;GGT7;BPNT2;MGST3;GSTM1;SLC35B3;SULT1A2;COMT;GSTM5;ABHD14B;SULT1A1;GSTM2;AS3MT;CNDP2;GCLC;GSTO2;UGP2;SLC35D1;PODXL2;GSTM4;MAT2B;ACSM2B
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,-0.30202800210976893,-1.057509429574548,0.42857142857142855,1.0,1.0,18/54,28.75%,B3GLCT;GALNT14;LARGE2;C1GALT1;POMGNT1;POFUT2;DAG1;SEMA5B;GCNT4;LARGE1;GALNT10;ST6GALNAC4;ST6GALNAC3;POC1B-GALNT4;GCNT1;ST3GAL4;GALNT3;GALNT2
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.3355193385606884,-1.0575048703737542,0.4482758620689655,1.0,1.0,11/27,29.81%,CTSL;GPC2;PIK3R4;CHMP4B;VCP;HSPG2;UVRAG;RNF103-CHMP3;VHL;PIK3C3;ZCRB1
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,-0.3214136406424478,-1.0565585249799831,0.3829787234042553,1.0,1.0,10/43,19.14%,PRKCD;MATK;CUL5;USP8;RNF41;DIAPH1;AKT2;AKT3;PIK3R1;AKT1
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,-0.27459668746931526,-1.056546995956509,0.43,1.0,1.0,23/139,12.82%,CLSPN;REXO2;DNA2;MCM5;RPA3;ORC3;CDC25C;H2BC14;PSMC5;PSMD5;PSMD8;PIAS4;HUS1;PSMD13;EXO1;ORC6;PSMB10;RAD50;H2BC13;RBBP8;RAD9B;RMI2;MDC1
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,-0.33431270477319913,-1.0565426478852304,0.35555555555555557,1.0,1.0,8/34,19.27%,VAMP3;ARHGDIB;JUP;VCP;NIPSNAP2;OSBPL11;WDR11;PKN2
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.2608027036323946,-1.055730807628297,0.4,1.0,1.0,77/341,21.98%,PDIA3;KLHL9;BTBD1;SEC22B;CTSL;VAMP3;ANAPC2;KLHL25;TRAIP;DZIP3;CDC16;ANAPC11;NEDD4;FBXO7;SMURF1;KCTD6;ELOC;SEC31A;UBE2W;SIAH1;RNF123;CUL5;UBA3;HECW2;PSMC5;ITGB5;FBXL18;GLMN;UBE3D;UBE2E2;CBLB;SKP1;PIK3R4;PSMD5;PSMD8;CDC26;RNF41;PSMD13;UFL1;ZBTB16;PSMB10;FBXO44;ANAPC5;ANAPC10;UBE2E3;NEDD4L;FBXO4;AREL1;RNF7;UBE2E1;DTX3L;CTSS;SIAH2;IKBKB;RNF213;SEC61G;UBE2H;UBE2Z;UBE2M;FBXO9;UBA7;SMURF2;RNF138;LNPEP;FBXO10;UBE2C;FBXO21;FBXL20;LY96;UBE2N;SPSB1;SOCS3;FBXW9;FBXW11;UBAC1;WWP1;UBR1
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,-0.31529111865310616,-1.0557256490915772,0.3977272727272727,1.0,1.0,4/36,5.15%,ABCC9;CAMK2A;FXYD2;FKBP1B
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,-0.27789807618147894,-1.055264382791988,0.44,1.0,1.0,17/108,11.32%,EFCAB7;IFT172;PRKAR2B;SMURF1;TTC21B;SPOPL;PSMC5;CDC73;HHAT;SMOX;SKP1;PSMD5;PSMD8;PSMD13;DISP2;PSMB10;VCP
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,0.25443346619608453,1.055014292501435,0.4,1.0,1.0,10/21,19.51%,DYNC1LI1;ARL13B;DYNC1H1;UBC;PARK7;UBB;DYNC1I2;PCNT;IFT88;DYNLL1
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.3133835997599207,-1.0547490052355506,0.4175824175824176,1.0,1.0,10/38,18.78%,IL9R;IL3RA;IL2RA;IL5RA;SYK;PIK3R3;STAT1;PIK3CB;PIK3R1;STAT5A
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.3547365153049569,-1.053867776383356,0.3953488372093023,1.0,1.0,5/24,12.52%,DNA2;EXO1;RAD50;RBBP8;RMI2
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,-0.3238838959178341,-1.0528157575933468,0.4318181818181818,1.0,1.0,10/33,19.14%,FXYD2;PLCB2;PIK3R3;AKT2;PIK3CB;PLCB4;G6PC3;AKT3;PIK3R1;AKT1
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,-0.2983500574115564,-1.0525548810000083,0.42424242424242425,1.0,1.0,17/76,15.66%,MAML2;RFNG;AGO1;RAB6A;LFNG;H2BC14;POGLUT1;EP300;H3C7;MAML3;MAMLD1;H2BC13;KAT2B;H2AC14;H3C13;H2AZ1;E2F1
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,-0.29375535891361365,-1.0521144344159465,0.4105263157894737,1.0,1.0,22/65,29.96%,YKT6;VAMP3;VRK2;ARHGDIB;OPHN1;STBD1;TRIO;DOCK4;ARHGAP1;PIK3R1;PREX1;PKN2;ARFGAP3;LBR;TFRC;PRKCSH;ANKLE2;STX5;KTN1;RHOG;NDUFA5;ARHGEF5
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,-0.3562157381713366,-1.0516764759778858,0.3764705882352941,1.0,1.0,12/24,34.36%,NSDHL;DHCR7;MVD;TM7SF2;PMVK;DHCR24;LBR;SC5D;LMBR1;FDFT1;FDPS;MVK
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.3460172001400601,-1.050845215777536,0.4111111111111111,1.0,1.0,9/24,30.99%,XRCC1;RPA3;SLC19A1;LRIG1;PCNA;POLR1B;RFC3;RPS27A;POLD4
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,-0.2648762621508116,-1.0507142858283127,0.38,1.0,1.0,77/249,29.81%,EDEM2;ZDHHC8;LARP1;CTSL;REXO2;DDX20;NUP88;RPS4X;SNRPE;RPS20;RPS15A;NUP37;ZDHHC3;SNRPB;SIKE1;GPC2;NUP133;RPS8;TYK2;POM121;PARP16;PIK3R4;RPS16;GEMIN8;CHMP4B;MAN2A1;VPS18;VCP;GEMIN5;KPNA2;GEMIN6;STAT1;RPS11;GANAB;HSPG2;AKT2;RPS10;IKBKB;RPS14;PARP4;UVRAG;AKT3;SNRPF;PARP14;RPS23;RPS29;AKT1;RPSA;ST6GALNAC4;UBE2N;TAB3;TRAF6;IFNAR1;RPS28;FUT8;ZDHHC5;SEC24D;RNF103-CHMP3;VHL;ST6GALNAC3;PRKCSH;MAP3K7;NOD2;YWHAZ;B2M;GEMIN2;CRB3;ST3GAL4;NUP43;RPS27A;PIK3C3;HSP90AB1;SMN1;RPS27;TLR7;YWHAQ;ZCRB1
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.2826544962948302,-1.0506761858684377,0.36,1.0,1.0,46/177,22.50%,UTP20;RPS4X;RPS20;RPS15A;DNAJC5;RPL39;BYSL;CSNK1D;RPL4;EMG1;RPS8;UTP25;RPL26L1;EXOSC9;RCL1;RPL38;SPPL2A;RPS16;RPP25;TEX10;EBNA1BP2;PDCD11;RPS11;RPL7A;RPP38;EXOSC6;RPL29;RPS10;RRP7A;EXOSC4;RPP14;RPS14;EXOSC3;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;EXOSC2;UTP11;RPS28;IMP4;UTP4
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.36007411178223125,-1.0505909023129074,0.4044943820224719,1.0,1.0,13/21,34.81%,PRKCD;PDZD2;PIK3R4;RNASE1;MAPK14;MAPK1;PIK3C3;S100A8;NCF4;MAPK11;PRKCB;RAC2;PRKCZ
prerank,Reactome_2022__M Phase R-HSA-68886,-0.26721906706554593,-1.050580979381999,0.34,1.0,1.0,89/360,23.41%,SIRT2;CNTRL;NEK2;CDK5RAP2;ANAPC2;CDC16;MZT2A;VRK2;ANAPC11;LPIN1;PRKAR2B;PPP2CB;XPO1;NUP88;DCTN3;GOLGA2;TUBGCP6;NUP37;CLASP1;CSNK1D;CENPO;NUP133;SKA1;H2BC14;NCAPD3;PSMC5;AKAP9;CENPU;POM121;HAUS2;DYNC1LI2;SPDL1;CENPF;HAUS8;PSMD5;PSMD8;WAPL;CDC26;INCENP;IST1;PLK1;CENPA;BUB3;PSMD13;H3C7;PSMB10;CHMP4B;PPP2R5E;H2BC13;CEP76;ITGB3BP;ANAPC5;HAUS1;ANAPC10;MAD1L1;CSNK2A2;ZWINT;H2AC14;FBXO5;H3C13;SPC25;ENSA;H2AZ1;UBE2E1;NEK9;SET;CDCA8;CLASP2;CEP290;DYNLL2;TUBA8;PPP2R1A;UBE2C;CEP192;PDS5B;TUBB2A;CENPT;KNL1;ACTR1A;CEP164;TUBGCP4;CEP78;HAUS7;TUBGCP2;LBR;ANAPC4;TUBB4A;H3-3B;NINL
prerank,KEGG_2021_Human__Gastric cancer,-0.2894445173802801,-1.050296231844822,0.36363636363636365,1.0,1.0,34/96,30.06%,ABCB1;TGFBR2;SMAD2;CCNE1;FZD2;JUP;WNT10A;FZD6;RARB;MLH1;CTNNA1;PIK3R3;GADD45G;TCF7L2;AKT2;E2F1;DDB2;PIK3CB;AKT3;PIK3R1;FZD3;AKT1;BAX;TCF7L1;CDKN2B;WNT5B;TP53;TGFB1;GADD45A;MAPK1;LRP5;HRAS;MAP2K1;CDKN1B
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,-0.3139198619085419,-1.048963671470684,0.40860215053763443,1.0,1.0,19/48,28.31%,RPA3;H2BC14;MLH1;H3C7;RAD50;H2BC13;RBBP8;H2AC14;H3C13;H2AZ1;MLH3;HID1;POLR1B;H3-3B;H2AX;TOP3A;H2AC19;MSH5;H2AB1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.293005205325262,-1.0487462895008544,0.3854166666666667,1.0,1.0,11/63,12.29%,ANAPC2;CDC16;ANAPC11;PSMC5;PSMD5;PSMD8;CDC26;PSMD13;PSMB10;ANAPC5;ANAPC10
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,-0.26282635331139514,-1.048441126049236,0.43,1.0,1.0,38/219,14.15%,SIRT2;ANAPC2;CDC16;VRK2;ANAPC11;PPP2CB;XPO1;NUP37;CLASP1;CENPO;NUP133;SKA1;PSMC5;CENPU;POM121;DYNC1LI2;SPDL1;CENPF;PSMD5;PSMD8;WAPL;CDC26;INCENP;IST1;PLK1;CENPA;BUB3;PSMD13;PSMB10;CHMP4B;PPP2R5E;ITGB3BP;ANAPC5;ANAPC10;MAD1L1;ZWINT;FBXO5;SPC25
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.2956135092468668,-1.0476289438137791,0.422680412371134,1.0,1.0,34/79,31.10%,HDAC3;H2BC14;PBX1;PIAS2;EZH2;POLR2I;RARB;EP300;H3C7;H2BC13;RBBP7;NCOA3;KMT2D;H2AC14;H3C13;ZNF335;H2AZ1;HOXB3;CNOT9;MEIS1;RARG;HOXB2;H3-3B;NCOR1;H2AX;EED;RBBP4;H2AC19;POLR2D;H2AB1;POLR2B;JUN;H2BC17;ASH2L
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,-0.31756631435754845,-1.0475339531637184,0.40860215053763443,1.0,1.0,16/41,34.51%,ERCC5;RPA3;ERCC4;PARP1;SLC19A1;DDB2;DDB1;PCNA;POLR1B;RFC3;GTF2H3;RPS27A;POLD4;GTF2H1;RBX1;POLD2
prerank,KEGG_2021_Human__Basal cell carcinoma,-0.3242077674268117,-1.046280627437629,0.41935483870967744,1.0,1.0,12/34,26.42%,FZD2;WNT10A;FZD6;GADD45G;TCF7L2;DDB2;FZD3;BAX;TCF7L1;WNT5B;TP53;GADD45A
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.29688199604073695,-1.0458352182936306,0.4891304347826087,1.0,1.0,18/66,21.54%,ARHGEF4;BCL2L11;MAGED1;ARHGEF39;ARHGEF18;ITGB3BP;PSEN1;PSENEN;TRIO;OBSCN;ARHGEF35;ARHGEF15;RNASE1;NCSTN;PREX1;MAPK8;GNA13;TRAF6
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.2787674346177763,-1.045677023344298,0.42,1.0,1.0,64/156,35.86%,CTNS;SLC8B1;SLC25A22;SLC30A7;ARL2BP;SLC39A3;SLC25A26;SLC16A7;SLC39A8;SLC43A2;SLC5A5;SLC9A3;SLC4A5;SLC39A1;SLC33A1;SLC20A1;SLC36A2;SLC24A4;SLC44A4;SLC27A1;SLC35D2;SLC4A10;SLC4A1;LCN15;SLC35A3;ARL2;SLC35B3;SLC7A8;SLC15A4;SLC2A14;SLC41A1;SLC35B4;SLC9A9;SLC16A3;SLC8A1;SLC22A16;SLCO4A1;EMB;SLC25A29;AHCYL2;MFSD4B;RSC1A1;SLC45A3;SLC30A1;SLC4A2;SLC9A4;SLC9A7;SLC1A4;SLC36A1;SLC30A6;SLC27A4;SLC39A14;SLC11A1;SLC31A1;SLC24A3;SLC16A10;SLC6A15;SLC5A9;SLC29A4;SLCO3A1;SLC22A5;SLC12A6;SLC2A4;SLC35D1
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.3220828616482535,-1.0447348941286654,0.37777777777777777,1.0,1.0,15/44,28.68%,NKIRAS2;NFKB2;ALPK1;LRRC14;IKBKB;NLRC5;N4BP1;UBE2N;TAB3;TRAF6;TP53;MAP3K7;NOD2;NKIRAS1;RPS27A
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",-0.26168909087794734,-1.0447307198707947,0.29,1.0,1.0,124/500,23.18%,SIRT2;CNTRL;NEK2;CDK5RAP2;ANAPC2;DNA2;MCM5;CDC16;MZT2A;VRK2;ANAPC11;LPIN1;PRKAR2B;PPP2CB;XPO1;NUP88;CDKN2C;DCTN3;GOLGA2;RPA3;ORC3;TUBGCP6;NUP37;CLASP1;CDC25C;CSNK1D;CENPO;NUP133;GINS4;SKA1;H2BC14;NCAPD3;CCNE1;PSMC5;AKAP9;MNAT1;FBXL18;CENPU;POM121;HAUS2;DYNC1LI2;SPDL1;SKP1;CENPF;HAUS8;PSMD5;PSMD8;WAPL;DYRK1A;CDC26;INCENP;IST1;PLK1;LIN9;CENPA;EP300;BUB3;PSMD13;H3C7;ORC6;PSMB10;CHMP4B;PPP2R5E;H2BC13;CEP76;ITGB3BP;ESCO2;ANAPC5;SLC19A1;HAUS1;ANAPC10;MAD1L1;DHFR;CSNK2A2;ZWINT;H2AC14;FBXO5;H3C13;SPC25;CDC25B;ENSA;LRIG1;H2AZ1;UBE2E1;AKT2;E2F1;NEK9;SET;CDCA8;AKT3;CLASP2;CEP290;DYNLL2;TK1;TUBA8;PPP2R1A;FKBPL;GINS3;UBE2C;BORA;AKT1;ESCO1;CEP192;PCNA;PDS5B;CCND2;TUBB2A;POLR1B;GINS1;CENPT;KNL1;ACTR1A;CEP164;TUBGCP4;FBXW11;CDKN2B;ABL1;CEP78;HAUS7;TUBGCP2;LBR;ANAPC4;TUBB4A;H3-3B
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.2868418557542375,-1.0442643963729792,0.40625,1.0,1.0,11/65,12.29%,ANAPC2;CDC16;ANAPC11;PSMC5;PSMD5;PSMD8;CDC26;PSMD13;PSMB10;ANAPC5;ANAPC10
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,-0.29780801549888297,-1.0405941425830287,0.4631578947368421,1.0,1.0,27/63,32.60%,USP9X;GGA3;APOE;SIAH1;H2BC14;H3C7;H2BC13;H2AC14;PSENEN;H3C13;HSPG2;H2AZ1;SIAH2;NCSTN;ADAM10;LTF;H3-3B;H2AX;B2M;H2AC19;ITM2B;H2AB1;RPS27A;SORL1;H2BC17;H2BC12;BACE1
prerank,Reactome_2022__tRNA Processing R-HSA-72306,-0.27598873891259,-1.0404611203603868,0.40404040404040403,1.0,1.0,26/101,22.41%,ELAC2;NUP88;FTSJ1;DUS2;NUP37;NUP133;POM121;TSEN2;METTL1;CTU1;RPP25;CTU2;TP53RK;RPP38;TRMT6;CSTF2;OSGEP;RPP14;QTRT1;HSD17B10;ADAT3;NSUN6;TRMT61B;LAGE3;LCMT2;TRMT10C
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.26175714685241996,-1.0398875321035153,0.42,1.0,1.0,68/181,34.86%,PDIA3;CD3D;NFKB2;NEDD4;SAP30;BCL2L11;CD58;CCNE1;PSMC5;TYK2;SIN3A;IL6;PSMD8;SYK;PSMD1;PSMD13;EIF2AK2;CD19;MAPK10;PIK3R3;STAT1;TRAF2;GADD45G;AKT2;E2F1;DDB2;IKBKB;PIK3CB;CD3E;AKT3;CD3G;PIK3R1;AKT1;BAX;BID;FADD;CCND2;MAPK8;TRAF6;IFNAR1;MAP2K4;TP53;MAP3K7;GADD45A;B2M;MAPK14;CASP3;TRAF5;RAC1;NFKBIE;LYN;CALR;CDKN1B;JUN;SAP30L;MAPK11;ADRM1;PSMC4;CR2;CD44;PSMD4;CHUK;GADD45B;MAPK13;IRAK4;JAK3;TRADD;CDK2
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.34884276294924177,-1.0398424995197197,0.43023255813953487,1.0,1.0,7/21,24.05%,RPA3;SLC19A1;LRIG1;APEX1;PCNA;POLR1B;RFC3
prerank,KEGG_2021_Human__Bile secretion,-0.3066169592765057,-1.0395691171261159,0.42105263157894735,1.0,1.0,12/43,20.32%,ABCB1;ABCB11;FXYD2;SLC9A3;SLC4A5;AQP9;ABCG2;ABCC2;ADCY3;NCEH1;SCT;CA2
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,-0.3502124808163776,-1.0389567306816587,0.42528735632183906,1.0,1.0,8/21,30.51%,EDEM2;RNF139;RNF185;TRIM13;UGGT1;RPS27A;RNF103;UGGT2
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,-0.29212614442780793,-1.0382655928007218,0.4673913043478261,1.0,1.0,7/51,9.86%,VRK2;LPIN1;NUP88;NUP37;NUP133;POM121;PLK1
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.2655538278809284,1.0368063652084858,0.36363636363636365,1.0,1.0,6/26,7.47%,EXOSC8;DCP2;ATF4;CEBPB;DDIT3;NFYA
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,-0.30691283597628277,-1.035193769080287,0.47191011235955055,1.0,1.0,5/40,3.73%,PRKCD;CREB1;PRKAR2B;CAMK2A;GNA11
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,-0.28492345964397126,-1.0351934739847142,0.4444444444444444,1.0,1.0,25/109,18.59%,CREB1;VPS37B;HDAC3;NUP88;NUP37;NUP133;H2BC14;MVB12B;SNF8;POM121;DYNC1LI2;EZH2;MVB12A;H3C7;PML;CHMP4B;H2AC12;H2BC13;RBBP7;H2AC14;H3C13;H2AC25;UBAP1;DYNLL2;RNASE1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,-0.31910454496117,-1.0346289503523207,0.4,1.0,1.0,10/35,20.36%,POU2F1;CRCP;ZNF143;POLR3B;SNAPC1;POLR3D;POLR3C;GTF3C4;GTF3A;GTF3C2
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,-0.2820094033943299,-1.0345982768288302,0.41935483870967744,1.0,1.0,16/84,16.64%,B3GLCT;GALK1;GFPT1;GPC2;C1GALT1;LFNG;CHSY1;POMGNT1;DAG1;VCAN;SEMA5B;MPDU1;HEXA;B3GAT3;HSPG2;LARGE1
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,-0.2800805242386264,-1.0337613737479314,0.44,1.0,1.0,39/101,31.75%,MED12L;HDAC3;NCOA1;FXYD2;FOXO1;SIN3A;PFKL;PLCB2;MED27;EP300;MED30;KAT2B;NCOA3;PIK3R3;STAT1;RCAN1;AKT2;MED24;PIK3CB;PLCB4;AKT3;PIK3R1;KAT2A;AKT1;PLCD3;MED1;MED17;NCOR1;TP53;MAPK1;ATP1B2;MED4;MED12;HRAS;MAP2K1;PFKP;ATP2A1;PFKM;MED13L
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,0.18971199156967788,1.0336206237812462,0.6,1.0,1.0,11/68,7.69%,IL24;TNFSF14;CXCR1;IL18RAP;IL20RB;CCR9;TNFRSF10C;CXCR2;IL10;CCL3;CCL28
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.27999236886452017,-1.0328198004724178,0.41,1.0,1.0,27/96,23.41%,CNTRL;NEK2;CDK5RAP2;AHI1;PRKAR2B;DCTN3;CLASP1;CSNK1D;AKAP9;HAUS2;HAUS8;PLK1;CEP76;KIF24;HAUS1;TTBK2;CEP290;PPP2R1A;NPHP4;CEP192;TMEM67;ACTR1A;CEP164;CEP78;HAUS7;TUBB4A;NINL
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,-0.29350405688714026,-1.032351904059115,0.45054945054945056,1.0,1.0,17/52,28.94%,ATP6V1E1;ATP6V0B;PIK3R4;ATP6V1E2;TCIRG1;THEM4;ATP6V0D1;AKT2;FGFR1;PIK3CB;PIK3R1;GRB10;MAPK1;PDE3B;ATP6V0C;PIK3C3;HRAS
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,-0.25953061315083453,-1.0323460790972283,0.46,1.0,1.0,35/218,12.51%,SIRT2;ANAPC2;CDC16;VRK2;ANAPC11;PPP2CB;XPO1;NUP37;CLASP1;CENPO;NUP133;SKA1;PSMC5;CENPU;POM121;DYNC1LI2;SPDL1;CENPF;PSMD5;PSMD8;WAPL;CDC26;INCENP;IST1;PLK1;CENPA;BUB3;PSMD13;PSMB10;CHMP4B;PPP2R5E;ITGB3BP;ANAPC5;ANAPC10;MAD1L1
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,-0.26977535435299504,-1.0317430500790385,0.4,1.0,1.0,49/175,26.85%,MMP9;CTSL;P3H1;PLOD3;MMP11;ITGA10;SERPINH1;COL9A1;NCAM1;CAPN5;PLOD1;ITGB5;LTBP1;ITGA5;P3H2;MFAP5;KLKB1;CTSG;LAMC1;HTRA1;DAG1;VCAN;PSEN1;PLEC;LAMC3;HSPG2;CTSS;CAPN2;ITGA4;JAM3;BMP1;ITGAX;NCSTN;ITGB2;DST;LMNB2;PCOLCE2;ADAM10;PPIB;MMP28;DCN;PLG;COL8A2;ADAM9;COL13A1;LOXL1;TGFB1;MMP17;CASP3
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.273748499140125,-1.0314399049685081,0.46938775510204084,1.0,1.0,53/131,35.25%,CREB1;NKIRAS2;PTPN4;NFKB2;PPP2CB;ECSIT;BIRC3;TMED7-TICAM2;MAP3K1;SKP1;MAPK10;ALPK1;TNIP2;DNM1;LRRC14;IKBKB;RPS6KA1;NLRC5;N4BP1;PPP2R1A;ITGB2;FADD;LY96;MEF2C;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;RPS6KA5;MAP2K4;RPS6KA3;MAPK7;DUSP6;TP53;MAP3K7;NOD2;MAPK14;MAPK1;NKIRAS1;RPS27A;MAP2K1;JUN;S100A8;NDUFA2;MAPK11;CHUK;RPS6KA2;MAPKAPK3;IRAK4;RIPK3;S100B
prerank,KEGG_2021_Human__Shigellosis,-0.2631066955676455,-1.0308169894534942,0.44,1.0,1.0,85/224,34.02%,PRKCD;SEPTIN6;GABARAPL2;BNIP3;CXCL8;WASF2;HCLS1;ATG16L1;FOXO1;ITGA5;GLMN;TLR5;PLCB2;SKP1;PIK3R4;CD14;H3C7;MAPK10;RRAGB;PIK3R3;BCL10;H3C13;U2AF1L4;DIAPH1;TRAF2;H3C6;CAST;CYTH4;AKT2;CAPN2;IKBKB;PIK3CB;PLCB4;AKT3;ATG5;PIK3R1;ARPC3;PFN2;H3-3A;CASP4;AKT1;MYL12A;BAX;FNBP1L;PLCD3;MAPK8;UBE2N;WIPI1;TAB3;TRAF6;FBXW11;ACTR3B;RPS6KA5;H3C15;MYL9;PXN;H3-3B;RPTOR;TP53;ARPC5;MAP3K7;MAPK14;MAPK1;TRAF5;CRK;RAC1;CCL5;RPS27A;PIK3C3;PFN1;ARHGEF2;H3C1;MYL5;JUN;TLN1;ACTR3;WIPI2;H3C4;MAPK11;RRAGD;RBX1;CD44;WASF1;CHUK;MAPK13
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.26035707360829563,-1.0301718847437917,0.41,1.0,1.0,124/448,26.38%,ZNF599;PDIA3;ZNF616;ZNF614;ZFP69;ZNF471;ZNF433;ZNF627;ZNF2;NXF1;ZNF543;ZNF610;ZNF30;EIF2AK4;POU2F1;ZNF41;BIRC3;EIF2S1;ZNF74;ZNF180;ZNF141;ZNF557;ZNF484;ZNF529;RBAK;ZNF700;ZNF135;ZNF343;ZNF256;ZNF91;ZNF546;ZNF749;ITGA5;TYK2;ZNF26;IL6;ZNF160;ZNF676;ZNF891;ZNF619;SYK;SRSF5;ZNF415;ZNF674;ZNF81;EIF2AK2;ZNF440;PML;ZNF132;ZNF320;PIK3R3;ZNF273;ZNF717;STAT1;ZNF562;ZNF331;ZNF84;TRAF2;ZFP92;EIF2B4;ZNF836;ZNF777;ZNF418;ZNF222;ZNF17;ZNF268;AKT2;ZNF7;ZNF211;ZNF480;IKBKB;ZNF226;PIK3CB;ZNF350;ZNF563;AKT3;PIK3R1;ZNF337;ALYREF;ZNF589;ZNF761;ZNF558;ZNF846;AKT1;ZNF766;ZNF814;ZNF275;BAX;EIF2B3;BID;ZNF77;FADD;ZNF300;ZNF587;ZNF551;SOCS3;ZNF721;ZNF783;TRAF6;ZNF486;IFNAR1;ZNF33A;ZNF699;ZNF227;ZNF829;ZNF354A;ZNF564;TSC1;IFNGR2;ZNF354C;ZNF225;ZFP37;ZNF519;ZNF324B;ZNF90;TP53;ZIK1;ZNF662;ZNF714;ZNF677;JAK2;ZNF559;MAP3K7;ZNF561
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,-0.32865268488539606,-1.0294414769292433,0.4444444444444444,1.0,1.0,7/25,19.90%,PPP2CB;FZD6;PPP2R5E;TNKS2;TCF7L2;PPP2R1A;PORCN
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,-0.30426908828644034,-1.0284041708203668,0.42105263157894735,1.0,1.0,26/58,32.34%,SAP30;HDAC3;ARID4A;SAP18;H2BC14;H3C7;H2AC12;H2BC13;RBBP7;MTA2;H2AC14;H3C13;H2AC25;BRMS1L;NCOR1;CHD4;RBBP4;DPEP3;H2AC19;TBL1XR1;CHD3;H2BC17;HDAC10;SAP30L;H2AC11;H2BC12
prerank,KEGG_2021_Human__Glucagon signaling pathway,-0.2924163692753827,-1.0274713154448243,0.5052631578947369,1.0,1.0,19/77,17.36%,PRKAG2;CREB1;PHKG1;CAMK2A;FOXO1;PFKL;PLCB2;CPT1A;CPT1B;EP300;PYGB;PHKB;PGAM2;PHKG2;PPARA;AKT2;PLCB4;G6PC3;AKT3
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,-0.36175953911992886,-1.024469752249869,0.45,1.0,1.0,8/17,32.05%,RPA3;SLC19A1;PCNA;POLR1B;REV1;RFC3;RPS27A;REV3L
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.2869788536145566,1.0242603895310936,0.35714285714285715,1.0,1.0,17/17,71.33%,SH3GL1;RNMT;UBC;UBB;EPS15;GRB2;CTNNB1;STAM2;SH3KBP1;CBLL1;STAM;UBA52;CBL;SRC;FZR1;HGS;RPS27A
prerank,KEGG_2021_Human__Glutathione metabolism,-0.2911871688753551,-1.0232019186026933,0.48936170212765956,1.0,1.0,11/45,16.59%,MGST1;MGST2;HPGDS;ODC1;GGT1;NAT8B;GSTA4;GSTO1;GGT7;MGST3;GSTM1
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.27248899340880955,-1.0226028397302922,0.49,1.0,1.0,46/185,21.94%,HIPK2;PCGF5;CTSL;PHC3;KCTD6;KMT2B;SCMH1;AGO1;IL2RA;H2BC14;PSMC5;SMARCD2;MNAT1;LMO2;SIN3A;CBX4;PSMD5;RNF2;PSMD8;FOXP3;EP300;PSMD13;H3C7;PML;PSMB10;H2BC13;KAT2B;GATA1;KMT2D;CSNK2A2;ARID1A;H2AC14;H3C13;GATA3;H2AZ1;TAL1;PRMT6;CBX6;CTLA4;TNRC6A;RUNX2;CCND2;SOCS3;TCF7L1;CBFB;ABL1
prerank,KEGG_2021_Human__Cushing syndrome,-0.27714128262784704,-1.02226201560361,0.47,1.0,1.0,24/102,21.73%,CACNA1I;CREB1;CDKN2C;CAMK2A;GNA11;PBX1;CCNE1;NR4A1;FZD2;USP8;WNT10A;PLCB2;FZD6;KMT2D;TCF7L2;E2F1;PLCB4;CACNA1H;FZD3;GNAI1;ADCY3;NCEH1;TCF7L1;CDKN2B
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,-0.28501710763705923,-1.0212080040324676,0.4387755102040816,1.0,1.0,19/97,16.50%,ELAC2;PIWIL2;NUP88;ANG;NUP37;AGO1;NUP133;H2BC14;POM121;PRKRA;POLR2I;IPO8;H3C7;H2BC13;H2AC14;H3C13;XPO5;H2AZ1;DGCR8
prerank,Reactome_2022__rRNA Processing R-HSA-72312,-0.2728932692091356,-1.021114700907403,0.37,1.0,1.0,50/197,22.50%,UTP20;ELAC2;RPS4X;RPS20;RPS15A;DNAJC5;RPL39;BYSL;CSNK1D;RPL4;EMG1;RPS8;UTP25;RPL26L1;EXOSC9;RCL1;RPL38;SPPL2A;RPS16;RPP25;DIMT1;TEX10;EBNA1BP2;PDCD11;RPS11;RPL7A;RPP38;EXOSC6;RPL29;RPS10;RRP7A;EXOSC4;RPP14;RPS14;EXOSC3;HSD17B10;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;EXOSC2;UTP11;RPS28;IMP4;TRMT10C;UTP4
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.268923199363798,-1.0208540379538942,0.42857142857142855,1.0,1.0,43/138,27.68%,PRKAG2;NDUFB2;MAP3K5;BCL2L11;COX5A;EIF2S1;CXCL8;UQCR10;NDUFC1;SDHC;NDUFB7;IL6;NDUFS7;NDUFS2;MAPK10;PIK3R3;TRAF2;PPARA;AKT2;SDHA;IKBKB;PIK3CB;AKT3;PIK3R1;AKT1;BAX;BID;NDUFS1;PRKAG1;MAPK8;SOCS3;NDUFA13;FOS;NDUFB6;COX8A;TGFB1;MAPK14;CASP3;COX7B;COX5B;NDUFS8;RAC1;PRKAB1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.3464938546409501,-1.0201442808312602,0.4634146341463415,1.0,1.0,8/26,24.74%,DNA2;EXO1;RAD50;RBBP8;RMI2;RTEL1;RAD51AP1;TOP3A
prerank,KEGG_2021_Human__Hippo signaling pathway,-0.2826193589241036,-1.0198661983182469,0.41836734693877553,1.0,1.0,32/111,24.13%,PPP2CB;TGFBR2;SMAD2;BIRC3;RASSF2;CSNK1D;FZD2;WNT10A;FZD6;AMOT;CTNNA1;NF2;BMP6;TCF7L2;BBC3;RASSF4;SMAD7;FZD3;PPP2R1A;ITGB2;CCND2;BMPR1A;LATS2;TCF7L1;FBXW11;ID2;WTIP;DLG5;BMPR2;DCHS1;PAK1;WNT5B
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.3299889915740953,-1.019704486933422,0.47191011235955055,1.0,1.0,5/36,7.31%,XPO1;NUP88;NUP37;NUP133;POM121
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.32295918603121965,-1.016465903148662,0.4946236559139785,1.0,1.0,6/25,15.20%,NAMPT;NCOA1;LIN9;PPARA;BHLHE41;BMAL1
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.2723500316092279,-1.0162446182911562,0.46,1.0,1.0,27/128,18.31%,ALDH2;MGST1;AKR1A1;CYP4F12;TPST2;CYB5R3;MTARC1;NCOA1;MGST2;BPNT1;HPGDS;PAOX;SMOX;GGT1;GSTA4;ALDH1B1;GSTO1;GGT7;CYP4B1;AKR7A2;BPNT2;MGST3;ACSS2;GSTM1;SLC35B3;AKR7L;MIA3
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,0.18836676623778653,1.0160015883382942,0.5,1.0,1.0,18/57,17.65%,FYTTD1;SRSF1;SRRM1;WDR33;CPSF3;SYMPK;EIF4A3;UPF3B;CSTF2T;SRSF6;COLEC12;MAGOHB;NCBP1;THOC1;RNPS1;MAGOH;THOC3;CSTF1
prerank,KEGG_2021_Human__Breast cancer,-0.28041986335711133,-1.0159258138847214,0.48,1.0,1.0,32/94,30.09%,NFKB2;JAG1;NCOA1;FZD2;WNT10A;FZD6;IGF1R;NCOA3;PIK3R3;GADD45G;TCF7L2;AKT2;E2F1;DDB2;FGFR1;PIK3CB;AKT3;PIK3R1;FZD3;AKT1;BAX;TCF7L1;FOS;HEY1;WNT5B;TP53;GADD45A;MAPK1;LRP5;HRAS;MAP2K1;JUN
prerank,KEGG_2021_Human__Apoptosis,-0.2671882312053225,-1.0155942680234675,0.5154639175257731,1.0,1.0,46/129,31.52%,CTSF;CTSL;MAP3K5;BCL2L11;BIRC3;EIF2S1;IL3RA;PARP1;TRAF1;MAPK10;PIK3R3;TRAF2;GADD45G;BBC3;AKT2;CTSS;CAPN2;IKBKB;PIK3CB;PARP4;AKT3;PIK3R1;TUBA8;AKT1;BAX;PRF1;LMNB2;BID;DFFB;FADD;MAPK8;FOS;GZMB;NTRK1;TP53;GADD45A;CASP3;MAPK1;HRAS;PARP3;MAP2K1;JUN;SPTA1;CTSC;ENDOG;TNFRSF10B
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,-0.257863026463862,-1.0152580051650963,0.39,1.0,1.0,80/200,35.88%,ANAPC2;CREB1;CD3D;CDC16;NFKB2;ANAPC11;XPO1;CDKN2C;TGFBR2;SMAD2;CRTC1;ELK1;IL2RA;CCNE1;MAP3K1;IL6;CDC26;ETS1;EP300;BUB3;MAPK10;KAT2B;ANAPC5;ANAPC10;MAD1L1;PIK3R3;FOSL1;AKT2;E2F1;IKBKB;VAC14;PIK3CB;CD3E;AKT3;CD3G;PIK3R1;STAT5A;KAT2A;AKT1;ITGB2;ADCY3;BAX;CCND2;MAPK8;FOS;CDKN2B;PTTG2;CHEK1;ANAPC4;MAP2K4;EGR1;TP53;ANAPC7;TGFB1;B2M;IL15RA;MAPK1;VDAC2;HRAS;TBPL2;MAP2K1;CALR;JUN;TLN1;ELK4;PPP3CC;FDPS;ADCY7;CHUK;MAP3K3;TCF3;SPI1;JAK3;CDK2;ESPL1;STAT5B;NRP1;CCND3;MAP2K2;PTEN
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.2803703503050395,-1.0147872923716734,0.45918367346938777,1.0,1.0,12/71,12.29%,ANAPC2;CDC16;ANAPC11;PSMC5;PSMD5;PSMD8;CDC26;PLK1;PSMD13;PSMB10;ANAPC5;ANAPC10
prerank,KEGG_2021_Human__Steroid biosynthesis,-0.36236997877031024,-1.0147433489396482,0.47674418604651164,1.0,1.0,7/16,29.64%,NSDHL;DHCR7;TM7SF2;DHCR24;LBR;SC5D;FDFT1
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,0.19775415887428097,1.0146991231385014,0.42857142857142855,1.0,1.0,23/59,21.90%,PSMB5;SKP2;CDKN1A;PSMD9;PSMC3;PSMC6;PSMB7;CCNE2;PSME2;UBC;PSMD11;CCND1;CKS1B;PSMD6;UBB;PSMF1;PSMD3;CUL1;PSMB3;CDK4;PSMB2;PTK6;PSMA7
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.26994081323599084,-1.0146659844785857,0.46,1.0,1.0,50/143,32.02%,GPR132;INSL3;CCR5;CXCL8;CMKLR1;LPAR6;P2RY14;MC1R;UTS2B;GPR68;F2R;GNRH1;S1PR2;UTS2R;NMUR1;GHRL;S1PR1;HRH2;CXCR4;CXCR5;UTS2;PLPPR2;P2RY6;C5AR1;RLN2;OXER1;S1PR5;ADORA2A;SUCNR1;DHX34;P2RY1;KISS1R;TBXA2R;XK;SSTR2;ADORA2B;CCR1;ADORA3;NTSR1;CCRL2;AGXT;CCL5;PTAFR;LTB4R2;CXCL3;ACKR3;CCL2;OPN3;PTGDR2;HEBP1
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.3122294667911253,-1.0140539354339817,0.3793103448275862,1.0,1.0,7/40,11.87%,NUP88;NUP37;NUP133;POM121;EIF2AK2;KPNA4;KPNA2
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.30245202949326194,-1.0137936750416308,0.4090909090909091,1.0,1.0,3/27,8.84%,PDIA3;SEC31A;PIK3R4
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,-0.3076345303502964,-1.0112618588746791,0.4588235294117647,1.0,1.0,11/38,22.44%,CLTCL1;FXYD2;AP2M1;PLCB2;KLK1;CLTB;DNM1;PLCB4;VDR;SLC8A1;CLTC
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.29390795427462474,-1.0111318428085605,0.42857142857142855,1.0,1.0,14/40,28.88%,SDSL;KYAT3;DNMT1;GOT1;IL4I1;DNMT3B;KYAT1;MTAP;ADI1;BHMT2;LDHB;AHCYL2;LDHA;BCAT1
prerank,Reactome_2022__G2/M Transition R-HSA-69275,-0.2652417765680409,-1.0095151258213722,0.51,1.0,1.0,29/177,12.18%,CNTRL;NEK2;CDK5RAP2;MZT2A;PRKAR2B;PPP2CB;XPO1;DCTN3;TUBGCP6;CLASP1;CDC25C;CSNK1D;PSMC5;AKAP9;MNAT1;FBXL18;HAUS2;SKP1;CENPF;HAUS8;PSMD5;PSMD8;PLK1;LIN9;EP300;PSMD13;PSMB10;CEP76;HAUS1
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,-0.2642883249467295,-1.0088859498724485,0.44,1.0,1.0,95/254,32.34%,PRKCD;REXO2;PPP2CB;XPO1;MYH9;FMNL3;PPP1R14A;NUP37;CLASP1;CDC25C;ABI1;CENPO;PRC1;PDZD2;NUP133;WASF2;SKA1;H2BC14;CENPU;CYFIP2;RHPN1;KLKB1;DYNC1LI2;SPDL1;CENPF;PIK3R4;RTKN;INCENP;PLK1;CENPA;BUB3;H3C7;CTNNA1;PPP2R5E;H2BC13;ITGB3BP;NF2;RHOC;MAD1L1;ZWINT;H2AC14;IQGAP1;H3C13;SPC25;DIAPH1;H2AZ1;WAS;CDCA8;CLASP2;DYNLL2;ARPC3;PFN2;PPP2R1A;RNASE1;PKN2;FMNL2;LIMK2;CENPT;KNL1;ABL1;MYL9;H3-3B;H2AX;MYLK;NCKAP1L;ARPC5;YWHAZ;MAPK14;MAPK1;H2AC19;RHPN2;WIPF1;FMNL1;H2AB1;KTN1;NUP43;PIK3C3;PFN1;RPS27;YWHAQ;RHOG;CDKN1B;ACTR3;NUP85;BUB1;H2BC17;S100A8;KIF2C;BAIAP2;NCF4;CENPN;MAPK11;NCKIPSD;CENPM;H2BC12
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,-0.26681156442681453,-1.008883146164357,0.53,1.0,1.0,53/145,32.19%,YKT6;B4GALT2;SEC22B;ACTR10;COPZ2;DCTN3;GOLGA2;SEC31A;CSNK1D;ARF4;TMEM115;DYNC1LI2;BET1L;MAN2A1;COPB1;ANK2;B4GALT3;TRAPPC1;ANKRD28;NAPG;COPE;ARF5;SPTBN1;DYNLL2;MIA3;DCTN4;COPZ1;ACTR1A;FUT8;CNIH2;ARFGAP3;GOSR1;MCFD2;ST8SIA6;SEC24D;SERPINA1;COG3;STX5;ARCN1;PPP6C;COG2;COPB2;COG7;ST3GAL4;SEC16A;CNIH3;SPTA1;TFG;TRAPPC6A;CTSC;CD59;KDELR1;FOLR2
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.3177050670507587,-1.0087015198025984,0.47191011235955055,1.0,1.0,5/34,9.55%,NUP88;NUP37;NUP133;POM121;PIAS4
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,-0.33240143656891974,-1.0081645136020234,0.4939759036144578,1.0,1.0,6/23,17.57%,IL3RA;IL2RA;IL5RA;PIK3R3;PIK3CB;PIK3R1
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,-0.33209699270884724,-1.0075107495308109,0.4567901234567901,1.0,1.0,4/23,9.85%,STK38;RNF20;HNRNPC;RHOBTB1
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,-0.362834959498612,-1.0074148386016195,0.5432098765432098,1.0,1.0,4/18,16.84%,CD3D;PAG1;PTPRJ;CD3E
prerank,KEGG_2021_Human__Wnt signaling pathway,-0.2760309475461121,-1.0073943996918306,0.4897959183673469,1.0,1.0,46/106,33.90%,CAMK2A;SIAH1;FZD2;CBY1;WNT10A;PLCB2;SKP1;FZD6;TLE2;EP300;CACYBP;MAPK10;CSNK2A2;PSEN1;FOSL1;TCF7L2;LGR6;LGR4;PLCB4;TLE1;FZD3;NLK;CHD8;PORCN;CCND2;MAPK8;TCF7L1;FBXW11;PRICKLE2;WNT5B;SENP2;TP53;MAP3K7;TBL1XR1;RAC1;PPARD;RAC3;LRP5;JUN;SFRP2;PRICKLE1;PPP3CC;TLE4;RBX1;PRKCB;RAC2
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,0.11295012871789176,1.0070958206830998,0.0,1.0,1.0,33/107,21.90%,PSMB5;ORAI2;CD79B;PSMD9;PSMC3;PSMC6;PSMB7;NFATC3;CALM1;CLSTN1;PSME2;UBC;PPP3CA;FYN;PSMD11;REL;NCK1;PSMD6;UBB;PSMF1;ITPR2;AHCYL1;PSMD3;BTRC;CD79A;IKBKG;CUL1;TRPC1;PSMB3;VAV1;PSMB2;GRB2;PSMA7
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.2740226439596429,-1.006531839938145,0.5052631578947369,1.0,1.0,32/76,38.16%,XRCC1;TCEA1;ERCC5;RPA3;ERCC4;UVSSA;MNAT1;POLR2I;EP300;SLC19A1;LRIG1;DDB1;PCNA;POLR1B;COPS8;RFC3;GTF2H3;GPS1;COPS2;POLR2D;RPS27A;POLR2B;ELL;POLD4;GTF2H1;RBX1;POLD2;CDK7;AQR;COPS4;COPS6;POLR2H
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.3543244931677481,-1.0055748010172563,0.47619047619047616,1.0,1.0,5/17,17.99%,ARF4;PKD1;EXOC5;EXOC7;EXOC3
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,-0.25548265252331576,-1.0055447995180429,0.46,1.0,1.0,111/420,24.77%,PLXNA4;CDK5R1;MMP9;CREB1;KIF4A;ITGA10;AKAP5;MYH9;RPS4X;ELOC;RPS20;SEMA6A;RPS15A;CLASP1;RPL39;CLTCL1;SIAH1;RPS6KA4;COL9A1;RPL4;EPHB3;DPYSL4;NCAM1;USP33;PSMC5;RPS8;NCBP2;RPL26L1;ITGA5;EPHA1;DOK4;RPL38;AP2M1;LYPLA2;LAMC1;PSMD5;PSMD8;SHTN1;PSMD13;RPS16;CACNB3;PSMB10;RANBP9;RRAS;DAG1;RHOC;CNTN1;CXCR4;CSNK2A2;PSEN1;PLXNB1;CLTB;PIK3R3;PSENEN;ANK2;RPS11;RPL7A;TRIO;DNM1;ALCAM;RPL29;SIAH2;RPS10;FGFR1;MSN;PIK3CB;RPS14;DOK2;PIK3R1;RPS6KA1;RPS23;CACNA1H;RPS29;CLASP2;RPL30;SPTBN1;RPLP2;ARPC3;PFN2;RELN;RNASE1;RPL35;NCSTN;RPL27;PKN2;MYL12A;RPL14;RPSA;LIMK2;ADAM10;CACNB2;MAPK8;CAP1;CACNB4;CNTNAP1;L1CAM;TRPC6;ABL1;RPS28;CLTC;RPS6KA5;MYL9;TYROBP;PDLIM7;PLXNB3;RPS6KA3;GRB10;RPL15;MAPK7;RPL36AL;RPL11
prerank,KEGG_2021_Human__Arginine and proline metabolism,-0.310411400990102,-1.0050002138525376,0.46511627906976744,1.0,1.0,7/38,13.32%,ALDH2;CARNS1;SMOX;ODC1;ALDH1B1;GOT1;ALDH4A1
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,-0.29334159759311,-1.003800085162085,0.43333333333333335,1.0,1.0,12/41,27.44%,ATP10D;CAMK2A;FXYD2;ATP8A1;ATP2C2;ATP13A2;ATP11A;ATP10B;ATP9B;ATP8B3;ATP8B2;ATP1B2
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.1504829444223757,1.0034188520679885,0.5,1.0,1.0,15/91,10.90%,ASXL1;PSMB5;UCHL1;INO80;PSMD9;PSMC3;PSMC6;PSMB7;H2AC4;PSME2;INO80D;HCFC1;UBC;FOXK2;PSMD11
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,0.261259431933974,1.0030336820784265,0.4,1.0,1.0,6/18,11.88%,RHOB;VPS72;LIMK1;ROCK2;MYH11;PPP1R12A
prerank,KEGG_2021_Human__RNA degradation,-0.27501056547730207,-1.0030118752721024,0.5212765957446809,1.0,1.0,16/68,20.08%,TOB2;PAN2;CNOT10;LSM1;EXOSC9;PFKL;DCP1A;BTG2;CNOT6L;EXOSC6;CNOT9;EXOSC4;EXOSC3;CNOT2;TOB1;EXOSC2
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,-0.2522120475948565,-1.0026746622215432,0.5,1.0,1.0,98/331,29.45%,EDEM2;ZDHHC8;LARP1;CTSL;REXO2;SAP30;ARID4A;DDX20;SAP18;NUP88;RPS4X;SNRPE;RPS20;RPS15A;NUP37;ZDHHC3;SNRPB;FXYD2;SIKE1;GPC2;NUP133;RPS8;TYK2;POM121;ZBP1;AP2M1;PARP16;PIK3R4;S1PR1;SYK;RPS16;GEMIN8;CHMP4B;MAN2A1;VPS18;VCP;GEMIN5;KPNA2;RBBP7;GEMIN6;MTA2;STAT1;RPS11;GANAB;HSPG2;AKT2;ITGA4;RPS10;IKBKB;SIGMAR1;RPS14;PARP4;UVRAG;AKT3;SNRPF;PARP14;RPS23;RPS29;AKT1;RPSA;ST6GALNAC4;UBE2N;TAB3;TRAF6;IFNAR1;RPS28;FUT8;ZDHHC5;COMT;CHURC1-FNTB;BRMS1L;SEC24D;CHD4;IFNGR2;RNF103-CHMP3;VHL;ST6GALNAC3;PRKCSH;RBBP4;JAK2;MAP3K7;NOD2;YWHAZ;B2M;DPEP3;GEMIN2;CRB3;ATP1B2;ST3GAL4;NUP43;RPS27A;PIK3C3;HSP90AB1;SMN1;CHD3;RPS27;TLR7;YWHAQ
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,-0.30435007112878143,-1.0023672332257163,0.4673913043478261,1.0,1.0,15/45,27.05%,CHIT1;GALK1;CYB5R3;GFPT1;MPI;UAP1L1;HEXA;GMDS;GPI;NAGK;FCSK;PGM3;CYB5R1;UXS1;CMAS
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.3334544286293003,-1.002319415997073,0.5106382978723404,1.0,1.0,11/39,23.78%,ORMDL3;SPTLC1;SPTLC2;SGPP2;SAMD8;ALDH3B1;SPNS2;ACER2;CSNK1G2;SPTSSA;ORMDL2
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.2408310429984919,1.00150121483576,0.5625,1.0,1.0,8/19,16.99%,RHOB;ARHGEF11;LIMK1;ROCK2;RND1;MYH11;SEMA4D;MYH10
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,-0.27293512361003136,-1.001439253542922,0.46938775510204084,1.0,1.0,21/107,15.31%,ANAPC2;MCM5;CDC16;ANAPC11;ORC3;H2BC14;PSMC5;PSMD5;PSMD8;CDC26;PSMD13;H3C7;ORC6;PSMB10;H2BC13;ANAPC5;ANAPC10;H2AC14;H3C13;H2AZ1;UBE2E1
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.26833055882944057,-1.0000416693208138,0.49,1.0,1.0,62/187,30.82%,UTP20;RPS4X;RPS20;RPS15A;DNAJC5;RPL39;BYSL;CSNK1D;RPL4;EMG1;RPS8;UTP25;RPL26L1;EXOSC9;RCL1;RPL38;SPPL2A;RPS16;RPP25;DIMT1;TEX10;EBNA1BP2;PDCD11;RPS11;RPL7A;RPP38;EXOSC6;RPL29;RPS10;RRP7A;EXOSC4;RPP14;RPS14;EXOSC3;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;EXOSC2;UTP11;RPS28;IMP4;UTP4;RPL15;RPL36AL;RPL11;NOP14;DKC1;RPL34;MPHOSPH10;DDX47;RPS27A;RPL36A;RPS27;SENP3;RPL26;PWP2;TSR1
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.15724148496800666,1.0,1.0,1.0,1.0,32/113,16.57%,PPIF;ATF4;GNA12;BAD;SLC25A6;KCNMA1;GUCY1A1;NFATC3;SLC25A4;PIK3CG;MYLK3;CALM1;PLCB1;CREB3L2;ROCK2;RAF1;ADCY9;PPP3CA;SLC25A5;ADRA1A;ATF2;PPP1R12A;PLCB3;IRS2;CREB3L4;KCNMB1;PRKG1;KCNMB3;MEF2D;CREB5;MAPK3;ITPR2
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,0.13020343441018145,1.0,1.0,1.0,1.0,25/166,9.96%,COX6C;NCF2;PSMB5;RXRA;MUL1;ATF4;HMOX2;SQSTM1;SKP2;PSMD9;PSMC3;ABCC1;PSMC6;PSMB7;SIN3B;CYBB;TKT;MAP1LC3B;PSME2;CYCS;CREBBP;MAFG;TBL1X;SRXN1;UBC
prerank,Reactome_2022__Autophagy R-HSA-9612973,-0.264654699917227,-0.9984864534116851,0.5102040816326531,1.0,1.0,36/121,25.04%,PRKAG2;VPS37B;GABARAPL2;ATG16L1;MVB12B;LAMTOR2;DYNC1LI2;TOMM7;PIK3R4;FUNDC1;TOMM20;MVB12A;TOMM6;CHMP4B;VCP;RRAGB;CSNK2A2;HDAC6;PLIN2;UVRAG;UBAP1;ATG5;GFAP;DYNLL2;RNASE1;MFN1;MTMR3;PRKAG1;UBE2N;USP30;WIPI1;ATG9A;TSC1;RNF103-CHMP3;ATG7;RPTOR
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,-0.26308795395072293,-0.997648829809821,0.5306122448979592,1.0,1.0,29/127,21.54%,ARHGEF4;SMPD3;HDAC3;NSMAF;BCL2L11;BIRC3;MAGED1;TRAF1;ARHGEF39;SPPL2A;ARHGEF18;ITGB3BP;PSEN1;PSENEN;TRIO;OBSCN;ARHGEF35;ARHGEF15;IKBKB;TNFRSF10D;RNASE1;NCSTN;PREX1;TAX1BP1;FADD;MAPK8;GNA13;TAB3;TRAF6
prerank,KEGG_2021_Human__Sphingolipid metabolism,-0.3093320541177676,-0.9973956810695013,0.4725274725274725,1.0,1.0,5/40,5.70%,SMPD3;SPTLC1;SPTLC2;GALC;SGPP2
prerank,KEGG_2021_Human__Protein export,-0.3215594762569265,-0.9973441528370044,0.4819277108433735,1.0,1.0,12/23,38.56%,SEC62;SRP14;SRP19;SEC61G;SRPRB;SEC63;SRPRA;SPCS1;SPCS3;SEC11C;SEC11A;SEC61B
prerank,Reactome_2022__DNA Replication R-HSA-69306,-0.260690925836249,-0.9970344661784201,0.52,1.0,1.0,28/150,15.31%,ANAPC2;DNA2;MCM5;CDC16;ANAPC11;RPA3;ORC3;GINS4;H2BC14;CCNE1;PSMC5;SKP1;PSMD5;PSMD8;CDC26;PSMD13;H3C7;ORC6;PSMB10;H2BC13;ANAPC5;SLC19A1;ANAPC10;H2AC14;H3C13;LRIG1;H2AZ1;UBE2E1
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,-0.28020353596416453,-0.9969879084627798,0.5154639175257731,1.0,1.0,15/65,19.46%,CD3D;PPP2CB;BTLA;PPP2R5E;PIK3R3;THEM4;AKT2;CD3E;AKT3;PIK3R1;PPP2R1A;RNASE1;AKT1;PKN2;CTLA4
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,-0.2853328697122778,-0.9963485433668748,0.5360824742268041,1.0,1.0,21/60,30.59%,PRKAG2;ITGA10;ITGB5;CACNG8;ITGA5;IL6;CACNB3;DAG1;DES;ITGA4;CACNA2D2;PRKAG1;CACNB2;CACNB4;SLC8A1;TGFB1;TPM2;PRKAB1;ITGB8;ITGB7;ATP2A1
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,-0.27994544830094836,-0.9957118176848387,0.5106382978723404,1.0,1.0,22/51,34.79%,CXCL8;SIKE1;MAP3K1;MAPK10;TRAF2;IKBKB;ATG5;FADD;MAPK8;TRAF6;OTUD5;MAP3K7;MAPK14;DDX3X;DHX58;MAPK11;PIN1;CHUK;MAPK13;TBKBP1;IL12A;TRADD
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,-0.2593781320133943,-0.9956216234384377,0.5151515151515151,1.0,1.0,34/159,19.93%,YKT6;ARHGEF4;VAMP3;FAM13A;VRK2;ARHGAP17;ARHGDIB;OPHN1;JAG1;ABI1;ARHGAP10;WASF2;ARHGAP42;ARHGAP23;CYFIP2;SH3BP1;ARHGEF39;ALS2;ARHGEF18;FAM13B;ARHGAP27;PIK3R3;IQGAP1;TRIO;DOCK4;ARHGAP1;ARHGEF15;WAS;PIK3R1;ARAP2;RNASE1;PREX1;PKN2;DEF6
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,-0.2742912947350572,-0.9952558470273126,0.46464646464646464,1.0,1.0,17/78,19.09%,BPGM;PPP2CB;NUP88;NUP37;NUP133;MAP4K5;LOC112694756;SLC37A1;POM121;PFKL;SLC25A11;SLC25A12;PGAM2;SLC25A1;G6PC3;PPP2R1A;HOOK3
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.2520659933580373,-0.9952142228055162,0.54,1.0,1.0,122/386,29.76%,TPH1;CDK5R1;TNS3;MMP9;PRKCD;CREB1;ATP6V1E1;NEDD4;HDAC3;PPP2CB;GGA3;TRIB1;MATK;ABI1;APOE;PGF;COL9A1;CUL5;PAG1;WASF2;JUP;NCBP2;PTPRK;ATP6V0B;CYFIP2;SPRY2;USP8;SIN3A;PLAT;AP2M1;SPINT2;PIK3R4;ATP6V1E2;LAMC1;POLR2I;RNF41;EP300;SH2D2A;RANBP9;CTNNA1;THBS4;IGF1R;MAP2K5;PSEN1;PIK3R3;SOCS6;PTPRJ;FOSL1;STAT1;PSENEN;PRDM1;TCIRG1;DIAPH1;THEM4;ATP6V0D1;SPRY1;DNM1;LAMC3;LRIG1;AKT2;FGFBP2;FGFR1;SPRED1;PIK3CB;AKT3;PIK3R1;ADORA2A;GFAP;RPS6KA1;FRS3;PPP2R1A;RNASE1;NCSTN;STAT5A;AKT1;PKN2;HPN;BAX;LMNB2;ADAM10;MEF2C;FOS;WWP1;ID2;CHEK1;CLTC;RPS6KA5;PTPN12;SH2B2;NCOR1;CHD4;RPS6KA3;GRB10;MAPK7;DUSP6;FOSB;EGR1;NTRK1;PLG;NCKAP1L;JAK2;COPS2;RAP1A;PDGFC;MAPK14;MAPK1;RANBP10;CRK;PDE3B;POLR2D;LYN;GALNT3;RPS27A;ATP6V0C;PIK3C3;DNAL4;HRAS;RICTOR;POLR2B;MAP2K1;NRP2;TIAL1
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.35714208037258743,-0.9950596047153099,0.47619047619047616,1.0,1.0,7/17,20.08%,EXOSC9;DCP1A;EXOSC6;EXOSC4;EXOSC3;AKT1;EXOSC2
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,-0.27804799884001297,-0.9943650915395311,0.5,1.0,1.0,14/55,23.82%,PLXNA4;CDK5R1;MYH9;SEMA6A;DPYSL4;RRAS;RHOC;PLXNB1;RNASE1;PKN2;LIMK2;MYL9;TYROBP;PLXNB3
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.282340053512683,-0.993012496607125,0.5212765957446809,1.0,1.0,20/55,32.77%,SCAP;INSIG2;NCOA1;DHCR7;MVD;LIN9;PPARA;TM7SF2;PMVK;SEC24D;SC5D;DAND5;TBL1XR1;CARM1;LMBR1;FDFT1;MBTPS2;ELOVL6;FDPS;CHD9
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,-0.27699349686890756,-0.9926640062132402,0.4725274725274725,1.0,1.0,9/50,14.41%,SLC46A1;ATP6V1E1;ATP6V0B;SKP1;ATP6V1E2;ABCG2;STEAP3;TCIRG1;ATP6V0D1
prerank,Reactome_2022__HIV Infection R-HSA-162906,-0.25621043248090664,-0.9925441078487441,0.55,1.0,1.0,75/220,33.48%,VPS4B;TCEA1;AP1M1;VPS37B;XPO1;NUP88;ELOC;CCR5;NUP37;TAF5;CUL5;NUP133;MVB12B;PSMC5;MNAT1;NCBP2;TAF1;POM121;NMT2;AP2M1;SKP1;TAF4;POLR2I;PSMD5;PSMD8;XRCC5;MVB12A;PSMD13;PSMB10;CHMP4B;CXCR4;ELOA;NELFA;NEDD4L;LRIG1;AP1S1;RNGTT;UBAP1;CCNT2;RNASE1;PKN2;SSRP1;GTF2A1;NPM1;XRCC4;TAF12;TAF15;SUPT4H1;RNF103-CHMP3;CDK9;GTF2H3;CHMP5;B2M;TAF9B;TAF2;POLR2D;PSME1;KPNA1;NUP43;RPS27A;PSMA4;POLR2B;SGIP1;NUP85;ELL;AP1M2;SUPT5H;VPS4A;GTF2H1;RBX1;PSMC4;DOCK2;NELFCD;PSMD4;TAF11
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.2520386601539543,-0.9925153887344303,0.53,1.0,1.0,80/381,19.14%,ARHGEF4;PRKCD;CREB1;DGKQ;ABHD12;PRKAR2B;RGS19;PPP2CB;CAMK2A;TAS2R50;GPR132;INSL3;GNA11;CCR5;CXCL8;CMKLR1;LPAR6;P2RY14;MC1R;UTS2B;FZD2;GPR68;ITGA5;RGS18;F2R;SMOX;GNRH1;TAS2R60;S1PR2;WNT10A;PLCB2;UTS2R;GNG5;NMUR1;ARHGEF39;GHRL;S1PR1;FZD6;ARHGEF18;HRH2;PIK3R5;DGKH;CRHBP;ADM;RHOC;KPNA2;CXCR4;CXCR5;DGKA;PLXNB1;PIK3R3;UTS2;PLPPR2;P2RY6;RAMP1;C5AR1;RLN2;TRIO;DGKG;OBSCN;ARRB1;OXER1;AKT2;ARHGEF35;ARHGEF15;PDE7A;S1PR5;PLCB4;AKT3;PIK3R1;ADORA2A;RPS6KA1;PDE2A;PPP2R1A;PDE3A;GNAI1;PREX1;SUCNR1;DHX34;AKT1
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,-0.268634598587123,-0.9899591010011964,0.5106382978723404,1.0,1.0,17/94,18.27%,CTSF;CTSL;KIF4A;ACTR10;AP1M1;DCTN3;SEC31A;KIF5C;DYNC1LI2;AP2M1;KIF3C;DNM1;ACTR1B;CTSS;AP1S1;KIF22;DYNLL2
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.29958975857745057,-0.9898893289603742,0.5,1.0,1.0,13/37,29.28%,HDAC3;NCOA1;APOE;AGO1;EP300;ABCA1;TNRC6A;NCOR1;EEPD1;CETP;TBL1XR1;NRIP1;KDM3A
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.27699317739075563,-0.9884821726503787,0.5204081632653061,1.0,1.0,18/81,18.24%,EIF4A1;NEDD4;NUP88;NUP37;PDZD2;NUP133;POM121;PDE12;EIF4E3;EIF2AK2;KPNA4;KPNA2;STAT1;EIF4G3;UBE2E1;EIF4G2;EIF4A2;UBA7
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.3125399241966775,-0.9879996803457433,0.5116279069767442,1.0,1.0,12/30,30.58%,USP9X;UBE2W;UBE2E3;UBE2E1;UBE2H;UBE2Z;UBE2C;UBA6;RPS27A;UBE2R2;UBE2G1;UBE2T
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,-0.25981378707621433,-0.9878272088355604,0.57,1.0,1.0,29/179,12.18%,CNTRL;NEK2;CDK5RAP2;MZT2A;PRKAR2B;PPP2CB;XPO1;DCTN3;TUBGCP6;CLASP1;CDC25C;CSNK1D;PSMC5;AKAP9;MNAT1;FBXL18;HAUS2;SKP1;CENPF;HAUS8;PSMD5;PSMD8;PLK1;LIN9;EP300;PSMD13;PSMB10;CEP76;HAUS1
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.34515669401251936,-0.9874717067867959,0.5058823529411764,1.0,1.0,6/18,20.73%,CAMK2A;CACNG8;RANGRF;FGF11;CACNA2D2;CACNB2
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,0.2332286309077302,0.9866028054870362,0.42857142857142855,1.0,1.0,9/42,8.53%,SERPINB2;VPS72;RALA;PDCD4;S100A9;IL10;CNN2;PSME2;HNRNPF
prerank,Reactome_2022__Translation R-HSA-72766,-0.25430199867621267,-0.9864117192202453,0.55,1.0,1.0,59/276,19.98%,EIF4A1;MRPS16;MRPL55;MRPS25;FARSA;DARS1;GFM2;RPS4X;EIF2S1;RPS20;RPS15A;PPA2;NARS1;RPL39;MARS2;MRPL43;PPA1;MRPL15;RPL4;AARS2;RPS8;EARS2;RPL26L1;SRP14;QARS1;RPL38;EIF3B;MRPL57;MTIF2;CHCHD1;RPS16;SSR2;MTRF1L;EIF1AX;MRPS23;RPS11;RPL7A;EIF2B4;RPL29;SARS1;SRP19;RPS10;SEC61G;MRPL45;RPS14;PARS2;EIF4A2;RPS23;RPS29;RPL30;RPLP2;RPL35;SRPRB;RPL27;RPL14;MRPS7;RPSA;EIF2B3;EEF1D
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,-0.256493268563281,-0.9854123148865334,0.58,1.0,1.0,77/240,29.00%,PPP2CB;XPO1;SMURF1;CAMK2A;CCDC88C;AGO1;VPS26A;BCL9;H2BC14;RORA;PSMC5;FZD2;VPS35;CDC73;CBY1;USP8;AP2M1;WNT10A;PLCB2;SKP1;GNG5;PSMD5;PSMD8;FZD6;TLE2;EP300;DACT1;PSMD13;H3C7;SOX13;PSMB10;PPP2R5E;H2BC13;TNKS2;NCOA3;KMT2D;CSNK2A2;CLTB;H2AC14;H3C13;TCF7L2;LGR6;H2AZ1;LGR4;AKT2;SMURF2;TLE1;PPP2R1A;RNASE1;NLK;AKT1;CHD8;TNRC6A;PORCN;LEO1;TCF7L1;CLTC;H3-3B;CSNK1G2;GNG3;H2AX;WNT5B;PROC;GNG10;SOX6;MAP3K7;YWHAZ;H2AC19;GNG7;BCL9L;PSME1;KLHL12;H2AB1;LRP5;RPS27A;PSMA4;PFN1
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,0.19442414755810275,0.9850834943001435,0.5,1.0,1.0,19/55,21.90%,PRKACB;SUFU;PSMB5;PSMD9;PSMC3;PSMC6;PSMB7;PSME2;UBC;PSMD11;PSMD6;UBB;PSMF1;PSMD3;BTRC;CUL1;PSMB3;PSMB2;PSMA7
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.19442414755810275,0.9850834943001435,0.5,1.0,1.0,19/55,21.90%,PRKACB;SUFU;PSMB5;PSMD9;PSMC3;PSMC6;PSMB7;PSME2;UBC;PSMD11;PSMD6;UBB;PSMF1;PSMD3;BTRC;CUL1;PSMB3;PSMB2;PSMA7
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,-0.34825740502972996,-0.9841530452688305,0.47435897435897434,1.0,1.0,9/19,34.18%,RPA3;VCP;SLC19A1;PCNA;POLR1B;RFC3;RPS27A;RCHY1;POLH
prerank,Reactome_2022__Protein Localization R-HSA-9609507,-0.26636581767272405,-0.9839961369032396,0.57,1.0,1.0,47/157,28.85%,USP9X;GFER;TIMM8B;CMC4;ACOT8;GRPEL1;PAOX;SAMM50;PEX2;FIS1;CYB5A;TOMM7;BCS1L;CHCHD3;ZFAND6;ECH1;ECI2;TOMM20;TOMM6;SLC25A12;PEX14;PMPCA;TIMM9;HMGCL;SEC61G;PEX12;TIMM17A;PEX11B;SLC25A17;TIMM13;ACOX1;TIMM23;TIMM50;CMC2;TIMM10B;CHCHD7;ACOT2;IDH3G;CS;PEX10;SERP1;STX5;ACBD5;AGXT;MTX1;RPS27A;PEX3
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,0.2624159973774791,0.9835841720196468,0.3333333333333333,1.0,1.0,15/15,73.78%,HSD17B12;STARD4;FDXR;AKR1B15;HSD17B11;FDX2;STARD3;TSPO;SRD5A3;SRD5A1;FDX1;POMC;STARD3NL;AKR1B1;TSPOAP1
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,-0.2736838481469903,-0.9812294657298145,0.5434782608695652,1.0,1.0,14/55,20.08%,EIF4A1;CNOT10;LSM1;EXOSC9;DCP1A;CNOT6L;EXOSC6;CNOT9;EXOSC4;EIF4A2;EXOSC3;CNOT2;NT5C3B;EXOSC2
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,0.2478958376602295,0.9812102884493864,0.4166666666666667,1.0,1.0,8/25,11.28%,PDP2;RXRA;LDHD;PDPK1;GSTZ1;PDHA1;PDPR;GLO1
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.3466133674998165,-0.9811832316504067,0.5,1.0,1.0,5/20,17.99%,SLC30A7;KIF5C;EXOC5;EXOC7;EXOC3
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.33241555050333693,-0.9808454521598335,0.47674418604651164,1.0,1.0,7/25,16.92%,LOC112694756;SLC37A1;SLC25A11;SLC25A12;PGAM2;SLC25A1;G6PC3
prerank,Reactome_2022__DNA Repair R-HSA-73894,-0.24856951085052928,-0.9806978968374415,0.58,1.0,1.0,78/298,26.12%,XRCC1;PPP4R2;CLSPN;TCEA1;DNA2;ERCC5;XPC;FANCE;MPG;RPA3;FAAP20;ERCC4;H2BC14;UVSSA;PARP1;ASCC2;MNAT1;TDP1;UBXN1;OGG1;POT1;FANCL;POLR2I;XRCC5;PIAS4;APBB1;HUS1;EP300;MLH1;EXO1;VCP;RAD50;H2BC13;RBBP8;KPNA2;SLC19A1;RAD9B;RMI2;MDC1;PARG;H2AC14;POLN;TDP2;ASCC3;LRIG1;H2AZ1;MGMT;DDB2;DDB1;APEX1;ACTR5;WDR48;UBA7;PCNA;POLR1B;MAPK8;UBE2N;REV1;XRCC4;SMARCA5;COPS8;ABL1;RTEL1;CHEK1;NEIL3;EYA3;RAD51AP1;H2AX;RFC3;TOP3A;GTF2H3;UNG;TERF1;TINF2;TP53;POLI;GPS1;COPS2
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,-0.30664584535559686,-0.9799220318342012,0.5543478260869565,1.0,1.0,11/33,28.68%,CDKN2C;AGO1;MDM4;ETS1;E2F1;TNRC6A;CDKN2B;TP53;DAND5;MAPK1;RPS27A
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,-0.26170114304171715,-0.9798376750684911,0.5454545454545454,1.0,1.0,35/140,23.85%,ALDH2;PRKAG2;CREB1;PRKAR2B;AKAP5;CAMK2A;DNAJC5;KCNJ15;KCNJ2;CACNG8;LIN7C;ALDH5A1;AP2M1;PLCB2;GNG5;SYN3;CACNB3;ACHE;LGALS12;KPNA2;CHRNE;GABRR2;CHRNA5;RPS6KA1;CACNA2D2;NCALD;RNASE1;GNAI1;PRKAG1;CACNB2;CACNB4;SH2D3C;COMT;GNG3;RPS6KA3
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.2761260832072044,-0.9793932136615792,0.5050505050505051,1.0,1.0,22/71,25.45%,DNAJC3;APOE;SGPP2;LTBP1;KLKB1;CTSG;IL6;LAMC1;KLK1;VCAN;ANO8;MIA3;FSTL3;LMNB2;ADAM10;IGFBP3;C4A;FUCA2;PROC;SERPINA1;PRKCSH;PLG
prerank,KEGG_2021_Human__Basal transcription factors,-0.2991076445981606,-0.9790568918411117,0.5604395604395604,1.0,1.0,20/41,38.41%,TAF5;MNAT1;TAF1;TAF4;GTF2H2C_2;GTF2A1;TAF12;TAF15;GTF2H3;TAF9B;TAF2;TBPL2;TAF4B;GTF2I;GTF2H1;TAF11;TAF6L;CDK7;GTF2E1;TAF6
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.2633512359704279,-0.9784876410750815,0.5876288659793815,1.0,1.0,21/98,18.76%,PRKAG2;CREB1;PRKAR2B;AKAP5;CAMK2A;KCNJ15;KCNJ2;CACNG8;LIN7C;AP2M1;PLCB2;GNG5;LGALS12;KPNA2;CHRNE;GABRR2;CHRNA5;RPS6KA1;NCALD;RNASE1;GNAI1
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,-0.3624084202362571,-0.978475974946024,0.4482758620689655,1.0,1.0,4/16,13.93%,ATP5F1E;DMAC2L;ATP5ME;ATP5MG
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,-0.2807789300690668,-0.9778924338690521,0.59375,1.0,1.0,20/54,32.34%,H2BC14;UBXN1;PIAS4;APBB1;RAD50;H2BC13;KPNA2;MDC1;MAPK8;UBE2N;SMARCA5;ABL1;EYA3;H2AX;TP53;RPS27A;ABRAXAS1;RNF168;H2BC17;H2BC12
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,-0.2982145533271631,-0.9764259543804912,0.5154639175257731,1.0,1.0,19/40,32.34%,H2BC14;EZH2;H3C7;H2BC13;DNMT1;RBBP7;H2AC14;H3C13;H2AZ1;DNMT3B;H3-3B;H2AX;EED;RBBP4;H2AC19;H2AB1;PRIM1;H2BC17;H2BC12
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,0.21029336737594778,0.9764213328835023,0.625,1.0,1.0,8/25,20.06%,SCD5;ELOVL5;BAAT;HSD17B12;ACOT7;ACOT1;ELOVL3;HACD3
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,0.24058089264787752,0.9756850320174902,0.4090909090909091,1.0,1.0,8/20,19.81%,WDR33;CPSF3;SYMPK;CSTF2T;COLEC12;NCBP1;CSTF1;CSTF3
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.3054857410525189,-0.9753086539487632,0.5494505494505495,1.0,1.0,11/37,27.02%,HDAC3;FKBP9;CCNE1;AP3M1;WRAP53;FBXO4;CCT7;KIFC3;FBXW9;TP53;FBXW5
prerank,KEGG_2021_Human__Colorectal cancer,-0.26877448256425296,-0.9751684856259653,0.5612244897959183,1.0,1.0,37/82,36.93%,BCL2L11;TGFBR2;SMAD2;MLH1;MAPK10;PIK3R3;GADD45G;TCF7L2;BBC3;AKT2;DDB2;PIK3CB;AKT3;PIK3R1;AKT1;BAX;MAPK8;TCF7L1;FOS;TP53;TGFB1;GADD45A;CASP3;MAPK1;RAC1;MSH6;RAC3;HRAS;MAP2K1;JUN;RAC2;GADD45B;MAP2K2;RALB;RHOA;TGFB3;APPL1
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,0.2028662861198884,0.9733785326434895,0.5,1.0,1.0,10/52,8.53%,SERPINB2;IL23R;VPS72;RALA;PDCD4;S100A9;IL10;CNN2;PSME2;HNRNPF
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,-0.28820718668150325,-0.9732918173015866,0.5157894736842106,1.0,1.0,16/47,28.41%,SMARCD2;PRMT7;H3C7;H2AC12;RBBP7;ARID1A;H2AC14;H3C13;H2AZ1;H2AC25;PRMT6;H2AX;JAK2;H2AC19;H2AB1;CARM1
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.2937349440965251,-0.9729744633485101,0.5773195876288659,1.0,1.0,10/54,17.18%,AP1M1;SNX5;DNAJC6;AP3S1;SNX2;IGF2R;BLOC1S3;ARRB1;AP1S1;AP4B1
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.26072977162082006,-0.9726026963780331,0.62,1.0,1.0,30/110,27.19%,ETFDH;NDUFB2;ATP5F1E;TMEM126B;ECSIT;COX5A;UQCR10;NDUFC1;NDUFB7;NDUFAF6;NDUFS7;NDUFS2;DMAC2L;ATP5ME;ATP5MG;COA1;SDHA;NDUFS1;COQ10B;COX20;NDUFA13;ATP5F1C;NDUFB6;ETFB;COX8A;SCO2;COX18;COX7B;COX5B;NDUFS8
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,-0.25562206335535514,-0.9725857439313497,0.52,1.0,1.0,35/200,13.98%,TAS2R50;GPR132;INSL3;CCR5;CXCL8;CMKLR1;LPAR6;P2RY14;MC1R;UTS2B;FZD2;GPR68;F2R;SMOX;GNRH1;TAS2R60;S1PR2;WNT10A;UTS2R;GNG5;NMUR1;GHRL;S1PR1;FZD6;HRH2;CRHBP;ADM;CXCR4;CXCR5;UTS2;PLPPR2;P2RY6;RAMP1;C5AR1;RLN2
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,-0.28784866954323424,-0.9709098950493621,0.5543478260869565,1.0,1.0,10/54,16.82%,ELAC2;NUP88;NUP37;NUP133;POM121;TSEN2;RPP25;RPP38;CSTF2;RPP14
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,-0.3192106725014754,-0.9703864936252952,0.5357142857142857,1.0,1.0,13/29,34.53%,CCNE1;LIN9;DHFR;FBXO5;E2F1;TK1;PCNA;CDK1;RBBP4;LIN54;E2F6;TFDP2;CDC25A
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,-0.3697552651817672,-0.9701874417774103,0.5394736842105263,1.0,1.0,12/15,44.74%,PGA4;ADORA2A;TTF1;CCDC59;ADORA2B;ADA2;P2RY2;SFTPD;CSF2RA;CKAP4;CSF2RB;ABCA3
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,-0.2864458635945968,-0.9699015832763604,0.5222222222222223,1.0,1.0,8/44,13.99%,FLOT2;LIN7C;RTN3;NRXN2;DBNL;HOMER1;LRFN1;PPFIBP1
prerank,Reactome_2022__Inflammasomes R-HSA-622312,-0.3402109559990517,-0.9675706409378827,0.5714285714285714,1.0,1.0,2/21,2.27%,NFKB2;MEFV
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.27585252561077594,-0.9674982009074811,0.5567010309278351,1.0,1.0,18/56,23.94%,H2BC14;DEK;EP300;H3C7;H2BC13;KAT2B;TAF1C;H2AC14;H3C13;TAF1B;H2AZ1;POLR1G;POLR1E;KAT2A;POLR1B;SMARCA5;H3-3B;H2AX
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.25641989525824854,-0.9672396375548444,0.53,1.0,1.0,53/159,28.84%,PPP2CB;XPO1;CCDC88C;BCL9;H2BC14;PSMC5;FZD2;CDC73;CBY1;USP8;PSMD5;PSMD8;FZD6;TLE2;EP300;DACT1;PSMD13;H3C7;SOX13;PSMB10;PPP2R5E;H2BC13;TNKS2;KMT2D;CSNK2A2;H2AC14;H3C13;TCF7L2;LGR6;H2AZ1;LGR4;AKT2;SMURF2;TLE1;PPP2R1A;AKT1;CHD8;LEO1;TCF7L1;H3-3B;CSNK1G2;H2AX;PROC;SOX6;YWHAZ;H2AC19;BCL9L;PSME1;KLHL12;H2AB1;LRP5;RPS27A;PSMA4
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,-0.3010204507802704,-0.9671749650142946,0.5591397849462365,1.0,1.0,17/34,35.52%,MPG;H2BC14;OGG1;POT1;H2BC13;H2AC14;H2AZ1;NEIL3;H2AX;TERF1;TINF2;H2AC19;H2AB1;H2BC17;H2BC12;TERF2IP;H2AC7
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,-0.26321231603055195,-0.9656367483756385,0.5816326530612245,1.0,1.0,25/90,27.19%,ETFDH;NDUFB2;TMEM126B;ECSIT;COX5A;UQCR10;NDUFC1;NDUFB7;NDUFAF6;NDUFS7;NDUFS2;COA1;SDHA;NDUFS1;COQ10B;COX20;NDUFA13;NDUFB6;ETFB;COX8A;SCO2;COX18;COX7B;COX5B;NDUFS8
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,-0.3520172611796869,-0.965277658726747,0.4888888888888889,1.0,1.0,12/19,41.67%,NCAM1;ITGA5;CSNK2A2;FGFR1;RNASE1;L1CAM;MAPK1;MAP2K1;NRP1;MAP2K2;ITGB3;VAV2
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.2944876283787037,-0.9646869817413104,0.5625,1.0,1.0,25/51,35.52%,CENPO;H2BC14;CENPU;CENPA;H2BC13;ITGB3BP;RBBP7;H2AC14;H2AZ1;NPM1;SMARCA5;CENPT;KNL1;H2AX;MIS18A;RBBP4;H2AC19;H2AB1;H2BC17;CENPN;CENPM;H2BC12;MIS18BP1;RUVBL1;H2AC7
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,-0.2916535091189982,-0.9646400440456053,0.5568181818181818,1.0,1.0,10/35,23.22%,B4GALT2;B4GALNT3;MAN2A1;HEXA;B4GALT3;STT3B;ALG3;ALG1;FUT8;MGAT2
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,-0.2772663593030907,-0.9643989005258959,0.5876288659793815,1.0,1.0,17/83,17.35%,VPS37B;NUP88;NUP37;NUP133;H2BC14;MVB12B;SNF8;POM121;MVB12A;H3C7;CHMP4B;H2AC12;H2BC13;H2AC14;H3C13;H2AC25;UBAP1
prerank,KEGG_2021_Human__Tight junction,-0.2589220699036909,-0.9638957192049251,0.5656565656565656,1.0,1.0,32/129,23.06%,PRKAG2;ARHGAP17;NEDD4;PPP2CB;MAP3K5;MYH9;HCLS1;MAP3K1;TJAP1;STK11;ARHGEF18;AMOT;MAPK10;NF2;NEDD4L;TJP3;JAM3;HSPA4;MSN;WAS;ARPC3;TUBA8;PPP2R1A;MYL12A;PCNA;PRKAG1;MAPK8;YBX3;ACTR3B;SYNPO;MYL9;RAP2C
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.21538031090285967,0.9636627647936118,0.45,1.0,1.0,8/21,17.64%,GNB5;GNB2;CALM1;PLCB1;DLG1;PLCB3;GNG8;GNB1
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.34695425739145735,-0.9626267465250461,0.5949367088607594,1.0,1.0,9/17,26.77%,EXOSC9;EXOSC6;EXOSC4;EXOSC3;AKT1;EXOSC2;KHSRP;YWHAZ;MAPK14
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.2865781021951633,-0.962393277650426,0.5777777777777777,1.0,1.0,12/46,20.73%,EPS8L2;MYH9;DNAJC5;TRIOBP;PLS1;SYP;ESPN;MSN;CACNA2D2;SPTBN1;CDH23;CACNB2
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,-0.3401816317199359,-0.9621961268884561,0.5604395604395604,1.0,1.0,8/21,28.88%,BCKDHA;SLC25A44;PPM1K;HSD17B10;IVD;BCKDK;ACADSB;BCAT1
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.2774937845242518,-0.9619654482027278,0.5208333333333334,1.0,1.0,12/55,15.95%,ITGA10;COL9A1;ITGB5;ITGA5;LAMB4;LAMC1;SV2A;THBS4;DAG1;LAMC3;HSPG2;ITGA4
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.24467648546765763,-0.9618286454021491,0.6,1.0,1.0,72/351,19.14%,ARHGEF4;PRKCD;CREB1;DGKQ;ABHD12;PRKAR2B;RGS19;PPP2CB;CAMK2A;TAS2R50;GPR132;INSL3;GNA11;CCR5;CXCL8;LPAR6;P2RY14;MC1R;UTS2B;GPR68;ITGA5;RGS18;F2R;GNRH1;TAS2R60;S1PR2;PLCB2;UTS2R;GNG5;NMUR1;ARHGEF39;GHRL;ARHGEF18;HRH2;PIK3R5;DGKH;ADM;RHOC;KPNA2;CXCR4;CXCR5;DGKA;PLXNB1;PIK3R3;UTS2;P2RY6;RAMP1;C5AR1;RLN2;TRIO;DGKG;OBSCN;ARRB1;OXER1;AKT2;ARHGEF35;ARHGEF15;PDE7A;S1PR5;PLCB4;AKT3;PIK3R1;ADORA2A;RPS6KA1;PDE2A;PPP2R1A;PDE3A;GNAI1;PREX1;SUCNR1;DHX34;AKT1
prerank,KEGG_2021_Human__MAPK signaling pathway,-0.24653436868771922,-0.9617219096273006,0.6,1.0,1.0,92/225,35.05%,CACNA1I;NFKB2;MAP3K5;ECSIT;TGFBR2;ELK1;RPS6KA4;PGF;NR4A1;CACNG8;HSPA6;MAPK8IP3;MAP3K1;RASGRP4;MRAS;MAP3K4;CD14;CACNB3;MAPK10;RRAS;IGF1R;MAP2K5;TRAF2;GADD45G;CDC25B;ARRB1;AKT2;MAP3K12;RRAS2;IKBKB;FGFR1;AKT3;RPS6KA1;CACNA1H;CACNA2D2;DUSP10;MAP3K6;NLK;AKT1;MAP4K3;CACNB2;MEF2C;MAPK8;CACNB4;PPM1A;TRAF6;FOS;DUSP2;RPS6KA5;MAP3K20;PAK1;MAP2K4;DUSP1;RPS6KA3;MAPK7;DUSP6;NTRK1;TP53;TGFB1;MAP3K7;RAP1A;GADD45A;PDGFC;MAPK14;CASP3;MAPK1;CRK;RAC1;RAC3;HRAS;MAP2K1;JUN;ELK4;PTPN7;PPP3CC;JUND;MAPK11;CSF1;INSR;PRKCB;CHUK;MAP3K3;RAC2;GADD45B;RPS6KA2;MAPK13;RASGRP2;MAPKAPK3;IRAK4;TRADD;TAOK2;PDGFRA
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.2613802886174248,-0.960908756164365,0.5729166666666666,1.0,1.0,47/107,36.55%,TPH1;CDK5R1;CREB1;PPP2CB;TRIB1;AP2M1;EP300;MAP2K5;FOSL1;DNM1;PIK3CB;PIK3R1;ADORA2A;RPS6KA1;FRS3;PPP2R1A;RNASE1;BAX;MEF2C;FOS;ID2;CLTC;RPS6KA5;CHD4;RPS6KA3;MAPK7;DUSP6;FOSB;EGR1;NTRK1;RAP1A;MAPK14;MAPK1;CRK;DNAL4;HRAS;MAP2K1;JUND;MAPK11;RPS6KA2;REST;MAPK13;MAPKAPK3;MAP2K2;RALB;RHOA;BCL11B
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,-0.2871624933326476,-0.9606299553841741,0.5208333333333334,1.0,1.0,22/46,39.15%,CLSPN;PRKCD;BCAP31;DBNL;H1-2;H1-3;PLEC;PKN2;ADD1;DFFB;PROC;CASP3;KPNA1;H1-0;DNM1L;HMGB2;VIM;CASP6;H1-5;FZR1;BMX;KPNB1
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.29265143114706993,-0.9598924684011704,0.5161290322580645,1.0,1.0,6/41,7.31%,NXF1;NUP88;NUP37;NUP133;NCBP2;POM121
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,-0.29138288815400665,-0.9587022576310482,0.5517241379310345,1.0,1.0,4/41,2.69%,PRKAG2;CREB1;PRKAR2B;CAMK2A
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,-0.2585946807486442,-0.9584485434356623,0.5670103092783505,1.0,1.0,37/88,35.52%,DNA2;RPA3;H2BC14;POT1;POLR2I;CTC1;H2BC13;SLC19A1;WRAP53;H2AC14;LRIG1;H2AZ1;ANKRD28;PCNA;POLR1B;RTEL1;H3-3B;H2AX;RFC3;TERF1;TINF2;PIF1;DKC1;PPP6C;H2AC19;POLR2D;H2AB1;PRIM1;POLR2B;H2BC17;POLD4;H2BC12;POLD2;CDK2;RUVBL1;TERF2IP;H2AC7
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,-0.28442185829204336,-0.9583501619409027,0.5617977528089888,1.0,1.0,9/45,18.78%,CNTRL;FGFR1OP2;NCBP2;POLR2I;ERLIN2;STAT1;FGFR1;PIK3R1;STAT5A
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,0.25264193575101695,0.9582516974658258,0.5833333333333334,1.0,1.0,7/22,17.60%,AREG;HBEGF;UBC;EREG;EPGN;UBB;PLCG1
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,-0.30975484346326854,-0.9579612505827987,0.5730337078651685,1.0,1.0,18/30,43.66%,EP300;MYSM1;H2AC12;KAT2B;H2AC14;H2AC25;H2AC19;RPS27A;ABRAXAS1;H2AC11;STAMBP;PSMD14;H2AC7;H2AC21;UIMC1;H2AC6;UBA52;STAM
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.3038976717638715,-0.9579159647262989,0.5454545454545454,1.0,1.0,9/32,21.37%,ACTR10;DCTN3;RAB6A;RAB3GAP1;DYNC1LI2;DYNLL2;DCTN4;BICD2;ACTR1A
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,-0.2451710897674735,-0.9575233941332483,0.5959595959595959,1.0,1.0,39/157,23.97%,EPS8L2;MYH9;TAS2R50;DNAJC5;APOE;GPC2;OR2B11;TRIOBP;OR4K17;KCNJ2;OR10H5;SCNN1D;RDH5;EBF1;PLS1;NMT2;PLCB2;OR6C74;OR2T33;SYP;OR6N1;PPEF1;OR52K2;ESPN;RNF7;HSPG2;DHRS9;MSN;CAMKMT;CACNA2D2;SPTBN1;CDH23;CACNB2;OR2A7;OR11G2;OR1A1;CHURC1-FNTB;OR7A17;OR1I1
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,-0.2566837965419192,-0.9574158822659063,0.5670103092783505,1.0,1.0,18/79,17.85%,B4GALT2;GPC2;CHSY1;IDUA;CHST7;GLCE;VCAN;GNS;SLC35D2;HYAL3;HEXA;B3GAT3;IDS;B4GALT3;HSPG2;SGSH;SLC35B3;NAGLU
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.2924181004404631,-0.957256981502682,0.5157894736842106,1.0,1.0,10/38,20.36%,POU2F1;CRCP;ZNF143;POLR3B;SNAPC1;POLR3D;POLR3C;GTF3C4;GTF3A;GTF3C2
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.2583205539982211,-0.9565053200355222,0.6,1.0,1.0,23/74,28.92%,MED18;HDAC3;NCOA1;EBF1;CDK8;MED25;MED27;LIN9;EP300;MED30;NCOA3;PPARA;MED24;MED17;MED15;MED21;NCOR1;MED26;TGFB1;TBL1XR1;CARM1;MED4;MED12
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,-0.29328171491657956,-0.9557414546377484,0.4805194805194805,1.0,1.0,2/22,2.12%,PRKAR2B;PPP2CB
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.28074504251172694,-0.9556891438606687,0.6145833333333334,1.0,1.0,26/63,32.34%,KMT2B;AGO1;H2BC14;SIN3A;EP300;H3C7;H2BC13;KAT2B;GATA1;KMT2D;H2AC14;H3C13;H2AZ1;PRMT6;TNRC6A;CBFB;MYL9;H3-3B;H2AX;GP1BA;H2AC19;H2AB1;H2BC17;ASH2L;NFE2;H2BC12
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,-0.245004201757299,-0.9556284332908841,0.56,1.0,1.0,82/255,30.67%,EDEM2;YKT6;PDIA3;B4GALT2;SEC22B;ACTR10;COPZ2;DCTN3;GOLGA2;SEC31A;GFPT1;CSNK1D;ARF4;TMEM115;MVD;UBXN1;DERL1;NGLY1;DYNC1LI2;BET1L;MAN2A1;VCP;MPDU1;B4GALNT2;COPB1;ANK2;GANAB;GMDS;B4GALT3;ALG5;TRAPPC1;ANKRD28;RNF139;NAPG;COPE;RNF185;ARF5;SPTBN1;DYNLL2;MIA3;TRIM13;ALG3;DCTN4;COPZ1;ST6GALNAC4;NAGK;ACTR1A;ALG1;FUT8;CNIH2;ARFGAP3;GOSR1;FCSK;MCFD2;ST8SIA6;PGM3;SEC24D;UGGT1;ST6GALNAC3;SERPINA1;PRKCSH;COG3;STX5;ARCN1;PPP6C;ALG2;CMAS;COG2;COPB2;COG7;ST3GAL4;SEC16A;RPS27A;CNIH3;ENGASE;RNF103;CALR;SPTA1;TFG;UGGT2;TRAPPC6A;CTSC
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,0.260785037542687,0.9553957424816166,0.42857142857142855,1.0,1.0,3/16,4.61%,GNB5;PTGIR;GNB2
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.27802637544926273,-0.9535336229686034,0.5161290322580645,1.0,1.0,23/54,32.34%,RNF20;H2BC14;CDC73;DERL1;PEX2;VCP;H2BC13;SHPRH;PEX14;BCL10;UBE2E1;CTR9;PEX12;PCNA;UBE2N;LEO1;TMEM129;PEX10;RPS27A;RNF40;H2BC17;RTF1;H2BC12
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,-0.27084358753317234,-0.9529968873182819,0.5520833333333334,1.0,1.0,10/67,10.99%,EFCAB7;SMURF1;SPOPL;PSMC5;CDC73;SMOX;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,-0.3481096883085031,-0.9528285053786477,0.5316455696202531,1.0,1.0,8/16,29.13%,EXOSC9;EXOSC6;EXOSC4;EXOSC3;NT5C3B;EXOSC2;HBS1L;DCPS
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.3118648880707502,-0.9528088431958716,0.6129032258064516,1.0,1.0,15/34,33.40%,ABI1;WASF2;CYFIP2;WAS;ARPC3;RNASE1;ABL1;NCKAP1L;ARPC5;MAPK1;WIPF1;ACTR3;BAIAP2;NCKIPSD;WASF1
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,-0.2878630087231401,-0.9527864425895801,0.48314606741573035,1.0,1.0,5/37,8.61%,CCR5;CXCL8;TNFRSF1B;TYK2;IL6
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,-0.2502318337779202,-0.9526280097901624,0.64,1.0,1.0,75/219,30.90%,MMP9;CREB1;ZNF217;HDAC3;XPO1;POU2F1;KCTD6;NCOA1;DLAT;APOE;AGO1;PDK4;H2BC14;RDH5;CPT1A;GNG5;POLR2I;RARB;EP300;H3C7;H2BC13;KAT2B;ABCA1;IGF1R;KPNA2;NCOA3;PIK3R3;H2AC14;H3C13;GATA3;H2AZ1;AKT2;CXXC5;DHRS9;AKT3;PIK3R1;ALDH1A2;GNAI1;AKT1;TNRC6A;GTF2A1;RDH14;CBFB;FOS;RARG;CAV2;H3-3B;GNG3;NCOR1;H2AX;CDK9;GNG10;EEPD1;FOSB;PDK2;DAND5;CETP;MAPK1;H2AC19;TBL1XR1;NRIP1;GNG7;POLR2D;PPARD;H2AB1;CARM1;HSP90AB1;HRAS;POLR2B;KDM3A;GNG4;CDKN1B;JUN;ZDHHC21;H2BC17
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.2610269825327201,-0.9524206662490072,0.5918367346938775,1.0,1.0,30/110,24.77%,RPS4X;RPS20;RPS15A;RPL39;RPL4;RPS8;NCBP2;RPL26L1;RPL38;DCP1A;RPS16;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;PPP2R1A;RPL35;RPL27;RPL14;RPSA;RPS28;SMG1;RPL15;RPL36AL;RPL11
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.27828321467011713,-0.9516053318085477,0.6526315789473685,1.0,1.0,13/62,17.88%,DTX4;NKIRAS2;NFKB2;CRCP;POLR3B;ZBP1;XRCC5;EP300;DHX9;POLR3D;POLR3C;IKBKB;AIM2
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.3223466932726513,-0.9511676106767527,0.5294117647058824,1.0,1.0,8/19,31.41%,GGT1;ABCG2;GGT7;ABCC2;GSTM1;ABCC4;SULT1A1;CNDP2
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,-0.2865675701480187,-0.9497406181646516,0.5473684210526316,1.0,1.0,16/38,34.97%,MMP9;PIK3R3;SOCS6;STAT1;PIK3R1;RNASE1;STAT5A;CHEK1;SH2B2;GRB10;JAK2;LYN;HRAS;GRAP;GRAP2;STAT5B
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.28449742515435955,-0.9494785009914846,0.5204081632653061,1.0,1.0,24/55,32.57%,BCL9;H2BC14;CDC73;TLE2;EP300;H3C7;H2BC13;KMT2D;H2AC14;H3C13;TCF7L2;H2AZ1;TLE1;LEO1;TCF7L1;H3-3B;H2AX;H2AC19;BCL9L;H2AB1;H2BC17;ASH2L;H2BC12;TLE4
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,-0.285143522418855,-0.9493737733157779,0.5729166666666666,1.0,1.0,18/54,28.94%,TNS3;GGA3;USP8;SPINT2;LAMC1;RANBP9;PTPRJ;LAMC3;LRIG1;PIK3R1;RNASE1;HPN;LMNB2;RAP1A;RANBP10;CRK;RPS27A;HRAS
prerank,KEGG_2021_Human__Insulin signaling pathway,-0.25990263783938894,-0.9493006116098536,0.5612244897959183,1.0,1.0,36/115,27.68%,FLOT2;PRKAG2;PHKG1;PRKAR2B;ELK1;FOXO1;CBLB;MAPK10;PYGB;PHKB;PIK3R3;PHKG2;PPP1R3E;AKT2;IKBKB;PIK3CB;G6PC3;AKT3;PIK3R1;EXOC7;AKT1;PPP1R3F;PRKAG1;MAPK8;LIPE;SOCS3;SORBS1;SH2B2;TSC1;PHKA2;PYGL;RPTOR;MAPK1;CRK;PDE3B;PRKAB1
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.2604183679688815,-0.9491475755346709,0.6185567010309279,1.0,1.0,20/84,21.54%,ARHGEF4;HDAC3;BCL2L11;MAGED1;ARHGEF39;ARHGEF18;ITGB3BP;PSEN1;PSENEN;TRIO;OBSCN;ARHGEF35;ARHGEF15;IKBKB;RNASE1;NCSTN;PREX1;MAPK8;GNA13;TRAF6
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,-0.3236419516477978,-0.9481763061177596,0.5487804878048781,1.0,1.0,3/16,11.16%,ANG;JUP;CTNNA1
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.26561117022808123,-0.9479136726008808,0.5833333333333334,1.0,1.0,20/80,26.12%,XRCC1;ERCC5;XPC;RPA3;ERCC4;PARP1;MNAT1;SLC19A1;LRIG1;DDB2;DDB1;ACTR5;PCNA;POLR1B;UBE2N;COPS8;RFC3;GTF2H3;GPS1;COPS2
prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.25541531321139344,-0.9478580379592758,0.6,1.0,1.0,39/95,34.81%,MMP9;CREB1;TGFBR2;SMAD2;INSL3;ACTA2;PLCB2;GNG5;MAPK10;PIK3R3;RLN2;ARRB1;AKT2;PIK3CB;PLCB4;AKT3;PIK3R1;GNAI1;AKT1;ADCY3;MAPK8;FOS;GNG3;MAP2K4;GNG10;TGFB1;MAPK14;MAPK1;GNG7;HRAS;MAP2K1;GNG4;JUN;MAPK11;ADCY7;MAPK13;GNAI3;COL4A4;PRKCZ
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,-0.2657931974726878,-0.9477768386166576,0.5625,1.0,1.0,19/75,22.68%,MMP9;MYH9;CLTCL1;EPHB3;EPHA1;AP2M1;PSEN1;CLTB;PSENEN;DNM1;ARPC3;RNASE1;NCSTN;PKN2;MYL12A;LIMK2;ADAM10;CLTC;MYL9
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,0.2530870943066332,0.9472240293566245,0.3684210526315789,1.0,1.0,16/16,74.71%,RALA;MAPK12;GRB2;SOS1;NRAS;MAPKAPK2;SHC1;SRC;RALGDS;RALB;MAPKAPK3;MAPK13;MAPK11;HRAS;MAPK14;NTRK1
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.2808082918292291,-0.9464126367344432,0.5494505494505495,1.0,1.0,16/56,20.83%,PRKAG2;DYNC1LI2;TOMM7;FUNDC1;TOMM20;TOMM6;VCP;CSNK2A2;HDAC6;PLIN2;ATG5;DYNLL2;MFN1;PRKAG1;UBE2N;USP30
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.3153739973645647,-0.9459189568855679,0.5806451612903226,1.0,1.0,3/25,6.98%,NKIRAS2;NFKB2;MAP3K1
prerank,KEGG_2021_Human__Cholinergic synapse,-0.26459341185909135,-0.9453051482358217,0.5851063829787234,1.0,1.0,28/77,29.76%,CREB1;CAMK2A;GNA11;KCNJ2;PLCB2;GNG5;PIK3R5;ACHE;KCNQ1;PIK3R3;AKT2;PIK3CB;PLCB4;AKT3;PIK3R1;GNAI1;AKT1;ADCY3;FOS;GNG3;GNG10;KCNQ5;JAK2;MAPK1;GNG7;HRAS;MAP2K1;GNG4
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,-0.24178029728933575,-0.9448555274523626,0.63,1.0,1.0,86/227,35.52%,KMT5B;DOT1L;NFKB2;RIOX2;SAP30;HDAC3;ARID4A;SAP18;NCOA1;KMT2B;H2BC14;SMARCD2;AEBP2;PRMT7;EP400;EZH2;UTY;EP300;H3C7;ING5;H2AC12;H2BC13;KAT2B;KAT7;ZZZ3;RBBP7;KMT2D;SAP130;MTA2;ARID1A;H2AC14;H3C13;H2AZ1;TADA2B;BRD8;H2AC25;SETD3;SETDB2;PRMT6;KAT2A;TAF12;HAT1;KAT6A;SETD6;BRMS1L;NSD1;NCOR1;CHD4;H2AX;ELP3;EED;RBBP4;JAK2;PADI4;KAT6B;JADE1;DPEP3;H2AC19;TBL1XR1;SETD7;H2AB1;CARM1;CHD3;KDM3A;MSL3;KANSL2;YEATS4;PHF8;H2BC17;ASH2L;MSL2;HDAC10;SAP30L;H2AC11;H2BC12;ARID5B;ING3;TAF6L;REST;BRWD1;TADA2A;BRPF3;SETD2;RUVBL1;KMT2C;H2AC7
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.28967841266953315,-0.9446294771779938,0.5376344086021505,1.0,1.0,6/42,7.31%,NXF1;NUP88;NUP37;NUP133;NCBP2;POM121
prerank,KEGG_2021_Human__mTOR signaling pathway,-0.24950336881981972,-0.9423916517838393,0.66,1.0,1.0,49/124,36.53%,ATP6V1E1;LPIN1;FZD2;LAMTOR2;DEPTOR;WNT10A;ATP6V1E2;STK11;FZD6;WDR59;IGF1R;RRAGB;PIK3R3;TELO2;FNIP1;AKT2;IKBKB;PIK3CB;STRADA;AKT3;PIK3R1;RPS6KA1;FZD3;AKT1;TSC1;RPS6KA3;WNT5B;GRB10;NPRL3;RPTOR;MAPK1;MIOS;LRP5;HRAS;RICTOR;NPRL2;MAP2K1;LPIN2;RRAGD;INSR;EIF4E;EIF4E2;PRKCB;CHUK;RPS6KA2;MAP2K2;PTEN;RHOA;LAMTOR4
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,-0.3155576390093522,-0.9413282806024014,0.5909090909090909,1.0,1.0,9/27,28.94%,KLRD1;SYK;KLRK1;PIK3CB;PIK3R1;RNASE1;TYROBP;B2M;HRAS
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.26241599737747906,0.9412332559204142,0.6086956521739131,1.0,1.0,15/15,73.78%,PPFIA3;ARL6IP5;STXBP1;PPFIA1;VAMP2;PPFIA4;SLC1A3;SNAP25;SLC1A2;SLC38A2;STX1A;GLS2;SLC1A7;RAB3A;TSPOAP1
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,-0.34415389992151735,-0.9409930091379441,0.611764705882353,1.0,1.0,4/18,18.59%,CDK5R1;PIK3R1;FRS3;RNASE1
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.34373175604021927,-0.9403275001132797,0.6049382716049383,1.0,1.0,9/19,33.19%,SUCLG1;DLST;SDHA;SUCLG2;IDH3G;CS;IDH2;SDHD;OGDH
prerank,KEGG_2021_Human__Cellular senescence,-0.24687319979532868,-0.9402421710559935,0.62,1.0,1.0,60/143,36.86%,HIPK2;TGFBR2;SMAD2;CXCL8;TRPM7;CCNE1;FOXO1;MRAS;IL6;LIN9;ETS1;HUS1;RAD50;RRAS;RAD9B;PIK3R3;GADD45G;AKT2;E2F1;CAPN2;RRAS2;PIK3CB;AKT3;PIK3R1;HIPK1;AKT1;CCND2;FBXW11;CDKN2B;CHEK1;IGFBP3;ZFP36L2;TSC1;RAD1;CDK1;TP53;RBBP4;TGFB1;GADD45A;MAPK14;MAPK1;LIN54;VDAC2;HRAS;MAP2K1;PPP3CC;TRAF3IP2;RAD9A;MAPK11;GADD45B;MAPK13;CDC25A;CDK2;ZFP36L1;CCND3;MAP2K2;PTEN;TGFB3;FOXM1;NFATC1
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,0.2064290400174939,0.9401926221396533,0.6428571428571429,1.0,1.0,26/26,79.39%,NPL;NEU3;ST8SIA1;NANP;ST6GALNAC1;ST8SIA4;NANS;ST3GAL2;ST6GALNAC2;EGFL7;GNE;SLC17A5;ST3GAL3;CTSA;ST6GAL1;GLB1;SLC35A1;ST6GALNAC6;ST3GAL1;ST3GAL6;ST3GAL5;ST3GAL4;CMAS;ST6GALNAC3;ST8SIA6;ST6GALNAC4
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.2859931128711589,-0.9386778671719491,0.5842696629213483,1.0,1.0,14/34,33.25%,EPS8L2;MYH9;TRIOBP;PLS1;ESPN;MSN;SPTBN1;CDH23;CIB2;LHFPL5;RIPOR2;TWF2;TMIE;TMC1
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.2564497656000308,-0.938349623081436,0.5816326530612245,1.0,1.0,29/90,27.23%,CREB1;JUNB;GNA11;MAP3K1;PLCB2;GHRL;EP300;MAPK10;PIK3R3;STAT1;AKT2;PIK3CB;PLCB4;AKT3;PIK3R1;GNAI1;STAT5A;AKT1;ADCY3;MAPK8;SOCS3;FOS;IGFBP3;MAP2K4;SSTR2;JAK2;MAPK14;MAPK1;CRK
prerank,KEGG_2021_Human__Hepatocellular carcinoma,-0.24798393642256958,-0.9381841557721043,0.59,1.0,1.0,39/130,29.83%,MGST1;TGFBR2;SMAD2;ELK1;MGST2;SMARCD2;FZD2;WNT10A;FZD6;GSTA4;IGF1R;GSTO1;PIK3R3;ARID1A;GADD45G;TCF7L2;AKT2;E2F1;MGST3;DDB2;GSTM1;PIK3CB;AKT3;PIK3R1;FZD3;AKT1;BAX;TCF7L1;GSTM5;WNT5B;TXNRD2;TP53;TGFB1;GADD45A;MAPK1;LRP5;HRAS;MAP2K1;GSTM2
prerank,KEGG_2021_Human__Type I diabetes mellitus,0.20421570399861527,0.9377926452163212,0.5,1.0,1.0,33/35,65.41%,HLA-DPA1;HLA-DPB1;FAS;HLA-DQA1;HLA-DOB;TNF;LTA;HLA-DRA;HLA-A;HLA-DMA;HLA-B;HLA-C;HLA-DRB1;CD28;HLA-DMB;HLA-DRB5;CD86;HLA-F;HLA-DOA;HLA-E;HLA-DRB4;PTPRN2;HLA-G;HSPD1;CD80;FASLG;HLA-DRB3;IFNG;ICA1;HLA-DQB1;IL1B;PTPRN;IL12A
prerank,KEGG_2021_Human__Ferroptosis,-0.2950242452432852,-0.9376971696891098,0.5777777777777777,1.0,1.0,15/39,27.56%,SLC39A8;ACSL4;STEAP3;PCBP2;ACSL6;ACSL3;ATG5;NCOA4;LPCAT3;ATG7;TFRC;TP53;MAP1LC3B2;FTH1;VDAC2
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,-0.26934338761388077,-0.9376107688820343,0.6091954022988506,1.0,1.0,21/54,31.86%,REXO2;AVEN;BCL2L11;BBC3;AKT2;E2F1;AKT3;DYNLL2;AKT1;BAX;BID;MAPK8;GZMB;CARD8;TP53;YWHAZ;CASP3;MAPK1;YWHAQ;PPP3CC;BMF
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.30334418068898045,-0.9374384997279332,0.5617977528089888,1.0,1.0,10/27,27.68%,PRKAG2;LAMTOR2;STK11;RRAGB;STRADA;PRKAG1;PPM1A;TSC1;RPTOR;PRKAB1
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.3224325632537506,-0.9370220513677863,0.6097560975609756,1.0,1.0,8/21,30.06%,CREB1;XPO1;AKT2;AKT3;AKT1;FOS;MAPK1;CDKN1B
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,-0.26845279485703993,-0.9367915062067131,0.6122448979591837,1.0,1.0,17/71,23.78%,SMPD3;ORMDL3;SPTLC1;STS;SPTLC2;GALC;SGPP2;SAMD8;HEXA;ALDH3B1;CERK;SPNS2;ACER2;CSNK1G2;SUMF1;SPTSSA;ORMDL2
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,-0.26277272864876355,-0.93505240047118,0.6195652173913043,1.0,1.0,16/50,29.74%,ATP6V1E1;LAMTOR2;ATP6V0B;ATP6V1E2;WDR59;RRAGB;TCIRG1;ATP6V0D1;FNIP1;SZT2;NPRL3;RPTOR;MIOS;ATP6V0C;NPRL2;ITFG2
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,-0.24812495214743546,-0.9346344633919311,0.62,1.0,1.0,22/124,15.31%,ANAPC2;MCM5;CDC16;ANAPC11;RPA3;ORC3;H2BC14;PSMC5;PSMD5;PSMD8;CDC26;PSMD13;H3C7;ORC6;PSMB10;H2BC13;ANAPC5;ANAPC10;H2AC14;H3C13;H2AZ1;UBE2E1
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.24143922302840976,-0.9341779337556466,0.6060606060606061,1.0,1.0,27/157,17.85%,AMN;APRT;B3GLCT;GALK1;GFPT1;MMUT;GPC2;C1GALT1;LFNG;CHSY1;POMGNT1;GGT1;IDUA;GALNS;DAG1;VCAN;GNS;SEMA5B;MPDU1;HEXA;B3GAT3;IDS;HSPG2;SGSH;LARGE1;G6PC3;NAGLU
prerank,KEGG_2021_Human__Influenza A,-0.2425169351828165,-0.9340389335693035,0.6363636363636364,1.0,1.0,40/139,29.41%,DNAJC3;BCL2L2-PABPN1;NXF1;XPO1;EIF2S1;RAB11B;HNRNPUL1;CXCL8;TYK2;IL6;EP300;EIF2AK2;PML;KPNA2;PIK3R3;RAE1;STAT1;AKT2;IKBKB;PIK3CB;AKT3;PIK3R1;RSAD2;AKT1;BAX;BID;FADD;SOCS3;IFNAR1;CIITA;IFNGR2;PLG;JAK2;MX1;CASP3;MAPK1;CCL5;KPNA1;TLR7;MAP2K1
prerank,KEGG_2021_Human__Necroptosis,-0.2537438973036105,-0.9333131976996838,0.6907216494845361,1.0,1.0,42/133,28.80%,VPS4B;GLUD1;CAMK2A;BIRC3;TRPM7;H2AB2;PARP1;TYK2;ZBP1;FAF1;H2AC8;EIF2AK2;MAPK10;PYGB;CHMP4B;H2AC12;SPATA2;STAT1;H2AC14;TRAF2;H2AZ1;CAPN2;STAT5A;BAX;BID;FADD;MAPK8;IFNAR1;IFNGR2;H2AX;RNF103-CHMP3;PYGL;MLKL;CHMP5;JAK2;FTH1;STAT4;H2AC19;TRAF5;VDAC2;H2AB1;HSP90AB1
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.2632255971838822,-0.9329953064128937,0.5979381443298969,1.0,1.0,27/71,28.92%,H2BC14;DEK;EP300;H3C7;H2BC13;KAT2B;TAF1C;RBBP7;MTA2;H2AC14;H3C13;TAF1B;H2AZ1;POLR1G;POLR1E;KAT2A;POLR1B;SMARCA5;TTF1;H3-3B;CHD4;H2AX;RBBP4;DPEP3;H2AC19;H2AB1;CHD3
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,-0.24946900215592813,-0.9329904975808173,0.67,1.0,1.0,57/167,31.38%,MMP9;CREB1;ZNF217;XPO1;POU2F1;KCTD6;NCOA1;AGO1;H2BC14;GNG5;POLR2I;EP300;H3C7;H2BC13;KAT2B;IGF1R;KPNA2;NCOA3;PIK3R3;H2AC14;H3C13;GATA3;H2AZ1;AKT2;CXXC5;AKT3;PIK3R1;GNAI1;AKT1;TNRC6A;GTF2A1;CBFB;FOS;CAV2;H3-3B;GNG3;H2AX;CDK9;GNG10;FOSB;DAND5;MAPK1;H2AC19;NRIP1;GNG7;POLR2D;H2AB1;CARM1;HSP90AB1;HRAS;POLR2B;GNG4;CDKN1B;JUN;ZDHHC21;H2BC17;JUND
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.2507131208325226,-0.9329421725757744,0.5670103092783505,1.0,1.0,27/108,27.96%,LAIR2;CD3D;KLRD1;SELL;IFITM1;NPDC1;KLRG1;CD22;CD19;KLRK1;ITGA4;JAML;CLEC1B;CD3E;CD40LG;ITGB2;CD300A;SLAMF7;TYROBP;TARP;NCR3LG1;CD226;TREML1;KLRF1;B2M;CD200;CD300E
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,-0.2435977677647505,-0.9326790768386469,0.5858585858585859,1.0,1.0,53/162,31.55%,ARHGEF4;PIKFYVE;ITGA10;MYH9;FGD3;SSH2;WASF2;SSH3;ITGB5;ITGA5;CYFIP2;F2R;MRAS;RRAS;CXCR4;PIK3R3;IQGAP1;DIAPH1;ITGA4;RRAS2;FGFR1;MSN;PIK3CB;ITGAX;PIK3R1;ARPC3;PFN2;MYL12A;ITGB2;PPP1R12C;LIMK2;GNA13;ACTR3B;MYL9;PXN;PAK1;MYLK;NCKAP1L;ARPC5;PDGFC;MAPK1;CRK;RAC1;ITGB8;RAC3;HRAS;PFN1;MAP2K1;ITGB7;MYL5;ACTR3;ITGAD;BAIAP2
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.24141133655175043,-0.9323878908424422,0.66,1.0,1.0,66/165,36.42%,MMP9;PRKCD;NDUFB2;ATP5F1E;CAMK2A;COX5A;TGFBR2;SMAD2;GFPT1;PDK4;UQCR10;NDUFC1;PARP1;SDHC;NDUFB7;PLCB2;NDUFS7;CPT1B;NDUFS2;MAPK10;PIK3R3;PPARA;AKT2;SDHA;PIK3CB;PLCB4;AKT3;PIK3R1;MPC2;AKT1;NDUFS1;MAPK8;NDUFA13;ATP5F1C;NDUFB6;COX8A;TGFB1;PDK2;MAPK14;COX7B;COX5B;NDUFS8;VDAC2;RAC1;NDUFA5;PTPA;ATP5PO;ATP2A1;NCF4;NDUFA2;MAPK11;UQCR11;SDHD;INSR;PRKCB;NDUFA11;RAC2;MAPK13;NDUFV3;PRKCZ;NDUFA4;SLC2A4;PTEN;ATP5MC2;TGFB3;COX4I1
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,-0.2593767998586387,-0.9323151820794449,0.6354166666666666,1.0,1.0,18/79,19.93%,VAMP3;VRK2;ARHGAP17;OPHN1;ABI1;WASF2;ARHGAP42;SAMM50;STBD1;PIK3R3;IQGAP1;TRIO;DOCK4;ARHGAP1;PIK3R1;PREX1;PKN2;DEF6
prerank,KEGG_2021_Human__Mineral absorption,-0.28271011248620576,-0.9321600107582353,0.6136363636363636,1.0,1.0,5/36,7.43%,SLC46A1;FXYD2;TRPM7;SLC9A3;MT1X
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.30375506284427134,-0.9314819168999972,0.5365853658536586,1.0,1.0,8/26,21.64%,IDUA;GALNS;GNS;IDS;SGSH;G6PC3;NAGLU;HGSNAT
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.35263156142458435,-0.9311276371581914,0.5357142857142857,1.0,1.0,8/17,30.01%,PIGQ;PIGO;PIGZ;PIGV;PIGL;PIGW;PIGB;PIGA
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.2677907940320279,-0.930744104511493,0.6363636363636364,1.0,1.0,26/60,35.77%,MAML2;AGO1;H2BC14;EP300;H3C7;MAML3;MAMLD1;H2BC13;KAT2B;H2AC14;H3C13;H2AZ1;E2F1;KAT2A;TNRC6A;H3-3B;H2AX;TP53;H2AC19;H2AB1;JUN;H2BC17;H2BC12;TFDP2;H2AC7;NOTCH3
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,-0.2617793304864292,-0.930133316374445,0.6326530612244898,1.0,1.0,16/86,13.82%,CREB1;HDAC3;NUP88;NUP37;NUP133;H2BC14;POM121;DYNC1LI2;EZH2;H3C7;PML;H2AC12;H2BC13;RBBP7;H2AC14;H3C13
prerank,Reactome_2022__Reproduction R-HSA-1474165,-0.24601741452627815,-0.9297837886567272,0.6363636363636364,1.0,1.0,26/85,28.31%,RPA3;HVCN1;SYNE1;H2BC14;POT1;MLH1;H3C7;RAD50;H2BC13;CATSPER2;RBBP8;H2AC14;H3C13;H2AZ1;MLH3;HID1;POLR1B;CATSPER1;H3-3B;H2AX;TOP3A;TERF1;TINF2;H2AC19;MSH5;H2AB1
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,-0.28725992393470323,-0.9292330299982797,0.6444444444444445,1.0,1.0,13/37,30.06%,BCL2L11;SYK;SOCS6;PTPRJ;AKT2;AKT3;PIK3R1;STAT5A;AKT1;GRB10;RPS27A;HRAS;CDKN1B
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,-0.23392679559138124,-0.9289717374841894,0.69,1.0,1.0,76/386,19.93%,YKT6;STK38;MACO1;USP9X;ARHGEF4;FLOT2;VAMP3;FAM13A;CPNE8;VRK2;ARHGAP17;RNF20;ARHGAP11B;ARHGDIB;FMNL3;OPHN1;JAG1;CDC42EP2;ABI1;ARHGAP10;WASF2;ARHGAP42;DNMBP;JUP;SAMM50;ARHGAP23;SLK;KCTD3;HNRNPC;CYFIP2;SH3BP1;RHPN1;CDC42BPB;BCAP31;ARHGEF39;ALS2;RTKN;ARHGEF18;RHOBTB1;STBD1;FAM169A;FAM13B;ARHGAP27;VCP;TOR1AIP1;RHOC;STEAP3;NCOA3;PLXNB1;PIK3R3;ZNF512B;IQGAP1;DIAPH1;TRIO;DOCK4;OBSCN;NIPSNAP2;ARHGAP1;CCT7;ARHGEF15;OSBPL11;RRAS2;WAS;ITSN2;PIK3R1;SPTBN1;ARAP2;FRS3;RNASE1;PREX1;WDR11;PKN2;FMNL2;DST;FNBP1L;DEF6
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.24304302901504224,-0.927890294658563,0.63,1.0,1.0,38/108,34.86%,PPP4R2;CLSPN;DNA2;RPA3;ERCC4;H2BC14;PIAS4;HUS1;EXO1;RAD50;H2BC13;RBBP8;SLC19A1;RAD9B;RMI2;MDC1;PCNA;POLR1B;UBE2N;ABL1;RTEL1;CHEK1;RAD51AP1;H2AX;RFC3;TOP3A;RPS27A;TOPBP1;ABRAXAS1;RNF168;H2BC17;POLD4;RAD9A;H2BC12;RAD52;POLH;POLD2;CDK2
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.2778987373026584,-0.9278592012546729,0.6292134831460674,1.0,1.0,16/44,30.12%,DNAJC3;SEC31A;GFPT1;KLHDC3;DDX11;ATP6V0D1;SRPRB;ADD1;EXTL2;WIPI1;DNAJB11;SRPRA;SERP1;CUL7;HYOU1;TLN1
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,-0.3456321063785589,-0.9277750945391159,0.5822784810126582,1.0,1.0,2/15,7.93%,TAS2R50;TAS2R60
prerank,Reactome_2022__Kinesins R-HSA-983189,-0.28357007359042463,-0.9270545721775244,0.5777777777777777,1.0,1.0,12/35,31.33%,KIF4A;KIF6;KIF5C;KIF19;KIF13B;KIF3C;KIF22;KIF1C;KIF9;KIF21B;KIF3B;KIF2C
prerank,KEGG_2021_Human__Primary immunodeficiency,-0.2827032566275927,-0.9263140278868472,0.5777777777777777,1.0,1.0,9/32,27.01%,CD3D;RFXAP;CD19;CD3E;CD40LG;CIITA;UNG;ORAI1;ZAP70
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.24402407204548515,-0.9231302909344529,0.6868686868686869,1.0,1.0,53/153,33.19%,ETFDH;NDUFB2;ATP5F1E;TMEM126B;ECSIT;COX5A;DLAT;PDK4;UQCR10;NDUFC1;NDUFB7;NDUFAF6;NDUFS7;SUCLG1;NDUFS2;DLST;DMAC2L;ATP5ME;ATP5MG;COA1;SDHA;MPC2;NDUFS1;SUCLG2;COQ10B;COX20;NDUFA13;SLC16A3;ATP5F1C;NDUFB6;LDHB;HAGH;ETFB;IDH3G;CS;COX8A;SCO2;COX18;PDK2;COX7B;COX5B;NDUFS8;PPARD;LDHA;NDUFA5;ATP5PO;IDH2;L2HGDH;NDUFA2;UQCR11;SDHD;LRPPRC;OGDH
prerank,KEGG_2021_Human__Pathways in cancer,-0.23068980831294802,-0.9229281909084117,0.73,1.0,1.0,125/391,30.11%,MMP9;MGST1;NFKB2;BCL2L11;CAMK2A;TGFBR2;SMAD2;BIRC3;ELOC;JAG1;NCOA1;GNA11;IL3RA;ELK1;CXCL8;PGF;LPAR6;IL2RA;MGST2;RALBP1;CCNE1;FOXO1;FZD2;JUP;F2R;LAMB4;RASGRP4;IL5RA;TRAF1;WNT10A;PLCB2;SKP1;IL6;GNG5;LAMC1;BCR;FZD6;GSTA4;RARB;RUNX1T1;ETS1;EP300;MLH1;ZBTB16;PML;MAPK10;CTNNA1;DAPK2;IGF1R;CXCR4;NCOA3;GSTO1;PIK3R3;STAT1;TRAF2;GADD45G;TCF7L2;LAMC3;PIM1;BBC3;AKT2;E2F1;MGST3;DDB2;IKBKB;GSTM1;FGFR1;PIK3CB;PLCB4;AKT3;PIK3R1;FZD3;GNAI1;STAT5A;AKT1;ADCY3;BAX;BID;FADD;CCND2;MAPK8;GNA13;TCF7L1;TRAF6;FOS;CDKN2B;IFNAR1;NCOA4;ABL1;HEY1;RPS6KA5;GNG3;IFNGR2;GSTM5;WNT5B;GNG10;TXNRD2;VHL;NTRK1;TP53;JAK2;TGFB1;GADD45A;CASP3;IL6ST;IL15RA;MAPK1;STAT4;TRAF5;CRK;GNG7;CCDC6;RAC1;MSH6;PPARD;RAC3;LRP5;HSP90AB1;HRAS;MAP2K1;GNG4;GSTM2;CDKN1B;JUN;EPAS1
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.25364953033155424,-0.9228727320441629,0.6836734693877551,1.0,1.0,14/89,11.55%,MAML2;BCL2L11;SMURF1;JAG1;PSMC5;GATD3;PSMD5;PSMD8;EP300;PSMD13;MAML3;PSMB10;MAMLD1;KAT2B
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,-0.24543484804384214,-0.9218258132173474,0.64,1.0,1.0,20/136,11.66%,ABCC9;NUP88;ABCB11;SLC5A5;NUP37;NUP133;MAP4K5;PSMC5;DERL1;POM121;PSMD5;PSMD8;SLC33A1;ERLIN2;PSMD13;SLC36A2;SLC24A4;PSMB10;VCP;ABCA1
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.2654092410663861,-0.9217985520003836,0.65625,1.0,1.0,19/53,32.34%,H2BC14;UBXN1;PIAS4;APBB1;RAD50;H2BC13;MDC1;MAPK8;UBE2N;SMARCA5;ABL1;EYA3;H2AX;TP53;RPS27A;ABRAXAS1;RNF168;H2BC17;H2BC12
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.29014831157635357,-0.9200322171515004,0.6521739130434783,1.0,1.0,12/37,28.94%,KLRD1;SYK;KLRK1;SIGLEC16;PIK3CB;PIK3R1;RNASE1;SIGLEC14;TYROBP;B2M;CD300E;HRAS
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.23995739882175787,-0.9199750859766821,0.6767676767676768,1.0,1.0,68/151,42.07%,TRPV2;PRKCD;MEFV;NAMPT;GABARAPL2;BIRC3;GBP5;CXCL8;TRPM7;ATG16L1;TYK2;PLCB2;IL6;MAPK10;STAT1;TRAF2;IKBKB;PLCB4;ATG5;AIM2;CASP4;PKN2;MFN1;FADD;MAPK8;DEFA3;TAB3;TRAF6;IFNAR1;CARD8;IFI16;MAP3K7;NOD2;MAPK14;MAPK1;TRAF5;VDAC2;CCL5;HSP90AB1;CXCL3;JUN;NEK7;CCL2;DNM1L;GBP2;MAPK11;CHUK;MAPK13;CTSB;IRAK4;RIPK3;DEFA4;GABARAP;RHOA;IL1B;CAMP;NFKBIB;RBCK1;GSDMD;XIAP;ITPR3;IL18;JAK1;ERBIN;MFN2;CASP5;CASP1;BIRC2
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,-0.26870302926858736,-0.9194101654860787,0.6,1.0,1.0,12/49,20.73%,EPS8L2;MYH9;DNAJC5;TRIOBP;PLS1;SYP;ESPN;MSN;CACNA2D2;SPTBN1;CDH23;CACNB2
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,-0.24215189171178703,-0.9193031199092019,0.66,1.0,1.0,71/183,34.87%,PDIA3;CD3D;AP1M1;ELOC;GNA11;CCR5;CDC25C;CUL5;TNFRSF1B;SKP1;GNG5;MAPK10;CXCR4;PIK3R3;TRAF2;RNF7;AKT2;AP1S1;IKBKB;PIK3CB;CD3E;DDB1;AKT3;CD3G;PIK3R1;GNAI1;AKT1;BAX;LIMK2;BID;FADD;MAPK8;TRAF6;FBXW11;FOS;CHEK1;PXN;GNG3;PAK1;GNG10;CDK1;WEE1;MAP3K7;B2M;MAPK14;CASP3;MAPK1;TRAF5;CRK;APOBEC3H;GNG7;RAC1;RAC3;HRAS;MAP2K1;GNG4;CALR;AP1G2;JUN;PPP3CC;AP1M2;MAPK11;RBX1;PRKCB;CHUK;RAC2;MAPK13;GNAI3;IRAK4;TRADD;APOBEC3F
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.1459567086510373,0.9192375525483444,1.0,1.0,1.0,18/85,12.67%,AREG;IL1RL1;PIP5K1C;PPP2R5B;KIT;FGFR2;RNMT;CLSTN1;PPP2R5C;PIK3R2;HBEGF;PDGFRB;FYN;MYD88;ESR1;LCK;IRS2;EREG
prerank,KEGG_2021_Human__Endometrial cancer,-0.26433487560383906,-0.9184325755626259,0.5670103092783505,1.0,1.0,19/54,29.41%,ELK1;MLH1;CTNNA1;PIK3R3;GADD45G;TCF7L2;AKT2;DDB2;PIK3CB;AKT3;PIK3R1;AKT1;BAX;TCF7L1;TP53;GADD45A;MAPK1;HRAS;MAP2K1
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.2560719038706262,-0.9181269816874164,0.6597938144329897,1.0,1.0,31/81,35.77%,CD3D;MAML2;JAG1;IL2RA;TYK2;MAML3;MAPK10;STAT1;GATA3;IKBKB;CD3E;CD3G;STAT5A;MAPK8;FOS;IFNGR2;JAK2;MAPK14;MAPK1;ZAP70;STAT4;NFKBIE;JUN;PPP3CC;MAPK11;CHUK;MAPK13;IL12A;JAK3;STAT5B;NOTCH3
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,-0.2906911240314569,-0.9180827206483038,0.5684210526315789,1.0,1.0,13/33,32.83%,LAMTOR2;IQGAP1;APBB1IP;ARRB1;KSR1;CNKSR1;RAP1A;MAPK1;HRAS;MAP2K1;TLN1;WDR83;CNKSR2
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.2978599348838361,-0.9174656333437269,0.6309523809523809,1.0,1.0,6/25,19.14%,CREB1;NR4A1;FOXO1;AKT2;AKT3;AKT1
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.25942640595782646,-0.9171083023300973,0.59375,1.0,1.0,15/53,28.68%,EDEM2;ZDHHC8;ZDHHC3;PARP16;MAN2A1;GANAB;PARP4;PARP14;ST6GALNAC4;FUT8;ZDHHC5;ST6GALNAC3;PRKCSH;ST3GAL4;RPS27A
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.293593006422607,-0.9166724851747114,0.5444444444444444,1.0,1.0,20/28,53.93%,PARP16;GANAB;PARP4;PARP14;ST6GALNAC4;ST6GALNAC3;PRKCSH;ST3GAL4;RPS27A;PARP9;PARP6;ST3GAL1;ST6GAL1;UBA52;CANX;GSK3A;ST3GAL3;PARP8;UBE2I;PARP10
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,-0.2607263927501695,-0.9146797620086563,0.6041666666666666,1.0,1.0,11/69,11.66%,ABCC9;ABCB11;PSMC5;DERL1;PSMD5;PSMD8;ERLIN2;PSMD13;PSMB10;VCP;ABCA1
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.26064534832397235,-0.9137171557462826,0.6063829787234043,1.0,1.0,25/56,35.52%,H2BC14;CCNE1;POT1;EP400;RAD50;H2BC13;H1-2;H1-3;H2AC14;H2AZ1;CABIN1;H2AX;TERF1;HMGA2;TINF2;TP53;H2AC19;H2AB1;H1-0;CDKN1B;H2BC17;H2BC12;CDK2;TERF2IP;H2AC7
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.24800284846311182,-0.9137019076162478,0.7,1.0,1.0,12/110,9.97%,SCAP;INSIG2;ACOT8;NSDHL;ABCB11;NCOA1;DHCR7;OSBPL3;MVD;LDLRAP1;PIAS4;LIN9
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,-0.25879038496457385,-0.9118756082358428,0.6421052631578947,1.0,1.0,14/66,17.72%,LSM10;CDC40;SNRPE;SNRPB;NCBP2;THOC7;THOC6;SRSF5;CPSF2;PAPOLA;U2AF1L4;CSTF2;SNRPF;ALYREF
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,-0.2559493115756398,-0.9112607920230538,0.6391752577319587,1.0,1.0,18/58,29.96%,FLOT2;VAMP3;OPHN1;JUP;SLK;RTKN;DIAPH1;ARHGAP1;PIK3R1;PREX1;PKN2;ANLN;STARD8;TFRC;RHPN2;ARHGEF10L;ARHGEF2;ARHGEF5
prerank,KEGG_2021_Human__Human papillomavirus infection,-0.23501884685497232,-0.9086968294774533,0.76,1.0,1.0,72/253,30.06%,CREB1;ATP6V1E1;MAML2;RFNG;ITGA10;PPP2CB;JAG1;COL9A1;LFNG;CCNE1;FOXO1;FZD2;ITGB5;ITGA5;TYK2;ATP6V0B;HES6;LAMB4;BCAP31;WNT10A;ATP6V1E2;LAMC1;FZD6;EP300;EIF2AK2;MAML3;PPP2R5E;THBS4;PSEN1;PPP2R3A;PIK3R3;STAT1;TCIRG1;ATP6V0D1;TCF7L2;LAMC3;AKT2;E2F1;ITGA4;IKBKB;PIK3CB;AKT3;PIK3R1;RELN;FZD3;PPP2R1A;AKT1;BAX;FADD;CCND2;TCF7L1;IFNAR1;HEY1;PXN;TSC1;CHD4;WNT5B;TP53;MX1;IRF1;CASP3;MAPK1;CRB3;ITGB8;ATP6V0C;HRAS;TBPL2;MAP2K1;ITGB7;PPP2R3B;COL6A3;CDKN1B
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,-0.254770946305505,-0.9085024632689337,0.711340206185567,1.0,1.0,37/110,31.38%,ZNF217;POU2F1;KCTD6;NCOA1;AGO1;H2BC14;POLR2I;EP300;H3C7;H2BC13;KAT2B;KPNA2;NCOA3;H2AC14;H3C13;GATA3;H2AZ1;CXXC5;TNRC6A;GTF2A1;CBFB;FOS;H3-3B;H2AX;CDK9;FOSB;DAND5;H2AC19;NRIP1;POLR2D;H2AB1;CARM1;HSP90AB1;POLR2B;JUN;H2BC17;JUND
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.22814635918480525,-0.9081368843875087,0.79,1.0,1.0,116/437,27.98%,GLIPR1;DNAJC3;CHIT1;MMP9;APRT;PIKFYVE;PRKCD;MGST1;ACTR10;AP1M1;SELL;CD58;TBC1D10C;CYB5R3;ORMDL3;HVCN1;DNAJC5;UNC13D;RAB37;TMED7-TICAM2;PA2G4;RAB6A;ATP8A1;TMEM179B;LOC112694756;PGLYRP1;JUP;TNFRSF1B;LAMTOR2;HSPA6;SRP14;PFKL;CTSG;RAB31;XRCC5;GMFG;IST1;STBD1;IGF2R;DBNL;GALNS;PSMD13;MANBA;PYGB;VCP;TMBIM1;CANT1;GNS;PSEN1;PTPRJ;RNASET2;ALDH3B1;TNFAIP6;C5AR1;COPB1;CHI3L1;IQGAP1;MCEMP1;TCIRG1;CPNE3;DIAPH1;ATP11A;ACTR1B;RCAN1;CREG1;ARMC8;TRAPPC1;CTSS;PRCP;CRACR2A;ITGAX;ERP44;CEP290;SLC15A4;RNASE1;NCSTN;CD93;HOOK3;FGL2;ITGB2;CD300A;ADAM10;DPP7;CAP1;CHAMP1;LTF;HGSNAT;CEACAM21;P2RX1;SIGLEC14;FRK;MMP28;TYROBP;RAP2C;FUCA2;RAP2B;ATG7;PYGL;YPEL5;FCER1G;SERPINA1;PRKCSH;NCKAP1L;ARPC5;MOSPD2;RAP1A;FTH1;B2M;ITM2C;MAPK14;MAPK1;AZU1;ILF2;SERPINB1;NIT2;ABCA13
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.27348451877001023,-0.9078683994952294,0.6494845360824743,1.0,1.0,22/57,33.40%,MYH9;ABI1;WASF2;CYFIP2;SYK;NF2;WAS;ARPC3;RNASE1;ABL1;TARP;NCKAP1L;ARPC5;MAPK1;CRK;WIPF1;HSP90AB1;ACTR3;BAIAP2;NCKIPSD;MYO10;WASF1
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,-0.28456076602591546,-0.9073366672230245,0.625,1.0,1.0,18/40,33.24%,H2BC14;NCAPD3;PLK1;H3C7;H2BC13;H2AC14;H3C13;H2AZ1;SET;H3-3B;H2AX;CDK1;H2AC19;H2AB1;PHF8;H2BC17;H2BC12;SMC4
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,0.12969902115859164,0.907304806634164,0.625,1.0,1.0,8/51,10.66%,H2BC15;H2AZ2;H2BC3;H2AC4;SYCE2;LMNA;SUN2;REC8
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.284013934961609,-0.9063511619034151,0.6292134831460674,1.0,1.0,4/34,7.31%,NUP88;NUP37;NUP133;POM121
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.2439068785722162,-0.9058128366418521,0.74,1.0,1.0,67/169,34.17%,H2BC7;CLEC7A;HDAC3;H2BC14;H2AB2;AQP9;CTSG;PLCB2;H2AC8;SYK;H3C7;H2AC12;H2BC13;PIK3R3;H2AC14;C5AR1;H3C13;HDAC11;H3C6;H2AZ1;HDAC6;AKT2;PIK3CB;PLCB4;AKT3;PIK3R1;H3-3A;CASP4;AKT1;ITGB2;SELP;CLCN5;HAT1;H4C12;H4C14;H3C15;H3-3B;H2AX;ATG7;GP1BA;PADI4;MAP3K7;MAPK14;MAPK1;H2AC19;AZU1;VDAC2;RAC1;H2AB1;TLR7;H3C1;MAP2K1;H4C4;CLCN3;H2BC17;H2AC18;HDAC10;H3C4;NCF4;MAPK11;H2AC11;SIGLEC9;H2BC12;PRKCB;RAC2;MAPK13;H4C6
prerank,Reactome_2022__Meiosis R-HSA-1500620,-0.24040944286487564,-0.9043232769417082,0.673469387755102,1.0,1.0,23/74,28.31%,RPA3;SYNE1;H2BC14;POT1;MLH1;H3C7;RAD50;H2BC13;RBBP8;H2AC14;H3C13;H2AZ1;MLH3;HID1;POLR1B;H3-3B;H2AX;TOP3A;TERF1;TINF2;H2AC19;MSH5;H2AB1
prerank,KEGG_2021_Human__Salmonella infection,-0.23336014763394547,-0.9038990368873626,0.72,1.0,1.0,78/226,30.42%,ACTR10;DCTN3;BIRC3;ABI1;CXCL8;M6PR;SNX18;KIF5C;CYFIP2;TLR5;DYNC1LI2;PIK3C2B;SKP1;EXOC5;RAB9A;IL6;SNX33;CD14;MAPK10;VPS18;RRAS;KPNA4;AHNAK;TRAF2;TCF7L2;ACTR1B;CYTH4;AKT2;IKBKB;PIK3CB;AKT3;EXOC7;DYNLL2;ARPC3;PFN2;TUBA8;CASP4;AKT1;DYNC2H1;MYL12A;BAX;DCTN4;FADD;TUBB2A;LY96;MAPK8;TAB3;TCF7L1;ACTR1A;TRAF6;FOS;ACTR3B;MYL9;DYNC2LI1;TUBB4A;PAK1;TUBB1;MAP2K4;CSE1L;MLKL;NCKAP1L;ARPC5;MAP3K7;MAPK14;CASP3;MAPK1;RAC1;KPNA3;KPNA1;PIK3C3;HSP90AB1;HRAS;PFN1;MAP2K1;RHOG;MYL5;JUN;ACTR3
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,-0.28197366562251275,-0.9033673828579984,0.5888888888888889,1.0,1.0,4/30,10.27%,CAMK2A;SERPINH1;HSPA6;EP300
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,-0.2687920733696818,-0.9029013500930583,0.6555555555555556,1.0,1.0,16/46,30.12%,DNAJC3;SEC31A;GFPT1;KLHDC3;DDX11;ATP6V0D1;SRPRB;ADD1;EXTL2;WIPI1;DNAJB11;SRPRA;SERP1;CUL7;HYOU1;TLN1
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,-0.2820293848555944,-0.9016262673764774,0.6511627906976745,1.0,1.0,3/31,3.55%,MCM5;RPA3;ORC3
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,-0.25549123863189727,-0.9005728985126138,0.6770833333333334,1.0,1.0,16/78,18.76%,PRKAG2;PRKAR2B;PPP2CB;AKAP5;GNA11;PLCB2;GNG5;ACSL4;STK11;CACNB3;IQGAP1;ACSL3;CACNA2D2;KCNC2;PPP2R1A;GNAI1
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,-0.27309049732767354,-0.9005193242848594,0.6195652173913043,1.0,1.0,5/37,8.54%,FANCE;RPA3;FAAP20;ERCC4;FANCL
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.2793404238727958,-0.9004540746969795,0.6914893617021277,1.0,1.0,21/55,33.40%,MYH9;ABI1;WASF2;CYFIP2;SYK;WAS;ARPC3;RNASE1;ABL1;TARP;NCKAP1L;ARPC5;MAPK1;CRK;WIPF1;LYN;ACTR3;BAIAP2;NCKIPSD;MYO10;WASF1
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.2545607493693029,-0.9003942775203175,0.6701030927835051,1.0,1.0,12/71,14.01%,NXF1;NUP88;CDC40;NUP37;NUP133;NCBP2;THOC7;POM121;THOC6;SRSF5;GLE1;U2AF1L4
prerank,KEGG_2021_Human__Axon guidance,-0.238266870194593,-0.9000129542526857,0.7373737373737373,1.0,1.0,51/126,37.15%,PLXNA4;SEMA4B;SRGAP3;CAMK2A;SEMA6A;EPHB3;SSH2;SSH3;EPHA1;NTNG2;RRAS;CXCR4;PLXNB1;SEMA5B;PIK3R3;SEMA6C;PIK3CB;PIK3R1;FZD3;GNAI1;MYL12A;LIMK2;L1CAM;TRPC6;ABL1;MYL9;BMPR2;PAK1;PLXNB3;WNT5B;SEMA4A;MAPK1;RAC1;EFNB1;RAC3;HRAS;MYL5;NCK2;PPP3CC;PARD6B;RAC2;EPHB6;SEMA3C;PARD6G;GNAI3;PRKCZ;NRP1;PLXNC1;RHOA;PAK2;ABLIM2
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.33213969614547545,-0.8999300552293347,0.5975609756097561,1.0,1.0,7/16,29.93%,EP400;H1-2;H1-3;CABIN1;HMGA2;TP53;H1-0
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,-0.2926307619244268,-0.8996214985088794,0.6162790697674418,1.0,1.0,9/27,26.90%,DPYD;UPB1;NUDT15;NUDT9;NT5E;NT5C1A;ITPA;SCO2;ENTPD2
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.30372175882852565,-0.8985565080880408,0.5882352941176471,1.0,1.0,5/24,16.50%,AGO1;PRKRA;POLR2I;XPO5;DGCR8
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,-0.2725942692252154,-0.8983448943082976,0.6483516483516484,1.0,1.0,14/38,30.40%,CREB1;COL9A1;NCAM1;CACNB3;FGFR1;CACNA1H;SPTBN1;CACNB2;CACNB4;RPS6KA5;MAPK1;HRAS;COL6A3;SPTA1
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.326981670669384,-0.8980271014468096,0.6219512195121951,1.0,1.0,8/18,33.76%,LRRC14;IKBKB;NLRC5;N4BP1;TRAF6;TP53;RPS27A;CHUK
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,-0.28841104282321733,-0.8959306156064384,0.627906976744186,1.0,1.0,4/24,7.45%,ITGB5;LTBP1;ITGA5;MFAP5
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.15220373599485792,0.8957343409853817,0.7142857142857143,1.0,1.0,12/67,10.90%,CITED2;PSMB5;PSMD9;PSMC3;PSMC6;PSMB7;HIF1A;VEGFA;PSME2;CREBBP;UBC;PSMD11
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,-0.2522926965720287,-0.8951888956622338,0.6774193548387096,1.0,1.0,9/65,12.04%,TCEA1;ERCC5;RPA3;ERCC4;UVSSA;MNAT1;POLR2I;EP300;SLC19A1
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.28011140910614024,-0.8948067537748896,0.6436781609195402,1.0,1.0,10/29,28.94%,PIK3R4;IGF1R;THEM4;AKT2;FGFR1;PIK3CB;PIK3R1;PDE3B;PIK3C3;HRAS
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,-0.2645423067560038,-0.8942944521048583,0.6458333333333334,1.0,1.0,21/59,29.45%,REXO2;MYH9;PPP1R14A;CDC25C;H2BC14;KLKB1;H3C7;H2BC13;RHOC;H2AC14;H3C13;H2AZ1;RNASE1;PKN2;MYL9;H3-3B;H2AX;YWHAZ;H2AC19;H2AB1;YWHAQ
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,-0.23827414526640964,-0.893309110642954,0.6868686868686869,1.0,1.0,30/108,25.04%,PRKAG2;GABARAPL2;ATG16L1;LAMTOR2;DYNC1LI2;TOMM7;PIK3R4;FUNDC1;TOMM20;TOMM6;CHMP4B;VCP;RRAGB;CSNK2A2;HDAC6;PLIN2;UVRAG;ATG5;DYNLL2;MFN1;MTMR3;PRKAG1;UBE2N;USP30;WIPI1;ATG9A;TSC1;RNF103-CHMP3;ATG7;RPTOR
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,-0.24250611966374902,-0.8920144637985409,0.6804123711340206,1.0,1.0,14/85,13.98%,INSL3;CCR5;CXCL8;MC1R;UTS2B;F2R;UTS2R;NMUR1;GHRL;CXCR4;CXCR5;UTS2;C5AR1;RLN2
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,-0.301518214905248,-0.8917430495040822,0.6,1.0,1.0,6/21,21.04%,COL9A1;NCAM1;CACNB3;CACNA1H;CACNB2;CACNB4
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,-0.2513189091310236,-0.8916128795522423,0.6739130434782609,1.0,1.0,21/63,32.19%,YKT6;SEC22B;GOLGA2;SEC31A;CSNK1D;TRAPPC1;ANKRD28;NAPG;CNIH2;MCFD2;SEC24D;SERPINA1;STX5;PPP6C;SEC16A;CNIH3;TFG;TRAPPC6A;CTSC;CD59;FOLR2
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,-0.2584444122731251,-0.8914965655833591,0.6373626373626373,1.0,1.0,7/54,8.95%,PTP4A2;RAB37;RAB6A;CHML;RAB21;RAB9A;RAB31
prerank,Reactome_2022__Protein Folding R-HSA-391251,-0.25278266496943114,-0.8907553147605081,0.7216494845360825,1.0,1.0,25/82,27.44%,HDAC3;TBCA;FKBP9;GNA11;CCNE1;GNG5;AP3M1;CSNK2A2;WRAP53;TBCC;FBXO4;CCT7;ARL2;TUBA8;KIFC3;TUBB2A;PFDN2;FBXW9;TUBB4A;GNG3;TBCE;GNG10;TP53;FBXW5;GNG7
prerank,KEGG_2021_Human__cAMP signaling pathway,-0.2346904131791582,-0.8902409905840541,0.69,1.0,1.0,40/125,30.59%,CREB1;CAMK2A;FXYD2;F2R;GHRL;EP300;MAPK10;RRAS;PIK3R3;HCN2;PPARA;AKT2;RRAS2;PIK3CB;AKT3;PIK3R1;ADORA2A;PDE3A;GNAI1;SUCNR1;AKT1;ADCY3;ACOX1;MAPK8;LIPE;FOS;MYL9;PAK1;SSTR2;ORAI1;ABCC4;RAP1A;MAPK1;ATP1B2;PDE3B;RAC1;RAC3;MAP2K1;JUN;ATP2A1
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,-0.28877204955896724,-0.889316822463066,0.6853932584269663,1.0,1.0,10/31,28.94%,PPP2CB;SPRY2;FGFR1;SPRED1;PIK3R1;FRS3;PPP2R1A;MAPK1;RPS27A;HRAS
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,-0.2847666395675451,-0.8885704478031351,0.6483516483516484,1.0,1.0,4/33,7.31%,NUP88;NUP37;NUP133;POM121
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.2579947120372745,-0.887388951466021,0.7070707070707071,1.0,1.0,29/81,33.40%,PRKCD;MYH9;ABI1;WASF2;CYFIP2;SYK;NF2;PIK3CB;PLD4;WAS;PIK3R1;ARPC3;RNASE1;PLPP5;ABL1;TARP;PRKCSH;NCKAP1L;ARPC5;MAPK1;CRK;WIPF1;LYN;HSP90AB1;ACTR3;BAIAP2;NCKIPSD;MYO10;WASF1
prerank,KEGG_2021_Human__Apelin signaling pathway,-0.2468227332096971,-0.8872014934822966,0.7244897959183674,1.0,1.0,37/106,29.76%,PRKAG2;GABARAPL2;SMAD2;JAG1;ACTA2;PLAT;PLCB2;MRAS;GNG5;PIK3R4;PIK3R5;RRAS;AKT2;RRAS2;PLCB4;AKT3;GNAI1;AKT1;ADCY3;PRKAG1;MEF2C;GNA13;LIPE;SLC8A1;GNG3;MYLK;GNG10;EGR1;KLF2;MAPK1;GNG7;PDE3B;PRKAB1;PIK3C3;HRAS;MAP2K1;GNG4
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,-0.23827186525702226,-0.8869400305778969,0.74,1.0,1.0,19/107,17.05%,VRK2;LPIN1;PPP2CB;NUP88;GOLGA2;NUP37;NUP133;H2BC14;NCAPD3;POM121;PLK1;H3C7;H2BC13;H2AC14;H3C13;ENSA;H2AZ1;NEK9;SET
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,-0.2527330887724583,-0.8835312235677664,0.7395833333333334,1.0,1.0,18/62,25.43%,DNAJC3;APOE;SGPP2;LTBP1;IL6;LAMC1;VCAN;ANO8;MIA3;FSTL3;LMNB2;ADAM10;IGFBP3;C4A;FUCA2;PROC;SERPINA1;PRKCSH
prerank,KEGG_2021_Human__Hepatitis B,-0.2292686447339894,-0.8824768907182924,0.7272727272727273,1.0,1.0,56/140,34.97%,MMP9;CREB1;TGFBR2;ELK1;CXCL8;CCNE1;TYK2;MAP3K1;IL6;EP300;MAPK10;PIK3R3;STAT1;HSPG2;AKT2;E2F1;DDB2;IKBKB;PIK3CB;DDB1;AKT3;PIK3R1;STAT5A;AKT1;BAX;PCNA;BID;FADD;MAPK8;TRAF6;FOS;IFNAR1;MAP2K4;TP53;JAK2;TGFB1;MAP3K7;YWHAZ;MAPK14;CASP3;MAPK1;STAT4;HRAS;MAP2K1;YWHAQ;JUN;DDX3X;MAPK11;ATP6AP1;PRKCB;CHUK;MAPK13;IRAK4;JAK3;CDK2;STAT5B
prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.24506092505782603,-0.8819711060699588,0.6767676767676768,1.0,1.0,34/85,35.84%,DGKQ;WASF2;DGKH;MAPK10;SLC44A4;DGKA;PIK3R3;DGKG;CHKB;AKT2;PIK3CB;WAS;AKT3;PIK3R1;CHPT1;AKT1;MAPK8;FOS;LYPLA1;TSC1;DGKE;PDGFC;MAPK1;RAC1;RAC3;HRAS;MAP2K1;JUN;WASF1;PRKCB;RAC2;SLC22A5;PDGFRA;MAP2K2
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,-0.2738280593969705,-0.8818267905602856,0.6170212765957447,1.0,1.0,12/29,34.47%,PRKCD;RGS19;GNG5;GNAI1;GNG3;GNG10;GNG7;GNG4;GNAZ;ADCY7;PRKCB;GNAI3
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,-0.28825456439597597,-0.8817429585370489,0.6470588235294118,1.0,1.0,4/23,16.38%,SERPINH1;HSPA6;EP300;HSBP1
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.24967271338159192,-0.8814177572110133,0.6559139784946236,1.0,1.0,20/63,32.91%,XRCC1;TCEA1;RPA3;UVSSA;MNAT1;POLR2I;EP300;SLC19A1;LRIG1;DDB1;PCNA;POLR1B;RFC3;GTF2H3;POLR2D;RPS27A;POLR2B;POLD4;GTF2H1;RBX1
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,-0.25877697207926553,-0.8814120439147908,0.6736842105263158,1.0,1.0,20/44,39.48%,TAF5;MNAT1;TAF1;TAF4;POLR2I;GTF2A1;TAF12;TAF15;GTF2H3;TAF9B;TAF2;POLR2D;POLR2B;GTF2H1;TAF11;CDK7;POLR2H;GTF2E1;TAF6;POLR2C
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.26165764719372003,-0.8811090282400234,0.6914893617021277,1.0,1.0,9/59,12.80%,ALDH2;CYP4F12;CYB5R3;MTARC1;NCOA1;PAOX;SMOX;ALDH1B1;CYP4B1
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.25849541448486296,-0.880264787375824,0.6470588235294118,1.0,1.0,10/51,19.59%,ZDHHC8;AMN;APOE;LDLRAP1;AP2M1;ABCA1;LMF1;BMP1;LIPG;NCEH1
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,0.21218425555938764,0.8781668942190287,0.7,1.0,1.0,6/27,11.80%,TIRAP;TLR3;TLR2;S100A9;MYD88;TICAM1
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.2610747854841358,-0.8776350202282491,0.673469387755102,1.0,1.0,19/55,27.06%,PHC3;HDAC3;SCMH1;LAMTOR2;CBX4;EZH2;RNF2;RBBP7;RRAGB;MTA2;CBX6;CHD4;RPTOR;EGR1;EED;TP53;RBBP4;MAPK1;DPEP3
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.23448032970701554,-0.8768194514754096,0.79,1.0,1.0,38/181,19.76%,AKAP5;RPS4X;ELOC;RPS20;RPS15A;CLASP1;RPL39;RPL4;USP33;PSMC5;RPS8;NCBP2;RPL26L1;RPL38;PSMD5;PSMD8;PSMD13;RPS16;PSMB10;DAG1;CXCR4;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;CLASP2;RPL30;RPLP2;PFN2;RNASE1;RPL35;RPL27;PKN2;RPL14;RPSA
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.2558695577299857,-0.8761600807584555,0.7127659574468085,1.0,1.0,13/57,15.66%,CREB1;CEBPE;GFI1;H2BC14;DEK;EP300;H3C7;PML;H2BC13;H2AC14;H3C13;H2AZ1;E2F1
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,-0.32999833913352705,-0.8757488445819495,0.6,1.0,1.0,1/15,0.08%,PLXNA4
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,-0.22395763225067764,-0.8750576444668944,0.81,1.0,1.0,93/194,43.81%,FLOT2;CLSPN;PRKCD;REXO2;AVEN;BCL2L11;BIRC3;MAGED1;ARHGAP10;TMED7-TICAM2;PSMC5;BCAP31;PSMD5;PSMD8;DBNL;PSMD13;PSMB10;CHMP4B;DAPK2;H1-2;H1-3;PLEC;BBC3;AKT2;E2F1;AKT3;DYNLL2;CASP4;AKT1;PKN2;ADD1;BAX;BID;DFFB;FADD;LY96;MAPK8;GZMB;CARD8;RNF103-CHMP3;PROC;MLKL;TP53;IRF1;YWHAZ;CASP3;MAPK1;PSME1;KPNA1;RPS27A;PSMA4;MED12;YWHAQ;H1-0;DNM1L;PPP3CC;TNFRSF10B;BMF;NDUFA2;PSMC4;PSMD4;TFDP2;RIPK3;TRADD;PSMD14;HMGB2;VIM;CASP6;TP53BP2;APPL1;H1-5;IL1B;CFLAR;FZR1;BMX;OGT;KPNB1;GSDMD;XIAP;SEPTIN4;IL18;PSMA5;PSMC1;CASP5;CASP1;BIRC2;TNFSF10;UBA52;PSME4;MAPT;YWHAE;OMA1;PPP3R1
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.2340383123946801,-0.8737730761034206,0.7448979591836735,1.0,1.0,20/106,21.58%,XRCC1;TCEA1;ERCC5;XPC;RPA3;ERCC4;UVSSA;PARP1;MNAT1;POLR2I;EP300;SLC19A1;LRIG1;DDB2;DDB1;ACTR5;PCNA;POLR1B;UBE2N;COPS8
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.2274413843059112,-0.8736111039951323,0.76,1.0,1.0,24/119,19.14%,GABARAPL2;GGA3;TBC1D10C;RIN1;RAB6A;TBC1D10B;CHML;RAB21;TBC1D15;TBC1D24;RAB3GAP1;RGPD1;RAB9A;ALS2;RAB31;DENND2A;TRAPPC11;TRAPPC1;AKT2;GDI1;AKT3;RAB27B;RIN3;AKT1
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.22819822139216592,-0.8735947774121976,0.75,1.0,1.0,54/166,30.09%,CREB1;GABARAPL2;CCR5;CXCL8;TYK2;IL6;GNG5;SYK;PIK3R5;EP300;EIF2AK2;MAPK10;PIK3R3;CLEC2B;STAT1;TRAF2;TCF7L2;RCAN1;AKT2;E2F1;IKBKB;PIK3CB;AKT3;PIK3R1;PREX1;AKT1;BAX;BID;FADD;MAPK8;TCF7L1;FOS;IFNAR1;GNG3;MAP2K4;CCR4;GNG10;TP53;JAK2;CCR1;MAPK14;CASP3;IL6ST;MAPK1;GNG7;RAC1;LYN;RPS27A;PIK3C3;HRAS;MAP2K1;CXCL3;GNG4;JUN
prerank,KEGG_2021_Human__Adherens junction,-0.259846844812446,-0.873256920711597,0.6881720430107527,1.0,1.0,26/61,33.90%,TGFBR2;WASF2;EP300;CTNNA1;SSX2IP;IGF1R;CSNK2A2;PTPRJ;IQGAP1;TCF7L2;FGFR1;WAS;NLK;TCF7L1;SORBS1;ACP1;PTPRM;MAP3K7;MAPK1;RAC1;RAC3;PTPRF;BAIAP2;WASF1;INSR;RAC2
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.22200211067991546,-0.8732177816305792,0.9,1.0,1.0,75/365,20.84%,CLCN6;CNTRL;CREB1;FGFR1OP2;MAML2;HDAC3;PPP2CB;BCL2L11;CAMK2A;MYH9;TGFBR2;SMAD2;JAG1;SEC31A;NR4A1;PSMC5;FOXO1;AKAP9;GATD3;NCBP2;HHAT;CDK8;MRAS;SKP1;POLR2I;PSMD5;PSMD8;FZD6;EP300;ERLIN2;PSMD13;MAML3;CD19;PSMB10;PPP2R5E;MAMLD1;VCP;KAT2B;TNKS2;MECP2;PSEN1;PIK3R3;SND1;STAT1;PSENEN;IQGAP1;HDAC11;PPFIBP1;APBB1IP;TCF7L2;ARRB1;HDAC6;AKT2;RNF213;FGFR1;SPRED1;MSN;PIK3CB;AKT3;PIK3R1;DUSP10;WDR48;SPTBN1;FRS3;PPP2R1A;RNASE1;NCSTN;STAT5A;KAT2A;AKT1;HIP1;PORCN;ADAM10;NPM1;FAM114A2
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,-0.2934664754877562,-0.873114914903389,0.6506024096385542,1.0,1.0,2/20,1.85%,LPIN1;DGAT2
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,-0.24622574156815583,-0.8722385018421173,0.6947368421052632,1.0,1.0,23/78,27.68%,PRKAG2;REXO2;COX5A;AGO1;LAMTOR2;RRAGB;AKT2;AKT3;AKT1;TNRC6A;PRKAG1;COX20;RRM2B;TSC1;COX8A;SCO2;RPTOR;TP53;COX18;YWHAZ;COX7B;COX5B;PRKAB1
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.31439472764833976,-0.8722221368484515,0.6790123456790124,1.0,1.0,6/17,20.08%,EXOSC9;DCP1A;EXOSC6;EXOSC4;EXOSC3;EXOSC2
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.27617161961021275,-0.8716206760923408,0.7191011235955056,1.0,1.0,4/34,7.31%,NUP88;NUP37;NUP133;POM121
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.27999687013370544,-0.8715265049063882,0.6547619047619048,1.0,1.0,11/25,35.15%,POT1;CTC1;SLC19A1;PCNA;RFC3;TERF1;TINF2;PRIM1;POLD4;POLD2;TERF2IP
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.25319798606234367,-0.8700596970094805,0.6736842105263158,1.0,1.0,22/49,40.03%,SNRPE;SNRNP35;SNRPB;NCBP2;POLR2I;SF3B6;SNRPF;DDX42;YBX1;POLR2D;SRSF7;POLR2B;ZMAT5;ZCRB1;SRSF2;SNRNP48;DDX23;POLR2H;RNPC3;PRPF8;POLR2C;SNRNP200
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.2306648282419187,-0.8700121529017699,0.78,1.0,1.0,61/210,27.44%,PIKFYVE;PRKCD;TEX264;DGKQ;ABHD12;HRG;MAGED2;CHID1;STXBP2;GNA11;SGPP2;LOC112694756;F2R;GNG5;SYK;PIK3R5;DGKH;CD109;ITIH4;PLEK;DGKA;PIK3R3;APBB1IP;DGKG;ARRB1;CLEC1B;PIK3CB;MPL;SCCPDH;PIK3R1;RAB27B;RNASE1;GNAI1;AKT1;P2RY1;GNA13;CAP1;SRGN;TRPC6;TAGLN2;TBXA2R;SOD1;GNG3;PCYOX1L;SYTL4;GNG10;DGKE;FCER1G;SERPINA1;PLG;GP1BA;ABCC4;CYB5R1;TGFB1;RAP1A;YWHAZ;MAPK14;MAPK1;CRK;SELENOP;GNG7
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,-0.3012796788820842,-0.8698269934337203,0.6309523809523809,1.0,1.0,4/17,14.89%,CRCP;POLR3B;POLR3D;POLR3C
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.2575118476516392,-0.8680217475611489,0.7052631578947368,1.0,1.0,11/49,20.55%,PRKAG2;REXO2;MYH9;EXOC5;AKT2;EXOC7;EXOC3;LNPEP;RNASE1;AKT1;PRKAG1
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.3187916497572812,-0.8674656594177207,0.6708860759493671,1.0,1.0,8/16,33.76%,SKP1;TNIP2;IKBKB;FBXW11;MAP2K4;RPS27A;MAP2K1;CHUK
prerank,KEGG_2021_Human__Ribosome,-0.23174742282760605,-0.8640030292627141,0.7474747474747475,1.0,1.0,75/133,48.15%,MRPS16;RPS4X;RPS20;RPS15A;RPL39;MRPL15;RPL4;RPS8;RPL26L1;RPL38;RPS16;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;MRPS7;RPSA;RPS26;RPS28;MRPS6;RPL15;RPL36AL;RPL11;MRPL32;MRPL1;RPL34;MRPS11;RPS27A;RPL36A;RPS27;RPL26;RPS12;MRPL10;RNA5-8SN2;RPL8;MRPS15;RPL41;MRPL12;RPL18A;RPLP0;MRPL23;RPL10A;RPL6;RSL24D1;RPS10-NUDT3;RPL18;RPL36A-HNRNPH2;MRPS21;MRPL19;MRPL2;RPL36;MRPL11;UBA52;MRPS9;RPS2;MRPL16;RPL3;RPS19;MRPS17;MRPS18A;MRPL21;MRPL28;MRPL30;RPS27L;RPL13;RPS6;RPL3L
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,0.25012837219625794,0.8633126206490275,0.6842105263157895,1.0,1.0,4/15,9.66%,RIGI;MAVS;CREBBP;IKBKE
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,-0.21834101188916302,-0.8629059587888447,0.84,1.0,1.0,110/294,36.66%,NDUFB2;ATP5F1E;ACTR10;MAP3K5;NXF1;NUP88;GABARAPL2;DCTN3;COX5A;TOMM40L;ANG;EIF2S1;NUP37;WDR41;UQCR10;NDUFC1;NUP133;PSMC5;SDHC;TNFRSF1B;KIF5C;NDUFB7;DERL1;POM121;ANXA7;DNAH1;PIK3R4;ALS2;NDUFS7;PSMD8;FUS;PSMD1;NDUFS2;PSMD13;VCP;GLE1;SPG11;RAE1;TRAF2;ACTR1B;HDAC6;SDHA;SIGMAR1;UBQLN4;ALYREF;PFN2;TUBA8;GPX3;BAX;DCTN4;BID;NDUFS1;TUBB2A;CAT;WIPI1;ACTR1A;NDUFA13;ATP5F1C;NDUFB6;DNAH14;TUBB4A;SOD1;TUBB1;COX8A;TP53;MAPK14;CASP3;COX7B;COX5B;NDUFS8;RAC1;SRSF7;ATXN2;ATG2A;NUP43;PIK3C3;DNAL4;PSMA4;PFN1;NDUFA5;ATP5PO;NUP85;TUBB6;DNAH17;PPP3CC;WIPI2;NDUFA2;MAPK11;TUBB3;HNRNPA1L2;ADRM1;UQCR11;SRSF3;SDHD;PSMC4;PSMD4;HNRNPA2B1;NDUFA11;MAPK13;HAP1;NDUFV3;TOMM40;NDUFA4;PSMD14;GABARAP;ATP5MC2;TUBB4B;COX4I1;CHCHD10;ATXN2L
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.21737714637539118,-0.8627402641066463,0.87,1.0,1.0,126/459,27.44%,GLG1;PIKFYVE;PRKCD;TEX264;KIF4A;CD48;CD99L2;DGKQ;ABHD12;PRKAR2B;ITGA10;PPP2CB;HRG;MAGED2;SELL;ZFPM2;CHID1;CD58;STXBP2;GNA11;KIF6;SGPP2;LOC112694756;KIF5C;ITGA5;PPIL2;F2R;P2RX4;JMJD1C;SIN3A;KLKB1;PLAT;ZNF160;GNG5;SYK;PIK3R5;DGKH;CD109;H3C7;ITIH4;KIF19;PPP2R5E;PLEK;KIF13B;GATA1;STIM1;DGKA;PIK3R3;KIF3C;H3C13;APBB1IP;AK3;DGKG;DOCK4;ARRB1;GATA3;PRCP;ITGA4;JAM3;TNFRSF10D;JAML;CLEC1B;PIK3CB;MPL;DOK2;SCCPDH;ITGAX;SLC7A8;PIK3R1;PDE2A;KIF22;RAB27B;PPP2R1A;RNASE1;GNAI1;AKT1;MFN1;ITGB2;P2RY1;GNA13;CAP1;SRGN;L1CAM;SLC16A3;TRPC6;SLC8A1;TAGLN2;TBXA2R;CEACAM21;ABL1;P2RX1;PDE9A;JCHAIN;H3-3B;SOD1;GNG3;SH2B2;KIF1C;PROC;PCYOX1L;SYTL4;GNG10;DGKE;GUCY1B1;KIF9;FCER1G;SERPINA1;TP53;PLG;ORAI1;WEE1;JAK2;GP1BA;ABCC4;CYB5R1;TGFB1;RAP1A;IRF1;YWHAZ;MAPK14;MAPK1;KIF21B;CRK;SELENOP;ATP1B2;GNG7
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,-0.2768341293787871,-0.8624420014186478,0.6702127659574468,1.0,1.0,9/30,21.71%,DLAT;PDK4;RDH5;CPT1A;RARB;DHRS9;ALDH1A2;RDH14;RARG
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,-0.3281706689498927,-0.8624411209215415,0.6708860759493671,1.0,1.0,7/16,34.05%,EPHB3;RNASE1;PKN2;MYL12A;EFNB1;NCK2;EPHB6
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.23258289411470331,-0.8619490876958061,0.7575757575757576,1.0,1.0,31/150,19.76%,RPS4X;ELOC;RPS20;RPS15A;RPL39;RPL4;USP33;PSMC5;RPS8;NCBP2;RPL26L1;RPL38;PSMD5;PSMD8;PSMD13;RPS16;PSMB10;DAG1;RPS11;RPL7A;RPL29;RPS10;RPS14;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,-0.23499458266727777,-0.8616119285608673,0.6875,1.0,1.0,8/70,8.73%,PRKCD;CREB1;PRKAR2B;PPP2CB;CAMK2A;GNA11;PLCB2;GNG5
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.26081205322988643,-0.8607609076905908,0.7708333333333334,1.0,1.0,10/57,17.16%,USP9X;ACOT8;PAOX;PEX2;ZFAND6;ECH1;ECI2;PEX14;HMGCL;PEX12
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,-0.2540014269451822,-0.8607464611165601,0.7142857142857143,1.0,1.0,17/46,28.92%,MNAT1;UBTF;KAT2B;TAF1C;RBBP7;MTA2;TAF1B;POLR1G;POLR1E;KAT2A;POLR1B;TTF1;CHD4;GTF2H3;RBBP4;DPEP3;CHD3
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.252600856492538,-0.8605156817160876,0.711340206185567,1.0,1.0,17/48,33.31%,SLC30A7;SLC39A3;SLC16A7;SLC39A8;SLC39A1;SLC44A4;SLC41A1;SLC16A3;SLC22A16;EMB;RSC1A1;SLC30A1;SLC30A6;SLC39A14;SLC11A1;SLC31A1;SLC6A15
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,-0.25884995839014535,-0.8604455223246491,0.6781609195402298,1.0,1.0,4/35,9.85%,STK38;RNF20;HNRNPC;RHOBTB1
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,-0.2699094361209932,-0.8601491163243689,0.6666666666666666,1.0,1.0,11/33,26.66%,PHC3;EZH2;RNF2;RBBP8;RBBP7;E2F1;L3MBTL2;CHEK1;EED;RBBP4;RYBP
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.2354417144958458,-0.8599512110069379,0.7142857142857143,1.0,1.0,30/83,30.75%,DNAJC3;EIF2S1;SEC31A;GFPT1;CXCL8;KLHDC3;EXOSC9;DDX11;ATP6V0D1;EXOSC6;EXOSC4;EXOSC3;SRPRB;ADD1;EXTL2;EXOSC2;WIPI1;DNAJB11;KHSRP;SRPRA;ATF3;ASNS;SERP1;CUL7;HYOU1;EIF2S3;CALR;TLN1;MBTPS2;CCL2
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.26420035940209163,-0.8598700022382644,0.6702127659574468,1.0,1.0,14/43,29.76%,FZD2;SMOX;WNT10A;GNG5;FZD6;CRHBP;ADM;RAMP1;SCT;GNG3;GNG10;GNG7;PTRH2;GNG4
prerank,KEGG_2021_Human__Cocaine addiction,-0.29471090477646233,-0.858961353003186,0.6785714285714286,1.0,1.0,2/25,1.06%,CDK5R1;CREB1
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,0.18098200707158538,0.8588839634502984,0.6,1.0,1.0,9/29,16.78%,ARNT2;RXRA;CYP4F2;CYP4F3;CYP46A1;TBXAS1;CYP2S1;FDXR;CYP2R1
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.29128666672249437,-0.8587698635977468,0.7078651685393258,1.0,1.0,10/31,23.28%,ARL2BP;SLC33A1;SLC27A1;SLC35D2;LCN15;SLC35A3;ARL2;SLC35B3;SLC35B4;SLCO4A1
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,-0.30538948898194684,-0.857638454921366,0.7058823529411765,1.0,1.0,1/16,0.93%,PRKCD
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,-0.264535449480246,-0.8566194121015465,0.6666666666666666,1.0,1.0,7/37,17.57%,VAMP3;FAM169A;TOR1AIP1;STEAP3;DIAPH1;ARHGAP1;PIK3R1
prerank,KEGG_2021_Human__Coronavirus disease,-0.22347706667556022,-0.8560440070607384,0.75,1.0,1.0,59/188,30.75%,RPS4X;RPS20;RPS15A;RPL39;CXCL8;RPL4;RPS8;RPL26L1;TYK2;RPL38;IL6;SYK;RPS16;EIF2AK2;MAPK10;PIK3R3;STAT1;C5AR1;RPS11;RPL7A;RPL29;RPS10;IKBKB;PIK3CB;RPS14;PIK3R1;RPS23;RPS29;RPL30;RPLP2;RPL35;RPL27;RPL14;RPSA;SELP;RPS26;MAPK8;TRAF6;FOS;IFNAR1;RPS28;C4A;RPL15;RPL36AL;RPL11;MX1;MAP3K7;RPL34;C1S;MAPK14;IL6ST;MAPK1;RPS27A;RPL36A;RPS27;TLR7;JUN;RPL26;CCL2
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,-0.2759164324250908,-0.8558599388355492,0.6896551724137931,1.0,1.0,11/27,34.86%,CCNE1;DYRK1A;LIN9;E2F1;PCNA;CDK1;RBBP4;LIN54;TFDP2;CDC25A;CDK2
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,-0.23114852097076188,-0.8554223455642592,0.77,1.0,1.0,39/130,28.92%,PHC3;NEDD4;HDAC3;SCMH1;AGO1;PSMC5;LAMTOR2;CBX4;EZH2;PSMD5;RNF2;PSMD8;PSMD13;PML;PSMB10;CNOT6L;TNKS2;RBBP7;RRAGB;CSNK2A2;MTA2;AKT2;AKT3;CBX6;AKT1;TNRC6A;FRK;CHD4;RPTOR;EGR1;EED;TP53;RBBP4;MAPK1;DPEP3;PSME1;RPS27A;PSMA4;CHD3
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.2706022980862005,-0.8549390619190133,0.6511627906976745,1.0,1.0,19/29,52.34%,FLOT2;BIRC3;FADD;MLKL;RPS27A;TNFRSF10B;RIPK3;TRADD;CFLAR;OGT;XIAP;BIRC2;TNFSF10;UBA52;FASLG;HSP90AA1;STUB1;FLOT1;PELI1
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,-0.23233742115857034,-0.8545424325485685,0.7653061224489796,1.0,1.0,14/90,16.38%,NUP88;CAMK2A;RPA3;NUP37;SERPINH1;NUP133;HSPA6;POM121;EP300;BAG3;VCP;HDAC6;HSPA4;HSBP1
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.26599380360471936,-0.8540430411262147,0.7157894736842105,1.0,1.0,15/35,32.34%,ORC3;H2BC14;H3C7;ORC6;H2BC13;H2AC14;H3C13;H2AZ1;H3-3B;H2AX;H2AC19;H2AB1;KPNA1;H2BC17;H2BC12
prerank,Reactome_2022__TNF Signaling R-HSA-75893,-0.25459409642491604,-0.8538924492464958,0.6741573033707865,1.0,1.0,9/43,21.06%,SMPD3;NSMAF;BIRC3;TRAF1;SPPL2A;IKBKB;TAX1BP1;FADD;TAB3
prerank,KEGG_2021_Human__Cholesterol metabolism,-0.27221306858880634,-0.8537199503917842,0.7045454545454546,1.0,1.0,10/33,29.42%,ABCB11;APOE;LDLRAP1;ABCA1;LIPG;NCEH1;CETP;LCAT;VDAC2;STAR
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.24149700949658964,-0.853157001220127,0.6938775510204082,1.0,1.0,18/55,28.41%,HDAC3;COX5A;NCOA1;SIN3A;LIN9;STAP2;PPARA;HBA1;COX20;NCOR1;BLVRA;COX8A;SCO2;COX18;COX7B;COX5B;TBL1XR1;CARM1
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,-0.31339847479216115,-0.8529829721835444,0.6829268292682927,1.0,1.0,5/17,21.65%,AGO1;PML;TNRC6A;CCND2;CBFB
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.1605584555473301,0.8528391058169124,0.75,1.0,1.0,10/64,7.83%,PDE1B;GNB5;PTGIR;ORAI2;GNB2;KCNMA1;PPP2R5B;GUCY1A1;CALM1;PPP2R5C
prerank,KEGG_2021_Human__Longevity regulating pathway,-0.2336660912289844,-0.8528248118143179,0.7731958762886598,1.0,1.0,22/83,25.44%,PRKAG2;CREB1;FOXO1;HSPA6;CLPB;STK11;IGF1R;PIK3R3;AKT2;PIK3CB;AKT3;ATG5;PIK3R1;AKT1;ADCY3;BAX;PRKAG1;CAT;SOD1;TSC1;RPTOR;TP53
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.2559421049840594,-0.8517039783142061,0.7021276595744681,1.0,1.0,19/49,32.19%,PIGQ;NTNG2;CD109;PIGO;NRN1L;LYPD5;RECK;NEGR1;PIGZ;CD52;LYPD2;PIGS;PIGV;PIGL;PIGW;PIGB;PIGA;LYPD3;FOLR2
prerank,KEGG_2021_Human__Melanogenesis,-0.24011124484855634,-0.8513090968345698,0.7551020408163265,1.0,1.0,14/63,21.36%,CREB1;CAMK2A;MC1R;FZD2;WNT10A;PLCB2;FZD6;EP300;TCF7L2;PLCB4;FZD3;GNAI1;ADCY3;TCF7L1
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,-0.33450978340567644,-0.850729344046347,0.6447368421052632,1.0,1.0,7/15,31.98%,TMED7-TICAM2;LY96;TAB3;TRAF6;MAP3K7;RPS27A;NDUFA2
prerank,KEGG_2021_Human__Huntington disease,-0.2151167737286636,-0.8502687692331877,0.83,1.0,1.0,90/247,35.47%,CREB1;NDUFB2;ATP5F1E;ACTR10;MAP3K5;DCTN3;COX5A;CLTCL1;UQCR10;NDUFC1;PSMC5;SDHC;KIF5C;NDUFB7;SIN3A;DNAH1;AP2M1;PLCB2;TAF4;PIK3R4;POLR2I;NDUFS7;PSMD8;PSMD1;NDUFS2;EP300;PSMD13;MAPK10;MAP3K10;CLTB;TRAF2;ACTR1B;BBC3;SDHA;PLCB4;TUBA8;GPX3;HIP1;BAX;DCTN4;NDUFS1;TUBB2A;MAPK8;WIPI1;ACTR1A;NDUFA13;ATP5F1C;NDUFB6;CLTC;DNAH14;TUBB4A;SOD1;TUBB1;COX8A;POLR2J3;TP53;CASP3;COX7B;COX5B;NDUFS8;VDAC2;POLR2D;ATG2A;PIK3C3;DNAL4;PSMA4;POLR2B;TBPL2;TAF4B;NDUFA5;ATP5PO;TUBB6;DNAH17;WIPI2;NDUFA2;TUBB3;ADRM1;UQCR11;SDHD;PSMC4;DLG4;PSMD4;NDUFA11;HTT;REST;HAP1;NDUFV3;NDUFA4;POLR2J2;PSMD14
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,-0.2700211668245597,-0.8500378986507467,0.6483516483516484,1.0,1.0,13/33,32.83%,CAMK2A;IQGAP1;APBB1IP;ARRB1;KSR1;CNKSR1;JAK2;RAP1A;MAPK1;HRAS;MAP2K1;TLN1;CNKSR2
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,-0.2647118991669293,-0.8494118767786715,0.6818181818181818,1.0,1.0,9/29,24.88%,MNAT1;UBTF;TAF1C;TAF1B;POLR1G;POLR1E;POLR1B;TTF1;GTF2H3
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,-0.2831518804202115,-0.8489520781868416,0.6818181818181818,1.0,1.0,8/25,26.12%,APOE;PSEN1;PSENEN;GFAP;NCSTN;STAT5A;NCOR1;COPS2
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.2559266030695479,-0.8486371806552386,0.7126436781609196,1.0,1.0,5/47,6.53%,PRKAG2;CREB1;PRKAR2B;CAMK2A;LIN7C
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,-0.2987035808387238,-0.8483879188175182,0.717948717948718,1.0,1.0,3/17,7.45%,ITGB5;LTBP1;MFAP5
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.2406043679300056,-0.8481975336489119,0.7,1.0,1.0,13/73,15.21%,NUP88;NUP37;AGO1;NUP133;H2BC14;POM121;POLR2I;IPO8;H3C7;H2BC13;H2AC14;H3C13;H2AZ1
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.263065909675501,-0.8480141909195673,0.7065217391304348,1.0,1.0,5/33,14.29%,CLSPN;PRKCD;BCAP31;DBNL;PLEC
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.23687734710425576,-0.8470010129132914,0.7216494845360825,1.0,1.0,8/56,10.99%,NFKB2;UBA3;PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.24766583690521796,-0.8468872288944435,0.7311827956989247,1.0,1.0,23/58,31.30%,SIRT3;PFKL;PDK1;PGAM2;PIK3R3;AKT2;FGFR1;PIK3CB;AKT3;PIK3R1;AKT1;SLC16A3;LDHB;SCO2;NTRK1;TP53;MAPK1;LDHA;HRAS;MAP2K1;PFKP;IDH2;PFKM
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.265915161695301,-0.8463777425364601,0.6853932584269663,1.0,1.0,13/24,41.83%,CHMP4B;CASP4;BAX;GZMB;RNF103-CHMP3;TP53;IRF1;CASP3;IL1B;GSDMD;IL18;CASP5;CASP1
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.2396929379678379,-0.8459673841435674,0.7676767676767676,1.0,1.0,18/63,27.75%,CREB1;PRKAR2B;INSL3;MC1R;IL6;GNG5;HRH2;ADM;RAMP1;RLN2;ADORA2A;GNAI1;SCT;GNG3;GNG10;ADORA2B;GNG7;PTRH2
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,-0.2816584324007967,-0.8458620632180983,0.6736842105263158,1.0,1.0,7/22,27.23%,TNS3;LAMC1;LAMC3;RNASE1;LMNB2;RAP1A;CRK
prerank,KEGG_2021_Human__Focal adhesion,-0.22326493535376193,-0.8451096777242956,0.82,1.0,1.0,48/154,30.12%,ITGA10;BIRC3;ELK1;PARVG;PGF;COL9A1;ITGB5;ITGA5;LAMB4;LAMC1;MAPK10;THBS4;IGF1R;PIK3R3;DIAPH1;LAMC3;AKT2;CAPN2;PARVB;ITGA4;PIK3CB;AKT3;PIK3R1;RELN;AKT1;MYL12A;PPP1R12C;CCND2;MAPK8;CAV2;MYL9;PXN;PAK1;MYLK;RAP1A;PDGFC;MAPK1;CRK;RAC1;ITGB8;RAC3;HRAS;MAP2K1;ITGB7;MYL5;COL6A3;JUN;TLN1
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,0.20858675172706753,0.8450459840898151,0.5833333333333334,1.0,1.0,10/27,19.40%,AREG;EPS15L1;SH3GL1;HBEGF;UBC;EREG;EPGN;UBB;EPN1;EPS15
prerank,KEGG_2021_Human__Fatty acid elongation,-0.2796491185807063,-0.8450304040112878,0.651685393258427,1.0,1.0,10/25,32.23%,PPT1;TECR;THEM5;THEM4;HADH;ELOVL7;ACOT2;HADHA;ELOVL6;ELOVL1
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,-0.2668017640204327,-0.844046891033885,0.7291666666666666,1.0,1.0,14/31,32.34%,H2BC14;H3C7;H2BC13;DNMT1;H2AC14;H3C13;H2AZ1;DNMT3B;H3-3B;H2AX;H2AC19;H2AB1;H2BC17;H2BC12
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,-0.2679145659380656,-0.8439869323136233,0.7093023255813954,1.0,1.0,10/30,28.94%,PIK3R4;IGF1R;THEM4;AKT2;FGFR1;PIK3CB;PIK3R1;PDE3B;PIK3C3;HRAS
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.2679145659380656,-0.8439869323136233,0.7093023255813954,1.0,1.0,10/30,28.94%,PIK3R4;IGF1R;THEM4;AKT2;FGFR1;PIK3CB;PIK3R1;PDE3B;PIK3C3;HRAS
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.303255778988609,-0.8436304846811006,0.6410256410256411,1.0,1.0,2/17,2.69%,CREB1;CAMK2A
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,-0.30014009525155505,-0.8427424746420277,0.7407407407407407,1.0,1.0,4/15,24.49%,PPP2CB;PPP2R5E;PPP2R1A;PROC
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,-0.24262650561394142,-0.8425542644898806,0.723404255319149,1.0,1.0,10/67,12.99%,NUP88;SLC5A5;NUP37;NUP133;MAP4K5;POM121;SLC33A1;SLC36A2;SLC24A4;SLC4A1
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.2360095531428153,-0.8422110232046284,0.776595744680851,1.0,1.0,27/55,43.23%,FLOT2;BIRC3;CHMP4B;CASP4;BAX;FADD;GZMB;RNF103-CHMP3;MLKL;TP53;IRF1;CASP3;RPS27A;TNFRSF10B;RIPK3;TRADD;IL1B;CFLAR;OGT;GSDMD;XIAP;IL18;CASP5;CASP1;BIRC2;TNFSF10;UBA52
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.234493096355339,-0.8419957141519859,0.7244897959183674,1.0,1.0,8/57,10.99%,NFKB2;UBA3;PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10
prerank,KEGG_2021_Human__Pancreatic cancer,-0.2271006604628753,-0.8418620616694581,0.7628865979381443,1.0,1.0,24/74,29.41%,TGFBR2;SMAD2;RALBP1;MAPK10;PIK3R3;STAT1;GADD45G;AKT2;E2F1;DDB2;IKBKB;PIK3CB;AKT3;PIK3R1;AKT1;BAX;MAPK8;TP53;TGFB1;GADD45A;MAPK1;RAC1;RAC3;MAP2K1
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.22213633205258904,-0.8415803983386845,0.7731958762886598,1.0,1.0,29/96,28.84%,HDAC3;SMURF1;PSMC5;GATD3;ITGA5;RBM14-RBM4;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;STAT1;HDAC6;AKT2;AKT3;AKT1;RUNX2;BAX;CBFB;WWP1;ABL1;HEY1;PPM1D;CDK1;PPARGC1B;MAPK1;PSME1;RPS27A;PSMA4
prerank,KEGG_2021_Human__Type II diabetes mellitus,-0.26518924336258026,-0.840834305966339,0.6989247311827957,1.0,1.0,8/34,21.29%,PRKCD;MAPK10;PIK3R3;IKBKB;PIK3CB;PIK3R1;MAPK8;SOCS3
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,-0.23343202426996543,-0.8402406783341195,0.7422680412371134,1.0,1.0,12/76,12.75%,SMURF1;RORA;PSMC5;FZD2;AP2M1;PSMD5;PSMD8;FZD6;PSMD13;PSMB10;NCOA3;CLTB
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.23541927301538934,-0.8385904037186599,0.7835051546391752,1.0,1.0,36/84,36.17%,CXCL8;TLR5;IL6;CD14;MAPK10;PIK3R3;IRF5;STAT1;AKT2;IKBKB;PIK3CB;AKT3;PIK3R1;AKT1;FADD;LY96;MAPK8;TRAF6;FOS;IFNAR1;MAP2K4;MAP3K7;MAPK14;MAPK1;RAC1;CCL5;TLR7;MAP2K1;JUN;MAPK11;CHUK;MAPK13;IRAK4;IL12A;MAP2K2;TLR1
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.31493347576652764,-0.83848130592744,0.6951219512195121,1.0,1.0,7/16,29.76%,KCNJ15;KCNJ2;GNG5;GNG3;GNG10;GNG7;GNG4
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.25749664008226303,-0.8372492369298403,0.7717391304347826,1.0,1.0,16/47,32.34%,H2BC14;TDP1;XRCC5;PIAS4;RAD50;H2BC13;MDC1;TDP2;UBE2N;XRCC4;H2AX;POLL;ABRAXAS1;RNF168;H2BC17;H2BC12
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,-0.23135115523246863,-0.8369344694952539,0.7216494845360825,1.0,1.0,9/66,10.99%,MCM5;ORC3;PSMC5;SKP1;PSMD5;PSMD8;PSMD13;ORC6;PSMB10
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,-0.2442466708643612,-0.8367968224777025,0.7021276595744681,1.0,1.0,5/46,8.99%,NUP88;NUP37;NUP133;POM121;POLR2I
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.2358987600997602,-0.8362995235539623,0.8085106382978723,1.0,1.0,10/74,10.43%,ICE1;POU2F1;TAF5;ZNF143;INTS4;ELL2;NCBP2;RPRD1B;POLR2I;SNAPC1
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.2588850486455096,-0.8362507783261746,0.7582417582417582,1.0,1.0,4/35,7.31%,NUP88;NUP37;NUP133;POM121
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.24832416185876952,-0.8362038859656815,0.7391304347826086,1.0,1.0,19/46,33.19%,DLAT;PDK4;SUCLG1;DLST;SDHA;MPC2;SUCLG2;SLC16A3;LDHB;HAGH;IDH3G;CS;PDK2;PPARD;LDHA;IDH2;L2HGDH;SDHD;OGDH
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.23280846409113753,0.8355795182156565,0.6875,1.0,1.0,2/15,2.27%,ARNT2;RXRA
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.24590016696847686,-0.8347891002894722,0.7446808510638298,1.0,1.0,11/54,18.20%,FANCE;RPA3;ERCC4;RPA1;FANCL;MLH1;RMI2;POLN;TELO2;WDR48;RPA2
prerank,KEGG_2021_Human__Tuberculosis,-0.209512306685789,-0.834142556699318,0.8061224489795918,1.0,1.0,74/148,45.27%,CREB1;CLEC7A;CAMK2A;ATP6V0B;IL6;CLEC4E;SYK;CD14;EP300;RFXAP;MAPK10;STAT1;BCL10;TCIRG1;ATP6V0D1;AKT2;CTSS;CORO1A;ITGAX;AKT3;EEA1;AKT1;VDR;ITGB2;BAX;BID;FADD;MAPK8;TRAF6;CIITA;KSR1;IFNGR2;FCER1G;JAK2;TGFB1;NOD2;MAPK14;CASP3;MAPK1;ATP6V0C;PIK3C3;PPP3CC;MAPK11;CD74;ATP6AP1;LSP1;MAPK13;IRAK4;IL12A;TRADD;RHOA;TLR1;TGFB3;IL1B;CAMP;ATP6V0A2;PLK3;HLA-DQB1;CR1;SPHK1;SRC;IL18;JAK1;IL23A;FCGR1A;TLR6;RIPK2;PPP3R1;RAB5A;LAMP2;NFKB1;IFNG;HLA-DRB3;IFNGR1
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.255494510180652,-0.8339555818219359,0.75,1.0,1.0,11/36,29.23%,PPP2CB;MDM4;PRDM1;AKT2;AKT3;PPP2R1A;AKT1;CDK1;TP53;RPS27A;RICTOR
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.29606329425446215,-0.8336704715015331,0.7558139534883721,1.0,1.0,9/20,29.76%,GNG5;CACNB3;CACNA2D2;GNAI1;CACNB2;GNG3;GNG10;GNG7;GNG4
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.29158223772113495,-0.8331868292048183,0.6987951807228916,1.0,1.0,12/19,47.92%,PPP2CB;SPRY2;FGFR1;PPP2R1A;MAPK1;RPS27A;PPP2CA;SRC;CBL;UBA52;FGF13;PTPN11
prerank,KEGG_2021_Human__AMPK signaling pathway,-0.21972435450207342,-0.8325284391232405,0.7857142857142857,1.0,1.0,23/102,21.14%,PRKAG2;CREB1;PPP2CB;RAB11B;FOXO1;PFKL;CPT1A;CPT1B;STK11;PPP2R5E;IGF1R;PPP2R3A;PIK3R3;AKT2;PIK3CB;G6PC3;STRADA;AKT3;PIK3R1;PPP2R1A;AKT1;PRKAG1;LIPE
prerank,KEGG_2021_Human__Vibrio cholerae infection,-0.2430453973046225,-0.8317393874412464,0.7142857142857143,1.0,1.0,8/41,19.49%,ATP6V1E1;ATP6V0B;ATP6V1E2;KCNQ1;TCIRG1;ATP6V0D1;SEC61G;ADCY3
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,-0.22756032084920308,-0.830431229412534,0.7755102040816326,1.0,1.0,12/91,11.32%,ABCC9;ABCB1;EIF2S1;ABCA6;PSMC5;DERL1;PSMD5;PSMD8;ERLIN2;PSMD13;PSMB10;VCP
prerank,KEGG_2021_Human__Protein digestion and absorption,-0.23907328391585964,-0.830070919348071,0.7555555555555555,1.0,1.0,19/49,34.74%,FXYD2;COL9A1;SLC9A3;PGA4;ELN;SLC36A2;KCNQ1;PRCP;SLC7A8;KCNN4;SLC8A1;COL8A2;COL13A1;ATP1B2;COL6A3;SLC36A1;SLC16A10;DPP4;COL4A4
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.2355093016789011,-0.8297222277089976,0.7551020408163265,1.0,1.0,15/67,21.66%,NKIRAS2;NFKB2;SIKE1;PDZD2;MAP3K1;EP300;PCBP2;IKBKB;ATG5;NLRC5;UBA7;TAX1BP1;FADD;TRAF6;OTUD5
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,-0.22689704742312616,-0.8285351847837343,0.7835051546391752,1.0,1.0,26/92,29.30%,SAP30;ARID4A;SAP18;FXYD2;TYK2;ZBP1;AP2M1;S1PR1;SYK;RBBP7;MTA2;ITGA4;SIGMAR1;IFNAR1;COMT;CHURC1-FNTB;BRMS1L;CHD4;IFNGR2;RBBP4;JAK2;DPEP3;ATP1B2;HSP90AB1;CHD3;TLR7
prerank,Reactome_2022__Neddylation R-HSA-8951664,-0.21364675543997683,-0.828430236420719,0.82,1.0,1.0,55/210,28.84%,KLHL9;BTBD1;KLHL25;FBXO7;ANKRD9;KCTD6;ELOC;COMMD7;CUL5;UBA3;PSMC5;COMMD8;FBXL18;SKP1;PSMD5;PSMD8;COMMD6;DCAF8;PSMD13;ZBTB16;PSMB10;VCP;FBXO44;RBBP7;SOCS6;COMMD4;FBXO4;RNF7;DCAF6;DDB2;DDB1;UBE2M;FBXO9;FBXO10;FBXO21;FBXL20;SPSB1;SOCS3;COPS8;FBXW9;FBXW11;ASB1;CCDC22;ASB7;VHL;GPS1;COPS2;DDA1;CUL7;FBXW5;COMMD2;PSME1;FBXL16;RPS27A;PSMA4
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,-0.24784667598296597,-0.8281724333883694,0.6774193548387096,1.0,1.0,17/56,27.44%,PRKAR2B;AKAP5;GNA11;PLCB2;GNG5;ACSL4;CACNB3;IQGAP1;ACSL3;CACNA2D2;KCNC2;GNAI1;CACNB2;GNG3;GNG10;RAP1A;GNG7
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.2697957272206951,-0.8280775681976961,0.648936170212766,1.0,1.0,14/29,40.86%,IQGAP1;APBB1IP;ARRB1;KSR1;CNKSR1;RAP1A;MAPK1;HRAS;MAP2K1;TLN1;CNKSR2;MAP2K2;SRC;ITGB3
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.29948438063142946,-0.8280674758461859,0.7317073170731707,1.0,1.0,9/16,46.26%,TMED7-TICAM2;FADD;LY96;TNFRSF10B;NDUFA2;TRADD;CFLAR;TNFSF10;FASLG
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.2187130610973965,-0.8269903821096084,0.8556701030927835,1.0,1.0,24/103,22.56%,CREB1;PPP2CB;CAMK2A;FXYD2;CACNG8;PLCB2;PIK3R5;CACNB3;PPP2R5E;KCNE1;KCNQ1;PPP2R3A;AKT2;PLCB4;AKT3;CACNA2D2;PPP2R1A;GNAI1;AKT1;ADCY3;CACNB2;CACNB4;SLC8A1;RPS6KA5
prerank,Reactome_2022__Apoptosis R-HSA-109581,-0.21679663669524535,-0.8267401406010693,0.8686868686868687,1.0,1.0,63/166,37.12%,CLSPN;PRKCD;REXO2;AVEN;BCL2L11;MAGED1;ARHGAP10;TMED7-TICAM2;PSMC5;BCAP31;PSMD5;PSMD8;DBNL;PSMD13;PSMB10;DAPK2;H1-2;H1-3;PLEC;BBC3;AKT2;E2F1;AKT3;DYNLL2;AKT1;PKN2;ADD1;BAX;BID;DFFB;FADD;LY96;MAPK8;GZMB;CARD8;PROC;TP53;YWHAZ;CASP3;MAPK1;PSME1;KPNA1;RPS27A;PSMA4;MED12;YWHAQ;H1-0;DNM1L;PPP3CC;TNFRSF10B;BMF;NDUFA2;PSMC4;PSMD4;TFDP2;TRADD;PSMD14;HMGB2;VIM;CASP6;TP53BP2;APPL1;H1-5
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.24468832368199378,-0.8265873405595191,0.7659574468085106,1.0,1.0,13/54,22.44%,MYH9;SEC31A;SKP1;MECP2;PPFIBP1;RNF213;MSN;PIK3R1;FRS3;STAT5A;HIP1;NPM1;CLTC
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,-0.2795003549878437,-0.8257305409267542,0.7674418604651163,1.0,1.0,9/28,28.94%,PPP2CB;SPRY2;PIK3R1;FRS3;PPP2R1A;MAPK1;GALNT3;RPS27A;HRAS
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,-0.2860339606529875,-0.8249304791246261,0.6875,1.0,1.0,5/22,15.01%,B4GALT2;GNS;SLC35D2;HEXA;B4GALT3
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,-0.26371081224212917,-0.8247699037033739,0.6853932584269663,1.0,1.0,7/23,22.68%,MYH9;RRAS;RHOC;PLXNB1;RNASE1;LIMK2;MYL9
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.2287631063552572,-0.82469018215674,0.7731958762886598,1.0,1.0,15/84,19.75%,CD3D;IL9R;IL3RA;IL2RA;ITGA5;CD22;IL5RA;IL6;CD14;CD19;ITGA4;CD3E;CD3G;CD5;CD7
prerank,KEGG_2021_Human__Pertussis,-0.227469306446047,-0.8244198455014584,0.7708333333333334,1.0,1.0,27/68,34.61%,CXCL8;ITGA5;IL6;CD14;MAPK10;C4BPA;GNAI1;ITGB2;LY96;MAPK8;TRAF6;FOS;C4A;IRF1;C1S;MAPK14;CASP3;MAPK1;JUN;C4BPB;IRF8;MAPK11;SERPING1;MAPK13;GNAI3;IRAK4;IL12A
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,-0.2652690430139212,-0.8235916053217482,0.7176470588235294,1.0,1.0,6/25,17.57%,PIK3R4;THEM4;AKT2;FGFR1;PIK3CB;PIK3R1
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,-0.23531697117162298,-0.8233894108419477,0.8041237113402062,1.0,1.0,27/76,28.92%,H2BC14;MNAT1;H3C7;H2BC13;UBTF;KAT2B;TAF1C;RBBP7;MTA2;H2AC14;H3C13;TAF1B;H2AZ1;POLR1G;POLR1E;KAT2A;POLR1B;TTF1;H3-3B;CHD4;H2AX;GTF2H3;RBBP4;DPEP3;H2AC19;H2AB1;CHD3
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,-0.23531697117162298,-0.8233894108419477,0.8041237113402062,1.0,1.0,27/76,28.92%,H2BC14;MNAT1;H3C7;H2BC13;UBTF;KAT2B;TAF1C;RBBP7;MTA2;H2AC14;H3C13;TAF1B;H2AZ1;POLR1G;POLR1E;KAT2A;POLR1B;TTF1;H3-3B;CHD4;H2AX;GTF2H3;RBBP4;DPEP3;H2AC19;H2AB1;CHD3
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.21676778841148286,-0.8226921052780348,0.7244897959183674,1.0,1.0,25/90,28.10%,EDARADD;NFKB2;BIRC3;CXCL8;PARP1;TRAF1;SYK;PIAS4;CD14;CSNK2A2;BCL10;TRAF2;GADD45G;IKBKB;CD40LG;EDA;LY96;TAB3;TRAF6;TNFSF13B;MAP3K7;GADD45A;ZAP70;TRAF5;LYN
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,-0.24642772776996852,-0.8220949696819414,0.6774193548387096,1.0,1.0,11/39,25.04%,PRKAG2;LAMTOR2;STK11;RRAGB;AKT2;STRADA;AKT1;PRKAG1;PPM1A;TSC1;RPTOR
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,-0.28556187021552315,-0.8216628732594314,0.7582417582417582,1.0,1.0,4/20,16.76%,ACAT1;MVD;ICMT;PMVK
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.23866489402135965,-0.8189387203789806,0.8085106382978723,1.0,1.0,21/61,30.65%,MMP9;CREB1;XPO1;GNG5;IGF1R;PIK3R3;AKT2;AKT3;PIK3R1;GNAI1;AKT1;FOS;CAV2;GNG3;GNG10;MAPK1;GNG7;HRAS;GNG4;CDKN1B;ZDHHC21
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.2570126869677538,-0.8184347135208488,0.6741573033707865,1.0,1.0,5/32,12.52%,DNA2;EXO1;RAD50;RBBP8;RMI2
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.2293054194939712,-0.8181630755592734,0.8144329896907216,1.0,1.0,13/80,14.01%,NXF1;NUP88;CDC40;NUP37;NUP133;NCBP2;THOC7;POM121;THOC6;SRSF5;CPSF2;GLE1;U2AF1L4
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.21669971452025844,-0.8181009258953632,0.8484848484848485,1.0,1.0,41/151,27.97%,MMP9;CTSL;CAMK2A;SMAD2;ELK1;HCLS1;FZD2;ITGB5;ITGA5;WNT10A;MRAS;FZD6;RRAS;IGF1R;PIK3R3;ANK2;IQGAP1;TFAP4;HSPG2;AKT2;RRAS2;FGFR1;MSN;PIK3CB;AKT3;PIK3R1;FZD3;AKT1;PPP1R12C;CAV2;DCN;PXN;PAK1;WNT5B;TP53;TGFB1;MAPK14;CASP3;MAPK1;RAC1;NANOG
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.2889523245244185,-0.8169490129555305,0.775,1.0,1.0,10/23,34.69%,BIRC3;TMED7-TICAM2;IKBKB;LY96;UBE2N;TRAF6;RPS27A;NDUFA2;CHUK;RIPK3
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,-0.2674269649004918,-0.816820376748876,0.7073170731707317,1.0,1.0,5/21,18.78%,H3C7;PIK3R3;H3C13;PIK3R1;STAT5A
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.24057826407917368,-0.8167600360432484,0.7222222222222222,1.0,1.0,10/48,19.95%,MTM1;INPP5K;PLEKHA4;PIK3C2B;PIK3R5;MTMR2;PIK3R3;PIK3CB;PIK3R1;MTMR3
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.2107929189945217,-0.8160224038820763,0.7319587628865979,1.0,1.0,11/91,10.99%,EDARADD;NFKB2;BIRC3;UBA3;PSMC5;TNFRSF1B;SKP1;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.27455232612257824,-0.815962973845578,0.7241379310344828,1.0,1.0,6/22,19.14%,PIK3R3;THEM4;AKT2;AKT3;PIK3R1;AKT1
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.27955927181842777,-0.8157224516425975,0.7469879518072289,1.0,1.0,15/21,55.00%,PIWIL2;POLR2I;POLR2D;POLR2B;TDRKH;MYBL1;POLR2H;POLR2C;HENMT1;TDRD9;POLR2L;POLR2K;HSP90AA1;PIWIL4;POLR2J
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,-0.2277177417270845,-0.815409186645152,0.7395833333333334,1.0,1.0,8/54,10.99%,OAZ1;PSMC5;PAOX;SMOX;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,-0.29297009558802806,-0.8147303098479154,0.7294117647058823,1.0,1.0,5/18,22.68%,MYH9;PRC1;RHOC;RNASE1;MYL9
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,0.2196887445142549,0.8144589609850078,0.7142857142857143,1.0,1.0,2/17,5.23%,PCSK5;ABCG1
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,-0.26463104239479984,-0.8136960130353338,0.7333333333333333,1.0,1.0,4/32,8.78%,DNAJC5;LIN7C;ALDH5A1;SYN3
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.2820194512146496,-0.8129539763532855,0.7159090909090909,1.0,1.0,10/25,30.01%,PIGQ;MPPE1;PIGO;PIGZ;PIGS;PIGV;PIGL;PIGW;PIGB;PIGA
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.22788479103792564,-0.812773839016007,0.7789473684210526,1.0,1.0,16/64,24.74%,DNA2;RPA3;HUS1;EXO1;RAD50;RBBP8;SLC19A1;RAD9B;RMI2;PCNA;POLR1B;RTEL1;CHEK1;RAD51AP1;RFC3;TOP3A
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.2250959674492879,-0.812544575054888,0.8020833333333334,1.0,1.0,24/83,29.59%,UCKL1;APRT;CTPS2;DPYD;UPB1;TK2;UCK2;NUDT15;NUDT9;TK1;NT5E;NT5C1A;DTYMK;DUT;ITPA;GUK1;RRM2B;SCO2;AK7;ENTPD2;AK1;PFAS;AK9;AMPD2
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.24107039530583074,-0.8122507047641168,0.6956521739130435,1.0,1.0,17/42,34.36%,NCOA1;DHCR7;MVD;LIN9;PPARA;TM7SF2;PMVK;SC5D;DAND5;TBL1XR1;CARM1;LMBR1;FDFT1;ELOVL6;FDPS;CHD9;MVK
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.23858592398266681,-0.8100655767318766,0.7340425531914894,1.0,1.0,12/40,28.10%,IL3RA;IL2RA;IL5RA;SYK;PIK3R3;PIK3CB;PIK3R1;STAT5A;JAK2;YWHAZ;CRK;LYN
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,-0.25643813038526686,-0.8095342501129182,0.7215189873417721,1.0,1.0,5/32,13.47%,SMPD3;STS;GALC;HEXA;CERK
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,-0.2720442439126396,-0.8093370295787048,0.7469879518072289,1.0,1.0,2/23,7.15%,STK38;HNRNPC
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.21160535651656107,-0.8090055928666822,0.8,1.0,1.0,32/119,28.94%,PRKCD;CLEC7A;NFKB2;CLEC6A;UBA3;PSMC5;SKP1;PSMD5;PSMD8;CLEC4E;SYK;EP300;PSMD13;PSMB10;BCL10;CLEC10A;IKBKB;UBE2M;PKN2;UBE2N;TAB3;TRAF6;FBXW11;RPS6KA5;CLEC4A;FCER1G;MAP3K7;PSME1;LYN;RPS27A;PSMA4;HRAS
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.1605180990890326,0.8084576914904159,1.0,1.0,1.0,15/54,18.41%,LIMS2;CLDN9;FLNA;NECTIN2;CLDN5;FBLIM1;AFDN;CD151;PRKCI;CLDN12;ILK;ARHGEF6;CDH13;ITGA6;CADM1
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.23892472503700696,-0.8083640743319022,0.8041237113402062,1.0,1.0,20/55,32.83%,CLCN6;BCL2L11;CAMK2A;AKAP9;SND1;IQGAP1;APBB1IP;ARRB1;FAM114A2;KSR1;ATG7;CNKSR1;JAK2;RAP1A;MAPK1;HRAS;MAP2K1;TLN1;AGK;CNKSR2
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.2196530457886172,-0.8083620541857918,0.797979797979798,1.0,1.0,29/107,28.94%,GLG1;CD48;CD99L2;SELL;CD58;ITGA5;PPIL2;ITGA4;JAM3;TNFRSF10D;JAML;PIK3CB;DOK2;ITGAX;SLC7A8;PIK3R1;ITGB2;L1CAM;SLC16A3;CEACAM21;JCHAIN;PROC;FCER1G;TGFB1;SELENOP;ATP1B2;LYN;THBD;HRAS
prerank,KEGG_2021_Human__Thermogenesis,-0.21458005190871915,-0.8081466979299019,0.86,1.0,1.0,68/187,36.42%,PRKAG2;CREB1;NDUFB2;ATP5F1E;MAP3K5;COX5A;UQCR10;NDUFC1;SMARCD2;SDHC;NDUFB7;CPT1A;NDUFAF6;NDUFS7;CPT1B;ACSL4;NDUFS2;ACSL6;ATP5ME;ARID1A;ATP5MG;COA1;SDHA;ACSL3;FGFR1;RPS6KA1;NDUFAF8;ADCY3;NDUFS1;PRKAG1;LIPE;COX20;NDUFA13;ATP5F1C;NDUFB6;TSC1;COA3;RPS6KA3;SLC25A29;COX8A;RPTOR;COX18;MAPK14;COX7B;COX5B;NDUFS8;PRKAB1;HRAS;KDM3A;NDUFA5;ATP5PO;PNPLA2;NDUFA2;MAPK11;UQCR11;SDHD;ADCY7;NDUFA11;RPS6KA2;MAPK13;BMP8B;NDUFV3;NDUFA4;ZNF516;ATP5MF;ATP5MC2;NDUFAF2;COX4I1
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.30132276175754485,-0.8078190902410107,0.75,1.0,1.0,2/15,9.35%,DTX4;XRCC5
prerank,Reactome_2022__Signal Amplification R-HSA-392518,-0.2670085877720541,-0.8064500462631108,0.7978723404255319,1.0,1.0,20/28,48.30%,GNA11;GNG5;GNAI1;P2RY1;GNA13;TBXA2R;GNG3;GNG10;MAPK14;GNG7;GNG4;GNAI3;GNB3;GNGT2;SRC;P2RY12;AAMP;GNAI2;GNG11;GNG2
prerank,KEGG_2021_Human__Cell adhesion molecules,-0.21720946708915162,-0.8062542083710607,0.7916666666666666,1.0,1.0,21/109,22.09%,GLG1;CD99L2;SELL;CD58;NCAM1;CD22;NRXN2;NTNG2;CNTN1;VCAN;NEGR1;ALCAM;ITGA4;JAM3;CD40LG;ITGB2;CTLA4;SELP;CNTNAP1;L1CAM;CD276
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,-0.24174246362937596,-0.8058706052521909,0.7659574468085106,1.0,1.0,13/43,28.94%,NEDD4;APOE;PSEN1;PSENEN;PIK3R1;GFAP;NCSTN;STAT5A;WWP1;NCOR1;COPS2;RPS27A;HRAS
prerank,Reactome_2022__Mitophagy R-HSA-5205647,-0.26524921095570486,-0.8040777859999844,0.7261904761904762,1.0,1.0,7/28,19.35%,TOMM7;FUNDC1;TOMM20;TOMM6;CSNK2A2;ATG5;MFN1
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,0.2049604672549572,0.8035508065602408,0.7222222222222222,1.0,1.0,3/17,6.62%,IL24;IL20RB;IFNLR1
prerank,KEGG_2021_Human__Long-term potentiation,0.15656929955958557,0.8020011780558972,0.875,1.0,1.0,9/46,12.15%,PRKACB;ATF4;CALM1;PLCB1;CAMK2G;CREBBP;RAF1;PPP3CA;PLCB3
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.24415581679190979,-0.8017331231535382,0.7835051546391752,1.0,1.0,19/43,32.34%,H2BC14;H3C7;H2BC13;RBBP7;MTA2;H2AC14;H3C13;H2AZ1;TTF1;H3-3B;CHD4;H2AX;RBBP4;DPEP3;H2AC19;H2AB1;CHD3;H2BC17;H2BC12
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,0.16497854389547892,0.8015814735703124,0.7777777777777778,1.0,1.0,6/37,7.69%,CXCR1;CCR9;CXCR2;CNOT6;CCL3;CCL28
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.26514123896965297,-0.8005261201245595,0.6781609195402298,1.0,1.0,10/22,36.17%,IST1;CHMP4B;TUBA8;TUBB2A;TUBB4A;RNF103-CHMP3;TUBB6;TUBB3;VPS4A;TUBB4B
prerank,KEGG_2021_Human__Acute myeloid leukemia,-0.22515906948542022,-0.7997289960591877,0.7741935483870968,1.0,1.0,16/65,19.14%,CEBPE;JUP;CD14;RUNX1T1;ZBTB16;PML;PIK3R3;TCF7L2;PIM1;AKT2;IKBKB;PIK3CB;AKT3;PIK3R1;STAT5A;AKT1
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.22129196890742894,-0.7994918791181834,0.8061224489795918,1.0,1.0,7/75,7.31%,NUP88;RPA3;NUP37;SERPINH1;NUP133;HSPA6;POM121
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,-0.21389707074119696,-0.7984354760688115,0.8585858585858586,1.0,1.0,15/127,10.99%,AP1M1;XPO1;NUP88;ELOC;NUP37;CUL5;NUP133;PSMC5;POM121;AP2M1;SKP1;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,-0.27448529477322126,-0.797396248379497,0.7325581395348837,1.0,1.0,4/20,13.41%,PHKG1;PYGB;PHKB;PHKG2
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.21727104265802005,-0.7964425822982902,0.86,1.0,1.0,28/141,20.48%,PRKAG2;ACOT8;PCTP;PPT1;MMUT;HPGDS;PTGES;GGT1;CPT1A;PTGDS;ACSL4;ECI2;ACSM3;TECR;THEM5;ACOXL;ACSL6;CYP4B1;ACOT9;THEM4;SLC25A1;ACSL3;HADH;ALOX12;ACOT13;HPGD;SLC25A17;ACOX1
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,0.16505553659733163,0.7963333793201876,0.8333333333333334,1.0,1.0,13/52,16.21%,PSMB5;ERLEC1;PSMD9;PSMC3;PSMC6;PSMB7;PSME2;UBC;PSMD11;SYVN1;PSMD6;UBB;PSMF1
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.2391737393031049,-0.7962307480515889,0.7634408602150538,1.0,1.0,11/35,28.68%,SMAD2;CDK8;EP300;CCNT2;SMAD7;YBX1;CDKN2B;CDK9;DAND5;MAPK1;RPS27A
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,-0.2470081651294488,-0.7962156264552295,0.7333333333333333,1.0,1.0,9/28,28.94%,PIK3R4;THEM4;AKT2;FGFR1;PIK3CB;PIK3R1;PDE3B;PIK3C3;HRAS
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,-0.28703643694504294,-0.79554751117146,0.7654320987654321,1.0,1.0,4/15,15.18%,GPC2;GLCE;SLC35D2;HSPG2
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.21708921398746228,-0.7953862435836507,0.826530612244898,1.0,1.0,27/79,33.90%,IFITM1;CD22;SYK;CD19;PIK3R3;BCL10;AKT2;IKBKB;PIK3CB;AKT3;PIK3R1;AKT1;FOS;MAPK1;RAC1;NFKBIE;LYN;RAC3;HRAS;MAP2K1;JUN;PPP3CC;PIK3AP1;CR2;PRKCB;CHUK;RAC2
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.2501919013754858,-0.7951980633920327,0.7362637362637363,1.0,1.0,13/36,32.83%,CAMK2A;IQGAP1;APBB1IP;ARRB1;KSR1;CNKSR1;JAK2;RAP1A;MAPK1;HRAS;MAP2K1;TLN1;CNKSR2
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,-0.2621573179422774,-0.7949014883086223,0.7741935483870968,1.0,1.0,13/30,32.34%,H2BC14;H3C7;H2BC13;UBTF;H2AC14;H3C13;H2AZ1;H3-3B;H2AX;H2AC19;H2AB1;H2BC17;H2BC12
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.2150305369930122,-0.7946445854778152,0.8631578947368421,1.0,1.0,23/87,25.22%,RIN1;RAB6A;CHML;RAB21;RAB3GAP1;RGPD1;RAB9A;ALS2;RAB31;DENND2A;TRAPPC11;TRAPPC1;AKT2;GDI1;AKT3;RAB27B;RIN3;AKT1;RABGEF1;DENND4B;TRAPPC12;DENND1B;SBF2
prerank,KEGG_2021_Human__Small cell lung cancer,-0.2174971248438525,-0.7940289267570552,0.8383838383838383,1.0,1.0,21/79,21.73%,BIRC3;CCNE1;LAMB4;TRAF1;LAMC1;RARB;PIK3R3;TRAF2;GADD45G;LAMC3;AKT2;E2F1;DDB2;IKBKB;PIK3CB;AKT3;PIK3R1;AKT1;BAX;TRAF6;CDKN2B
prerank,KEGG_2021_Human__Spliceosome,-0.20762928662917257,-0.7939477954495111,0.8469387755102041,1.0,1.0,27/139,21.35%,PRPF18;RNU5A-1;CDC40;SNRPE;SNRPB;PPIH;NCBP2;HSPA6;CCDC12;HNRNPC;PQBP1;TCERG1;FUS;SRSF5;PPIL1;DHX15;SF3B6;PLRG1;U2AF1L4;SNRPF;ALYREF;PUF60;PRPF3;DHX38;DDX42;DHX8;U2SURP
prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.21389068117917948,-0.7936753329870027,0.8064516129032258,1.0,1.0,15/84,18.54%,BCL2L2-PABPN1;PPP2CB;SAP18;NXF1;NCBP2;FUS;PPP2R5E;CPSF2;GLE1;PAPOLA;PPP2R3A;CSTF2;RNGTT;ALYREF;PPP2R1A
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.21251615825257372,0.7934386079875735,0.7857142857142857,1.0,1.0,5/18,16.28%,COL28A1;COL4A3;COL7A1;COL6A1;COL6A2
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,-0.24867848552291,-0.7929646625148438,0.7888888888888889,1.0,1.0,9/34,22.66%,USP9X;ZNF512B;IQGAP1;PIK3R1;SPTBN1;PKN2;DST;CLTC;DLG5
prerank,KEGG_2021_Human__Prostate cancer,-0.22309591784722044,-0.7926998796822824,0.7959183673469388,1.0,1.0,26/86,30.06%,MMP9;CREB1;CCNE1;FOXO1;PLAT;EP300;IGF1R;PIK3R3;TCF7L2;AKT2;E2F1;IKBKB;FGFR1;PIK3CB;AKT3;PIK3R1;AKT1;TCF7L1;TP53;PDGFC;MAPK1;HSP90AB1;HRAS;MAP2K1;ZEB1;CDKN1B
prerank,KEGG_2021_Human__Yersinia infection,-0.21842795310122956,-0.7910905125543118,0.8888888888888888,1.0,1.0,53/128,37.37%,MEFV;CXCL8;WASF2;ITGA5;IL6;MAPK10;PIK3R3;TRAF2;AKT2;ITGA4;IKBKB;PIK3CB;WAS;AKT3;PIK3R1;RPS6KA1;ARPC3;AKT1;PKN2;MAPK8;TRAF6;FOS;ACTR3B;PXN;MAP2K4;RPS6KA3;ARPC5;MAP3K7;MAPK14;MAPK1;ZAP70;CRK;RAC1;WIPF1;RAC3;MAP2K1;FYB1;RHOG;JUN;ACTR3;CCL2;BAIAP2;MAPK11;CHUK;RAC2;RPS6KA2;MAPK13;IRAK4;MAP2K2;RHOA;GIT2;NFATC1;IL1B
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,0.20076750092436774,0.7910161894594594,0.7894736842105263,1.0,1.0,5/18,17.36%,PRKACB;CREBBP;FYN;ICAM3;RNASE3
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,-0.29132437327243116,-0.7907477615502071,0.7875,1.0,1.0,9/16,43.23%,PPP2CB;SPRY2;PPP2R1A;MAPK1;RPS27A;PPP2CA;SRC;CBL;UBA52
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.2099821785464383,-0.7896140931400633,0.7857142857142857,1.0,1.0,18/95,21.66%,PRKCD;CLEC7A;NFKB2;UBA3;PSMC5;SKP1;PSMD5;PSMD8;SYK;PSMD13;PSMB10;BCL10;IKBKB;UBE2M;UBE2N;TAB3;TRAF6;FBXW11
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.2627381924424489,-0.7894901055802944,0.735632183908046,1.0,1.0,9/34,22.88%,CREB1;ARHGDIB;RAB11B;DYNC1LI2;DYNLL2;DYNC2H1;ADCY3;DCTN4;DYNC2LI1
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.23112161694236605,-0.7881526232534245,0.7604166666666666,1.0,1.0,7/51,10.99%,ELOC;CUL5;PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,KEGG_2021_Human__N-Glycan biosynthesis,-0.225219632611296,-0.7877532435673873,0.7692307692307693,1.0,1.0,10/45,23.22%,B4GALT2;MAN2A1;GANAB;B4GALT3;ALG5;STT3B;ALG3;ALG1;FUT8;MGAT2
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.287121491814505,-0.7865477176294381,0.7638888888888888,1.0,1.0,6/15,30.31%,SMAD2;FOXO1;CCNG2;GADD45A;CDKN1B;PCBP4
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",0.1910813023257485,0.7863803587285829,0.6666666666666666,1.0,1.0,4/20,8.13%,GNB5;PDE6A;CALM1;FNTA
prerank,KEGG_2021_Human__Rheumatoid arthritis,-0.2163620283756539,-0.7862527602537956,0.8020833333333334,1.0,1.0,21/73,32.89%,CTSL;ATP6V1E1;CXCL8;ATP6V0B;IL6;ATP6V1E2;TCIRG1;ATP6V0D1;ITGB2;CTLA4;FOS;TNFSF13;TNFSF13B;TGFB1;CCL5;ATP6V0C;CXCL3;JUN;CCL2;CSF1;ATP6AP1
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,-0.25454047802494073,-0.7859523011607606,0.75,1.0,1.0,14/27,40.04%,KCNJ15;KCNJ2;GNG5;GABRR2;GNAI1;GNG3;GNG10;GNG7;GNG4;ADCY7;GNAI3;ARHGEF9;GNB3;GNGT2
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,-0.24833130551582347,-0.7842992921975136,0.7954545454545454,1.0,1.0,14/33,39.48%,MNAT1;NCBP2;POLR2I;NELFA;SUPT4H1;GTF2H3;POLR2D;POLR2B;SUPT5H;GTF2H1;NELFCD;CDK7;POLR2H;POLR2C
prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.1502817903861544,0.7840471628273052,0.8,1.0,1.0,56/57,80.56%,C1QC;MASP2;IL10;FPR3;FCGR2C;C4B;HLA-DPA1;C3;SELPLG;HLA-DPB1;HLA-DQA1;FPR2;HLA-DOB;ITGAM;HLA-DRA;FPR1;FCGR3B;DEFA1;HLA-DMA;FCGR3A;HLA-DRB1;KRT15;HLA-DMB;HLA-DRB5;FCGR2A;ITGAL;C3AR1;C5;HLA-DOA;ICAM1;HLA-DRB4;DEFA1B;C2;FCGR2B;C1R;C1QB;C1QA;FCAR;KRT23;HLA-DRB3;CFI;FCGR1A;KRT10;HLA-DQB1;CFD;CAMP;DEFA4;KRT18;PTAFR;C1S;PLG;C4A;DEFA3;CFH;SELP;ITGB2
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",-0.2642056178297444,-0.7836702008678679,0.7529411764705882,1.0,1.0,2/20,8.41%,TAS2R50;PLCB2
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.2514802509490246,-0.7833253676105377,0.7840909090909091,1.0,1.0,3/27,7.31%,NUP37;NUP133;POM121
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,-0.23065534283118544,-0.7828766248064232,0.8085106382978723,1.0,1.0,19/47,36.29%,PPP2CB;CDKN2C;CCNE1;MNAT1;SKP1;E2F1;PPP2R1A;CCND2;CDKN2B;ABL1;JAK2;LYN;RPS27A;PPP2R3B;CDKN1B;TFDP2;CDK2;CCND3;CDK7
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,-0.2140637593401849,-0.7822968053326677,0.89,1.0,1.0,56/168,34.47%,CREB1;NFKB2;PRKAR2B;MEFV;MYH9;INSL3;ABI1;WASF2;MC1R;CYFIP2;P2RX4;CTSG;GGT1;IL6;GNG5;SYK;HRH2;ADM;RAMP1;RLN2;RHBDF2;WAS;ADORA2A;ARPC3;RNASE1;NT5E;GNAI1;SCT;MAPK8;ABL1;GNG3;TARP;GNG10;ADORA2B;NCKAP1L;ARPC5;MAPK14;MAPK1;DPEP3;CRK;GNG7;PTRH2;WIPF1;LYN;HSP90AB1;GNG4;JUN;ACTR3;BAIAP2;NCKIPSD;GNAZ;MYO10;WASF1;ADCY7;POMC;GNAI3
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,-0.24022043369355534,-0.782274197413865,0.7888888888888889,1.0,1.0,20/47,36.71%,RPA3;VCP;SLC19A1;DDB1;WDR48;UBA7;PCNA;POLR1B;REV1;RFC3;POLI;RPS27A;POLD4;RCHY1;REV3L;RBX1;POLH;POLD2;TRIM25;DTL
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,-0.21566605813749068,-0.7821094074696396,0.85,1.0,1.0,46/101,40.06%,NCOA1;H2BC14;EP400;EP300;H3C7;ING5;H2AC12;H2BC13;KAT2B;KAT7;ZZZ3;RBBP7;SAP130;H2AC14;H3C13;TADA2B;BRD8;H2AC25;KAT2A;TAF12;HAT1;KAT6A;ELP3;KAT6B;JADE1;H2AC19;MSL3;KANSL2;YEATS4;H2BC17;MSL2;H2AC11;H2BC12;ING3;TAF6L;TADA2A;BRPF3;RUVBL1;H2AC7;KAT8;SUPT7L;H2AC21;H2BC9;OGT;KANSL3;KDELR2
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.2097207975442323,-0.7815891738671189,0.8787878787878788,1.0,1.0,53/136,35.84%,MGST1;CREB1;JAG1;MGST2;HPGDS;GSTA4;KPNA4;KPNA2;GSTO1;PIK3R3;ARRB1;PPARA;AKT2;E2F1;MGST3;GSTM1;PIK3CB;AKT3;PIK3R1;RPS6KA1;GNAI1;STAT5A;AKT1;VDR;ADCY3;PAQR7;FOS;SULT1A2;RPS6KA3;GSTM5;JAK2;MAPK1;KPNA3;KPNA1;HSP90AB1;HRAS;MAP2K1;SULT1A1;CYP1B1;GSTM2;JUN;NAT1;CYP3A5;GSTO2;CHRNB4;ADCY7;PRKCB;RPS6KA2;GNAI3;CDC25A;STAT5B;CCND3;MAP2K2
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.24631001739650865,-0.7811120613646176,0.7647058823529411,1.0,1.0,2/31,3.21%,FLOT2;BIRC3
prerank,KEGG_2021_Human__Allograft rejection,0.17703035274815423,0.7808438059265934,0.8333333333333334,1.0,1.0,33/33,82.33%,IL10;IL4;HLA-DPA1;HLA-DPB1;FAS;HLA-DQA1;HLA-DOB;TNF;HLA-DRA;HLA-A;HLA-DMA;HLA-B;HLA-C;HLA-DRB1;CD28;HLA-DMB;CD40;HLA-DRB5;CD86;HLA-F;HLA-DOA;HLA-E;HLA-DRB4;HLA-G;CD80;FASLG;HLA-DRB3;IFNG;HLA-DQB1;IL12A;GZMB;PRF1;CD40LG
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,-0.2567160045670529,-0.7797464613903995,0.7415730337078652,1.0,1.0,4/20,14.89%,CRCP;POLR3B;POLR3D;POLR3C
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.24982610763348972,-0.7791559306350637,0.7840909090909091,1.0,1.0,15/30,43.51%,RPA3;SLC19A1;DDB1;WDR48;PCNA;POLR1B;RFC3;RPS27A;POLD4;RBX1;POLD2;DTL;UBA52;POLE2;POLE3
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,-0.22302243411380387,-0.7789308724685926,0.8775510204081632,1.0,1.0,23/69,31.34%,CLCN6;BCL2L11;CAMK2A;AKAP9;MRAS;SND1;IQGAP1;APBB1IP;ARRB1;SPRED1;DUSP10;FAM114A2;KSR1;ATG7;DUSP6;CNKSR1;JAK2;RAP1A;MAPK1;HRAS;MAP2K1;TLN1;AGK
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.2564381734343744,-0.7786481282764062,0.7659574468085106,1.0,1.0,9/26,34.07%,ACOT8;ECI2;ACOXL;SLC25A17;ACOX1;ACBD5;CROT;ABCD1;AMACR
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,-0.2098256699618459,-0.7785116243927771,0.8865979381443299,1.0,1.0,23/113,19.49%,DGKQ;CXCL8;LPAR6;F2R;PLCB2;MRAS;SYK;PIK3R5;DGKH;RRAS;DGKA;PIK3R3;DGKG;DNM1;CYTH4;AKT2;RRAS2;PIK3CB;PLCB4;AKT3;PIK3R1;AKT1;ADCY3
prerank,KEGG_2021_Human__Gastric acid secretion,-0.23279676051738307,-0.7777761179251762,0.8709677419354839,1.0,1.0,15/49,28.49%,CAMK2A;KCNJ15;KCNJ2;PLCB2;HRH2;KCNQ1;PLCB4;GNAI1;ADCY3;CA2;SSTR2;MYLK;ATP1B2;SLC4A2;SLC9A4
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,-0.2698269150706519,-0.7772469205288814,0.6823529411764706,1.0,1.0,6/18,28.99%,STAT1;PIK3CB;PIK3R1;WDR48;HRAS;ETV6
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.2097381603385214,-0.7771082515831838,0.8210526315789474,1.0,1.0,20/66,32.39%,SIRT2;VRK2;NUP37;NUP133;POM121;IST1;CHMP4B;TUBA8;PPP2R1A;TUBB2A;LBR;TUBB4A;RNF103-CHMP3;CDK1;ANKLE2;NUP43;NUP85;TUBB6;TUBB3;VPS4A
prerank,Reactome_2022__Myogenesis R-HSA-525793,-0.2686305762260158,-0.7762807712036546,0.7590361445783133,1.0,1.0,7/19,26.77%,CTNNA1;TCF7L2;MEF2C;TCF7L1;ABL1;BNIP2;MAPK14
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.2168838127955062,-0.7747805490857534,0.8064516129032258,1.0,1.0,12/63,21.49%,CACNA1I;CREB1;CAMK2A;GNA11;NR4A1;PLCB2;PLCB4;CACNA1H;PDE2A;ADCY3;LIPE;ATF1
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.21788832617744386,-0.7741531442464428,0.865979381443299,1.0,1.0,26/95,28.10%,CREB1;PRKAR2B;MYH9;INSL3;MC1R;GGT1;IL6;GNG5;SYK;HRH2;ADM;RAMP1;RLN2;RHBDF2;ADORA2A;GNAI1;SCT;GNG3;TARP;GNG10;ADORA2B;MAPK14;DPEP3;GNG7;PTRH2;LYN
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.2408478232633562,-0.7732706290824329,0.7065217391304348,1.0,1.0,7/27,20.36%,CRCP;POLR3B;POLR3D;POLR3C;GTF3C4;GTF3A;GTF3C2
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,0.1752967435751446,0.773189064967961,0.75,1.0,1.0,19/49,23.94%,PSMB5;PSMD9;PSMC3;PSMC6;PSMB7;PSME2;UBC;PSMD11;CCND1;PSMD6;UBB;PSMF1;PSMD3;PSMB3;CDK4;PSMB2;PSMA7;PSMA6;PSMB4
prerank,Reactome_2022__Keratinization R-HSA-6805567,-0.24605627358897472,-0.7730559047473863,0.8041237113402062,1.0,1.0,12/30,35.38%,JUP;KRTAP5-11;RCAN1;KRT73;PPL;KRT8;SPINK9;EVPL;KRT18;ST14;KAZN;PERP
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.20952676524285524,-0.7724415284279601,0.9052631578947369,1.0,1.0,40/117,34.29%,CREB1;JUNB;NFKB2;TGFBR2;TYK2;SYK;MAPK10;PIK3R3;FOSL1;STAT1;TRAF2;AKT2;IKBKB;PIK3CB;AKT3;PIK3R1;AKT1;MAPK8;SOCS3;TRAF6;FOS;IFNAR1;TYROBP;IFNGR2;FOSB;TGFB1;MAP3K7;MAPK14;MAPK1;RAC1;MAP2K1;JUN;PPP3CC;JUND;NCF4;MAPK11;CSF1;CHUK;MAPK13;SPI1
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,-0.2601802602540668,-0.7712310283523117,0.7333333333333333,1.0,1.0,12/23,40.04%,KCNJ15;KCNJ2;GNG5;GNAI1;GNG3;GNG10;GNG7;GNG4;ADCY7;GNAI3;GNB3;GNGT2
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.2595541689553592,-0.7698733507046635,0.8068181818181818,1.0,1.0,10/23,39.48%,NCBP2;POLR2I;NELFA;SUPT4H1;POLR2D;POLR2B;SUPT5H;NELFCD;POLR2H;POLR2C
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.2052680433092278,-0.769856308551374,0.7878787878787878,1.0,1.0,17/87,21.67%,MMP9;POU2F1;CXCL8;RORA;FOXO1;TNFRSF1B;TYK2;IL6;S1PR1;STAT1;GATA3;ITGAX;PIK3R1;AKT1;ITGB2;SOCS3;FOS
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.2400000308040489,-0.7697026561111618,0.8111111111111111,1.0,1.0,4/37,7.31%,NUP88;NUP37;NUP133;POM121
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,0.18587561900621705,0.7688056551702674,0.8181818181818182,1.0,1.0,4/21,8.13%,GNB5;PDE6A;CALM1;FNTA
prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.20568377455484244,-0.7683981929051122,0.8979591836734694,1.0,1.0,50/142,36.36%,MMP9;ABCB1;ZFPM2;BCL2L11;CDC25C;MDM4;CCNE1;ITGA5;SPRY2;EZH2;EP300;DNMT1;PIK3R3;RECK;PIM1;CDC25B;E2F1;DNMT3B;IKBKB;PIK3CB;PIK3R1;FZD3;CCND2;ABL1;RPS6KA5;BMPR2;MAPK7;HMGA2;RPTOR;TP53;SLC45A3;CASP3;MAPK1;CRK;HRAS;MAP2K1;CYP1B1;ZEB1;CDKN1B;BMF;CD44;ST14;PRKCB;CDC25A;PDGFRA;NOTCH3;MAP2K2;PTEN;RHOA;VIM
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",-0.23322462926464205,-0.7680204467583268,0.7978723404255319,1.0,1.0,18/41,35.52%,MPG;H2BC14;OGG1;POT1;H2BC13;H2AC14;H2AZ1;NEIL3;H2AX;UNG;TERF1;TINF2;H2AC19;H2AB1;H2BC17;H2BC12;TERF2IP;H2AC7
prerank,KEGG_2021_Human__GnRH signaling pathway,-0.2179822983541563,-0.7668818567685989,0.8958333333333334,1.0,1.0,25/71,34.02%,PRKCD;CAMK2A;GNA11;ELK1;MAP3K1;GNRH1;PLCB2;MAP3K4;MAPK10;PLCB4;ADCY3;MAPK8;MAP2K4;MAPK7;EGR1;MAPK14;MAPK1;HRAS;MAP2K1;JUN;MAPK11;ADCY7;PRKCB;MAP3K3;MAPK13
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,-0.27285544003184425,-0.7661666765164091,0.7733333333333333,1.0,1.0,7/18,30.59%,P2RX4;STIM1;TRPC6;SLC8A1;P2RX1;ORAI1;ATP2A1
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,-0.2304049318792016,-0.7659852260113681,0.8111111111111111,1.0,1.0,10/35,29.23%,PPP2CB;MDM4;AKT2;AKT3;PPP2R1A;AKT1;CDK1;TP53;RPS27A;RICTOR
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.27090543774603887,-0.7642311006071645,0.7831325301204819,1.0,1.0,11/18,47.92%,PPP2CB;SPRY2;PPP2R1A;MAPK1;RPS27A;PPP2CA;SRC;CBL;UBA52;FGF13;PTPN11
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,-0.2527490222644567,-0.7636320851132823,0.7816091954022989,1.0,1.0,8/28,28.94%,PPP2CB;SPRY2;PIK3R1;FRS3;PPP2R1A;MAPK1;RPS27A;HRAS
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,-0.22398256140926656,-0.7629241607640048,0.7789473684210526,1.0,1.0,10/36,23.75%,NR2C1;RORA;NR4A1;RARB;NR1D1;PPARA;NR2C2AP;VDR;RARG;NCOR1
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.19915111834785862,-0.762747648515141,0.9191919191919192,1.0,1.0,52/146,36.29%,MCM5;PPP2CB;CDKN2C;RPA3;ORC3;CCNE1;PSMC5;MNAT1;SKP1;PSMD5;PSMD8;DYRK1A;LIN9;PSMD13;ORC6;PSMB10;DHFR;FBXO5;AKT2;E2F1;AKT3;TK1;PPP2R1A;AKT1;PCNA;CCND2;POLR1B;CDKN2B;ABL1;CDK1;RBBP4;WEE1;JAK2;LIN54;PSME1;LYN;RPS27A;PSMA4;PRIM1;PPP2R3B;CDKN1B;RPA4;MCM8;PSMC4;E2F6;PSMD4;TFDP2;CDC25A;CDK2;PSMD14;CCND3;CDK7
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,-0.20452886301717052,-0.7617643749676843,0.8673469387755102,1.0,1.0,10/85,10.99%,IFT172;PRKAR2B;TTC21B;PSMC5;SMOX;SKP1;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,-0.24657103858007956,-0.7617015160022164,0.8292682926829268,1.0,1.0,6/28,20.71%,LIN7C;NRXN2;DBNL;HOMER1;HOMER3;PDLIM5
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.17733255919454807,0.7615809139401114,0.8888888888888888,1.0,1.0,6/34,9.92%,TNFAIP1;UBXN11;CKB;ARHGAP21;PIK3R2;TXNL1
prerank,KEGG_2021_Human__Renin secretion,0.16955101911886755,0.7610117820740309,0.9,1.0,1.0,6/40,7.12%,PRKACB;PDE1B;KCNMA1;GUCY1A1;CALM1;PLCB1
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,-0.24124373808595964,-0.760937695062234,0.7906976744186046,1.0,1.0,5/33,12.52%,DNA2;EXO1;RAD50;RBBP8;RMI2
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,-0.24373423729242708,-0.7601746334117482,0.8,1.0,1.0,11/33,28.94%,PIK3R4;THEM4;AKT2;FGFR1;PIK3CB;PIK3R1;GRB10;MAPK1;PDE3B;PIK3C3;HRAS
prerank,Reactome_2022__RAS Processing R-HSA-9648002,-0.2685249165942837,-0.7597989124597627,0.7931034482758621,1.0,1.0,5/17,23.13%,ABHD17B;ICMT;ARL2;LYPLA1;CHURC1-FNTB
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,-0.2500973841434125,-0.7588518584767662,0.7586206896551724,1.0,1.0,4/25,13.82%,RIOX2;UTY;H3C7;H3C13
prerank,KEGG_2021_Human__Autoimmune thyroid disease,0.1770303527481542,0.7577667436715744,0.8333333333333334,1.0,1.0,33/33,82.33%,IL10;IL4;HLA-DPA1;HLA-DPB1;FAS;HLA-DQA1;HLA-DOB;HLA-DRA;HLA-A;HLA-DMA;HLA-B;HLA-C;HLA-DRB1;CD28;HLA-DMB;CD40;HLA-DRB5;CD86;TSHR;HLA-F;HLA-DOA;HLA-E;HLA-DRB4;HLA-G;CD80;FASLG;HLA-DRB3;HLA-DQB1;TG;GZMB;PRF1;CTLA4;CD40LG
prerank,Reactome_2022__Complement Cascade R-HSA-166658,-0.23764329648457,-0.7576663102794783,0.8279569892473119,1.0,1.0,14/41,33.36%,PIKFYVE;HNRNPC;CD19;GZMM;C5AR1;C4BPA;CFH;C4A;C1S;C4BPB;CD59;SERPING1;CR2;CPNE2
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.15708970835302738,0.7575188492444033,1.0,1.0,1.0,13/52,16.21%,PSMB5;PSMD9;PSMC3;PSMC6;PSMB7;PSME2;UBC;PSMD11;PSMD6;HSPB1;HSPA1A;UBB;PSMF1
prerank,KEGG_2021_Human__Viral carcinogenesis,-0.19625384486691838,-0.7571910865174254,0.91,1.0,1.0,65/188,34.97%,H2BC7;CREB1;NFKB2;HDAC3;CCR5;H2BC14;CCNE1;TRAF1;SYK;EP300;EIF2AK2;H2BC13;KAT2B;MAD1L1;PIK3R3;SND1;HDAC11;ATP6V0D1;TRAF2;HDAC6;VAC14;PIK3CB;DDB1;PIK3R1;GTF2H2C_2;STAT5A;KAT2A;HPN;BAX;CCND2;GTF2A1;H4C12;CDKN2B;CHEK1;H4C14;PXN;CHD4;CCR4;GTF2H3;CDK1;TP53;YWHAZ;CASP3;IL6ST;MAPK1;TRAF5;RAC1;LYN;HRAS;TBPL2;YWHAQ;CDKN1B;JUN;H4C4;H2BC17;DDX3X;HDAC10;H2BC12;GTF2H1;H4C6;JAK3;TRADD;CDK2;H2BC10;STAT5B
prerank,KEGG_2021_Human__Melanoma,-0.2204557306962187,-0.757041570890458,0.8421052631578947,1.0,1.0,22/51,35.88%,IGF1R;PIK3R3;GADD45G;AKT2;E2F1;DDB2;FGFR1;PIK3CB;AKT3;PIK3R1;AKT1;BAX;TP53;GADD45A;PDGFC;MAPK1;HRAS;MAP2K1;GADD45B;PDGFRA;MAP2K2;PTEN
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,-0.27524229133609146,-0.7570053450514416,0.8133333333333334,1.0,1.0,8/17,32.45%,VCPKMT;METTL21A;VCP;CAMKMT;EEF2KMT;ETFB;EEF1AKMT1;EEF2
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.19344570973118969,-0.7569559031841047,0.94,1.0,1.0,47/238,22.04%,NXF1;NUP88;CDC40;DNAJC8;METTL14;SNRPE;SNRNP35;HNRNPUL1;NUP37;SNRPB;NUP133;PPIH;NCBP2;HNRNPC;THOC7;POM121;PQBP1;THOC6;POLR2I;SF1;FUS;SRSF5;PPIL1;DHX15;CPSF2;SF3B6;GLE1;PAPOLA;PCBP2;PPIL3;DHX9;PLRG1;U2AF1L4;CSTF2;HNRNPL;RBM5;SNRPF;ALYREF;PUF60;PRPF3;DHX38;SUGP1;DDX42;YBX1;U2SURP;SRRT;POLDIP3
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.1899252849765693,0.756125706881235,0.8,1.0,1.0,6/17,17.64%,GNB5;GNB2;PLCB1;PLCB3;GNG8;GNB1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.1899252849765693,0.756125706881235,0.8,1.0,1.0,6/17,17.64%,GNB5;GNB2;PLCB1;PLCB3;GNG8;GNB1
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,-0.21303906527939,-0.7561028870126509,0.8350515463917526,1.0,1.0,23/81,27.75%,PRKAR2B;INSL3;MC1R;ITGA5;GNG5;HRH2;ADM;RAMP1;RLN2;ARRB1;PDE7A;ADORA2A;PDE2A;PDE3A;GNAI1;SCT;GRK3;GNG3;GNG10;ADORA2B;GNG7;PDE3B;PTRH2
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,-0.2181047050008035,-0.7558866893276845,0.865979381443299,1.0,1.0,12/57,16.06%,H2BC14;MNAT1;H3C7;H2BC13;UBTF;TAF1C;H2AC14;H3C13;TAF1B;H2AZ1;POLR1G;POLR1E
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,0.17427623068017145,0.7558017331284509,0.9285714285714286,1.0,1.0,7/25,18.38%,NCF2;CYBB;CYCS;TXNRD1;NCF1;GSTP1;GSR
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,-0.23778183492611546,-0.7555212559242362,0.7934782608695652,1.0,1.0,14/30,35.52%,H2BC14;POT1;H2BC13;H2AC14;H2AZ1;H2AX;TERF1;TINF2;H2AC19;H2AB1;H2BC17;H2BC12;TERF2IP;H2AC7
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.29329817361810867,-0.7551010450547586,0.7763157894736842,1.0,1.0,7/16,31.98%,TMED7-TICAM2;LY96;TAB3;TRAF6;MAP3K7;RPS27A;NDUFA2
prerank,KEGG_2021_Human__Arachidonic acid metabolism,-0.23946588549280923,-0.7549809090183099,0.8043478260869565,1.0,1.0,5/38,9.16%,PLA2G2C;HPGDS;PTGES;GGT1;PTGDS
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.23791568864379428,-0.7542326440249599,0.7857142857142857,1.0,1.0,11/23,41.03%,SLC43A2;SLC36A2;SLC7A8;SLC25A29;SLC1A4;SLC36A1;SLC16A10;SLC6A15;SLC43A1;SLC38A5;SLC3A1
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,-0.20158007375093467,-0.7540296153604359,0.8673469387755102,1.0,1.0,29/108,27.01%,IL9R;IL3RA;IL2RA;PIAS2;TYK2;IL5RA;IL6;PIAS4;EP300;PIK3R3;SOCS6;STAT1;PIM1;AKT2;PIK3CB;MPL;AKT3;PIK3R1;GFAP;STAT5A;AKT1;CCND2;SOCS3;IFNAR1;IFNGR2;JAK2;IL6ST;IL15RA;STAT4
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,-0.23859651656667769,-0.7535736365789117,0.7252747252747253,1.0,1.0,11/29,32.19%,SEC22B;MIA3;CNIH2;MCFD2;SEC24D;SERPINA1;STX5;CNIH3;CTSC;CD59;FOLR2
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,-0.22235627864263763,-0.7525665715380481,0.7956989247311828,1.0,1.0,13/38,32.87%,USP9X;IQGAP1;ITSN2;PIK3R1;SPTBN1;PKN2;DST;CLTC;DLG5;ARHGAP30;HGS;NCK2;ARHGAP31
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.2312732642616571,-0.7521025245870713,0.7849462365591398,1.0,1.0,2/31,1.85%,CREB1;PRKAR2B
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,-0.21000339023352013,-0.7515928096297186,0.845360824742268,1.0,1.0,11/86,13.80%,MRPS16;MRPL55;MRPS25;GFM2;MRPL43;MRPL15;MRPL57;MTIF2;CHCHD1;MTRF1L;MRPS23
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.23154934029138302,-0.7515732680037124,0.782608695652174,1.0,1.0,20/38,43.51%,RPA3;VCP;SLC19A1;UBA7;PCNA;POLR1B;REV1;RFC3;POLI;RPS27A;POLD4;RCHY1;REV3L;POLH;POLD2;TRIM25;MAD2L2;UBA52;POLE2;POLE3
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,-0.26230739207665044,-0.7514384477617707,0.8076923076923077,1.0,1.0,2/15,9.55%,PIAS2;PIAS4
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.21044918725862607,-0.7507437351807942,0.8105263157894737,1.0,1.0,12/67,20.76%,TRPV2;PRKCD;CAMK2A;PLCB2;MAPK10;PIK3R3;PIK3CB;PLCB4;PIK3R1;ALOX12;ADCY3;MAPK8
prerank,KEGG_2021_Human__Toxoplasmosis,-0.19820543654179595,-0.7505581186494468,0.9393939393939394,1.0,1.0,27/102,26.97%,BIRC3;CCR5;HSPA6;TYK2;LAMB4;LAMC1;PIK3R5;MAPK10;STAT1;LAMC3;AKT2;IKBKB;AKT3;CD40LG;GNAI1;AKT1;LY96;MAPK8;TRAF6;CIITA;IFNGR2;JAK2;TGFB1;MAP3K7;MAPK14;CASP3;MAPK1
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.24437929206942688,-0.7505109520433043,0.7317073170731707,1.0,1.0,10/27,37.05%,AP1M1;AP2M1;AP1S1;RNASE1;PKN2;B2M;AP1M2;DOCK2;PACS1;AP1S2
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.19472294067829332,-0.7494765615526509,0.9,1.0,1.0,17/175,8.76%,PRKCD;CREB1;PRKAR2B;RGS19;PPP2CB;CAMK2A;TAS2R50;GNA11;CCR5;CXCL8;P2RY14;RGS18;TAS2R60;S1PR2;PLCB2;GNG5;NMUR1
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,-0.20079361282311015,-0.7480220339915964,0.8645833333333334,1.0,1.0,10/94,10.99%,PDIA3;SEC22B;CTSL;VAMP3;PSMC5;ITGB5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.20143529861462142,-0.7470415616833154,0.8469387755102041,1.0,1.0,32/94,36.89%,CD48;KLRD1;SYK;KLRK1;KLRC3;PIK3R3;PIK3CB;PIK3R1;ITGB2;PRF1;BID;IFNAR1;TYROBP;PAK1;GZMB;IFNGR2;FCER1G;CASP3;MAPK1;ZAP70;RAC1;RAC3;HRAS;MAP2K1;PPP3CC;TNFRSF10B;SH2D1A;PRKCB;RAC2;MAP2K2;NFATC1;KLRC1
prerank,KEGG_2021_Human__Gap junction,-0.21340698409613437,-0.7468282748999223,0.7849462365591398,1.0,1.0,26/61,36.17%,GNA11;CSNK1D;PLCB2;MAP2K5;PLCB4;TUBA8;GNAI1;ADCY3;TUBB2A;TUBB4A;TUBB1;MAPK7;GUCY1B1;CDK1;PDGFC;MAPK1;HRAS;MAP2K1;TUBB6;TUBB3;ADCY7;PRKCB;GNAI3;PDGFRA;MAP2K2;TUBB4B
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,-0.19219663810662083,-0.746781098878229,0.94,1.0,1.0,69/244,30.06%,CREB1;ITGA10;PPP2CB;BCL2L11;IL3RA;PGF;COL9A1;LPAR6;IL2RA;CCNE1;NR4A1;ITGB5;ITGA5;F2R;LAMB4;IL6;GNG5;LAMC1;STK11;SYK;PIK3R5;CD19;PPP2R5E;THBS4;IGF1R;PPP2R3A;PIK3R3;THEM4;SGK3;LAMC3;AKT2;ITGA4;IKBKB;FGFR1;PIK3CB;TCL1A;G6PC3;AKT3;PIK3R1;RELN;PPP2R1A;PHLPP2;AKT1;PKN2;CCND2;IFNAR1;GNG3;TSC1;GNG10;RPTOR;NTRK1;TP53;JAK2;PDGFC;YWHAZ;MAPK1;GNG7;RAC1;MTCP1;ITGB8;HSP90AB1;HRAS;MAP2K1;YWHAQ;ITGB7;GNG4;PPP2R3B;COL6A3;CDKN1B
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.20079987382457673,-0.7466231365951193,0.83,1.0,1.0,24/100,26.21%,PIKFYVE;TEX264;HRG;MAGED2;CHID1;STXBP2;SGPP2;LOC112694756;CD109;ITIH4;PLEK;SCCPDH;RAB27B;CAP1;SRGN;TAGLN2;SOD1;PCYOX1L;SYTL4;SERPINA1;PLG;ABCC4;CYB5R1;TGFB1
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.16578171364713903,0.746503264844033,0.8571428571428571,1.0,1.0,3/28,4.61%,PRKACB;GNB5;GNB2
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.19940166430746672,-0.7462287267287565,0.8541666666666666,1.0,1.0,29/110,27.21%,KIF4A;PRKAR2B;ZFPM2;KIF6;KIF5C;JMJD1C;SIN3A;H3C7;KIF19;KIF13B;GATA1;KIF3C;H3C13;AK3;DOCK4;GATA3;KIF22;RNASE1;MFN1;ABL1;H3-3B;SH2B2;KIF1C;KIF9;TP53;WEE1;JAK2;IRF1;KIF21B
prerank,KEGG_2021_Human__Retinol metabolism,0.17920816844287968,0.7449771194653945,1.0,1.0,1.0,6/19,16.09%,UGT2B4;DHRS4L2;RETSAT;RDH11;ALDH1A1;CYP2S1
prerank,KEGG_2021_Human__Parkinson disease,0.13033914103073135,0.7440160897251533,1.0,1.0,1.0,34/208,10.90%,PRKACB;COX6C;PPIF;PSMB5;KLC3;UCHL1;ATF4;TUBA4A;BCL2L1;UBE2L3;SLC25A6;NDUFB10;PSMD9;PSMC3;PSMC6;APAF1;PSMB7;DDIT3;UBA1;SLC25A4;ATP5F1D;CALM1;CAMK2G;ATP5F1B;CYCS;NDUFB1;NDUFS6;MCU;UBC;UQCRQ;TRAP1;SLC25A5;NDUFA6;PSMD11
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,-0.24360271906251124,-0.7435561163628771,0.8555555555555555,1.0,1.0,8/33,19.27%,PIK3R3;THEM4;AKT2;AKT3;PIK3R1;RNASE1;AKT1;PKN2
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.2526862068898192,-0.7425820756647078,0.7435897435897436,1.0,1.0,3/20,15.78%,AP1M1;AP2M1;AP1S1
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.21431031100304887,-0.7417611598321792,0.8125,1.0,1.0,7/54,10.99%,SMURF1;PSMC5;FZD2;PSMD5;PSMD8;PSMD13;PSMB10
prerank,KEGG_2021_Human__Thyroid cancer,-0.2355765894607134,-0.7413470128693239,0.8172043010752689,1.0,1.0,14/35,30.48%,GADD45G;TCF7L2;DDB2;BAX;TCF7L1;NCOA4;NTRK1;TP53;GADD45A;MAPK1;CCDC6;HRAS;MAP2K1;TFG
prerank,KEGG_2021_Human__Alzheimer disease,-0.19082819850130914,-0.7411224994791306,0.97,1.0,1.0,101/292,36.42%,CDK5R1;NDUFB2;ATP5F1E;MAP3K5;COX5A;EIF2S1;APOE;UQCR10;NDUFC1;PSMC5;FZD2;SDHC;KIF5C;NDUFB7;RTN3;WNT10A;PLCB2;IL6;PIK3R4;NDUFS7;PSMD8;FZD6;PSMD1;APBB1;NDUFS2;PSMD13;EIF2AK2;MAPK10;CSNK2A2;PSEN1;PIK3R3;PSENEN;TRAF2;AKT2;CAPN2;SDHA;IKBKB;PIK3CB;PLCB4;AKT3;PIK3R1;HSD17B10;TUBA8;FZD3;NCSTN;AKT1;BID;NDUFS1;FADD;TUBB2A;ADAM10;MAPK8;WIPI1;NDUFA13;ATP5F1C;NDUFB6;TUBB4A;TUBB1;WNT5B;COX8A;BACE2;CASP3;COX7B;MAPK1;COX5B;NDUFS8;VDAC2;ATG2A;LRP5;PIK3C3;PSMA4;HRAS;MAP2K1;RTN4;NDUFA5;ATP5PO;ATP2A1;TUBB6;PPP3CC;WIPI2;NDUFA2;TUBB3;ADRM1;UQCR11;CSF1;SDHD;BACE1;PSMC4;PSMD4;INSR;CHUK;NDUFA11;NDUFV3;LPL;SNCA;NDUFA4;PSMD14;MAP2K2;ATP5MC2;TUBB4B;COX4I1
prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.20429993525401494,-0.740490374641808,0.8979591836734694,1.0,1.0,16/88,19.49%,MMP9;PRKCD;CREB1;NCOA1;HSPA6;PLCB2;NCOA3;PIK3R3;AKT2;PIK3CB;PLCB4;AKT3;PIK3R1;GNAI1;AKT1;ADCY3
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.24156029857767586,-0.7400782388927866,0.8117647058823529,1.0,1.0,7/25,28.61%,PPP2CB;FZD2;PPP2R5E;PPP2R1A;CSNK1G2;PROC;LRP5
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,-0.26454397622702447,-0.7398710752728355,0.7701149425287356,1.0,1.0,10/19,41.42%,STXBP2;TYK2;STX3;CASP3;CSF1;IL32;PRTN3;CSF3R;JAK1;STX1A
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,-0.23833137541139274,-0.7397207228536303,0.7634408602150538,1.0,1.0,12/31,30.75%,EIF2S1;CXCL8;EXOSC9;EXOSC6;EXOSC4;EXOSC3;EXOSC2;KHSRP;ATF3;ASNS;EIF2S3;CCL2
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.22324317179288128,-0.738260431437978,0.8842105263157894,1.0,1.0,9/44,21.14%,ABCB1;GGT1;ABCG2;GGT7;ABCC2;NUDT15;GSTM1;RNASE1;GUK1
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,-0.21154839923258328,-0.7380410887291058,0.8854166666666666,1.0,1.0,34/76,40.62%,HDAC3;FKBP9;GNA11;CCNE1;GNG5;AP3M1;CSNK2A2;WRAP53;FBXO4;CCT7;TUBA8;KIFC3;TUBB2A;PFDN2;FBXW9;TUBB4A;GNG3;GNG10;TP53;FBXW5;GNG7;GNG4;TUBB6;TUBB3;FBXW2;TUBB4B;RGS7;CCT4;GNB3;ARFGEF2;FBXL5;GNGT2;SPHK1;CCT8
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.23633943981050942,-0.7372889043778456,0.8651685393258427,1.0,1.0,10/30,29.76%,PRKAR2B;AKAP5;GNG5;IQGAP1;KCNC2;GNG3;GNG10;RAP1A;GNG7;GNG4
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.2546763317819028,-0.7365521235566787,0.8658536585365854,1.0,1.0,10/24,30.84%,CTSG;RNF213;CORO1A;LTF;B2M;MAPK1;ENO1;KPNA1;RPS27A;HGS
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.1757569133238605,0.7359451820379244,0.75,1.0,1.0,20/20,82.44%,HBEGF;EREG;PLCG1;GRB2;SOS1;EGF;NRG4;PIK3CA;NRAS;NRG1;CDC37;ERBB2;HSP90AA1;PIGU;SHC1;ERBIN;ERBB3;HRAS;PTPN12;PIK3R1
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.21045879293084888,-0.7344700329580064,0.8229166666666666,1.0,1.0,7/51,10.99%,PSMC5;FBXL18;SKP1;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.25524855459849455,-0.7339407617926157,0.7710843373493976,1.0,1.0,11/19,47.92%,PPP2CB;SPRY2;PPP2R1A;MAPK1;RPS27A;PPP2CA;SRC;CBL;UBA52;FGF13;PTPN11
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,-0.2153558492629302,-0.7328404310662987,0.8924731182795699,1.0,1.0,17/59,29.76%,PPP2CB;NCBP2;SPRY2;POLR2I;FGFBP2;FGFR1;SPRED1;PIK3R1;FRS3;PPP2R1A;MAPK1;POLR2D;GALNT3;RPS27A;HRAS;POLR2B;TIAL1
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.23488047921372646,-0.7325595088806934,0.8478260869565217,1.0,1.0,8/35,15.21%,H2BC14;H3C7;H2BC13;TAF1C;H2AC14;H3C13;TAF1B;H2AZ1
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.2578769274820302,-0.7317982676250391,0.7951807228915663,1.0,1.0,7/19,32.23%,ACSL4;TECR;ACSL6;ACSL3;ELOVL7;ELOVL6;ELOVL1
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.21780599141094864,-0.7307423243114307,0.8723404255319149,1.0,1.0,23/45,42.14%,H2BC14;POT1;POLR2I;H2BC13;H2AC14;H2AZ1;H3-3B;H2AX;TERF1;TINF2;H2AC19;POLR2D;H2AB1;POLR2B;H2BC17;H2BC12;TERF2IP;H2AC7;POLR2H;H2BC9;POLR2C;DAXX;H2AC6
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.25348519389820645,-0.7293281866882737,0.7692307692307693,1.0,1.0,8/20,29.76%,GNA11;GNG5;GNA13;TBXA2R;GNG3;GNG10;GNG7;GNG4
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.15895887538749398,0.7284618843440422,0.8888888888888888,1.0,1.0,6/24,15.88%,LAMTOR1;SLC38A9;RPS6KB1;RRAGA;MLST8;RRAGC
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.17103978362726985,0.727900992118362,1.0,1.0,1.0,6/37,10.74%,TNFAIP1;KIDINS220;UBXN11;PIK3R2;TXNL1;KIF14
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.26173745012412947,-0.7271574791789063,0.8295454545454546,1.0,1.0,9/17,42.05%,PIK3R1;SPTBN1;STAT5A;TRIP11;HRAS;ETV6;STAT5B;GOLGB1;GAB2
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.22684206626894318,-0.7267717491500533,0.8105263157894737,1.0,1.0,13/31,36.54%,RPA3;SLC19A1;UBA7;PCNA;POLR1B;REV1;RFC3;POLI;RPS27A;POLD4;POLH;POLD2;TRIM25
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,-0.21662144322718285,-0.7256625345772049,0.8736842105263158,1.0,1.0,14/52,27.44%,CAMK2A;AGO1;FZD2;PLCB2;GNG5;FZD6;TCF7L2;NLK;TNRC6A;TCF7L1;GNG3;GNG10;MAP3K7;GNG7
prerank,KEGG_2021_Human__RNA polymerase,-0.2213488207136902,-0.7248718624570587,0.7840909090909091,1.0,1.0,10/31,29.25%,POLR3B;POLR2I;POLR3D;POLR3C;POLR1E;POLR1B;POLR2J3;POLR2D;POLR3G;POLR2B
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.19884853274686304,-0.7247933136257101,0.865979381443299,1.0,1.0,51/98,45.27%,CD3D;TGFBR2;SMAD2;IL2RA;RORA;TYK2;IL6;FOXP3;MAPK10;STAT1;GATA3;IKBKB;CD3E;CD3G;STAT5A;MAPK8;FOS;IFNGR2;JAK2;TGFB1;MAPK14;IL6ST;MAPK1;ZAP70;NFKBIE;HSP90AB1;JUN;PPP3CC;MAPK11;CHUK;MAPK13;JAK3;STAT5B;NFATC1;IL1B;NFKBIB;HLA-DQB1;TGFBR1;JAK1;LAT;IL23A;IL2RB;PPP3R1;NFKB1;RORC;IFNG;IL27RA;HLA-DRB3;STAT3;AHR;IFNGR1
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,-0.25028482208534475,-0.7236424702739042,0.7831325301204819,1.0,1.0,6/18,25.44%,STEAP3;BBC3;PRELID3A;BAX;BID;TP53
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,0.14873881804689318,0.722581732054218,0.9230769230769231,1.0,1.0,11/22,27.72%,CAMLG;GET4;PRNP;UBL4A;VAPA;OTOF;APP;BAG6;HMOX1;GET3;ALDH3A2
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,-0.20501269421599524,-0.7222205808320653,0.8556701030927835,1.0,1.0,10/80,13.80%,MRPS16;MRPL55;MRPS25;GFM2;MRPL43;MRPL15;MRPL57;CHCHD1;MTRF1L;MRPS23
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.19234565620500116,-0.7221250064561462,0.87,1.0,1.0,41/104,39.25%,PIKFYVE;TEX264;HRG;MAGED2;CHID1;STXBP2;SGPP2;LOC112694756;CD109;ITIH4;PLEK;SCCPDH;RAB27B;CAP1;SRGN;TAGLN2;SOD1;PCYOX1L;SYTL4;SERPINA1;PLG;ABCC4;CYB5R1;TGFB1;SELENOP;PFN1;TLN1;ORM1;SERPING1;OLA1;PRKCB;ANXA5;BRPF3;TGFB3;TMSB4X;GTPBP2;ACTN1;A1BG;CYRIB;LY6G6F;THBS1
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.18250330781928728,-0.7218104664661802,0.98,1.0,1.0,124/364,36.17%,CDK5R1;NDUFB2;ATP5F1E;ACTR10;MAP3K5;GABARAPL2;DCTN3;CAMK2A;COX5A;TOMM40L;EIF2S1;WDR41;UQCR10;NDUFC1;PSMC5;FZD2;SDHC;TNFRSF1B;KIF5C;NDUFB7;DERL1;DNAH1;WNT10A;PLCB2;IL6;PIK3R4;ALS2;NDUFS7;PSMD8;FZD6;FUS;PSMD1;NDUFS2;PSMD13;MAPK10;VCP;MAP3K10;CSNK2A2;PSEN1;SPG11;TRAF2;ACTR1B;CAPN2;SDHA;SIGMAR1;PLCB4;HSD17B10;UBA7;TUBA8;FZD3;GPX3;MFN1;HIP1;BAX;DCTN4;BID;NDUFS1;FADD;TUBB2A;MAPK8;CAT;WIPI1;ACTR1A;NDUFA13;ATP5F1C;NDUFB6;DNAH14;TUBB4A;SOD1;TUBB1;WNT5B;COX8A;ATXN1;MAPK14;CASP3;COX7B;MAPK1;COX5B;NDUFS8;VDAC2;RAC1;ATXN2;ATG2A;LRP5;RPS27A;PIK3C3;DNAL4;PSMA4;HRAS;MAP2K1;UBE2G1;ATXN1L;NDUFA5;ATP5PO;ATP2A1;TUBB6;DNAH17;PPP3CC;WIPI2;NDUFA2;MAPK11;TUBB3;ADRM1;UQCR11;CSF1;SDHD;PSMC4;DLG4;PSMD4;PRKCB;NDUFA11;HTT;MAPK13;HAP1;NDUFV3;TOMM40;SNCA;NDUFA4;SEPTIN5;PSMD14;GABARAP;MAP2K2;ATP5MC2;TUBB4B
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.2646335104305284,-0.7216455625390108,0.7976190476190477,1.0,1.0,5/16,26.00%,KLKB1;ZNF160;PRCP;PROC;GP1BA
prerank,KEGG_2021_Human__GABAergic synapse,0.1364083112043948,0.7215045289934332,0.8,1.0,1.0,9/53,11.84%,PRKACB;GNB5;GNB2;SLC6A13;GABRG2;GNAO1;ADCY9;GABRD;GABARAPL1
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.17636670132081939,0.7211507116625706,0.8125,1.0,1.0,17/19,60.16%,HBEGF;EREG;PLCG1;GRB2;SOS1;EGF;NRG4;PIK3CA;NRAS;NRG1;CDC37;ERBB2;HSP90AA1;PIGU;SHC1;ERBIN;ERBB3
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.19750025811043206,-0.7199641790771606,0.8979591836734694,1.0,1.0,37/96,36.86%,CD3D;CBLB;MAPK10;PIK3R3;BCL10;AKT2;IKBKB;PIK3CB;CD3E;AKT3;CD3G;PIK3R1;CD40LG;AKT1;CTLA4;MAPK8;FOS;PAK1;MAP3K7;MAPK14;MAPK1;ZAP70;NFKBIE;HRAS;MAP2K1;JUN;NCK2;PPP3CC;MAPK11;CHUK;MAPK13;GRAP2;MAP2K2;RHOA;RASGRP1;PAK2;NFATC1
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.2471325704798164,-0.7196326337745996,0.7625,1.0,1.0,1/17,0.93%,PRKCD
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,0.17506615020945115,0.7180042992150356,0.8333333333333334,1.0,1.0,5/17,15.41%,SARM1;IKBKE;UBC;TICAM1;UBB
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,0.2063944158884341,0.7178034151764778,0.75,1.0,1.0,3/16,10.78%,GCHFR;CALM1;PTS
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.23792822307945372,-0.7177713813877892,0.8260869565217391,1.0,1.0,10/27,29.76%,GNA11;F2R;GNG5;ARRB1;GNA13;GNG3;GNG10;MAPK1;GNG7;GNG4
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.22917626184829293,-0.7175451804497511,0.8681318681318682,1.0,1.0,6/32,16.36%,PPT1;ACSL4;TECR;ACSL6;SLC25A1;ACSL3
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.20844304139555261,-0.7168981497070958,0.8947368421052632,1.0,1.0,8/57,11.32%,PSMC5;DERL1;PSMD5;PSMD8;ERLIN2;PSMD13;PSMB10;VCP
prerank,Reactome_2022__RAF Activation R-HSA-5673000,-0.22234076099696615,-0.7164937346454945,0.813953488372093,1.0,1.0,9/31,29.41%,PPP2CB;CAMK2A;MRAS;PPP2R5E;PPP2R1A;KSR1;JAK2;HRAS;MAP2K1
prerank,Reactome_2022__G1/S Transition R-HSA-69206,-0.18857238520160602,-0.7164812248849093,0.9494949494949495,1.0,1.0,24/128,20.71%,MCM5;PPP2CB;RPA3;ORC3;CCNE1;PSMC5;MNAT1;SKP1;PSMD5;PSMD8;LIN9;PSMD13;ORC6;PSMB10;DHFR;FBXO5;AKT2;E2F1;AKT3;TK1;PPP2R1A;AKT1;PCNA;POLR1B
prerank,Reactome_2022__RET Signaling R-HSA-8853659,-0.24024164086966449,-0.7152856632147756,0.8681318681318682,1.0,1.0,8/27,24.45%,DOK4;PIK3R3;PIK3CB;DOK2;PIK3R1;PDLIM7;GRB10;MAPK7
prerank,KEGG_2021_Human__Calcium signaling pathway,-0.184073833391643,-0.7152790331621809,0.9,1.0,1.0,35/127,28.91%,CACNA1I;PHKG1;MST1;CAMK2A;GNA11;F2R;P2RX4;PLCB2;HRH2;MCOLN2;ORAI3;STIM1;CXCR4;PHKB;PHKG2;FGFR1;PLCB4;ADORA2A;CACNA1H;ADCY3;ITPKB;PLCD3;SLC8A1;TBXA2R;P2RX1;PHKA2;MYLK;NTRK1;ADORA2B;ORAI1;PDGFC;NTSR1;VDAC2;PTAFR;LTB4R2
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,-0.2547784449528472,-0.7149624734117026,0.8780487804878049,1.0,1.0,7/19,28.94%,PIK3R3;STAT1;PIK3R1;STAT5A;JAK2;LYN;HRAS
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,0.12715804223568755,0.7137528199027253,0.8571428571428571,1.0,1.0,15/41,24.21%,CCR9;IL10;CCL28;IL15;TNFRSF17;LTBR;CCR10;IL4;HLA-DPA1;TNFRSF13C;HLA-DPB1;AICDA;HLA-DQA1;TNFRSF13B;HLA-DOB
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.18977101592788345,-0.7135773160143104,0.9191919191919192,1.0,1.0,55/153,34.97%,PRKCD;CCR5;CXCL8;PLCB2;GNG5;PIK3R5;CXCR4;CXCR5;PIK3R3;STAT1;ARRB1;AKT2;IKBKB;PIK3CB;PLCB4;WAS;AKT3;PIK3R1;GNAI1;PREX1;AKT1;ADCY3;GRK3;PXN;GNG3;PAK1;CCR4;GNG10;JAK2;CCR1;RAP1A;MAPK1;CRK;GNG7;RAC1;CCL5;LYN;RAC3;HRAS;MAP2K1;CXCL3;GNG4;GRK2;CCL2;DOCK2;ADCY7;PRKCB;CHUK;RAC2;RASGRP2;CXCR3;GNAI3;JAK3;PRKCZ;STAT5B
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,-0.18457110050860934,-0.7133097921266377,0.98,1.0,1.0,42/246,19.53%,ABHD17B;DUSP12;PPP2CB;XPO1;CAMK2A;CDC42EP2;IL3RA;AGO1;IL2RA;NCAM1;PSMC5;FOXO1;LAMTOR2;TYK2;RASGRP4;IL5RA;MRAS;PEA15;IL6;PSMD5;PSMD8;PSMD13;PSMB10;RANBP9;PPP2R5E;NCOA3;IQGAP1;APBB1IP;ARRB1;ICMT;FGFR1;SPRED1;PIK3CB;ARL2;PIK3R1;DUSP10;SPTBN1;FRS3;PPP2R1A;RNASE1;PKN2;TNRC6A
prerank,KEGG_2021_Human__Circadian entrainment,-0.20592740948706423,-0.7131813268417582,0.8877551020408163,1.0,1.0,16/57,27.44%,CACNA1I;CREB1;CAMK2A;PLCB2;GNG5;PLCB4;CACNA1H;GNAI1;ADCY3;FOS;RPS6KA5;GNG3;GNG10;GUCY1B1;MAPK1;GNG7
prerank,KEGG_2021_Human__Cardiac muscle contraction,-0.20930683921367402,-0.7123890316699876,0.8958333333333334,1.0,1.0,18/55,33.05%,COX5A;FXYD2;UQCR10;CACNG8;CACNB3;CACNA2D2;CACNB2;CACNB4;SLC8A1;COX8A;COX7B;TPM2;COX5B;ATP1B2;SLC9A7;ATP2A1;UQCR11;ASPH
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,-0.2625032279946191,-0.712270070029832,0.8333333333333334,1.0,1.0,6/20,24.13%,MYH9;NF2;RNASE1;PKN2;MYL9;MYLK
prerank,KEGG_2021_Human__Long-term depression,-0.21532853568326915,-0.7111663388930017,0.8571428571428571,1.0,1.0,17/44,35.84%,PPP2CB;GNA11;PLCB2;IGF1R;PLCB4;PPP2R1A;GNAI1;GNA13;GUCY1B1;MAPK1;LYN;HRAS;MAP2K1;GNAZ;PRKCB;GNAI3;MAP2K2
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,-0.24433275110628935,-0.7110281414569412,0.7674418604651163,1.0,1.0,4/17,20.18%,LAMC1;LAMC3;HSPG2;LMNB2
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,-0.2001183851309093,-0.7108395137155924,0.8775510204081632,1.0,1.0,33/89,36.09%,PRKCD;ABI1;PGF;WASF2;JUP;CYFIP2;SH2D2A;CTNNA1;THEM4;AKT2;PIK3CB;AKT3;PIK3R1;RNASE1;AKT1;PKN2;NCKAP1L;MAPK14;CRK;HRAS;RICTOR;NRP2;NCK2;BAIAP2;NCF4;MAPK11;WASF1;PRKCB;MAPK13;MAPKAPK3;PRKCZ;NRP1;RHOA
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,0.18404767307084313,0.7106823245814522,0.8888888888888888,1.0,1.0,2/15,4.61%,GNB5;GNB2
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,0.1272202997783145,0.7101155968495254,1.0,1.0,1.0,13/60,16.21%,PSMB5;PSMD9;PSMC3;PSMC6;PSMB7;PSME2;UBC;PSMD11;PSMD6;NF1;UBB;KBTBD7;PSMF1
prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.19221294387583981,-0.7096651804117283,0.9285714285714286,1.0,1.0,48/110,40.39%,PRKAG2;CAMK2A;ELK1;KCNJ2;CACNG8;PLCB2;PIK3R5;CACNB3;MAP2K5;RGS2;RCAN1;PLCB4;CACNA2D2;GNAI1;PPP1R12C;ADCY3;PRKAG1;CACNB2;MEF2C;CACNB4;FOS;MYL9;MYLK;MAPK7;GUCY1B1;MAPK1;PRKAB1;HRAS;MAP2K1;JUN;PPP3CC;NPR2;EEF2;ADCY7;PRKCB;MYL6B;GNAI3;MAP2K2;RHOA;NFATC1;MYL6;CACNA1D;PPP1CB;PRKAB2;ITPR3;CACNB1;SRC;ACTG1
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,-0.18204972802396838,-0.7086580046951758,0.99,1.0,1.0,44/257,19.53%,PRKCD;CREB1;PHC3;PRKAR2B;NEDD4;HDAC3;PPP2CB;CAMK2A;SCMH1;AGO1;NR4A1;PSMC5;FOXO1;LAMTOR2;CBX4;EZH2;PSMD5;RNF2;PSMD8;PSMD13;CD19;PML;PSMB10;PPP2R5E;CNOT6L;TNKS2;KPNA2;RBBP7;RRAGB;CSNK2A2;PIK3R3;MTA2;THEM4;AKT2;FGFR1;PIK3CB;AKT3;PIK3R1;PPP2R1A;RNASE1;CBX6;PHLPP2;AKT1;TNRC6A
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.20830724450699076,-0.7083590213788322,0.9381443298969072,1.0,1.0,16/60,27.77%,UTP20;EMG1;UTP25;RCL1;SPPL2A;DIMT1;PDCD11;RRP7A;RPS14;UTP11;IMP4;UTP4;NOP14;DKC1;MPHOSPH10;DDX47
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.25511182449361797,-0.7082054480443886,0.8607594936708861,1.0,1.0,5/19,23.11%,B4GALT2;MAN2A1;B4GALT3;FUT8;ST8SIA6
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,-0.26148979470690004,-0.7061290914542084,0.8846153846153846,1.0,1.0,3/16,18.54%,PPP2CB;PPP2R5E;PPP2R1A
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,-0.18407014505038383,-0.7059472094465085,0.9292929292929293,1.0,1.0,31/174,18.87%,USP9X;CLSPN;SMAD2;BIRC3;MDM4;RNF123;H2BC14;USP33;PSMC5;USP8;USP37;PSMD5;PSMD8;TOMM20;PSMD13;PSMB10;H2AC12;H2BC13;TNKS2;USP12;H2AC14;ARRB1;GATA3;TADA2B;H2AC25;SIAH2;DDB2;WDR48;SMURF2;SMAD7;KAT2A
prerank,KEGG_2021_Human__Arginine biosynthesis,-0.25689711601515586,-0.7059273715335387,0.8148148148148148,1.0,1.0,3/15,16.54%,GLUD1;GOT1;ABHD14A-ACY1
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.22048402576508982,-0.7057349849208452,0.8488372093023255,1.0,1.0,13/39,31.11%,DUSP12;PPP2CB;PPP2R5E;DUSP10;PPP2R1A;DUSP2;KSR1;DUSP6;MAPK1;RPS27A;HRAS;MAP2K1;PTPN7
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.17765985956802852,-0.7023918755983295,0.99,1.0,1.0,95/381,28.84%,MMP9;CREB1;NKIRAS2;PTPN4;PTPN23;NFKB2;PPP2CB;POU2F1;IL9R;STXBP2;CCR5;IL3RA;CXCL8;IL2RA;RORA;PSMC5;FOXO1;TNFRSF1B;TYK2;HNRNPDL;IL5RA;CTSG;SKP1;IL6;PSMD5;S1PR1;PSMD8;SYK;EBI3;PSMD13;H3C7;PSMB10;MAPK10;ALPK1;GSTO1;PIK3R3;STAT1;H3C13;TNIP2;LRRC14;GATA3;IKBKB;MSN;PIK3CB;ITGAX;PIK3R1;RPS6KA1;NLRC5;MTAP;N4BP1;PPP2R1A;STAT5A;AKT1;PKN2;ITGB2;MEF2C;MAPK8;UBE2N;TAB3;SOCS3;TRAF6;FBXW11;FOS;RPS6KA5;CRLF1;SOD1;PTPN12;MAP2K4;RPS6KA3;STX3;MAPK7;DUSP6;TP53;JAK2;TGFB1;CCR1;MAP3K7;NOD2;YWHAZ;MAPK14;CASP3;IL6ST;IL15RA;MAPK1;STAT4;IL18BP;CRK;CCL5;PSME1;NANOG;LYN;NKIRAS1;RPS27A;PTAFR;PSMA4
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.18886217038433503,-0.7016134005087818,0.8571428571428571,1.0,1.0,31/90,33.74%,CAMK2A;ELOC;PFKL;IL6;PDK1;EP300;IGF1R;PIK3R3;AKT2;PIK3CB;AKT3;PIK3R1;AKT1;LDHB;PFKFB3;IFNGR2;TFRC;VHL;MAPK1;ENO1;LDHA;MAP2K1;PFKP;CDKN1B;PFKM;RBX1;ALDOC;INSR;EIF4E;EIF4E2;PRKCB
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,-0.19777218430130716,-0.7015373231509465,0.8888888888888888,1.0,1.0,15/77,22.50%,REXO2;NXF1;XPO1;EMG1;RCL1;EIF6;RPP25;SNORD3A;CSNK2A2;RPP38;RRP7A;REXO1;SNORD3B-1;IMP4;UTP4
prerank,KEGG_2021_Human__ErbB signaling pathway,-0.19579020136765518,-0.7010129144532624,0.9183673469387755,1.0,1.0,32/73,40.30%,CAMK2A;ELK1;CBLB;MAPK10;PIK3R3;AKT2;PIK3CB;AKT3;PIK3R1;STAT5A;AKT1;MAPK8;ABL1;PAK1;MAP2K4;MAPK1;CRK;HRAS;MAP2K1;CDKN1B;JUN;NCK2;PRKCB;STAT5B;MAP2K2;PAK2;SHC4;PAK6;ERBB3;EIF4EBP1;RPS6KB2;SRC
prerank,KEGG_2021_Human__Insulin secretion,-0.19920347499078347,-0.7006727917154616,0.8913043478260869,1.0,1.0,5/51,8.41%,CREB1;CAMK2A;GNA11;FXYD2;PLCB2
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,-0.18197125647795204,-0.7000643097730468,0.98,1.0,1.0,40/229,19.53%,CREB1;PHC3;NEDD4;HDAC3;PPP2CB;SCMH1;AGO1;NR4A1;PSMC5;FOXO1;LAMTOR2;CBX4;EZH2;PSMD5;RNF2;PSMD8;PSMD13;CD19;PML;PSMB10;PPP2R5E;CNOT6L;TNKS2;RBBP7;RRAGB;CSNK2A2;PIK3R3;MTA2;THEM4;AKT2;FGFR1;PIK3CB;AKT3;PIK3R1;PPP2R1A;RNASE1;CBX6;PHLPP2;AKT1;TNRC6A
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.19479087018591507,-0.6993814858673717,0.9270833333333334,1.0,1.0,24/83,30.84%,VAMP3;CD3D;CLTCL1;M6PR;LDLRAP1;AP2M1;IGF2R;CLTB;ARRB1;ITSN2;NECAP2;GRK3;COPS8;CLTC;TARP;TFRC;GPS1;COPS2;STON1;RPS27A;SGIP1;KIAA0319;GRK2;HGS
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.2531565211296012,-0.6981908770300319,0.8148148148148148,1.0,1.0,12/21,44.14%,CTSG;RNF213;CORO1A;MAPK1;ENO1;KPNA1;RPS27A;HGS;KPNB1;UBA52;RAB5A;PGK1
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,-0.19856952650648013,-0.6973069192291919,0.9175257731958762,1.0,1.0,8/80,9.83%,MRPS16;MRPL55;MRPS25;MRPL43;MRPL15;MRPL57;MTIF2;CHCHD1
prerank,KEGG_2021_Human__Dilated cardiomyopathy,-0.20153413894142236,-0.696589842288532,0.9263157894736842,1.0,1.0,13/59,21.63%,ITGA10;ITGB5;CACNG8;ITGA5;CACNB3;DAG1;DES;ITGA4;CACNA2D2;ADCY3;CACNB2;CACNB4;SLC8A1
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.24262031753952928,-0.6960495303455683,0.8461538461538461,1.0,1.0,4/17,24.49%,PPP2CB;PPP2R5E;PPP2R1A;PROC
prerank,Reactome_2022__mRNA Capping R-HSA-72086,-0.2225086842600792,-0.6951734141944785,0.8588235294117647,1.0,1.0,12/29,39.48%,MNAT1;NCBP2;POLR2I;RNGTT;GTF2H3;POLR2D;POLR2B;SUPT5H;GTF2H1;CDK7;POLR2H;POLR2C
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.20008823197248493,-0.6948206826976836,0.8842105263157894,1.0,1.0,7/54,10.99%,SMURF1;PSMC5;PSMD5;PSMD8;EP300;PSMD13;PSMB10
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.20540723471899391,-0.69428064254086,0.8924731182795699,1.0,1.0,19/43,43.53%,KHDRBS2;CCNE1;STAP2;RNASE1;AKT1;SOCS3;CRK;RPS27A;HRAS;CDKN1B;EPAS1;CDK2;ARAP1;RHOA;ERBB3;KHDRBS1;CBL;UBA52;GPNMB
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,-0.20205973585759068,-0.6942407911760394,0.9456521739130435,1.0,1.0,8/57,11.32%,PSMC5;HHAT;PSMD5;PSMD8;PSMD13;DISP2;PSMB10;VCP
prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.1830195544775168,-0.6941526889231335,0.9489795918367347,1.0,1.0,68/152,41.67%,SIPA1L2;PGF;MAGI3;F2R;PLCB2;MRAS;RRAS;IGF1R;PIK3R3;APBB1IP;DOCK4;AKT2;FGFR1;PIK3CB;PLCB4;AKT3;PIK3R1;ADORA2A;RAPGEF5;PFN2;GNAI1;AKT1;ITGB2;ADCY3;P2RY1;ADORA2B;RAP1A;PDGFC;MAPK14;MAPK1;CRK;RAC1;RAC3;HRAS;SIPA1;PFN1;MAP2K1;FYB1;TLN1;MAPK11;CSF1;PARD6B;INSR;ADCY7;PRKCB;RAC2;MAPK13;RASGRP2;PARD6G;GNAI3;PRKCZ;PDGFRA;MAP2K2;RALB;RHOA;SKAP1;TLN2;ARAP3;RGS14;THBS1;SIPA1L3;RALGDS;SRC;ACTG1;ITGB3;VEGFB;LAT;VAV2
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.1703993855549781,0.6939057125992526,0.9333333333333333,1.0,1.0,2/17,4.61%,GNB5;GNB2
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.1890452713707376,-0.6930053545807675,0.9587628865979382,1.0,1.0,31/85,35.47%,PRKCD;XPO1;PSMC5;EXOSC9;PSMD5;DCP1A;PSMD8;PSMD13;PSMB10;EXOSC6;EXOSC4;SET;EXOSC3;AKT1;EXOSC2;KHSRP;TNFSF13;HNRNPD;YWHAZ;MAPK14;PSME1;RPS27A;PSMA4;MAPK11;PSMC4;PSMD4;XRN1;ENPP2;EIF4G1;ZFP36L1;PSMD14
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,-0.19480615850204117,-0.6929736943026982,0.90625,1.0,1.0,10/80,12.26%,XPO1;CDC42EP2;AGO1;PSMC5;FOXO1;PSMD5;PSMD8;PSMD13;PSMB10;NCOA3
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.2739036406221749,-0.6929199059283995,0.8055555555555556,1.0,1.0,2/15,8.78%,LIN7C;SYN3
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,-0.18741641990161464,-0.6924081030830235,0.8723404255319149,1.0,1.0,8/82,10.99%,PDIA3;SEC22B;VAMP3;PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.2414216661012997,-0.6906854812437634,0.8522727272727273,1.0,1.0,6/18,26.97%,SKP1;MECP2;STAT5A;NPM1;CLTC;MAPK1
prerank,KEGG_2021_Human__Dopaminergic synapse,-0.18898587265990405,-0.6900047665045901,0.96875,1.0,1.0,20/92,23.33%,CREB1;PPP2CB;CAMK2A;KIF5C;PLCB2;GNG5;MAPK10;PPP2R5E;PPP2R3A;ARRB1;AKT2;PLCB4;AKT3;PPP2R1A;GNAI1;AKT1;MAPK8;FOS;COMT;GNG3
prerank,KEGG_2021_Human__Purine metabolism,-0.18258013494113584,-0.6887607694845261,0.9479166666666666,1.0,1.0,30/101,29.59%,APRT;HDDC3;IMPDH1;NTPCR;CANT1;AK3;PDE7A;PDE2A;NUDT9;PDE3A;NT5E;NT5C1A;NT5C3B;ENPP3;ADCY3;ITPA;GUK1;RRM2B;PDE9A;PPAT;GUCY1B1;NME1-NME2;AK7;ENTPD2;PDE3B;AK1;PFAS;AK9;NUDT2;AMPD2
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.11006995188883818,0.6883445906472099,1.0,1.0,1.0,12/77,11.50%,PSMB5;PSMD9;PSMC3;PSMC6;PSMB7;NFATC3;CALM1;PSME2;UBC;PPP3CA;PSMD11;REL
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,-0.19126327144318883,-0.6877053503607672,0.8947368421052632,1.0,1.0,20/67,29.96%,ARHGEF4;GNG5;ARHGEF39;ARHGEF18;RHOC;PLXNB1;TRIO;OBSCN;ARHGEF35;ARHGEF15;PREX1;GNA13;TBXA2R;GNG3;GNG10;GNG7;ARHGEF10L;ARHGEF2;GNG4;ARHGEF5
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,-0.2171768285978229,-0.6871901272223144,0.8297872340425532,1.0,1.0,13/31,36.09%,SYK;PIK3R5;PIK3R3;CLEC1B;PIK3CB;PIK3R1;RNASE1;FCER1G;LYN;RHOG;RAC2;PRKCZ;RHOA
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.1930658100390895,-0.6864777030591336,0.8602150537634409,1.0,1.0,21/52,39.48%,TCEA1;UVSSA;MNAT1;POLR2I;EP300;DDB1;COPS8;GTF2H3;GPS1;COPS2;POLR2D;RPS27A;POLR2B;GTF2H1;RBX1;CDK7;AQR;COPS4;COPS6;POLR2H;POLR2C
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,0.17581456374371304,0.6861337380032466,1.0,1.0,1.0,26/26,82.44%,BCL2L1;CDKN1A;UBC;UBB;FLT3;GRB2;SOS1;PIK3CA;NRAS;ZMYM2;LONP1;MYO18A;PTPN11;UBA52;GAB2;CBL;FLT3LG;GOLGB1;STAT5B;ETV6;HRAS;RPS27A;TRIP11;STAT5A;SPTBN1;PIK3R1
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,-0.2602096985193695,-0.6860737863522389,0.8441558441558441,1.0,1.0,4/15,27.01%,CD3D;CD3E;TARP;ZAP70
prerank,KEGG_2021_Human__Homologous recombination,-0.208126470666608,-0.6847420866374947,0.872093023255814,1.0,1.0,16/41,39.08%,RPA3;RAD54B;RPA1;RAD50;RBBP8;RPA2;TOP3A;TOPBP1;ABRAXAS1;POLD4;RPA4;RAD52;POLD2;RAD51;SYCP3;UIMC1
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.20762512062434704,-0.6839542284868421,0.8631578947368421,1.0,1.0,17/39,35.52%,H2BC14;OGG1;POT1;H2BC13;H2AC14;H2AZ1;NEIL3;H2AX;UNG;TERF1;TINF2;H2AC19;H2AB1;H2BC17;H2BC12;TERF2IP;H2AC7
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,0.20925122841228602,0.6830125324321881,0.7894736842105263,1.0,1.0,11/17,31.56%,SLC25A16;PANK2;ENPP1;PANK3;SLC5A6;PPCS;VNN2;PANK4;VNN1;PDZD11;FASN
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,-0.21903506126408767,-0.6826226244005313,0.9058823529411765,1.0,1.0,21/32,48.58%,BIRC3;IKBKB;CASP4;UBE2N;TAB3;TRAF6;MAP3K7;NOD2;MAPK14;MAPK11;CHUK;MAPK13;ITCH;CASP1;BIRC2;RIPK2;AAMP;CARD9;IRAK1;UBE2V1;IRAK2
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.2351661033168187,-0.6824163792717121,0.8372093023255814,1.0,1.0,2/19,7.40%,PPP2CB;SPRY2
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,-0.17741892991622293,-0.6821930629437178,0.9797979797979798,1.0,1.0,37/188,21.72%,CDC40;DNAJC8;SNRPE;SNRNP35;HNRNPUL1;SNRPB;PPIH;NCBP2;HNRNPC;PQBP1;POLR2I;SF1;FUS;SRSF5;PPIL1;DHX15;CPSF2;SF3B6;PAPOLA;PCBP2;PPIL3;DHX9;PLRG1;U2AF1L4;CSTF2;HNRNPL;RBM5;SNRPF;ALYREF;PUF60;PRPF3;DHX38;SUGP1;DDX42;YBX1;U2SURP;SRRT
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.18722261699478757,-0.6820559893016639,0.9591836734693877,1.0,1.0,32/112,32.34%,H2BC7;SNRPB;H2BC14;H2AB2;CTSG;H2AC8;H3C7;H2AC12;H2BC13;H2AC14;H3C13;H3C6;H2AZ1;CD40LG;H3-3A;H4C12;H4C14;H3C15;H3-3B;C4A;H2AX;C1S;H2AC19;H2AB1;H3C1;H4C4;RO60;H2BC17;H2AC18;H3C4;H2AC11;H2BC12
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,-0.20517456607169132,-0.681815709378395,0.8333333333333334,1.0,1.0,14/33,34.47%,PIK3R3;AKT2;PIK3CB;AKT3;PIK3R1;GNAI1;AKT1;ADCY3;LIPE;PDE3B;PNPLA2;INSR;ADCY7;GNAI3
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.2438220134372196,-0.6809236981346117,0.8658536585365854,1.0,1.0,9/22,29.76%,GNG5;PIK3R5;AKT2;AKT3;AKT1;GNG3;GNG10;GNG7;GNG4
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,-0.17761013524648794,-0.6808496993154609,0.97,1.0,1.0,36/180,21.72%,CDC40;DNAJC8;SNRPE;HNRNPUL1;SNRPB;PPIH;NCBP2;HNRNPC;PQBP1;POLR2I;SF1;FUS;SRSF5;PPIL1;DHX15;CPSF2;SF3B6;PAPOLA;PCBP2;PPIL3;DHX9;PLRG1;U2AF1L4;CSTF2;HNRNPL;RBM5;SNRPF;ALYREF;PUF60;PRPF3;DHX38;SUGP1;DDX42;YBX1;U2SURP;SRRT
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.23844452076436445,-0.680435059905327,0.8804347826086957,1.0,1.0,8/21,29.76%,GNA11;GNG5;P2RY1;GNG3;GNG10;MAPK14;GNG7;GNG4
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,-0.19751760925776213,-0.6799255323001372,0.9340659340659341,1.0,1.0,9/49,17.09%,APOE;GPC2;RDH5;NMT2;PPEF1;RNF7;HSPG2;DHRS9;CAMKMT
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,-0.20817607918290812,-0.677710661226491,0.8705882352941177,1.0,1.0,13/39,29.97%,PLCB2;MIOX;ISYNA1;MINPP1;PLD4;PLCB4;ITPKB;PLCD3;PPIP5K1;IMPA1;IP6K2;IP6K1;INPP1
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.18416570033009064,0.6776826841190474,0.8571428571428571,1.0,1.0,6/16,20.93%,MOB1A;WWC1;LATS1;SAV1;WWTR1;STK4
prerank,KEGG_2021_Human__VEGF signaling pathway,-0.20399357253538167,-0.676111761261077,0.8695652173913043,1.0,1.0,21/52,35.84%,SH2D2A;PIK3R3;AKT2;PIK3CB;AKT3;PIK3R1;AKT1;PXN;MAPK14;MAPK1;RAC1;RAC3;HRAS;MAP2K1;PPP3CC;MAPK11;PRKCB;RAC2;MAPK13;MAPKAPK3;MAP2K2
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.18969892447228368,-0.6758462686253468,0.9393939393939394,1.0,1.0,27/83,34.47%,TXK;MMP9;CD99L2;CTNNA1;CXCR4;PIK3R3;ITGA4;JAM3;MSN;PIK3CB;PIK3R1;GNAI1;MYL12A;ITGB2;MYL9;PXN;RAP1A;MAPK14;RAC1;SIPA1;MYL5;NCF4;MAPK11;PRKCB;RAC2;MAPK13;GNAI3
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.19302183875954532,-0.6757773807922121,0.9081632653061225,1.0,1.0,29/82,34.81%,PRKCD;ABI1;WASF2;JUP;CYFIP2;SH2D2A;CTNNA1;THEM4;AKT2;PIK3CB;AKT3;PIK3R1;RNASE1;AKT1;PKN2;NCKAP1L;MAPK14;CRK;HRAS;RICTOR;NCK2;BAIAP2;NCF4;MAPK11;WASF1;PRKCB;MAPK13;MAPKAPK3;PRKCZ
prerank,KEGG_2021_Human__Fatty acid biosynthesis,-0.25147886450301526,-0.6756131715776534,0.8571428571428571,1.0,1.0,3/17,16.36%,ACSL4;ACSL6;ACSL3
prerank,KEGG_2021_Human__Morphine addiction,0.14122448243653077,0.6755888383798455,1.0,1.0,1.0,8/51,11.41%,PRKACB;PDE1B;GNB5;GNB2;GABRG2;GNAO1;ADCY9;GABRD
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,-0.19995649321965292,-0.675287064382524,0.90625,1.0,1.0,9/48,19.45%,ITGA10;COL9A1;ITGB5;ITGA5;HSPG2;ITGA4;JAM3;ITGAX;ITGB2
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,-0.24944742397917155,-0.6745331539953683,0.8658536585365854,1.0,1.0,6/18,28.10%,SYK;PIK3R3;PIK3CB;PIK3R1;CRK;LYN
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.17572810228949245,0.6715668138901731,0.9473684210526315,1.0,1.0,17/17,82.44%,UBC;UBB;PLCG1;GRB2;SOS1;EGF;PIK3CA;NRAS;CDC37;HSP90AA1;PIGU;SHC1;UBA52;CBL;HRAS;RPS27A;PIK3R1
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.20703103603221645,-0.6699014558853131,0.945054945054945,1.0,1.0,11/34,32.85%,TPST2;STS;ICMT;DPH6;GGCX;SUMF1;PROC;DPH7;BGLAP;EEF2;ARSB
prerank,KEGG_2021_Human__Amoebiasis,-0.19027354168248323,-0.6690278553797642,0.925531914893617,1.0,1.0,14/73,19.45%,GNA11;CXCL8;LAMB4;CTSG;PLCB2;IL6;LAMC1;CD14;PIK3R3;LAMC3;PIK3CB;PLCB4;PIK3R1;ITGB2
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,0.15476711130548865,0.6684846535470412,0.7857142857142857,0.9961298113757148,1.0,26/26,84.55%,TUBA4A;PFDN4;CCT2;TUBA1C;CCT6B;PFDN1;TUBA1B;TUBA1A;PFDN6;CCT3;CCT6A;TUBB;TCP1;CCT5;VBP1;PFDN5;CCT8;CCT4;TUBB4B;TUBB3;TUBB6;TUBB4A;PFDN2;TUBB2A;TUBA8;CCT7
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.18995538534434497,-0.6684597548365729,0.9263157894736842,1.0,1.0,6/48,10.99%,OAZ1;PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.21222593690840236,-0.6682000117058472,0.8461538461538461,1.0,1.0,6/26,20.36%,CRCP;POLR3B;POLR3D;POLR3C;GTF3C4;GTF3C2
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.18205211146010913,-0.6670293904100896,0.9795918367346939,1.0,1.0,33/125,29.76%,SMURF1;CAMK2A;AGO1;RORA;PSMC5;FZD2;AP2M1;PLCB2;GNG5;PSMD5;PSMD8;FZD6;PSMD13;PSMB10;NCOA3;CLTB;TCF7L2;SMURF2;RNASE1;NLK;TNRC6A;TCF7L1;CLTC;GNG3;WNT5B;GNG10;MAP3K7;GNG7;PSME1;RPS27A;PSMA4;PFN1;GNG4
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,-0.2079862704902677,-0.6636118045818948,0.8804347826086957,1.0,1.0,17/44,35.05%,COL9A1;PLAT;THBS4;STAT1;PIK3CB;PIK3R1;STAT5A;PTPN12;PLG;PDGFC;CRK;HRAS;COL6A3;NCK2;COL4A4;STAT5B;PDGFRA
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,-0.24074908014011365,-0.6634172229697343,0.9240506329113924,1.0,1.0,3/17,15.01%,B4GALT2;SLC35D2;B4GALT3
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.21306788026191317,-0.6630327007136253,0.9021739130434783,1.0,1.0,7/34,15.21%,H2BC14;KLKB1;H3C7;H2BC13;H2AC14;H3C13;H2AZ1
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.1939482715545526,-0.6628465979276997,0.9574468085106383,1.0,1.0,7/53,11.32%,PSMC5;HHAT;PSMD5;PSMD8;PSMD13;PSMB10;VCP
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.17155018945521205,-0.6625953989363308,1.0,1.0,1.0,34/213,18.54%,ABHD17B;DUSP12;PPP2CB;CAMK2A;IL3RA;IL2RA;NCAM1;PSMC5;LAMTOR2;TYK2;RASGRP4;IL5RA;MRAS;PEA15;IL6;PSMD5;PSMD8;PSMD13;PSMB10;RANBP9;PPP2R5E;IQGAP1;APBB1IP;ARRB1;ICMT;FGFR1;SPRED1;PIK3CB;ARL2;PIK3R1;DUSP10;SPTBN1;FRS3;PPP2R1A
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,-0.1975327097223377,-0.6610828462304317,0.9213483146067416,1.0,1.0,9/41,22.51%,B4GALT2;CHSY1;CHST7;GLCE;B3GAT3;B4GALT3;EXTL2;HS2ST1;FUT8
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.18624103870710645,-0.6609356979297022,0.9375,1.0,1.0,11/64,19.14%,NEDD4;PSMC5;PSMD5;PSMD8;PSMD13;PSMB10;TNKS2;CSNK2A2;AKT2;AKT3;AKT1
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.21797845799369825,-0.6590427802757374,0.8850574712643678,1.0,1.0,7/27,28.17%,F2R;KLKB1;ZNF160;PRCP;PROC;GP1BA;THBD
prerank,KEGG_2021_Human__Alcoholism,-0.17925879270753564,-0.6581420810447265,0.98,1.0,1.0,44/140,32.34%,H2BC7;CREB1;HDAC3;H2BC14;H2AB2;H2AC8;GNG5;H3C7;H2AC12;H2BC13;H2AC14;H3C13;HDAC11;H3C6;H2AZ1;HDAC6;ADORA2A;H3-3A;GNAI1;HAT1;H4C12;H4C14;H3C15;H3-3B;GNG3;H2AX;GNG10;FOSB;ADORA2B;MAPK1;H2AC19;GNG7;H2AB1;HRAS;H3C1;MAP2K1;GNG4;H4C4;H2BC17;H2AC18;HDAC10;H3C4;H2AC11;H2BC12
prerank,KEGG_2021_Human__Thyroid hormone synthesis,-0.19135335220529978,-0.6556188287857302,0.9325842696629213,1.0,1.0,9/51,19.49%,CREB1;SLC5A5;FXYD2;PLCB2;DUOX2;PLCB4;IYD;GPX3;ADCY3
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.15238642015162107,0.6544509396436654,1.0,0.9980509418065836,1.0,9/31,18.84%,RGS6;GNB5;GNB2;GNA15;CCT2;CCT6B;GNG8;GNB1;GNAQ
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.20542779023066554,-0.6544168982548311,0.8705882352941177,1.0,1.0,5/30,15.18%,ITGB5;LAMC1;DAG1;LAMC3;HSPG2
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,-0.24466155086992022,-0.6537194073509538,0.9222222222222223,1.0,1.0,5/17,26.17%,NUDT15;GSTM1;RNASE1;GUK1;ABCC4
prerank,KEGG_2021_Human__African trypanosomiasis,0.15230669334972957,0.6518118791278616,0.9545454545454546,0.9922659608277294,1.0,6/26,12.19%,HBA2;IL10;PLCB1;MYD88;PLCB3;THOP1
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,-0.2332085462749611,-0.6510661264684275,0.9213483146067416,1.0,1.0,12/22,45.06%,SYK;APBB1IP;AKT1;RAP1A;CRK;TLN1;RASGRP2;RASGRP1;SRC;ITGB3;SHC1;PTK2
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.17691256266682973,-0.6500071190887494,0.9347826086956522,1.0,1.0,16/57,31.37%,IFITM1;TYK2;IRF5;STAT1;RSAD2;SOCS3;IFNAR1;IFIT5;IFI27;EGR1;IP6K2;MX1;IRF1;KPNA1;GBP2;IRF8
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.17565983555492978,-0.6480697928010593,0.9693877551020408,1.0,1.0,33/128,28.94%,TXK;PSMC5;MAP3K1;RASGRP4;SKP1;PSMD5;PSMD8;SYK;PSMD13;PSMB10;MAPK10;BCL10;IKBKB;PIK3CB;SLC7A8;PIK3R1;RNASE1;PKN2;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;FOS;MAP2K4;FCER1G;MAP3K7;MAPK1;PSME1;LYN;RPS27A;PSMA4;HRAS
prerank,KEGG_2021_Human__Chronic myeloid leukemia,-0.18085964297152446,-0.6478255215174813,0.9263157894736842,1.0,1.0,23/73,30.06%,TGFBR2;BCR;PIK3R3;GADD45G;AKT2;E2F1;DDB2;IKBKB;PIK3CB;AKT3;PIK3R1;STAT5A;AKT1;BAX;ABL1;TP53;TGFB1;GADD45A;MAPK1;CRK;HRAS;MAP2K1;CDKN1B
prerank,KEGG_2021_Human__Starch and sucrose metabolism,-0.21290728676726253,-0.6459737842431006,0.9080459770114943,1.0,1.0,6/24,24.38%,GANC;PYGB;G6PC3;ENPP3;GPI;PYGL
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,-0.22471634634289442,-0.6428830520205957,0.8414634146341463,1.0,1.0,13/19,48.58%,UBE2N;TAB3;TRAF6;MAP3K7;NOD2;MAPK14;MAPK11;MAPKAPK3;RIPK2;IRAK1;UBE2V1;MAPKAPK2;IRAK2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.18277748654570072,-0.6427504171165538,0.9473684210526315,1.0,1.0,26/90,28.84%,H2BC14;PSMC5;MNAT1;LMO2;PSMD5;PSMD8;PSMD13;H3C7;PSMB10;H2BC13;GATA1;H2AC14;H3C13;GATA3;H2AZ1;TAL1;TCF7L1;CBFB;ABL1;H3-3B;H2AX;H2AC19;PSME1;H2AB1;RPS27A;PSMA4
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.16582155685127734,-0.6408847390704896,0.95,1.0,1.0,56/163,34.79%,MYH9;ABI1;CXCL8;WASF2;HCLS1;CYFIP2;F2R;TLR5;IL6;MAPK10;TRAF2;CYTH4;IKBKB;ARPC3;TUBA8;CASP4;BAX;FADD;TUBB2A;MAPK8;GNA13;TAB3;TRAF6;FOS;ABL1;ACTR3B;MYO1F;TUBB4A;PAK1;TUBB1;SEC24D;NCKAP1L;ARPC5;MAP3K7;MAPK14;CASP3;MAPK1;RAC1;WIPF1;ARHGEF2;TMED10;JUN;ACTR3;NCK2;TUBB6;TNFRSF10B;BAIAP2;MAPK11;TUBB3;BAIAP2L1;MYO10;WASF1;CHUK;MAPK13;IRAK4;TRADD
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,-0.18814053753981758,-0.6398350953312995,0.968421052631579,1.0,1.0,14/53,29.76%,PPP2CB;NCBP2;SPRY2;POLR2I;FGFBP2;PIK3R1;FRS3;PPP2R1A;MAPK1;POLR2D;RPS27A;HRAS;POLR2B;TIAL1
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.22701162009677933,-0.636711563136625,0.8764044943820225,1.0,1.0,13/18,48.30%,GNG5;GNAI1;GNG3;GNG10;GNG7;GNG4;GNAI3;GNB3;GNGT2;P2RY12;GNAI2;GNG11;GNG2
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.17516308842086523,-0.6366338524366368,0.9791666666666666,1.0,1.0,33/119,30.84%,VAMP3;CD3D;DNAJC6;CLTCL1;M6PR;SNX18;LDLRAP1;AP2M1;IGF2R;CLTB;DNM1;ARRB1;ITSN2;ARPC3;HIP1;FNBP1L;BIN1;NECAP2;GRK3;COPS8;CLTC;TARP;TFRC;ARPC5;GPS1;COPS2;STON1;RPS27A;SGIP1;KIAA0319;GRK2;ACTR3;HGS
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,0.15475019131955847,0.6337243593051508,0.9375,0.9962545763424185,1.0,24/24,84.55%,TUBA4A;PFDN4;CCT2;TUBA1C;CCT6B;PFDN1;TUBA1A;PFDN6;CCT3;CCT6A;TUBB;TCP1;CCT5;VBP1;PFDN5;CCT8;CCT4;TUBB4B;TUBB3;TUBB6;TUBB4A;PFDN2;TUBB2A;CCT7
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.20201545615265504,-0.6328364548796084,0.9069767441860465,1.0,1.0,11/27,39.48%,MNAT1;POLR2I;RNGTT;GTF2H3;POLR2D;POLR2B;SUPT5H;GTF2H1;CDK7;POLR2H;POLR2C
prerank,KEGG_2021_Human__Platelet activation,-0.16947123030948835,-0.6328197164324852,0.94,1.0,1.0,48/105,42.12%,F2R;PLCB2;SYK;PIK3R5;STIM1;PIK3R3;APBB1IP;AKT2;PIK3CB;PLCB4;AKT3;PIK3R1;GNAI1;AKT1;MYL12A;ADCY3;P2RY1;GNA13;TBXA2R;P2RX1;MYLK;GUCY1B1;FCER1G;ORAI1;GP1BA;RAP1A;MAPK14;MAPK1;LYN;TLN1;MAPK11;ADCY7;MAPK13;RASGRP2;GNAI3;PRKCZ;RHOA;RASGRP1;PTGS1;TLN2;PPP1CB;ITPR3;SRC;ACTG1;ITGB3;GP1BB;ARHGEF1;GP6
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,-0.22883916305742472,-0.6309358057256124,0.8974358974358975,1.0,1.0,1/19,1.47%,CD3D
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.18242472624280015,-0.630869026766674,0.9148936170212766,1.0,1.0,16/52,34.02%,NFKB2;MEFV;BIRC3;IKBKB;AIM2;CASP4;UBE2N;TAB3;TRAF6;MAP3K7;NOD2;MAPK14;HSP90AB1;MAPK11;CHUK;MAPK13
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.23560622686833305,-0.6291333893945116,0.9166666666666666,1.0,1.0,3/21,13.25%,SLC8B1;PHB2;PMPCA
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.2374473581375602,-0.6289262646860825,0.9259259259259259,1.0,1.0,5/16,27.32%,LIN9;E2F1;CDK1;RBBP4;LIN54
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,-0.16346763904530295,-0.628408502553365,0.97,1.0,1.0,33/136,29.41%,NKIRAS2;PTPN4;PTPN23;NFKB2;PSMC5;CTSG;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;ALPK1;TNIP2;LRRC14;IKBKB;NLRC5;N4BP1;MAPK8;UBE2N;TAB3;TRAF6;FBXW11;PTPN12;MAP2K4;TP53;MAP3K7;NOD2;IL18BP;PSME1;NKIRAS1;RPS27A;PSMA4;MAP2K1
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,-0.1982442437350272,-0.6283163156806226,0.9230769230769231,1.0,1.0,25/37,54.15%,HNRNPC;CD19;C5AR1;C4BPA;CFH;C4A;C1S;C4BPB;CD59;SERPING1;CR2;CPNE2;CFHR1;CR1;CFI;PROS1;ELANE;CFHR2;C1QA;C1QB;CD55;C1R;TTF2;CLU;CPNE1
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,-0.19519702086309368,-0.627510050176546,0.9130434782608695,1.0,1.0,7/40,18.84%,HPGDS;PTGES;GGT1;PTGDS;CYP4B1;ALOX12;HPGD
prerank,KEGG_2021_Human__Pancreatic secretion,-0.17472681622191177,-0.6271265066079647,0.9574468085106383,1.0,1.0,24/54,43.31%,PLA2G2C;FXYD2;PLCB2;KCNQ1;PLCB4;RAB27B;ADCY3;SCT;CA2;RAP1A;ATP1B2;RAC1;SLC4A2;ATP2A1;ADCY7;PRKCB;PNLIPRP1;RHOA;ATP1A3;ITPR3;CPA3;ATP2B1;SLC12A2;ATP1B3
prerank,KEGG_2021_Human__Other glycan degradation,-0.22304432201065383,-0.6263571334894045,0.9213483146067416,1.0,1.0,5/15,29.12%,MANBA;HEXA;MAN2C1;FUCA2;ENGASE
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.1622126008785377,-0.6248064537316886,1.0,1.0,1.0,32/207,18.54%,ABHD17B;DUSP12;PPP2CB;CAMK2A;IL3RA;IL2RA;NCAM1;PSMC5;LAMTOR2;RASGRP4;IL5RA;MRAS;PEA15;PSMD5;PSMD8;PSMD13;PSMB10;RANBP9;PPP2R5E;IQGAP1;APBB1IP;ARRB1;ICMT;FGFR1;SPRED1;PIK3CB;ARL2;PIK3R1;DUSP10;SPTBN1;FRS3;PPP2R1A
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,-0.20800281218102634,-0.6243151593548314,0.9534883720930233,1.0,1.0,10/29,29.76%,PLCB2;GNG5;PIK3R5;AKT2;AKT3;AKT1;GNG3;GNG10;GNG7;GNG4
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.21273206159675245,-0.6242796101731698,0.9204545454545454,1.0,1.0,5/22,19.35%,TOMM7;TOMM20;TOMM6;ATG5;MFN1
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.17523086998799173,-0.6242604105452316,0.9578947368421052,1.0,1.0,33/85,36.86%,CD3D;BATF2;CSNK2A2;PIK3R3;STAT1;AKT2;IKBKB;PIK3CB;CD3E;AKT3;CD3G;PIK3R1;AKT1;TRAF6;FOS;IFNGR2;JAK2;MAPK14;MAPK1;ZAP70;NFKBIE;HRAS;MAP2K1;JUN;PPP3CC;MAPK11;CHUK;MAP3K3;MAPK13;MAP2K2;PTEN;RASGRP1;NFATC1
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,0.13354908526569823,0.6196404087631731,1.0,0.9939336295330818,1.0,3/27,7.27%,MIGA1;AGPAT5;GPD1L
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,-0.1752108785258666,-0.6190401890853233,0.9690721649484536,1.0,1.0,7/80,9.83%,MRPS16;MRPL55;MRPS25;MRPL43;MRPL15;MRPL57;CHCHD1
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,-0.21156788043485192,-0.6189574097424974,0.9186046511627907,1.0,1.0,6/20,28.10%,STAT1;STAT5A;SOCS3;JAK2;MAPK1;LYN
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.17898112673464603,-0.616234435317756,0.9574468085106383,1.0,1.0,6/49,10.99%,PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,-0.18052302566050288,-0.615644076920469,0.9468085106382979,1.0,1.0,6/50,10.99%,ARHGAP10;PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,-0.2051138605604077,-0.6155353689942986,0.8513513513513513,1.0,1.0,2/23,6.34%,EDARADD;TNFRSF1B
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.16422659689795402,-0.6152167790580284,0.9479166666666666,1.0,1.0,6/86,4.85%,PRKCD;MYH9;PLA2G2C;PPP1R14A;GNA11;ACTA2
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,-0.2231560647844379,-0.6129527677519815,0.9195402298850575,1.0,1.0,8/19,35.38%,JUP;RCAN1;PPL;SPINK9;EVPL;ST14;KAZN;PERP
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,-0.1571038549432881,-0.612768352318113,0.98,1.0,1.0,39/248,18.87%,USP9X;CLSPN;TGFBR2;SMAD2;BIRC3;MDM4;RNF123;H2BC14;USP33;PSMC5;USP8;USP37;FOXK1;PSMD5;PSMD8;TOMM20;EP300;PSMD13;PSMB10;MYSM1;H2AC12;VCP;H2BC13;KAT2B;TNKS2;USP12;H2AC14;TNIP2;ARRB1;GATA3;TADA2B;H2AC25;SIAH2;DDB2;ACTR5;WDR48;SMURF2;SMAD7;KAT2A
prerank,KEGG_2021_Human__Malaria,-0.18265244380457255,-0.6103698965004207,0.9431818181818182,1.0,1.0,8/43,20.07%,CXCL8;IL6;KLRK1;THBS4;CD40LG;ITGB2;HBA1;SELP
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.173755557212527,-0.6092478472611789,0.9583333333333334,1.0,1.0,21/60,34.02%,SYK;MAPK10;PIK3R3;AKT2;PIK3CB;AKT3;PIK3R1;AKT1;MAPK8;MAP2K4;FCER1G;MAPK14;MAPK1;RAC1;LYN;RAC3;HRAS;MAP2K1;MAPK11;RAC2;MAPK13
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.1999200376109029,-0.60740126694756,0.9555555555555556,1.0,1.0,1/29,0.28%,TXK
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.1704945199826059,-0.6062707869324221,0.9787234042553191,1.0,1.0,7/63,10.99%,MDM4;CCNE1;PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,-0.1623301641279994,-0.6050460712010237,0.98989898989899,1.0,1.0,35/110,35.47%,NKIRAS2;NFKB2;PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;ALPK1;TNIP2;LRRC14;IKBKB;NLRC5;N4BP1;UBE2N;TAB3;TRAF6;FBXW11;MAP2K4;TP53;MAP3K7;NOD2;PSME1;NKIRAS1;RPS27A;PSMA4;MAP2K1;RBX1;PSMC4;PSMD4;CHUK;MAP3K3;IRAK4;S100B;PSMD14
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.17517769688465434,-0.6046334923321984,0.9893617021276596,1.0,1.0,7/52,13.67%,PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;FBXO5
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,-0.17489356981133264,-0.60422888743552,0.9680851063829787,1.0,1.0,6/54,10.99%,MDM4;PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,-0.19433770758697244,-0.6041989570456414,0.9186046511627907,1.0,1.0,5/26,17.57%,FXYD2;PIK3R3;NEDD4L;PIK3CB;PIK3R1
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.18622179652409188,-0.6036919950570581,0.9555555555555556,1.0,1.0,2/32,8.61%,KLRD1;IL6
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,-0.18263938849829406,-0.6022949618225253,0.9772727272727273,1.0,1.0,6/34,20.32%,BIRC3;TRAF1;SPPL2A;IKBKB;TAX1BP1;FADD
prerank,KEGG_2021_Human__Hepatitis C,-0.15634138332753023,-0.6020036689066531,0.98,1.0,1.0,24/124,21.80%,PPP2CB;EIF2AK4;EIF2S1;TYK2;EIF2AK2;PIK3R3;STAT1;TRAF2;PPARA;AKT2;E2F1;IKBKB;PIK3CB;AKT3;PIK3R1;RSAD2;PPP2R1A;AKT1;BAX;BID;FADD;SOCS3;TRAF6;IFNAR1
prerank,KEGG_2021_Human__Glioma,-0.17122085027746822,-0.6018878230395871,0.9565217391304348,1.0,1.0,22/65,35.88%,CAMK2A;IGF1R;PIK3R3;GADD45G;AKT2;E2F1;DDB2;PIK3CB;AKT3;PIK3R1;AKT1;BAX;TP53;GADD45A;MAPK1;HRAS;MAP2K1;PRKCB;GADD45B;PDGFRA;MAP2K2;PTEN
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.16370432121109343,-0.6008640226607491,0.9795918367346939,1.0,1.0,33/96,35.17%,NDUFB2;NDUFC1;NDUFB7;PLCB2;GNG5;NDUFS7;NDUFS2;MAPK10;GABRR2;PLCB4;GNAI1;ADCY3;NDUFS1;MAPK8;NDUFA13;NDUFB6;GNG3;GNG10;MAPK14;MAPK1;NDUFS8;GNG7;GNG4;NDUFA5;NDUFA2;MAPK11;ADCY7;PRKCB;NDUFA11;MAPK13;GNAI3;NDUFV3;NDUFA4
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.21027945566319362,-0.600647967251401,0.8809523809523809,1.0,1.0,2/18,8.99%,NCBP2;POLR2I
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.21027945566319362,-0.600647967251401,0.8809523809523809,1.0,1.0,2/18,8.99%,NCBP2;POLR2I
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.1680068451959609,-0.600467690353705,0.9368421052631579,1.0,1.0,8/63,13.28%,SMURF1;PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;STAT1
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.17390105736945874,-0.600452312955156,0.9583333333333334,1.0,1.0,6/51,10.99%,PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.2061953628554719,-0.6002652132739755,0.9625,1.0,1.0,5/21,20.11%,PLCB2;PLD4;PLCB4;ITPKB;PLCD3
prerank,KEGG_2021_Human__Prion disease,-0.1559466720468333,-0.5994351237857426,1.0,1.0,1.0,67/221,34.02%,PRKCD;CREB1;NDUFB2;ATP5F1E;COX5A;EIF2S1;UQCR10;NDUFC1;NCAM1;PSMC5;SDHC;HSPA6;KIF5C;NDUFB7;IL6;LAMC1;NDUFS7;PSMD8;PSMD1;NDUFS2;PSMD13;MAPK10;CSNK2A2;PIK3R3;SDHA;PIK3CB;PIK3R1;TUBA8;BAX;NDUFS1;TUBB2A;MAPK8;NDUFA13;ATP5F1C;CAV2;NDUFB6;TUBB4A;SOD1;TUBB1;COX8A;EGR1;MAPK14;CASP3;COX7B;MAPK1;COX5B;NDUFS8;VDAC2;RAC1;CCL5;PSMA4;NDUFA5;ATP5PO;TUBB6;PPP3CC;NCF4;NDUFA2;MAPK11;TUBB3;ADRM1;UQCR11;SDHD;PSMC4;PSMD4;NDUFA11;RAC2;MAPK13
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.1661555545540313,-0.5978624816943796,0.96,1.0,1.0,27/89,33.90%,PRKCD;WASF2;SYK;PIK3R3;ASAP2;AKT2;PIK3CB;WAS;AKT3;PIK3R1;ARPC3;AKT1;LIMK2;BIN1;ACTR3B;PAK1;ARPC5;MAPK1;CRK;RAC1;LYN;MAP2K1;ACTR3;MYO10;WASF1;PRKCB;RAC2
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.1729729990376917,-0.5971577643648505,0.968421052631579,1.0,1.0,7/53,12.73%,PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;TACC3
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.2196968564620575,-0.5959023519683312,0.9259259259259259,1.0,1.0,7/19,34.53%,LIN9;E2F1;PCNA;RBBP4;LIN54;TFDP2;CDC25A
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.16876461576008622,-0.5940401504801244,0.9479166666666666,1.0,1.0,7/54,14.94%,SMAD2;RORA;TLR5;IL6;FOXP3;STAT1;GATA3
prerank,KEGG_2021_Human__Fructose and mannose metabolism,-0.19655689124776646,-0.5939385239889198,0.8941176470588236,1.0,1.0,11/29,33.60%,MPI;PFKL;GMDS;SORD;FCSK;PFKFB3;AKR1B1;PFKP;PFKM;ALDOC;GMPPA
prerank,KEGG_2021_Human__Spinocerebellar ataxia,-0.15427320554190876,-0.5930704516611353,0.98,1.0,1.0,36/118,33.74%,KCND3;MAP3K5;RORA;PSMC5;PLCB2;PIK3R4;PSMD8;PSMD1;PSMD13;MAPK10;PIK3R3;TRAF2;AKT2;PIK3CB;PLCB4;AKT3;PIK3R1;RELN;AKT1;MAPK8;WIPI1;ATXN1;VDAC2;ATXN2;ATG2A;KCNC3;PIK3C3;PSMA4;TBPL2;ATXN1L;ATP2A1;WIPI2;ADRM1;PSMC4;PSMD4;PRKCB
prerank,KEGG_2021_Human__Renal cell carcinoma,-0.16890193012400745,-0.5909855021600333,0.9468085106382979,1.0,1.0,20/64,30.11%,ELOC;ETS1;EP300;PIK3R3;AKT2;PIK3CB;AKT3;PIK3R1;AKT1;PAK1;VHL;TGFB1;RAP1A;MAPK1;CRK;RAC1;HRAS;MAP2K1;JUN;EPAS1
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.16145661844112827,-0.5879875348431869,0.9797979797979798,1.0,1.0,9/82,11.23%,PPP2CB;PSMC5;SKP1;PSMD5;PSMD8;TLE2;PSMD13;PSMB10;PPP2R5E
prerank,KEGG_2021_Human__Tyrosine metabolism,-0.22671134390849212,-0.5864135808947437,0.9358974358974359,1.0,1.0,4/15,23.06%,GOT1;ALDH3B1;IL4I1;COMT
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,-0.21809967010504905,-0.585023958524465,0.9404761904761905,1.0,1.0,2/16,10.49%,PLAAT2;MBOAT1
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.15420676272531164,-0.5830126436651285,0.979381443298969,1.0,1.0,23/103,29.30%,LARP1;NUP88;NUP37;SIKE1;NUP133;TYK2;POM121;PIK3R4;KPNA2;STAT1;IKBKB;UBE2N;TAB3;TRAF6;IFNAR1;SEC24D;MAP3K7;NOD2;B2M;NUP43;PIK3C3;HSP90AB1;TLR7
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.17057806817940666,-0.5808668235266653,0.9574468085106383,1.0,1.0,18/56,33.10%,F2R;KLKB1;PLAT;C5AR1;ITGAX;C4BPA;ITGB2;CFH;C4A;PROC;SERPINA1;PLG;C1S;THBD;C4BPB;CD59;SERPING1;CR2
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.1508403761622726,-0.5799054014894143,1.0,1.0,1.0,50/177,31.99%,MMP9;MAP3K5;CAMK2A;POU2F1;EIF2S1;CXCL8;HSPA6;PLCB2;IL6;CD14;MAPK10;ABCA1;PIK3R3;TRAF2;AKT2;IKBKB;HSPA4;PIK3CB;PLCB4;AKT3;PIK3R1;CD40LG;AKT1;BAX;SELP;BID;LY96;MAPK8;TRAF6;FOS;MAP2K4;TP53;JAK2;MAP3K7;RAP1A;MAPK14;CASP3;MAPK1;RAC1;CCL5;LYN;HSP90AB1;HRAS;CXCL3;JUN;CCL2;PPP3CC;TNFRSF10B;NCF4;MAPK11
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.17010774031232245,-0.5756751135332626,0.978494623655914,1.0,1.0,5/44,10.99%,PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.19873504199769831,-0.575184819897708,0.9404761904761905,1.0,1.0,2/19,10.27%,MDM4;EP300
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,-0.160442204085266,-0.5738922773700829,0.9893617021276596,1.0,1.0,7/65,10.99%,MDM4;CCNE1;PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.19346017872623916,-0.5703591585280552,0.9767441860465116,1.0,1.0,7/29,29.55%,CD3D;CD3E;WAS;PKN2;TARP;ZAP70;FYB1
prerank,KEGG_2021_Human__Non-small cell lung cancer,-0.15912670609610222,-0.5701829086458662,0.968421052631579,1.0,1.0,13/66,19.80%,KIF5C;RARB;PIK3R3;GADD45G;AKT2;E2F1;DDB2;PIK3CB;AKT3;PIK3R1;STAT5A;AKT1;BAX
prerank,KEGG_2021_Human__Proteasome,-0.16540038298669507,-0.5672752611797498,0.9479166666666666,1.0,1.0,5/44,10.99%,PSMC5;PSMD8;PSMD1;PSMD13;PSMB10
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.18527563892139354,-0.5669973988528137,0.9310344827586207,1.0,1.0,13/36,38.16%,XPC;PARP1;DDB2;DDB1;ACTR5;COPS8;GPS1;COPS2;RPS27A;RBX1;RUVBL1;COPS4;COPS6
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,-0.17964329401474405,-0.564933592095773,0.9540229885057471,1.0,1.0,4/31,12.19%,PRKAR2B;AQP9;GNG5;AQP10
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.18844115674079454,-0.5622881500975568,0.9113924050632911,1.0,1.0,11/19,47.24%,MPDU1;ALG3;ALG1;ALG2;ALG8;ALG14;B4GALT1;GLB1;MAN1B1;CTSA;ALG11
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,-0.193085941561741,-0.5588084962959375,0.9879518072289156,1.0,1.0,7/23,28.94%,PIK3R5;PIK3CB;PIK3R1;STAT5A;JAK2;LYN;HRAS
prerank,Reactome_2022__TCR Signaling R-HSA-202403,-0.15199657177669745,-0.5585193125839524,0.99,1.0,1.0,19/111,21.66%,CD3D;PAG1;PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;PTPRJ;BCL10;IKBKB;PIK3CB;CD3E;WAS;PIK3R1;PKN2;UBE2N;TRAF6;FBXW11
prerank,KEGG_2021_Human__Bladder cancer,-0.17380096224268876,-0.5558570939661633,0.9560439560439561,1.0,1.0,9/37,29.41%,MMP9;CXCL8;DAPK2;E2F1;RPS6KA5;TP53;MAPK1;HRAS;MAP2K1
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,-0.16588232700214248,-0.555539563906119,0.967391304347826,1.0,1.0,6/52,10.99%,PSMC5;PSMD5;PSMD8;DACT1;PSMD13;PSMB10
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.17301159718815645,-0.5540320254962746,0.989010989010989,1.0,1.0,4/31,11.72%,CD22;SYK;CD19;STIM1
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.18834212345438744,-0.5537422883955787,0.9493670886075949,1.0,1.0,1/15,3.21%,BIRC3
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,-0.17817029624425204,-0.5514886076131613,0.967032967032967,1.0,1.0,18/33,44.79%,PRKAR2B;ITGA5;GNG5;GNAI1;GNG3;GNG10;GNG7;GNG4;GNAZ;ADCY7;GNAI3;GNB3;GPER1;GNGT2;SRC;PRKAR2A;SHC1;GNAI2
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,-0.168867529974612,-0.5445326829502509,0.9560439560439561,1.0,1.0,7/35,24.58%,FLOT2;RRAS2;PIK3R1;FRS3;DST;DLG5;TFRC
prerank,KEGG_2021_Human__Taste transduction,-0.17263877511343875,-0.5441369927929711,0.9655172413793104,1.0,1.0,3/33,8.41%,TAS2R50;TAS2R60;PLCB2
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,-0.1562999361203677,-0.5422355671893098,0.9896907216494846,1.0,1.0,6/52,11.58%,PSMC5;PSMD5;PSMD8;PSMD13;PSMB10;TNKS2
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.1825562257879354,-0.536371518742413,0.9294117647058824,1.0,1.0,9/20,40.62%,CCT7;TUBA8;TUBB2A;TUBB4A;TUBB6;TUBB3;TUBB4B;CCT4;CCT8
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.16951217030712157,-0.5355344904602918,0.9775280898876404,1.0,1.0,8/27,28.90%,CTPS2;DTYMK;DUT;GUK1;RRM2B;AK7;AK1;AK9
prerank,KEGG_2021_Human__Viral myocarditis,-0.1550245898079825,-0.5352206488507724,1.0,1.0,1.0,11/52,28.35%,DAG1;EIF4G3;EIF4G2;CD40LG;ITGB2;PRF1;BID;ABL1;CASP3;RAC1;RAC3
prerank,Reactome_2022__G-protein Activation R-HSA-202040,-0.19689878843653758,-0.5350834252370604,0.9545454545454546,1.0,1.0,9/18,40.04%,GNA11;GNG5;GNG3;GNG10;GNG7;GNG4;POMC;GNB3;GNGT2
prerank,KEGG_2021_Human__Glutamatergic synapse,0.11002957465320658,0.5322896810212874,1.0,1.0,1.0,15/65,17.64%,PRKACB;GNB5;GNB2;PLCB1;GNAO1;ADCY9;PPP3CA;PLCB3;PLA2G4C;GRIK2;JMJD7-PLA2G4B;MAPK3;ITPR2;GNG8;GNB1
prerank,KEGG_2021_Human__Ras signaling pathway,-0.13924219189055703,-0.5302302253428267,1.0,1.0,1.0,41/159,29.76%,PLA2G2C;RIN1;ELK1;PGF;RALBP1;RASGRP4;MRAS;GNG5;RGL1;ETS1;MAPK10;RRAS;IGF1R;PIK3R3;AKT2;RRAS2;IKBKB;FGFR1;PIK3CB;AKT3;PIK3R1;RAPGEF5;AKT1;MAPK8;ABL1;KSR1;GNG3;PAK1;GNG10;NTRK1;RAP1A;PDGFC;MAPK1;ZAP70;GNG7;RAC1;RAC3;RASA4B;HRAS;MAP2K1;GNG4
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.16719320777422578,-0.528012453313226,0.9764705882352941,1.0,1.0,10/25,42.07%,BIRC3;TRAF1;IKBKB;TAB3;MAP3K7;CHUK;TRADD;RBCK1;XIAP;BIRC2
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.14733117977111557,-0.5267036720373132,1.0,1.0,1.0,13/84,17.36%,CCNE1;PSMC5;MNAT1;SKP1;PSMD5;PSMD8;LIN9;PSMD13;PSMB10;CDC25B;AKT2;E2F1;AKT3
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.14687214900892137,-0.5194106335643123,0.9894736842105263,1.0,1.0,6/60,10.99%,ELOC;PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.14077363927742598,0.5191976729110034,0.9473684210526315,1.0,1.0,3/15,12.16%,KIT;FYN;LCK
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.1683526348980251,-0.516133903219938,0.9777777777777777,1.0,1.0,7/27,29.84%,APOE;HBA1;MARCO;JCHAIN;FTH1;HYOU1;CALR
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.17680331313540304,-0.5110495325717606,0.9666666666666667,1.0,1.0,14/27,45.06%,SYK;APBB1IP;MPL;AKT1;GP1BA;RAP1A;CRK;TLN1;RASGRP2;RASGRP1;SRC;ITGB3;SHC1;PTK2
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.18682535721972737,-0.5109299819789097,0.961038961038961,1.0,1.0,10/19,43.23%,BIRC3;IKBKB;UBE2N;TRAF6;RPS27A;CHUK;RIPK3;UBE2D2;BIRC2;UBA52
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,-0.14053676178868757,-0.51081084089439,1.0,1.0,1.0,15/90,21.66%,CD3D;PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;BCL10;IKBKB;PIK3CB;CD3E;PIK3R1;UBE2N;TRAF6;FBXW11
prerank,KEGG_2021_Human__Leishmaniasis,0.09337196698305779,0.5100596842305519,1.0,1.0,1.0,15/71,17.68%,NCF2;TLR2;EEF1A1;CYBB;IL10;FCGR2C;MYD88;MAPK12;MAPK3;TAB1;MARCKSL1;IL4;HLA-DPA1;NCF1;C3
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,-0.17696347796470552,-0.5097179085044922,0.9642857142857143,1.0,1.0,13/20,53.65%,ETHE1;MTAP;ADI1;BHMT2;TSTD1;MRI1;SUOX;ADO;GOT2;APIP;VSIG2;MTR;MPST
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,-0.1389805982193112,-0.5056130413254423,0.9895833333333334,1.0,1.0,18/76,28.84%,PSMC5;RASGRP4;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;BCL10;IKBKB;UBE2N;TAB3;TRAF6;FBXW11;MAP3K7;PSME1;LYN;RPS27A;PSMA4
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.14012564371501238,-0.5001963163866159,1.0,1.0,1.0,9/82,10.99%,CCNE1;PSMC5;MNAT1;SKP1;PSMD5;PSMD8;LIN9;PSMD13;PSMB10
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,-0.1761477362375915,-0.49988206360152937,0.974025974025974,1.0,1.0,5/20,26.97%,AVEN;BAX;CARD8;CASP3;MAPK1
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.1446579171164029,-0.49571922179491285,0.9894736842105263,1.0,1.0,5/47,10.99%,PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,-0.18189359916657116,-0.4951218654884158,0.9873417721518988,1.0,1.0,3/19,15.03%,USP8;PTPRJ;LRIG1
prerank,KEGG_2021_Human__Human cytomegalovirus infection,-0.12686955642872833,-0.4889991529090434,1.0,1.0,1.0,57/186,35.05%,PDIA3;CREB1;GNA11;CCR5;ELK1;CXCL8;PLCB2;IL6;GNG5;CXCR4;PIK3R3;TRAF2;AKT2;E2F1;IKBKB;PIK3CB;PLCB4;AKT3;PIK3R1;GNAI1;AKT1;ADCY3;BAX;BID;FADD;GNA13;PXN;GNG3;TSC1;GNG10;TP53;CCR1;B2M;MAPK14;CASP3;MAPK1;TRAF5;CRK;GNG7;RAC1;CCL5;RAC3;HRAS;MAP2K1;GNG4;CALR;CCL2;PPP3CC;MAPK11;ADCY7;PRKCB;CHUK;RAC2;MAPK13;GNAI3;TRADD;PDGFRA
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,-0.15425441487616282,-0.4876820099315735,1.0,1.0,1.0,13/36,36.54%,VCP;TNIP2;TRAF6;OTUD5;PROC;CDK1;TP53;YOD1;NOD2;RPS27A;PTEN;RHOA;TRIM25
prerank,KEGG_2021_Human__Serotonergic synapse,-0.14147122088082198,-0.48393605110012106,1.0,1.0,1.0,16/64,29.76%,TPH1;PLCB2;GNG5;PLCB4;TPH2;ALOX12;GNAI1;GNG3;DUSP1;GNG10;CASP3;MAPK1;GNG7;HRAS;MAP2K1;GNG4
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,-0.14225670457269723,-0.4824191671240853,0.9885057471264368,1.0,1.0,13/35,38.60%,PGLYRP1;CTSG;EPPIN;CHAMP1;LTF;GNLY;RO60;S100A8;SLC11A1;DEFA4;TLR1;DEFB105A;PRTN3
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.1412668851640614,-0.4806913254270165,1.0,1.0,1.0,5/49,10.99%,PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.1727342645321842,-0.48010343292961466,0.9651162790697675,1.0,1.0,7/17,35.81%,CCNE1;E2F1;CCND2;CDKN1B;TFDP2;CDK2;CCND3
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.13876415552786356,-0.47572815892813275,0.989247311827957,1.0,1.0,5/49,10.99%,PSMC5;PSMD5;PSMD8;PSMD13;PSMB10
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.16083057337878814,-0.47489914576786124,0.9885057471264368,1.0,1.0,2/23,8.73%,PRKAR2B;GNG5
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.13775642998311446,-0.47158850402664015,0.9893617021276596,1.0,1.0,14/42,36.73%,BCL2L14;STEAP3;BBC3;TNFRSF10D;PRELID3A;BAX;BID;IGFBP3;TP53;TRIAP1;TNFRSF10B;PERP;CASP6;TP53BP2
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.13606656838382075,-0.47086780862575045,0.9895833333333334,1.0,1.0,6/57,10.99%,PSMC5;PSMD5;PSMD8;PLK1;PSMD13;PSMB10
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,-0.1389827869515933,-0.4705203557340839,0.9893617021276596,1.0,1.0,11/43,30.84%,PAG1;PTPRK;SPRY2;SPRY1;LRIG1;PIK3R1;ADAM10;PTPN12;RPS27A;HRAS;HGS
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.17312905270234752,-0.4669480006643489,0.9875,1.0,1.0,14/15,71.59%,F2R;PROC;THBD;PRTN3;PROS1;TTF2;PROCR;PF4V1;F13A1;SERPINE2;F8;F5;PF4;CD177
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,-0.14957128529379218,-0.46450680095066116,1.0,1.0,1.0,13/30,40.30%,SIAH1;TRIO;SIAH2;RNASE1;MAPK8;TRPC6;MAPK14;MAPK11;MYO10;MAPK13;ABLIM2;NEO1;SRC
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,-0.1645762496070674,-0.46356250466651816,0.9866666666666667,1.0,1.0,5/20,27.44%,PPIL2;SLC7A8;L1CAM;SLC16A3;ATP1B2
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,-0.1525936146420636,-0.4607833781488414,0.9767441860465116,1.0,1.0,2/23,8.99%,NCBP2;POLR2I
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.13990076467098386,-0.45773397139800504,1.0,1.0,1.0,7/46,17.88%,POLR3B;ZBP1;IL6;POLR3D;POLR3C;IKBKB;AIM2
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,-0.16848047443848033,-0.4575930904239382,0.9879518072289156,1.0,1.0,2/15,12.98%,SOCS6;PTPRJ
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.1264648396511294,-0.45694295846445776,1.0,0.9993028771247368,1.0,29/69,42.53%,GFPT1;MVD;MPDU1;GMDS;ALG5;ALG3;ST6GALNAC4;NAGK;ALG1;FCSK;ST8SIA6;PGM3;ST6GALNAC3;ALG2;CMAS;ST3GAL4;ST3GAL5;GMPPA;ST3GAL6;ALG8;ALG14;ST3GAL1;SLPI;DPM3;ST6GALNAC6;SLC35A1;GLB1;PMM1;ST6GAL1
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,-0.13999866927059576,-0.45514830617531193,0.9887640449438202,0.9986664054039462,1.0,3/34,11.16%,ANG;JUP;CTNNA1
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,-0.14694030120592994,-0.44776439064735407,1.0,0.998829248978455,1.0,6/27,29.25%,NCBP2;POLR2I;PIK3R1;POLR2D;HRAS;POLR2B
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,-0.15298036326853612,-0.4420654903776853,1.0,0.9984655772456332,1.0,9/26,35.05%,STAT1;PIK3CB;PIK3R1;STAT5A;CRK;HRAS;NCK2;STAT5B;PDGFRA
prerank,KEGG_2021_Human__Ovarian steroidogenesis,-0.1501893388619905,-0.44065957050201837,1.0,0.99776566683195,1.0,8/25,33.73%,BMP6;IGF1R;ADCY3;ACOT2;STAR;CYP1B1;INSR;ADCY7
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.12287552790969836,-0.4393313452264382,1.0,0.9970258765971963,1.0,7/64,13.29%,PSMC5;SKP1;PSMD5;PSMD8;PSMD13;PSMB10;BCL10
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.1229132758208647,-0.42883248830457305,1.0,0.997058309518419,1.0,23/55,42.53%,GFPT1;MVD;GMDS;ALG5;ST6GALNAC4;NAGK;FCSK;ST8SIA6;PGM3;ST6GALNAC3;CMAS;ST3GAL4;ST3GAL5;GMPPA;ST3GAL6;ST3GAL1;SLPI;DPM3;ST6GALNAC6;SLC35A1;GLB1;PMM1;ST6GAL1
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,-0.15637471169481043,-0.42848741220386516,0.9770114942528736,0.9962465784858469,1.0,6/20,29.76%,GNG5;SCT;GNG3;GNG10;GNG7;GNG4
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,0.12783022440874786,0.4043115359570663,1.0,0.9992778479870013,1.0,4/15,15.41%,UBC;MYLIP;VLDLR;UBB
